sourceCode,sourceName,sourceFrequency,sourceAutoAssignedConceptIds,matchScore,mappingStatus,equivalence,statusSetBy,statusSetOn,conceptId,conceptName,domainId,mappingType,comment,createdBy,createdOn,assignedReviewer,ADD_INFO:sourceConceptId,ADD_INFO:sourceConceptClass,ADD_INFO:sourceDomain,ADD_INFO:sourceValidStartDate,ADD_INFO:sourceValidEndDate,ADD_INFO:sourceParents,ADD_INFO:sourceParentVocabulary,ADD_INFO:sourceName_fi,ADD_INFO:validationMessages,ADD_INFO:autoUpdatingInfo
1001,"Pt-Adrenocorticotropin Test, Card",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600101,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Adrenokortikotropiini-koe, lyhyt",,
1002,"Pt-Adrenocorticotropin Test, Long",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600102,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Adrenokortikotropiini-koe, pitkä",,
1003,"Pt-Adrenocorticotropin test, 21-hydroxylase deficiency",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600103,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Adrenokortikotropiini-koe, 21-hydroksylaasi entsyymipuute",,
1004,S -Adrenocorticotropin-releasing hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600104,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Adrenokortikotropiini-vapauttajahormoni,,
1005,Ts -Adrenocorticotropin-Releasing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600105,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Adrenokortikotropiini-vapauttajahormoni,,
1006,"Actinomyces, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600106,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Actinomyces, natiivivalmiste",,
1007,"Actinomyces, cultivation",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3028371,Actinomyces sp identified in Specimen by Organism specific culture,Measurement,MAPS_TO,,tays,1630368000000,,2000600107,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Actinomyces, viljely",,
1008,"Actinomyces, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600108,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Actinomyces, värjäys",,
1009,E-Adenosine triphosphate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600109,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Adenosiinitrifosfaatti,,
1010,E-Adenosine triphosphatase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600110,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Adenosiinitrifosfataasi,,
1011,"F -Adenovirus, antigen",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020393,Adenovirus Ag [Presence] in Stool,Measurement,MAPS_TO,,tays,1630368000000,,2000600111,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Adenovirus, antigeeni",,
1013,E -Adenylate kinase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600112,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Adenylaattikinaasi,,
1014,Li-Adenylate Kinase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600113,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Adenylaattikinaasi,,
1015,S-Adenylate kinase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600114,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Adenylaattikinaasi,,
1016,dU-Adrenaline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600115,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Adrenaliini,,
1017,P -Adrenaline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600116,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Adrenaliini,,
1019,dU-Adrenaline + noradrenaline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600117,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Adrenaliini + noradrenaliini,,
1020,P -Adrenocorticotropin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3035963,Corticotropin [Moles/volume] in Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600118,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Adrenokortikotropiini ,,
1021,"S -Adrenocorticotropin, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600119,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Adrenokortikotropiini, vasta-aineet",,
1022,Af-Alanine Aminotransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600120,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Alaniiniaminotransferaasi,,
1023,Li-Alanine Aminotransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600121,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Alaniiniaminotransferaasi,,
1024,P -Alaninaminotransferase,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3006923,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600122,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Alaniiniaminotransferaasi,,
1025,Pf-Alanine Aminotransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600123,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Alaniiniaminotransferaasi,,
1026,S -Alaninaminotransferase,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006923,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600124,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alaniiniaminotransferaasi,,
1027,Li-Albumin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3024474,Albumin [Mass/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600125,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Albumiini,,
1028,S -Albumin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024561,Albumin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600126,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Albumiini,,
1029,U -Albumin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3012516,Albumin [Mass/volume] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600127,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Albumiini,,
1030,U -Albumin (kval),-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3025987,Albumin [Presence] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600128,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Albumiini (kval),,
1031,E-Aldolas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600129,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Aldolaasi,,
1032,S -Aldolas,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027953,Aldolase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600130,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Aldolaasi,,
1033,dU-Aldosterone,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000690,Aldosterone [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600131,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Aldosteroni,,
1034,S -Aldosterone,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001788,Aldosterone [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600132,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Aldosteroni,,
1035,"Pt-Study of Aldosteronism, Basic Study",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600133,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Aldosteronismin tutkiminen, perustutkimus",,
1036,"S -Aldosterone, supine position",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004280,Aldosterone [Moles/volume] in Serum or Plasma --supine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600134,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Aldosteroni, makuu",,
1037,"S -Aldosterone, standing position",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003171,Aldosterone [Moles/volume] in Serum or Plasma --upright,Measurement,MAPS_TO,,HUS,1596153600000,,2000600135,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Aldosteroni, pysty",,
1038,S-Alpha-1-antitrypsin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3026285,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600136,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alfa-1-antitrypsiini,,
1039,Am-Alpha-1-fetoprotein,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3010296,Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000600137,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Alfa-1-fetoproteiini,,
1040,S-Alpha-1-fetoprotein,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3015916,Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600138,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alfa-1-fetoproteiini,,
1041,"S-Alpha-1-glycoprotein, acidic",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008877,Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600139,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Alfa-1-glykoproteiini, hapan",,
1042,S-Alpha-2-macroglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009827,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600140,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alfa-2-makroglobuliini,,
1043,S -Alpha-endorphin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600141,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alfa-endorfiini,,
1044,fS-Alpha lipoprotein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600142,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Alfa-lipoproteiini,,
1045,Li-Alkaline Phosphatase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600143,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Alkalinen fosfataasi,,
1046,S -Alkaline phosphatase,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3035995,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600144,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alkalinen fosfataasi,,
1047,"S -Alkaline phosphatase, inhibited",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600145,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Alkalinen fosfataasi, inhiboitu",,
1048,"S -Alkaline phosphatase, isoenzymes",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021952,Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability,Measurement,MAPS_TO,,HUS,1596153600000,,2000600146,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Alkalinen fosfataasi, isoentsyymit",,
1049,"S -Alkaline phosphatase, heat stable",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600147,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Alkalinen fosfataasi, lämpöstabiili",,
1050,"Bm-Alkaline phosphatase, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600148,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Alkalinen fosfataasi, värjäys",,
1051,"L-Alkaline phosphatase, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600149,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"L -Alkalinen fosfataasi, värjäys",,
1053,"S -Amöba, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600150,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ameeba, vasta-aineet",,
1054,"F -Amöba, native preparations",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600151,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"F -Ameeba, natiivivalmiste",,
1055,U -Amphetamine (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027944,Amphetamines [Presence] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600152,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Amfetamiini (kval),,
1056,Of-Amino Acids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600153,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Aminohapot,,
1057,Am-Amino Acids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600154,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Aminohapot,,
1058,dU-Amino Acids,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012864,Amino acids [Identifier] in 24 hour Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600155,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Aminohapot,,
1059,Li-Amino Acids,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3032940,Amino acids [Identifier] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600156,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Aminohapot,,
1060,F -Amino Acids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600157,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Aminohapot,,
1061,P -Amino Acids,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3013336,Amino acids [Identifier] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600158,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Aminohapot,,
1062,U-Amino Acids,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3032641,Amino acids panel - Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600159,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Aminohapot,,
1063,U -Amino Acids (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600160,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Aminohapot (kval),,
1068,S-Amitriptyline,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3019920,Amitriptyline [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600161,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Amitriptyliini,,
1069,Pt-Ammonium Chloride Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600162,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Ammoniumkloridi-koe,,
1070,fB-Ammoniumjon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600163,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fB-Ammonium-ioni,,
1071,fP-Ammonium ion,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023183,Ammonium ion [Moles/volume] in Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600164,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Ammonium-ioni,,
1072,U-Ammonium ion,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600165,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Ammonium-ioni,,
1073,Af-Amylas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600166,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Amylaasi,,
1074,As-Amylas,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3008691,Amylase [Enzymatic activity/volume] in Peritoneal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600167,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Amylaasi,,
1075,dU-Amylase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600168,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Amylaasi,,
1076,F -Amylase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600169,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Amylaasi,,
1077,Pa-Amylas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600170,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pa-Amylaasi,,
1078,S -Amylas,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016771,Amylase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600171,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Amylaasi,,
1079,Se-Amylas,-1,,0,APPROVED,UNREVIEWED,TAYS,1596153600000,3016771,Amylase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS,1596153600000,,2000600172,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Se-Amylaasi,,
1080,U -Amylas,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3017315,Amylase [Enzymatic activity/volume] in Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600173,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Amylaasi,,
1081,Pt-Amylasclearance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600174,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Amylaasin poistuma,,
1082,"Pt-Amylase test, 2 h",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600175,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Amylaasi-koe,2 h",,
1083,"S-Amylase, isoenzyme",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009876,Amylase isoenzyme 3 panel - Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600176,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Amylaasi, isoentsyymit",,
1084,"U-Amylase, isoenzyme",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600177,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Amylaasi, isoentsyymit",,
1085,S -Androstendion,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3022411,Androstenedione [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600178,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Androstendioni,,
1086,dU -Androsteron,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600179,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Androsteroni,,
1087,S -Androsterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600180,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Androsteroni,,
1088,"S -Angiotensin I, lying position",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600181,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Angiotensiini I, makuu",,
1089,"S -Angiotensin I, standing position",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600182,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Angiotensiini I, pysty",,
1090,"S -Angiotensin II, lying position",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600183,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Angiotensiini II, makuu",,
1091,"S -Angiotensin II, standing position",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600184,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Angiotensiini II, pysty",,
1092,fS-Angiotensin-1-convert,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3034780,Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600185,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Angiotensiini-1-konvertaasi,,
1093,"Bacteria, aerobic MIC determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600186,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Bakteeri, aerobinen MIC-määritys",,
1094,P -Antidiuretic hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600187,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Antidiureettinen hormoni,,
1095,"S -Antidiuretic hormone, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600188,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Antidiureettinen hormoni, vasta-aineet",,
1097,P -Coagulation factor VIII,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019250,Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000600189,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hyytymistekijä VIII,,
1098,"P -Coagulation factor VIII, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40761593,Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000600190,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Hyytymistekijä VIII, vasta-aineet",,
1100,S-Antistaphylolysin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3035947,Staphylolysin Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600191,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Antistafylolysiini,,
1101,S -Antistreptolysin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021236,Streptolysin O Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600192,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Antistreptolysiini,,
1102,"S -Antistreptolysin, absorbed",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600193,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Antistreptolysiini, absorboitu",,
1103,P-Antithrombin III,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000515,Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,Measurement,MAPS_TO,,HUS,1596153600000,,2000600194,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Antitrombiini III,,
1104,U -Antranilate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600195,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Antranilaatti,,
1105,P -Arginine vasopressin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600196,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Arginiini vasopressiini,,
1106,Pt-Arginine Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600197,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Arginiini-koe,,
1107,U -Aromatic hydrocarbons,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600198,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Aromaattiset hiilivedyt,,
1108,Ha-Arsen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600199,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ha-Arseeni,,
1109,U -Arsen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600200,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Arseeni,,
1110,dU-Arylsulfatas A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600201,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Aryylisulfataasi A,,
1111,L -Arylsulfatase A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600202,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,L -Aryylisulfataasi A,,
1112,dU-Arylsulfatas B,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600203,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Aryylisulfataasi B,,
1113,Vitamin fS-A,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3013005,Retinol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600204,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-A-vitamiini,,
1114,Vitamin fP-A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600205,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-A-vitamiini,,
1115,Pt-A Vitamin Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600206,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-A-vitamiini-koe,,
1116,S -Acetoacetate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600207,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Asetoasetaatti,,
1117,S -Acetoacetate (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600208,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Asetoasetaatti (kval),,
1118,U-Acetoacetate (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600209,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Asetoasetaatti (kval),,
1119,S -Acetone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600210,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Asetoni,,
1120,U -Acetone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600211,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Asetoni,,
1121,S -Ketones (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600212,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Asetoniaineet (kval),,
1122,U -Ketones (Qual),-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3028893,Ketones [Presence] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600213,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Asetoniaineet (kval),,
1123,E -Acetylcholinesterase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600214,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Asetyylikoliiniesteraasi,,
1124,Af-aspartate aminotransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600215,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Aspartaattiaminotransferaasi,,
1125,E -Aspartataminotransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600216,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Aspartaattiaminotransferaasi,,
1126,Li-aspartate aminotransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600217,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Aspartaattiaminotransferaasi,,
1127,Pf-Aspartate Aminotransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600218,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Aspartaattiaminotransferaasi,,
1128,S -Aspartataminotransferase,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013721,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600219,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Aspartaattiaminotransferaasi,,
1129,"S-Aspartate aminotransferase, isoenzymes",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600220,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Aspartaattiaminotransferaasi,isoentsyymit",,
1130,"S -Aspergillus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600221,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Aspergillus, vasta-aineet",,
1131,Ex-Charcot-Leyden crystals,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600222,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ex-Astmakiteet,,
1133,S -Avlosulfone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600223,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Avlosulfoni,,
1134,Vitamin B-B12,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600224,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -B12-vitamiini,,
1135,Vitamin E -B12,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600225,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -B12-vitamiini,,
1136,Vitamin Li-B12,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600226,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-B12-vitamiini,,
1137,Vitamin S -B12,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3009035,Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600227,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -B12-vitamiini,,
1138,Vitamin U-B12,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40757509,Cobalamin (Vitamin B12) [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600228,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -B12-vitamiini,,
1142,"Vitamin S-B12, bound to transcobalamin II",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43054903,Holo-transcobalamin II [Moles/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600229,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -B12-vitamiini, transkobalamiini II:een sitoutunut",,
1143,"Li-Bacteria, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600230,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Bakteeri, antigeeni",,
1144,"S -Bacteria, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600231,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Bakteeri, antigeeni",,
1145,"U -bacteria, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600232,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Bakteeri, antigeeni",,
1146,"Bacteria, phage typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600233,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, faagityypitys",,
1147,"Bacteria, antibiotic susceptibility determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600234,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Bakteeri, antibioottiherkkyysmääritys",,
1149,"Bacteria, aerobic species determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600235,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, aerobinen lajimääritys",,
1150,"Li-Bacteria, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600236,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Li-Bakteeri, natiivivalmiste",,
1151,"U -Bacteria, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600237,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"U -Bakteeri, natiivivalmiste",,
1152,Bacterial Typing,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600238,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, tyypitys",,
1153,B -Bacterial culture,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3023368,Bacteria identified in Blood by Culture,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600239,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Bakteeri, viljely",,
1154,Li -Bacterial culture,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3016914,Bacteria identified in Cerebral spinal fluid by Culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600240,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Bakteeri, viljely",,
1155,U- Bacterial culture,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3026008,Bacteria identified in Urine by Culture,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600241,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Bakteeri, viljely",,
1156,Bacterial culture,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002619,Bacteria identified in Specimen by Culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000600242,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, viljely",,
1157,Li-Bacterial Dyeing,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3033386,Bacteria [Presence] in Cerebral spinal fluid by Light microscopy,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600243,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Bakteeri, värjäys",,
1158,U -Bacterial staining,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600244,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Bakteeri, värjäys",,
1159,Bacterial staining,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3027247,Bacteria identified in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600245,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, värjäys",,
1159,Bacterial staining,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3037167,Microscopic observation [Identifier] in Specimen by Gram stain,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600245,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, värjäys",,
1161,S -Barbiturates,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600246,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Barbituraatit,,
1162,U -Barbiturates,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600247,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Barbituraatit,,
1163,"S -Barbiturates, Fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600248,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Barbituraatit, fraktiot",,
1164,"U -Barbiturates, Fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600249,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Barbituraatit, fraktiot",,
1165,S -Barbiturates (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600250,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Barbituraatit (kval),,
1166,U -Barbiturates (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600251,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Barbituraatit (kval),,
1168,L-Basophilic leukocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022096,Basophils/100 leukocytes in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600252,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,L -Basofiiliset leukosyytit,,
1169,S-Beta-1-glycoprotein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600253,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Beeta-1-glykoproteiini,,
1170,Li-Beta-2-microglobulin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009385,Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600254,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Beeta-2-mikroglobuliini,,
1171,S-Beta-2-microglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013201,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600255,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Beeta-2-mikroglobuliini,,
1172,U-Beta-2-microglobulin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3018081,Beta-2-Microglobulin [Mass/volume] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600256,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Beeta-2-mikroglobuliini,,
1173,S -Betaendorphine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600257,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Beeta-endorfiini,,
1174,fS-Betahydroxybutyrate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3003985,Beta hydroxybutyrate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600258,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Beeta-hydroksibutyraatti,,
1175,fS-Betalipoprotein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600259,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Beeta-lipoproteiini,,
1176,S-Betalipotropin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600260,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Beeta-lipotropiini,,
1177,S-Benzodiazepines,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600261,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Bentsodiatsepiinit,,
1178,U-Benzodiazepines (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000764,Benzodiazepines [Presence] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600262,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Bentsodiatsepiinit (kval),,
1179,Dj-Bicarbonate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600263,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Dj-Bikarbonaatti,,
1180,Gj-Bicarbonate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600264,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Bikarbonaatti,,
1181,Pa-Bicarbonate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600265,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pa-Bikarbonaatti,,
1182,Af-Bilirubin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600266,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Bilirubiini,,
1183,Am-Bilirubin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600267,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Bilirubiini,,
1184,Li-Bilirubin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600268,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Bilirubiini,,
1185,S -Bilirubin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006140,Bilirubin.total [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600269,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Bilirubiini,,
1186,F -Bilirubin (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600270,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Bilirubiini (kval),,
1187,U -Bilirubin (kval),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3018834,Bilirubin.total [Presence] in Urine by Test strip,Measurement,MAPS_TO,,HUS,1596153600000,,2000600271,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Bilirubiini (kval),,
1188,Am-Conjugated bilirubin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600272,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Bilirubiinikonjugaatit,,
1189,S -Conjugated bilirubin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019676,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600273,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Bilirubiinikonjugaatit,,
1190,Li-Blast Cells,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032352,Blasts [#/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000600274,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Blastisolut,,
1191,Pt-Bodyspletysmography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600275,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Bodyplethysmografia,,
1195,Pt-Body Plethysmography and Bronchodilation Examination,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600276,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Bodyplethysmografia ja bronkodilataatiotutkimus,,
1196,"Pt-Body plethysmography, provocation examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600277,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Bodyplethysmografia, provokaatiotutkimus",,
1199,P -Bradykinin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600278,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Bradykiniini,,
1200,S -Bromid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600279,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Bromidi,,
1201,U-Bromide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600280,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Bromidi,,
1202,U -Bromide (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600281,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Bromidi (kval),,
1203,"Pt-Bromsulftaleintest, retention",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600282,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Bromsulftaleiinikoe, retentio",,
1204,"Pt-Bromsulftaleintest, half-life",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600283,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Bromsulftaleiinikoe, puoliintumisaika",,
1205,"S -Brucella, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600284,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Brucella, vasta-aineet",,
1208,S-Immune complexes bound to C1q,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600285,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -C1q-sitoutuneet immunokompleksit,,
1209,S -C1-Esterase Inhibitor,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3003245,Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600286,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -C1-Esteraasin inhibiittori,,
1210,S -Factor B,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600287,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Faktori B,,
1211,P -Coagulation factor IX,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006109,Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000600288,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hyytymistekijä IX,,
1212,"S -Coccidioides, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600289,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Coccidioides, vasta-aineet",,
1213,"E -Coombs, direct (polyspecific antiserum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022907,Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells,Measurement,MAPS_TO,,HUS,1596153600000,,2000600290,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Coombs, suora (polyspesifinen antiseerumi)",,
1214,"E -Coombs, direct (monospecific antiserum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600291,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Coombs, suora (monospesifinen antiseerumi)",,
1216,S -C-reactive protein,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020460,C reactive protein [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600292,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -C-reaktiivinen proteiini,,
1217,S -C-reactive protein (qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000965,C reactive protein [Presence] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600293,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -C-reaktiivinen proteiini (kval),,
1218,Vitamin FP-C,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600294,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-C-vitamiini,,
1219,Vitamin D-C,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600295,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-C-vitamiini,,
1220,Vitamin S-D-25-OH,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40771025,25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600296,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -D-vitamiini-25-OH,,
1221,dU-Dehydroepiandrosterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600297,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Dehydroepiandrosteroni,,
1222,S -Dehydroepiandrosterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600298,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Dehydroepiandrosteroni,,
1225,"Pt-Dexamethasone Test, Card",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3048821,Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight,Measurement,MAPS_TO,,HUS,1596153600000,,2000600299,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Deksametasoni-koe, lyhyt",,
1226,"Pt-Dexamethasone Test, Long",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013517,Cortisol [Moles/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h,Measurement,MAPS_TO,,HUS,1596153600000,,2000600300,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Deksametasoni-koe, pitkä",,
1226,"Pt-Dexamethasone Test, Long",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3052367,Cortisol [Moles/volume] in Serum or Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h,Measurement,MAPS_TO,,HUS,1596153600000,,2000600300,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Deksametasoni-koe, pitkä",,
1228,dU-Delta-aminolevulinate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3004149,Delta aminolevulinate [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600301,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Delta-aminolevulinaatti,,
1229,E-Delta-Aminolevulinate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600302,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Delta-aminolevulinaatti,,
1230,U-Delta-Aminolevulinate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600303,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Delta-aminolevulinaatti,,
1231,E-Delta-aminolevulinate synthase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600304,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Delta-aminolevulinaattisyntaasi,,
1232,E-Delta-aminolevulinate dehydratase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600305,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Delta-aminolevulinaattidehydrataasi,,
1233,fS-Deoxycholate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600306,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Deoksikolaatti,,
1234,S -Deoxycorticosterone (11-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600307,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Deoksikortikosteroni (11-),,
1235,S -Deoxycortisol (11-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600308,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Deoksikortisoli (11-),,
1236,S -Deoxycortisol (21-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600309,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Deoksikortisoli (21-),,
1237,Pt-Deferoxamine mesylate test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600310,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Deferoksamiinimesylaatti-koe,,
1238,E -Diaforas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600311,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Diaforaasi,,
1239,S -Diamine Oxidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600312,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Diamiinioksidaasi,,
1240,S -Diazepam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600313,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Diatsepaami,,
1241,U-Diphenhydramine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600314,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Difenhydramiini,,
1242,Li-Phenytoin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600315,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Fenytoiini,,
1243,S -Phenytoin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019779,Phenytoin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600316,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fenytoiini,,
1244,Sa-Fenytoin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600317,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Fenytoiini,,
1245,U-Phenytoin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600318,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Fenytoiini,,
1246,"Pt Diffusion Capacity, single-breath method, basic measurement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600319,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Diffuusiokapasiteetti, single-breath-menetelmä, tavallinen perusmittaus",,
1247,Pt-Measurement of the components of diffusion capacity,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600320,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Diffuusiokapasiteetin osakomponenttien mittaaminen,,
1248,"Pt Diffusion Capacity, Steady-State Method",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600321,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Diffuusiokapasiteetti, steady-state-menetelmä",,
1250,"Pt Diffusion Capacity, rebreathing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600322,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Diffuusiokapasiteetti, rebreathing",,
1251,"E -Diphosphoglycerate (2,3-)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600323,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Difosfoglyseraatti (2,3-)",,
1252,E-Diphosphoglycerate mutation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600324,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Difosfoglyseraattimutaasi,,
1253,"S -Corynebacterium diphtheriae, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3047161,Corynebacterium diphtheriae Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000600325,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Corynebacterium diphtheriae, vasta-aineet",,
1254,"Corynebacterium diphtheriae, cultivation",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3006392,Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture,Measurement,MAPS_TO,,tays,1630368000000,,2000600326,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Corynebacterium diphtheriae, viljely",,
1255,S-Digitoxin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600327,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Digitoksiini,,
1256,S-Digoxin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027456,Digoxin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600328,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Digoksiini,,
1257,S-Dihydrotestosterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600329,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Dihydrotestosteroni,,
1258,S -Disopyramide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600330,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Disopyramidi,,
1259,"S DNA, denatured, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600331,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -DNA, denaturoitu, vasta-aineet",,
1261,"S DNA, native, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007916,DNA double strand Ab [Titer] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600332,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -DNA, natiivi, vasta-aineet",,
1263,U-Doxepin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600333,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Doksepiini,,
1264,dU-Dopamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600334,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Dopamiini,,
1265,S -Dopamine-beta-hydroxylase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600335,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Dopamiini-beeta-hydroksylaasi,,
1267,"S -Epsilon-Aminocaproic Acid, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600336,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epsilon-aminokapronihappo, vasta-aineet",,
1270,"Pt-ECG, 12 couplings at rest",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3044889,12 lead EKG panel,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600337,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, 12 kytkentää levossa",,
1271,"Pt-ECG, 15 connections",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3004451,EKG impression Narrative,Measurement,MAPS_TO,,tays,1630368000000,,2000600338,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, 15 kytkentää",,
1272,"Pt-ECG, including computer analysis",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3013512,EKG study,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600339,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, sisältäen tietokoneanalyysin",,
1274,"Pt-ECG, intracardiac examination of the conduction system",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600340,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, intrakardiaalinen johtumisratojen tutkimus",,
1276,"Pt-ECG, other special connections",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600341,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, muu erikoiskytkentä",,
1277,"Pt ECG, esophageal recording",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600342,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, esophagus-rekisteröinti",,
1279,Pt-ECG long-term training 24 h,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4098508,24 Hour ECG,Procedure,MAPS_TO,,TYKS,1631577600000,,2000600343,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,EKG:n pitkäaikaisrekisteröinti 24 h,,
1282,"Pt-ECG, fetus",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600344,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, sikiö",,
1283,"Pt ECG, intracardiac",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600345,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, sydämen sisäinen",,
1284,"Pt-ECG, telemetry",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600346,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, telemetria",,
1285,"S -Echinococcus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600347,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Echinococcus, vasta-aineet",,
1286,Echinococcus (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600348,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Echinococcus (kval),,
1287,"Pt-Electroencephalography (EEC), vigilant",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600349,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), valveilla",,
1288,Pt-Electroencephalography (EEG) with special electrodes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600350,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Elektroenkefalografia (EEG) erikoiselektrodeilla,,
1295,"Pt-Electroencephalography (EEC) long-term registration, first day",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600351,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) pitkäaikaisrekisteröinti, ensimmäinen vuorokausi",,
1298,"Pt-Electroencephalography (EEC), sleep deprivation or natural sleep",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600352,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), unideprivaatio tai luonnollinen uni",,
1299,Pt Multiple Sleep Latency Test (MSLT),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600353,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Nukahtamisviivetutkimus (MSLT),,
1301,"Pt-Electroneuromyography (ENMG), examination of 1-4 muscle or nerve segments",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600354,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt -Elektroneuromyografia (ENMG), 1-4 lihaksen tai hermosegmentin tutkimus",,
1302,"Pt-Electroneuromyography (ENMG), examination of an extremity or a problem",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600355,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt -Elektroneuromyografia (ENMG), yhden raajan tai ongelman tutkimus",,
1303,"Pt-Electroneuromyography (ENMG), special technology",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600356,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt -Elektroneuromyografia (ENMG), erikoistekniikka",,
1306,"Pt-Electroneurography (ENG), Examination of a Problem",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600357,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroneurografia (ENG), yhden ongelman tutkimus",,
1310,Pt-Electroneuromyography (ENMG) Repeated Stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600358,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Elektroneuromyografia (ENMG) toistostimulaatio,,
1312,Pt-Electroretinography (ERG) with Skin Electrodes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600359,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Elektroretinografia (ERG) ihoelektrodeilla,,
1314,B - Mercury,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3035060,Mercury [Moles/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600360,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Elohopea,,
1315,Ha-Mercury,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600361,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ha-Elohopea,,
1316,U -Kkicksilver,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044316,Mercury [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600362,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Elohopea,,
1317,E -Enolas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600363,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Enolaasi,,
1318,S -Enteroglucagon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600364,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Enteroglukagoni,,
1319,"F -Escherichia coli, enteroinvasive",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600365,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Escherichia coli, enteroinvasiivinen",,
1320,"F -Escherichia coli, enteropathogen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600366,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Escherichia coli, enteropatogeeninen",,
1325,"F -Escherichia coli, enterotoxigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600367,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Escherichia coli, enterotoksigeeninen",,
1329,Ns-Eosinophils from the nasal mucosa,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600368,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ns-Eosinofiilit nenän limakalvolta,,
1330,B -Eosinophils,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013115,Eosinophils [#/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600369,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Eosinofiilit,,
1331,"Ex-Eosinophils, Outgrowth",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3024684,Eosinophils [Presence] in Sputum by Wright stain,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600370,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ex-Eosinofiilit, yskös",,
1331,"Ex-Eosinophils, Outgrowth",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3029802,Eosinophils [Presence] in Sputum by Hansel stain,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600370,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ex-Eosinofiilit, yskös",,
1332,L -Eosinophils,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006504,Eosinophils/100 leukocytes in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600371,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,L -Eosinofiilit,,
1335,"S-Epstein-Barr virus, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3048929,Epstein Barr virus Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600372,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epstein-Barrin virus, vasta-aineet",,
1336,"S-Epstein-Barr virus, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3007080,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600373,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epstein-Barrin virus, IgG-vasta-aineet",,
1336,"S-Epstein-Barr virus, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3015681,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600373,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epstein-Barrin virus, IgG-vasta-aineet",,
1337,"S-Epstein-Barr virus, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3019209,Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600374,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epstein-Barrin virus, IgM-vasta-aineet",,
1337,"S-Epstein-Barr virus, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3027352,Epstein Barr virus nuclear IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600374,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epstein-Barrin virus, IgM-vasta-aineet",,
1338,Li-Erythrophages,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600375,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Erytrofaagit,,
1339,S -Erythropoietin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024172,Erythropoietin (EPO) [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600376,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Erytropoietiini,,
1340,As-Erythrocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600377,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Erytrosyytit,,
1341,B-erythrocytes,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3026361,Erythrocytes [#/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600378,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Erytrosyytit,,
1342,Li-Erythrocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027475,Erythrocytes [#/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000600379,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Erytrosyytit,,
1343,Pf erythrocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028308,Erythrocytes [#/volume] in Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000600380,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Erytrosyytit,,
1344,U-Erythrocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002582,Erythrocytes [#/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600381,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Erytrosyytit,,
1345,U-Erythrocytes (Qual),-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3045424,Erythrocytes [Presence] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600382,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Erytrosyytit (kval),,
1347,"E-Erythrocytes, acid hemolysis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600383,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"E -Erytrosyytit, happohemolyysi",,
1349,"E -Erythrocytes, distribution index by size",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600384,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"E -Erytrosyytit, kokojakaumaindeksi",,
1350,"E-Erythrocytes, average diameter",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600385,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"E -Erytrosyytit, keskiläpimitta",,
1352,"E -Erythrocytes, mechanical resistance",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600386,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"E -Erytrosyytit, mekaaninen resistenssi",,
1353,"E-Erythrocytes, osmotic resistance",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600387,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Erytrosyytit, osmoottinen resistenssi",,
1354,"E-Erythrocytes, osmotic resistance, incubation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600388,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Erytrosyytit, osmoottinen resistenssi, inkubaatio",,
1355,"E-Erythrocytes, Medium Thickness",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600389,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"E -Erytrosyytit, keskipaksuus",,
1357,"E -Erythrocytes, mean volume",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3024731,MCV [Entitic volume],Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600390,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Erytrosyytit, keskitilavuus",,
1358,"B-Erythrocytes, volume almond",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3009542,Hematocrit [Volume Fraction] of Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600391,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Erytrosyytit, tilavuusosuus",,
1359,"Bm-Esterase, non-specific, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600392,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Esteraasi, epäspesifinen, värjäys",,
1360,"L-Esterase, non-specific, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600393,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"L -Esteraasi, epäspesifinen, värjäys",,
1361,"Bm-Esterase, non-specific fluorescent, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600394,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Esteraasi, epäspesifinen fluoriherkkä, värjäys",,
1362,"L -Esterase, non-specific fluorescent, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600395,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"L -Esteraasi, epäspesifinen fluoriherkkä, värjäys",,
1363,"Bm-Esterase, non-specific acid, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600396,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bm-Esteraasi, epäspesifinen hapan, värjäys",,
1364,"L-Esterase, non-specific acid, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600397,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"L -Esteraasi, epäspesifinen hapan, värjäys",,
1365,dU-Estradiol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600398,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Estradioli,,
1366,S -Estradiol,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3026725,Estradiol (E2) [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600399,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Estradioli,,
1367,dU-Estriol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600400,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Estrioli,,
1368,S -Estriol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600401,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Estrioli,,
1369,dU-Estriol-16-alpha-glucuronide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600402,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Estrioli-16-alfa-glukuronidi,,
1370,"cU-Estriol, 12h secretion",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600403,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"cU-Estrioli, 12h eritys",,
1371,"S -Estriol, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600404,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Estrioli, vapaa",,
1372,dU Estrogens,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600405,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Estrogeenit,,
1373,"dU-Estrogens, Fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600406,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Estrogeenit, fraktiot",,
1374,dU-Estron,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600407,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Estroni,,
1375,S -Estron,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3014339,Estrone (E1) [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600408,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Estroni,,
1376,dU-Estron-16-glucuronide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600409,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Estroni-16-glukuronidi,,
1377,U -Estron-16-glucuronide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600410,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Estroni-16-glukuronidi,,
1378,B -Ethanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600411,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Etanoli,,
1379,G -Ethanol (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600412,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,G -Etanoli (kval),,
1380,P -Fibrin Monomers (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3043649,Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination,Measurement,MAPS_TO,,HUS,1596153600000,,2000600413,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Fibriinimonomeerit (kval),,
1381,dU-Ethiocolanolone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600414,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Etiokolanoloni,,
1382,S -Ethiocolanolone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600415,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Etiokolanoloni,,
1383,S -Etosuximide,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012787,Ethosuximide [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600416,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Etosuksimidi,,
1384,S -Eethylene glycol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600417,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Etyleeniglykoli,,
1385,B -Eethylene glycol (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600418,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Etyleeniglykoli (kval),,
1386,Gj-Ethylene glycol (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600419,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Etyleeniglykoli (kval),,
1387,S -Penobarbital,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009410,PHENobarbital [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600420,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fenobarbitaali,,
1388,dU-Phenol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600421,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Fenoli,,
1389,U -Phenol (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600422,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Fenoli (kval),,
1390,U -Phenol red,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600423,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Fenolipuna,,
1393,U-Phenothiazines (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600424,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Fenotiatsiinit (kval),,
1394,U -Penylpyruvate (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600425,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Fenyylipyruvaatti (kval),,
1395,S -Ferritin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001122,Ferritin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600426,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Ferritiini,,
1396,Gj-Fetal sulfoglycoprotein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600427,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Fetaalinen sulfoglykoproteiini,,
1397,P -Coagulation factor XIII (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600428,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Hyytymistekijä XIII (kval),,
1399,P -Fibrinogen,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016407,Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000600429,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Fibrinogeeni,,
1400,P -Fibrinogen (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600430,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Fibrinogeeni (kval),,
1401,S -Fibrinogen degradation products,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600431,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,S -Fibrinogeenin hajoamistuotteet,,
1402,U -Fibrinogen Degradation Products,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600432,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,U -Fibrinogeenin hajoamistuotteet,,
1403,S -Fibrinogen degradation products (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600433,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,S -Fibrinogeenin hajoamistuotteet (kval),,
1404,U -Fibrinogen Degradation Products (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600434,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,U -Fibrinogeenin hajoamistuotteet (kval),,
1405,P- Fibrinolystide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600435,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Fibrinolyysiaika,,
1406,"P- Fibrinolystide, euglobulin",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600436,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"P -Fibrinolyysiaika, euglobuliini",,
1407,Li-Fibronectin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600437,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Fibronektiini,,
1408,S-Fibronectin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600438,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fibronektiini,,
1409,B- Filaria (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600439,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Filaria (kval),,
1411,S-Fluoride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600440,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fluoridi,,
1412,U-Fluoride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600441,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Fluoridi,,
1413,fB-Folate,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3006270,Folate [Moles/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600442,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fB-Folaatti,,
1414,fE-Folate,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019309,Folate [Moles/volume] in Red Blood Cells,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600443,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fE-Folaatti,,
1415,fP-Folate,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021960,Folate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600444,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Folaatti,,
1416,fS-Folate,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021960,Folate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600445,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Folaatti,,
1417,Li-Folat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600446,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Folaatti,,
1418,U -Folat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600447,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Folaatti,,
1419,S -Follicle Stimulating Hormone Releasing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600448,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Follikkelia stimuloivan hormonin vapauttajahormoni,,
1420,Ts-Follicle Stimulating Hormone Releasing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600449,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Follikkelia stimuloivan hormonin vapauttajahormoni,,
1421,dU Follicle Stimulating Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600450,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Follikkelia stimuloiva hormoni,,
1422,S -Follicle Stimulating Hormone,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3023323,Follitropin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600451,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Follikkelia stimuloiva hormoni,,
1423,"Pt-Phonocardiography, Limited",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600452,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Fonokardiografia, suppea",,
1424,"Pt-Phonocardiography, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600453,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Fonokardiografia, vaativa",,
1425,"Pt-Phonocardiography, intracardiac",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600454,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Fonokardiografia, sydämen sisäinen",,
1426,dU-Formiminoglutamate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600455,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Forminoglutamaatti,,
1428,Am-Phosphatidylglycerol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600456,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Fosfatidyyliglyseroli,,
1429,"dU-Phosphate, inorganic",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032333,Phosphate [Mass or Moles] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600457,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Fosfaatti, epäorgaaninen",,
1430,"Df-Phosphate, inorganic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600458,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Df-Fosfaatti, epäorgaaninen",,
1431,"fP-Phosphate, inorganic",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3003458,Phosphate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600459,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fP-Fosfaatti, epäorgaaninen",,
1432,"fS-Phosphate, inorganic",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003458,Phosphate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600460,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Fosfaatti, epäorgaaninen",,
1433,"U -phosphate, inorganic",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022229,Phosphate [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600461,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Fosfaatti, epäorgaaninen",,
1435,E -Phosphofructokinase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600462,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Fosfofruktokinaasi,,
1436,E -Phosphogluconate dehydrogenase (6-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600463,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Fosfoglukonaattidehydrogenaasi (6-),,
1437,E -Phosphoglycerate kinase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600464,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Fosfoglyseraattikinaasi,,
1438,E -Phosphoglycerate mutation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600465,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Fosfoglyseraattimutaasi,,
1439,E -Glucose phosphatase isomerase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600466,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Glukoosifosfaatti-isomeraasi,,
1440,fS-Phospholipids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600467,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Fosfolipidit,,
1441,Sp-Fruktos,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600468,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sp-Fruktoosi,,
1442,Pt Fructo Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600469,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Fruktoosi-koe,,
1443,E -Galactose-1-phosphate-uridyltransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600470,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Galaktoosi-1-fosfaattiuridyylitransferaasi,,
1444,B -Galactose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600471,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Galaktoosi,,
1445,S -Galactose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600472,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Galaktoosi,,
1447,"Pt-Galactose test, half-life",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600473,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Galaktoosi-koe, puoliintumisaika",,
1448,fS-Gastrin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3010370,Gastrin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600474,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Gastriini,,
1449,"P -Gastroin inhibiting polypeptide, ventricular emptying inhibiting polypeptide",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600475,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Gastrointestinaalinen inhiboiva peptidi,,
1450,S -Gentamycin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3035510,Gentamicin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600476,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Gentamysiini,,
1452,"Giardia, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600477,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Giardia, natiivivalmiste",,
1453,"F -Giardia, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600478,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Giardia, värjäys",,
1454,"S -Gliadin, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600479,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Gliadiini, vasta-aineet",,
1455,"S -Gliadin, Antibodies (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600480,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Gliadiini, vasta-aineet (kval)",,
1456,"S -Glomerulus Basal Membrane, Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40762485,Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600481,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Glomerulustyvikalvo, vasta-aineet",,
1457,Pt-Glucagon Test (C-Peptide Determination),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600482,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Glukagoni-koe (C-peptidimääritys),,
1458,fS-Glucagon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600483,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Glukagoni,,
1459,Off-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600484,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Glukoosi,,
1460,Am-Glucos,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600485,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Glukoosi,,
1461,As-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600486,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Glukoosi,,
1462,B -Glucose,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020491,Glucose [Moles/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600487,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Glukoosi,,
1463,cU-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600488,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Glukoosi,,
1464,Di-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600489,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Glukoosi,,
1465,dU-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600490,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Glukoosi,,
1466,F -Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600491,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Glukoosi,,
1467,fB-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600492,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fB-Glukoosi,,
1468,fP-Glucose,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3018251,Fasting glucose [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600493,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Glukoosi,,
1469,fS-Glucose,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3018251,Fasting glucose [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600494,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Glukoosi,,
1470,Li-Glucose,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020044,Glucose [Moles/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000600495,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Glukoosi,,
1471,P -Glucose,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013826,Glucose [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600496,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Glukoosi,,
1472,Pf-Glucose,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036782,Glucose [Moles/volume] in Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000600497,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Glukoosi,,
1473,S -Glucose,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013826,Glucose [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600498,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Glukoosi,,
1474,Sy-Glucose,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020618,Glucose [Moles/volume] in Synovial fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000600499,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Glukoosi,,
1475,U-Glucose,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005570,Glucose [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600500,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Glukoosi,,
1478,F -Glucose (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3040980,Glucose [Presence] in Stool,Measurement,MAPS_TO,,HUS,1596153600000,,2000600501,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Glukoosi (kval),,
1479,U -Glucose (Qual),-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3020650,Glucose [Presence] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600502,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Glukoosi (kval),,
1480,B-Glucose-6-phosphate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600503,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Glukoosi-6-fosfaattidehydrogenaasi,,
1481,E-Glucose-6-phosphate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600504,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Glukoosi-6-fosfaattidehydrogenaasi,,
1482,Li-Glucose-6-phosphate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600505,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Glukoosi-6-fosfaattidehydrogenaasi,,
1483,"Pt-Glucose test, oral, short",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4012477,Glucose tolerance test,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600506,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Glukoosi-koe, oraalinen, lyhyt",,
1484,"Pt-Glucose test, oral, long",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600507,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Glukoosi-koe, oraalinen, pitkä",,
1485,"Pt-Glucose test, intravenous",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600508,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Glukoosi-koe, intravenöösinen",,
1487,"B -Glucose, diurnal curve",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600509,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Glukoosi, vrk-käyrä",,
1488,S -Glutamate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600510,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Glutamaattidehydrogenaasi,,
1489,S -Glutamyltransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600511,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Glutamyylitransferaasi,,
1490,E -Glutation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600512,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Glutationi,,
1491,E -Stability of glutathione,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600513,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Glutationin stabiilisuus,,
1492,E -Glutathione Reductase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600514,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Glutationireduktaasi,,
1494,E -Glycogen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600515,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Glykogeeni,,
1495,fS-Glycolate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600516,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Glykokolaatti,,
1496,dU-Glycosaminoglycans,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600517,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Glykosaminoglykaanit,,
1497,U -Glycosaminoglycans,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600518,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Glykosaminoglykaanit,,
1498,U -Glycosaminoglycans (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600519,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Glykosaminoglykaanit (kval),,
1499,"S -Glycosaminoglycans, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600520,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Glykosaminoglykaanit, vasta-aineet",,
1500,S -Glycerol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600521,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Glyseroli,,
1501,dU-Glycine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600522,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Glysiini,,
1502,fP-Glycine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600523,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Glysiini,,
1503,U -Glycine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600524,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Glysiini,,
1504,U -Glycine (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600525,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Glysiini (kval),,
1505,"S -Neisseria gonorrhoeae, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600526,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Neisseria gonorrhoeae, vasta-aineet",,
1506,"Neisseria gonorrhoeae, cultivation",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3028334,Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600527,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Neisseria gonorrhoeae, viljely",,
1507,"Neisseria gonorrhoeae, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600528,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Neisseria gonorrhoeae, värjäys",,
1508,S -Guanindeaminas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600529,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Guaniinideaminaasi,,
1509,P -Coagulation factor XII,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002348,Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000600530,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hyytymistekijä XII,,
1510,P-Pancreatic Peptide,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40758355,Pancreatic polypeptide [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600531,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Haimaperäinen peptidi,,
1511,"Pt-Pancreas, secretion, simple",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600532,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Haima, eritys, yksinkertainen",,
1512,"Pt-Pancreas, secretion, multiparametric (quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600533,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Haima, eritys, moniparametrinen (kvant)",,
1514,S- Acid phosphates,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020233,Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600534,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hapan fosfataasi,,
1515,Sp-Surt phosphatas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600535,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sp-Hapan fosfataasi,,
1516,Sy-Surt phosphatas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600536,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Hapan fosfataasi,,
1517,"S-Acid phosphatase, isoenzymes",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600537,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hapan fosfataasi, isoentsyymit",,
1518,"Bm-Surt phosphatase, prostate",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600538,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Hapan fosfataasi, prostata",,
1519,"S-Acid phosphate, prostate",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600539,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hapan fosfataasi, prostata",,
1520,"Sp-Surt phosphatase, prostate",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600540,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sp-Hapan fosfataasi, prostata",,
1521,"S-Acid phosphatase, tartrate inhibition",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600541,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hapan fosfataasi, tartraatti-inhibiitio",,
1522,"L-Acid phosphatase, tartrate inhibition, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600542,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"L -Hapan fosfataasi, tartraatti-inhibiitio, värjäys",,
1523,"Bm-Acid phosphatase, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600543,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Hapan fosfataasi, värjäys",,
1524,"L- Acid phosphatase, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600544,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"L -Hapan fosfataasi, värjäys",,
1525,Gj-Syror,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600545,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Hapot,,
1526,H -Acids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600546,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Hapot,,
1527,aB -Surhetsgrad,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019977,pH of Arterial blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600547,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,aB-Happamuusaste,,
1528,cB -Surighetgrad,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009343,pH of Capillary blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600548,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cB-Happamuusaste,,
1529,Gj -Surhetsgrad,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600549,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Happamuusaste,,
1530,U -Surhetsgrad,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3015736,pH of Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600550,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Happamuusaste,,
1531,vB -Surhetsgrad,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3012544,pH of Venous blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600551,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,vB-Happamuusaste,,
1532,zB -Surhetsgrad,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600552,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,zB-Happamuusaste,,
1533,aB -Oxygen saturation (hemoglobin),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016502,Oxygen saturation in Arterial blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600553,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,aB-Happikyllästeisyys (hemoglobiini),,
1534,cB -Oxygen saturation (hemoglobin),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600554,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cB-Happikyllästeisyys (hemoglobiini),,
1535,aB-Oxygen partial pressure,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027801,Oxygen [Partial pressure] in Arterial blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600555,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,aB-Happiosapaine,,
1536,cB-Oxygen partial pressure,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028626,Oxygen [Partial pressure] in Capillary blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600556,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cB-Happiosapaine,,
1537,vB-Oxygen partial pressure,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024354,Oxygen [Partial pressure] in Venous blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600557,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,vB-Happiosapaine,,
1538,eg oxygen partial pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600558,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,zB-Happiosapaine,,
1539,ab acid content,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600559,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,aB-Happisisältö,,
1540,cB oxygen content,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600560,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cB-Happisisältö,,
1541,aB-Syrabasbalans,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019060,Gas panel - Arterial blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600561,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,aB-Happoemästase,,
1542,cB-Syrabasbalans,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022313,Gas panel - Capillary blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600562,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cB-Happoemästase,,
1543,vB-Syrabasbalans,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000991,Gas panel - Venous blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600563,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,vB-Happoemästase,,
1544,zB-Syrabasbalans,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3039402,Gas panel - Mixed venous blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600564,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,zB-Happoemästase,,
1545,S-Haptoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3012336,Haptoglobin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600565,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Haptoglobiini,,
1546,E -Heinz Bodies,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600566,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Heinzin kappaleet,,
1547,E -Hexokinas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600567,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Heksokinaasi,,
1549,E -Hemsyntas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600568,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Hemisyntaasi,,
1551,Af-Hemoglobin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600569,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Af-Hemoglobiini,,
1552,B -Hemoglobin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3000963,Hemoglobin [Mass/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600570,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Hemoglobiini,,
1553,Li-Hemoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003675,Hemoglobin [Mass/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000600571,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Hemoglobiini,,
1554,P -Hemoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022493,Free Hemoglobin [Mass/volume] in Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600572,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hemoglobiini,,
1555,U -Hemoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002719,Hemoglobin [Mass/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600573,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Hemoglobiini,,
1556,U -Hemoglobin (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3011397,Hemoglobin [Presence] in Urine by Test strip,Measurement,MAPS_TO,,HUS,1596153600000,,2000600574,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Hemoglobiini (kval),,
1557,E-Medium Hemoglobin Concentration,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3003338,MCHC [Mass/volume],Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600575,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Hemoglobiini, keskimassakonsentraatio",,
1558,E -Medium Hemoglobin Mass,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3035941,MCH [Entitic mass],Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600576,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Hemoglobiini, keskimassa",,
1559,"B -Hemoglobin-A1, glycerate",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600577,LABfi Level 0,Measurement,2004-01-01,2010-12-31,,,"B -Hemoglobiini-A1, glykoitunut",,
1560,"B -Hemoglobin-A1C, glycerate",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3004410,Hemoglobin A1c/Hemoglobin.total in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600578,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hemoglobiini-A1C, glykoitunut",,
1561,B -Hemoglobin-A2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600579,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Hemoglobiini-A2,,
1562,"B -Hemoglobin, fetal",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3018738,Hemoglobin F/Hemoglobin.total in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600580,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hemoglobiini, fetaali",,
1563,"B -Hemoglobin, fetal, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600581,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hemoglobiini, fetaali, värjäys",,
1564,"B -Hemoglobin, fractions",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032868,Hemoglobin electrophoresis panel in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600582,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hemoglobiini, fraktiot",,
1565,"B -Hemoglobin, acid dissociation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600583,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hemoglobiini, happidissosiaatio",,
1566,"B -Hemoglobin, carbon monoxide",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023081,Carboxyhemoglobin/Hemoglobin.total in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600584,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hemoglobiini, hiilimonoksidi",,
1567,"Pt-Hemoglobin, total",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600585,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Hemoglobiini, kokonais",,
1568,"B -Hemoglobin, heat stable",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600586,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Hemoglobiini, lämpöstabiili",,
1570,S -Hemopexin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600587,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hemopeksiini,,
1571,S -Hemopexin (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600588,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hemopeksiini (kval),,
1572,U -Hemosiderin (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600589,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Hemosideriini (kval),,
1573,"Pt Respiration Regulation, Carbon Dioxide Stimulation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600590,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Hengityksen säätely, hiilidioksidistimulaatio",,
1576,Pt-Exhalation Gas Oxygen Partial Pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600591,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Uloshengityskaasun happiosapaine,,
1577,Pt-Exhalation gas carbon dioxide partial pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600592,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Uloshengityskaasun hiilidioksidiosapaine,,
1578,Pt-Exhalation gas nitrogen partial pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600593,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Uloshengityskaasun typpiosapaine,,
1579,Pt-Alveolar Oxygen Partial Pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600594,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Alveolien happiosapaine,,
1581,"Pt-Alveolar-arterial,oxygen partial pressure difference",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600595,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Alveoloartielli, happiosapaine-ero",,
1582,Pt-Alveolar Ventilation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600596,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Alveolaariventilaatio,,
1584,Pt-Oxygen Consumption,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600597,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Hapenkulutus,,
1586,Pt Carbon Dissolution,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600598,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Hiilidioksidin eritys,,
1588,Pt-Respiratory gases turnover containing rest and load measurements,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600599,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Hengityskaasujen vaihdunta sisältäen lepo- ja rasitusmittaukset,,
1590,Pt-Physiological dead state of respiration,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600600,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,Pt-Hengityksen fysiologinen kuollut tila,,
1592,"Pt-Measurement of the connection flow (right-left), oxygen respiration",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600601,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Oikovirtauksen (oikea-vasen) mittaaminen, happihengitys",,
1593,Pt-Breath minute ventilation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600602,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,Pt-Hengityksen minuuttiventilaatio,,
1595,"Pt-Respiratory gases, base metabolism",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600603,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Hengityskaasut, perusaineenvaihdunta",,
1596,"Pt-Unit volume of breath, tidal volume",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600604,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Pt-Hengityksen kertatilavuus, tidaalivolyymi",,
1598,"Pt-Respiratory gases, measurement of metabolism during work",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600605,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Hengityskaasut, työaineenvaihdunnan mittaus",,
1599,Pt-Heparin Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600606,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Hepariini-koe,,
1601,"S -Hepatitis A Virus, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3040363,Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600607,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"S -Hepatiitti A -virus, IgG-vasta-aineet",,
1602,"S -Hepatitis A Virus, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3013327,Hepatitis A virus IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600608,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti A -virus, IgM-vasta-aineet",,
1604,"S -Hepatitis B virus, e-antigen",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3027974,Hepatitis B virus e Ag [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000600609,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti B -virus, e-antigeeni",,
1605,"S -Hepatitis B virus, s-antigen",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019284,Hepatitis B virus surface Ag [Presence] in Serum,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600610,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti B -virus, s-antigeeni",,
1606,"S -Hepatitis B virus, c-antigen, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021879,Hepatitis B virus core Ab [Presence] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600611,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti B -virus, c-antigeeni, vasta-aineet",,
1607,"S -Hepatitis B virus, e-antigen, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013945,Hepatitis B virus e Ab [Presence] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600612,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti B -virus, e-antigeeni, vasta-aineet",,
1608,"S -Hepatitis B virus, s-antigen, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017797,Hepatitis B virus surface Ab [Presence] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600613,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti B -virus, s-antigeeni, vasta-aineet",,
1609,"Pt-Auditory Brain Strain Potentials (BAEP), Stimulation Study",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600614,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Akustinen aivorunkoherätevastetutkimus (BAEP),,
1611,"Pt-Auditory Brain Strain Potentials (BAEP) for Determining Hearing Threshold, Stimulation Study",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600615,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Akustinen aivorunkoherätevastetutkimus (BAEP) kuulokynnyksen määrittämiseksi,,
1612,"Pt-Somatosensory Reaction Potentials (SEP), a Nerve, Both Sides, Stimulation Examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600616,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Somatosensorinen herätevastetutkimus (SEP), yksi hermo molemmin puolin",,
1613,"Pt-Visual Reaction Potentials (VEP), Survey of the Whole Field of View, Stimulation Study",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600617,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Visuaalinen herätevastetutkimus (VEP), kokokenttätutkimus",,
1614,"Herpes simplex virus, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001964,Herpes simplex virus Ag [Presence] in Specimen,Measurement,MAPS_TO,,HUS,1596153600000,,2000600618,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Herpes simplex -virus, antigeeni",,
1615,"S -Herpes simplex virus, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3028679,Herpes simplex virus Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000600619,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Herpes simplex -virus, vasta-aineet",,
1616,"Herpes simplex virus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600620,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Herpes simplex -virus, viljely",,
1618,Di-Carbon Dioxide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600621,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Hiilidioksidi,,
1619,Dj-Carbon Dioxide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600622,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Dj-Hiilidioksidi,,
1620,P -Carbon dioxide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600623,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hiilidioksidi,,
1621,aB carbon dioxide partial pressure,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027946,Carbon dioxide [Partial pressure] in Arterial blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600624,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,aB-Hiilidioksidiosapaine,,
1622,cB carbon dioxide partial pressure,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023024,Carbon dioxide [Partial pressure] in Capillary blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600625,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cB-Hiilidioksidiosapaine,,
1623,vB carbon dioxide partial pressure,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021447,Carbon dioxide [Partial pressure] in Venous blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600626,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,vB-Hiilidioksidiosapaine,,
1624,eg carbon dioxide partial pressure,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021513,Carbon dioxide [Partial pressure] in Mixed venous blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000600627,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,zB-Hiilidioksidiosapaine,,
1625,G -Carbon monoxide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600628,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,G -Hiilimonoksidi,,
1626,"S -Yeast, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600629,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hiiva, antigeeni",,
1627,"S -Yeast, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600630,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hiiva, vasta-aineet",,
1628,"Yeast, cultivation",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3026389,Candida sp identified in Specimen by Organism specific culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600631,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Hiiva, viljely",,
1629,U-Hippurat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600632,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Hippuraatti,,
1630,Pt-Histidintest,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600633,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Histidiini-koe,,
1631,"S-Mold dust, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600634,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Homepöly, vasta-aineet",,
1632,dU-Homogentisic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600635,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Homogentisiinihappo,,
1633,U -Homogentisic acid (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600636,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Homogentisiinihappo (kval),,
1634,dU-Homovanillinate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3025504,Homovanillate [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600637,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Homovanillinaatti,,
1635,dU-Silver,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600638,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Hopea,,
1636,S -Silver,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600639,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hopea,,
1637,dU-Hydroxy-indolylacetate (5-),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3036309,5-Hydroxyindoleacetate [Moles/volume] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600640,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Hydroksi-indolyyliasetaatti (5-),,
1638,U-Hydroxy-indolylacetate (5-) (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600641,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Hydroksi-indolyyliasetaatti (5-) (kval),,
1639,S-Hydroxybutyrate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600642,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hydroksibutyraattidehydrogenaasi,,
1640,S- Hydroxychloroquine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600643,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hydroksiklorokiini,,
1641,dU-Hydroxycorticosteroids (17-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600644,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Hydroksikortikosteroidit (17-),,
1642,S -Hydroxycorticosteroids (17-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600645,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hydroksikortikosteroidit (17-),,
1643,dU-Hydroxyprogesterone (17-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600646,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Hydroksiprogesteroni (17-),,
1644,S- Hydroxyprogesterone (17-),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023530,17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600647,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hydroksiprogesteroni (17-),,
1645,dU-Hydroxyproline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600648,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Hydroksiproliini,,
1646,S-Hydroxyproline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600649,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hydroksiproliini,,
1647,"dU-Hydroxyproline, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600650,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Hydroksiproliini, vapaa",,
1648,P -Hydroxytryptamine (5-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600651,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hydroksitryptamiini (5-),,
1649,"Hygiene test, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600652,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Hygienianäyte, viljely",,
1650,B -Coagulation time,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600653,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -Hyytymisaika,,
1657,S -Antibodies to the basal membrane of the skin epithelium,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40760847,Basement membrane Ab [Titer] in Serum by Immunofluorescence,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600654,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Ihon epiteelin tyvikalvon vasta-aineet,,
1658,S -Antibodies to Skin Epithelial Adhesion Proteins,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42870308,Desmosome IgG Ab [Titer] in Serum by Immunofluorescence,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600655,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Ihon epiteelin väliaineen vasta-aineet,,
1660,S-Imipramine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600656,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Imipramiini,,
1661,U-Imipramine (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600657,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Imipramiini (kval),,
1662,B -Immunoblasts (Reactive Lymphocytes),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600658,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -Immunoblastit (reaktiiviset lymfosyytit),,
1663,Li-Immunoblaster,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600659,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Li-Immunoblastit,,
1664,dU-Immunoglobulin A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600660,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Immunoglobuliini A,,
1665,Li-Immunoglobulin A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600661,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Immunoglobuliini A,,
1666,S-Immunoglobulin A,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3007164,IgA [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600662,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Immunoglobuliini A,,
1667,U-Immunoglobulin A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600663,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Immunoglobuliini A,,
1668,dU-Immunoglobulin D,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600664,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Immunoglobuliini D,,
1669,Li-Immunoglobulin D,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600665,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Immunoglobuliini D,,
1670,S-Immunoglobulin D,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016135,IgD [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600666,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Immunoglobuliini D,,
1671,U-Immunoglobulin D,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600667,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Immunoglobuliini D,,
1672,Li-Immunoglobulin E,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600668,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Immunoglobuliini E,,
1673,S-Immunoglobulin E,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005322,IgE [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600669,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Immunoglobuliini E,,
1674,dU-Immunoglobulin G,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600670,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Immunoglobuliini G,,
1675,Li-Immunoglobulin G,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3007368,IgG [Mass/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600671,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Immunoglobuliini G,,
1676,S-Immunoglobulin G,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3005719,IgG [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600672,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Immunoglobuliini G,,
1677,U-Immunoglobulin G,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3047185,IgG [Mass/volume] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600673,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Immunoglobuliini G,,
1678,"dU-Immunoglobulin G, Fc fragment",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600674,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Immunoglobuliini G, Fc-fragmentti",,
1679,"U-Immunoglobulin G, Fc fragment",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600675,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Immunoglobuliini G, Fc-fragmentti",,
1680,"U-Immunoglobulin G, Fc fragment (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600676,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Immunoglobuliini G, Fc-fragmentti (kval)",,
1681,"dU-Immunoglobulin, light chains",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3005812,Immunoglobulin light chains [Presence] in 24 hour Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600677,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Immunoglobuliini, kevyet ketjut",,
1682,"S-Immunoglobulin, light chains",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600678,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini, kevyet ketjut",,
1683,"U-Immunoglobulin, light chains",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600679,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Immunoglobuliini, kevyet ketjut",,
1686,dU-Immunoglobulin M,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600680,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Immunoglobuliini M,,
1687,Li-Immunoglobulin M,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600681,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Immunoglobuliini M,,
1688,S-Immunoglobulin M,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3028026,IgM [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600682,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Immunoglobuliini M,,
1689,U-Immunoglobulin M,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600683,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Immunoglobuliini M,,
1690,Pt-Impedance Cardiography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600684,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Impedanssikardiografia,,
1694,dU-Indikan,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600685,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Indikaani,,
1695,U -Indikan,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600686,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Indikaani,,
1696,Pt Survey with Indocyanine Green,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600687,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Indosyaniinivihreäkoe,,
1700,fP-Insulin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3016523,Insulin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600688,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Insuliini,,
1701,S -Insulin,-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3016244,Insulin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,tyks,1631577600000,,2000600689,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Insuliini,,
1702,"S -Insulin, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600690,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Insuliini, vasta-aineet",,
1703,Pt Insulin Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600691,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Insuliini-koe,,
1704,Gj-Intrinsic factor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600692,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Intrinsic factor,,
1705,"S-Intrinsic factor, binding antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600693,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Intrinsic factor, sitovat vasta-aineet",,
1706,"S-Intrinsic factor, blocking antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600694,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Intrinsic factor, salpaavat vasta-aineet",,
1707,E -Inulin Hemolysis Study,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600695,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Inuliini-hemolyysitutkimus,,
1708,Pt-Inulinclearance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600696,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Inuliinin poistuma,,
1710,Ts-Isomaltas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600697,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Isomaltaasi,,
1711,S -Isocitrate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600698,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Isositraattidehydrogenaasi,,
1712,"S-Beta-2-glycoprotein, IgA antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600699,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Beeta-2-glykoproteiini, IgA-vasta-aineet",,
1713,"S-Beta-2-glycoprotein, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3018658,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600700,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Beeta-2-glykoproteiini, IgG-vasta-aineet",,
1714,"S-Beta-2-glycoprotein, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3043181,Beta 2 glycoprotein 1 IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000600701,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Beeta-2-glykoproteiini, IgM-vasta-aineet",,
1715,"Cytomegalovirus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3030558,Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000600702,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cytomegalovirus, nukleiinihappo (kvant)",,
1716,"S-Dengue virus, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600703,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Denguevirus, IgM-vasta-aineet",,
1717,"S -Echovirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600704,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Echovirus, vasta-aineet",,
1718,F -Elastas 1,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3000570,Elastase.pancreatic [Mass/mass] in Stool,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600705,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Elastaasi 1,,
1719,S -Elastas 1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600706,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Elastaasi 1,,
1720,"Hepatitis B virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3006559,Hepatitis B virus DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000600707,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Hepatiitti B -virus, nukleiinihappo (kvant)",,
1721,"S -Hepatitis C virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3021125,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000600708,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti C -virus, nukleiinihappo (kvant)",,
1722,"S-Immunoglobulin E, Bass Screening and Specification",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600709,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini E, perusseulonta ja erittely",,
1723,"Neisseria gonorrhoeae, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3011371,Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600710,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Neisseria gonorrhoeae, nukleiinihappo (kval)",,
1724,"S-Oxidized low density lipoproteins, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600711,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Oksidoituneet low density lipoproteiinit, IgG-vasta-aineet",,
1725,"B -PNH, Immunophenotyping",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600712,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -PNH, Immunofenotyypitys",,
1726,"S -Perinuclear factor, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600713,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Perinukleaarifaktori, vasta-aineet",,
1727,"S -Prothrombin, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600714,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Protrombiini, IgG-vasta-aineet",,
1728,"S -Rubella virus, antibodies, avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600715,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vihurirokkovirus, vasta-aineet, aviditeetti",,
1729,"Fl-Streptococcus agalactiae (B), cultivation",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3020321,Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600716,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Fl-Streptococcus agalactiae (B), viljely",,
1730,"Toxoplasma, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3006695,Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000600717,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Toxoplasma, nukleiinihappo (kval)",,
1731,P-Thromboplastin time,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3033658,Prothrombin time (PT) actual/Normal,Measurement,MAPS_TO,,HUS,1596153600000,,2000600718,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Tromboplastiiniaika,,
1732,"Pt-Registration of movement activity, actigraphy",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600719,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Liikeativiteettirekisteröinti, aktigrafia",,
1733,U -Anilin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600720,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Aniliini,,
1734,"U -Arsen, inorganic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600721,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Arseeni, epäorgaaninen",,
1735,U-Beryllium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600722,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Beryllium,,
1736,U -Butoxyacetic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600723,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Butoksietikkahappo,,
1737,"S-Chlamydia trachomatis, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600724,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia trachomatis, vasta-aineet",,
1738,"Chlamydia trachomatis and Neisseria gonorrhoeae, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009926,Chlamydia trachomatis rRNA [Presence] in Specimen by Probe,Measurement,MAPS_TO,,HUS,1596153600000,,2000600725,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Chlamydia trachomatis ja Neisseria gonorrhoeae, nukleiinihappo (kval)",,
1738,"Chlamydia trachomatis and Neisseria gonorrhoeae, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3010854,Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe,Measurement,MAPS_TO,,HUS,1596153600000,,2000600725,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Chlamydia trachomatis ja Neisseria gonorrhoeae, nukleiinihappo (kval)",,
1739,Ts-DNA Coupling Assay,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600726,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-DNA kytkentäanalyysi,,
1740,"Ts Dystrophy Genes, DNA Analysis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600727,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Dystrofiinigeeni, DNA-tutkimus",,
1741,U-Ethoxyacetic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600728,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Etoksietikkahappo,,
1742,U-Ethoxypropanoic acid (2-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600729,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Etoksipropaanihappo (2-),,
1743,U -Etylentiourea,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600730,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Etyleenitiourea,,
1744,U-Ethylhexanoic acid (2-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600731,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Etyyliheksaanihappo (2-),,
1745,Ts-Ewing's Sarcoma Fusion Transcript Study,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600732,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Ewingin sarkooman fuusiolähetin tutkimus,,
1746,"U -Phenoxy acids, chlorinated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600733,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Fenoksihapot, klooratut",,
1747,U-Phenoxybenzoic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600734,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Fenoksibentsoehappo,,
1748,"Ts-Genomic Hybridization Study, Comparative",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600735,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Genominen hybridisaatiotutkimus, vertaileva",,
1749,"Hepatitis C-virus, antibodies, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600736,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Hepatiitti C -virus, vasta-aineet, varmistus",,
1750,Pt Test for Ability to Stay Awake (MWT),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600737,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Hereilläpysymistutkimus (MWT),,
1751,"S-Mold dust, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600738,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Homepöly, IgG-vasta-aineet",,
1752,"Human Herpesvirus-6, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600739,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Human herpesvirus-6, nukleiinihappo (kval)",,
1753,"S -HI virus, antibodies, avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600740,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -HI virus, vasta-aineet, aviditeetti",,
1754,"HI virus, antibodies, confirmation (screened sample)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600741,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"HI-virus, vasta-aineet, varmistus (seulottu näyte)",,
1755,U -Karbendazim,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600742,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Karbendatsiimi,,
1756,"fP-Chlorine compounds, organic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600743,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fP-Klooriyhdisteet, orgaaniset",,
1757,"Ts-Gen for choroidemia, CHM * SAL gene defect",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600744,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Koroideremiageeni, CHM*SAL geenivirhe",,
1758,Ts-Gen for Cystic Fibrosis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600745,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Kystisen fibroosin geeni,,
1759,B -LDL receptor assay,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600746,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -LDL-reseptoritutkimus,,
1760,S -Mangan,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600747,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Mangaani,,
1761,U -Mandelic and phenylglyoxylic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600748,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Manteli- ja fenyyliglyoksyylihappo,,
1762,U-Mercaptobenzothiazole (2-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600749,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Merkaptobentsotiatsoli (2-),,
1763,U-Methoxyacetic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600750,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metoksietikkahappo,,
1764,U -Methoxypropanoic acid (2-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600751,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metoksipropaanihappo (2-),,
1765,U -Methylenebis (2-chloroaniline),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600752,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metyleenibis(2-kloorianiliini),,
1766,U-Methylenedianiline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600753,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metyleenidianiliini,,
1767,U -Methylethyl ketone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600754,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metyylietyyliketoni,,
1768,U -Methylhydroxymethylformamide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600755,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metyylihydroksimetyyliformamidi,,
1769,"U-Muconic acid, (trans, trans)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600756,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Mukonihappo, (trans,trans)",,
1770,B -Nickel,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600757,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Nikkeli,,
1771,U -Oxalat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600758,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Oksalaatti,,
1772,"S -Band virus, IgG Antibodies (Parotitic Virus Antibodies)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600759,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sikotautivirus, IgG-vasta-aineet",,
1773,S -Procalcitonin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3046279,Procalcitonin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600760,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prokalsitoniini,,
1774,U-propylene glycol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600761,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Propyleeniglykoli,,
1775,"S -Puumalavirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600762,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puumala-virus, vasta-aineet",,
1776,U -Pyrenol (1),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600763,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Pyrenoli (1),,
1777,U-Zinc,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600764,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Sinkki,,
1778,U-Thiocyanate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600765,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Tiosyanaatti,,
1779,U -Triazine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600766,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Triatsiini,,
1780,U -Trietylamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600767,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Trietyyliamiini,,
1781,"Chickenpox virus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3012202,Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600768,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Vesirokkovirus, nukleiinihappo (kval)",,
1782,U -Verbenol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600769,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Verbenoli,,
1783,B-Y chromosome aberrations,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600770,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Y-kromosomin poikkeavuuksia,,
1784,"Pt-Night Polygraphy, Outpatient",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600771,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Yöpolygrafia, ambulatorinen",,
1785,"Pt-Sleep Polygraphy, Limited, Outpatient",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600772,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Pt-Yöpolygrafia, suppea, ambulatorinen",,
1786,"S -Allergen, IgG4 Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600773,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Allergeeni, IgG4-vasta-aineet",,
1787,"U -Bacteria, special cultivation",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3026008,Bacteria identified in Urine by Culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600774,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Bakteeri, erikoisviljely",,
1788,"Enterococcus, vancomycin resistance, culture",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023601,Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000600775,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Enterokokki, vankomysiiniresistentti, viljely",,
1793,Ts-Mitochondrial Enzyme Assay,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600776,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Mitokondrioentsyymien tutkimus,,
1806,"S -Varicella-Zoster virus, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3012220,Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600777,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vesirokkovirus, IgM-vasta-aineet",,
1808,"Acanthamoeba, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600778,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Acanthamoeba, viljely",,
1809,"S -Actinomyces, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600779,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Actinomyces, vasta-aineet",,
1810,"U-Amphetamine and its derivatives, confirmation",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3027944,Amphetamines [Presence] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600780,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Amfetamiini ja sen johdannaiset, varmistus",,
1811,"Am-KEL Genotyping, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600781,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Am-KEL-genotyypitys, DNA-tutkimus",,
1812,"Am-RHCE gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600782,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,"Am-RHCE-geeni, DNA-tutkimus",,
1813,"S -Anisakis, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600783,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Anisakis, vasta-aineet",,
1814,P -Antiplasmin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600784,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Antiplasmiini,,
1815,"Am-RHD gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600785,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,"Am-RHD-geeni, DNA-tutkimus",,
1816,"S -Aspergillus, antigen",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3008536,Aspergillus sp Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600786,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Aspergillus, antigeeni",,
1817,"F -Astrovirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600787,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Astrovirus, nukleiinihappo (kval)",,
1818,"U -Barbiturate, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600788,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Barbituraatit, varmistus",,
1819,"S -Bartonella, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600789,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Bartonella, vasta-aineet",,
1820,"U-Benzodiazepines, Confirmation",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042517,Benzodiazepines panel - Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600790,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Bentsodiatsepiinit, varmistus",,
1821,"B -Borrelia, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600791,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"B -Borrelia, värjäys",,
1822,"U-Buprenorphine, confirmation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007463,Buprenorphine [Presence] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600792,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Buprenorfiini, varmistus",,
1823,"F -Calicivirus, nucleic acid (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600793,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Kalikivirus, nukleiinihappo (kval)",,
1824,"Li-Chlamydia pneumoniae, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015694,Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600794,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Chlamydia pneumoniae, IgG-vasta-aineet",,
1825,"Li-Chlamydia pneumoniae, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3017074,Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600795,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Chlamydia pneumoniae, IgM-vasta-aineet",,
1826,"Corynebacterium diphtheriae, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600796,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Corynebacterium diphtheriae, nukleiinihappo (kval)",,
1827,"Li-Coxsackie B5 virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600797,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Coxsackie B5 -virus, vasta-aineet",,
1828,"Cryptococcus neoformans, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600798,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cryptococcus neoformans, antigeeni",,
1829,"Li-Cysticercus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600799,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Cysticercus, vasta-aineet",,
1830,"S -Cysticercus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600800,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Cysticercus, vasta-aineet",,
1831,"S-Cytomegalovirus, Antibodies, Avidity",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,21492711,Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000600801,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Cytomegalovirus, vasta-aineet, aviditeetti",,
1832,"U -Dextropropoxyphene, Confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600802,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Dekstropropoksifeeni, varmistus",,
1833,"U -Dextropropoxifene, screening (qual.)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3037377,Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600803,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Dekstropropoksifeeni, seulonta (kval)",,
1834,"Li-Dengue Virus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600804,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Denguevirus, IgG-vasta-aineet",,
1835,"Li-Dengue Virus, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600805,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Denguevirus, IgM-vasta-aineet",,
1836,"Li-Dengue virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600806,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Denguevirus, vasta-aineet",,
1837,"Diastrophic dysplasia, DNA examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600807,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Diastrofinen dysplasia, DNA-tutkimus",,
1839,"Li-Enterovirus, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42868499,Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600808,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Enterovirus, IgG-vasta-aineet",,
1840,Ex-Eosinophilic Cationic Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600809,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ex-Eosinofiilisten granulosyyttien kationinen proteiini,,
1841,"Li-Epstein conifer virus, antibodies, avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600810,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Epstein-Barrin virus, vasta-aineet, aviditeetti",,
1842,"Li-Epstein-Barrvirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600811,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Epstein-Barrin virus, IgG-vasta-aineet",,
1843,"Li-Epstein-Barrvirus, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600812,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Epstein-Barrin virus, IgM-vasta-aineet",,
1844,"Li-Epstein-Barrvirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600813,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Epstein-Barrin virus, vasta-aineet",,
1845,"F -Escherichia coli, enterohemorrhagic, toxin",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600814,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Escherichia coli, enterohemorrhaginen,toxin",,
1846,"S -Fasciola, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600815,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Fasciola, vasta-aineet",,
1847,"U-Phenyclidine, screening (qual.)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3017509,Phencyclidine [Presence] in Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600816,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Fensyklidiini, seulonta (kval)",,
1848,"U-Phencyclidine, Confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600817,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Fensyklidiini, varmistus",,
1849,"P -Fibrinogen, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016628,Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000600818,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Fibrinogeeni, antigeeni",,
1850,"S -Filaria, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600819,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Filaria, vasta-aineet",,
1851,S-Fluvoxamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600820,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fluvoksamiini,,
1852,"Giardia (trophozoite), dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600821,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Giardia (trofotsoiitit), värjäys",,
1853,"T -Glycoproteins, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600822,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"T -Glykoproteiinit, IgG-vasta-aineet",,
1854,"B -Granulocyte, antigen determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600823,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Granulosyytti, antigeenityypitys",,
1855,"B -Granulocyte, antigen determination, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600824,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Granulosyytti, antigeenityypitys, DNA-tutkimus",,
1856,"Gr-Granulocyte, Antibodies (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600825,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Gr-Granulosyytti, vasta-aineet (kval)",,
1857,"S -Granulocyte, antibodies, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600826,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"S -Granulosyytti, vasta-aineet, tyypitys",,
1858,"B -Hemochromatosis, DNA Examination",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3027955,HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal,Measurement,MAPS_TO,,tays,1630368000000,,2000600827,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hemokromatoosi, DNA-tutkimus",,
1859,"S -Hepatitis C virus, genotype determination",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,37021073,Hepatitis C virus genotype in Serum or Plasma by Sequencing,Measurement,MAPS_TO,,tays,1630368000000,,2000600828,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti C virus, genotyypin määritys",,
1860,"Herpes simplex virus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3028369,Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600829,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Herpes simplex -virus, nukleiinihappo (kval)",,
1861,"Li-Herpes simplex virus type 1, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3031072,Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600830,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Herpes simplex -virus tyyppi 1, IgG-vasta-aineet",,
1862,"S-Herpes simplex virus type 1, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600831,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Herpes simplex -virus tyyppi 1, IgG-vasta-aineet",,
1863,"Li-Herpes simplex virus type 2, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3007695,Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600832,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Herpes simplex -virus tyyppi 2, IgG-vasta-aineet",,
1864,"S-Herpes simplex virus type 2, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600833,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Herpes simplex -virus tyyppi 2, IgG-vasta-aineet",,
1865,"S -Histoplasm, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600834,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Histoplasma, vasta-aineet",,
1866,"B -HLA-DRB Typing, DNA Testing",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024932,HLA-DR beta [Type],Measurement,MAPS_TO,,HUS,1596153600000,,2000600835,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-DRB, DNA-tutkimus",,
1867,P-Homocysteine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016724,Homocysteine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600836,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Homokysteiini,,
1868,S-Homocysteine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016724,Homocysteine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600837,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Homokysteiini,,
1869,"Li-Human Herpesvirus-6, Nucleic Acid (Qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3046896,Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000600838,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Human herpesvirus-6, nukleiinihappo (kval)",,
1870,"Li-Human Herpesvirus-6, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600839,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Human herpesvirus-6, vasta-aineet",,
1871,"S -Human herpesvirus-8, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600840,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Human herpesvirus-8, IgG-vasta-aineet",,
1872,U -Drug- and drug-screening (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600841,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Huume- ja lääkeaineseulonta (kval),,
1873,"B -Examination of Immunogranulocytopenia, Newborn",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600842,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Immuunigranulosytopeniatutkimus, vastasyntynyt",,
1874,"Li-Influenza B Virus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600843,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Influenssa B -virus, IgG-vasta-aineet",,
1875,"S -Incoovirus, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600844,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Inkoo-virus, IgM-vasta-aineet",,
1876,"Li-Incoovirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600845,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Inkoo-virus, vasta-aineet",,
1877,"Li-Japanese encephalitis virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600846,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Japanin enkefaliittivirus, vasta-aineet",,
1878,"S -Japanese encephalitis virus, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600847,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Japanin enkefaliittivirus, IgM-vasta-aineet",,
1879,S-Clindamycin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600848,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klindamysiini,,
1880,"U-Cannabis, Confirmation",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3028300,Cannabinoids [Presence] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600849,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Kannabis, varmistus",,
1881,U- Chemical screening,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3037467,Urinalysis macro (dipstick) panel - Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600850,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kemiallinen seulonta,,
1882,S-Chlordiazepoxide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600851,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klooridiatsepoksidi,,
1883,"Congenital chloride diarrhea, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600852,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Kongenitaalinen kloridiripuli, DNA-tutkimus",,
1884,"U -Cocaine, Confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600853,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Kokaiini, varmistus",,
1885,"S -Tissue Transglutaminase, IgA Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019050,Tissue transglutaminase IgA Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600854,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kudostransglutaminaasi, IgA-vasta-aineet",,
1886,"S -Tissue Transglutaminase, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3046870,Tissue transglutaminase IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000600855,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kudostransglutaminaasi, IgG-vasta-aineet",,
1887,S -Cystatin C,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3030366,Cystatin C [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600856,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kystatiini C,,
1888,"S-Legionella pneumophila, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600857,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Legionella pneumophila, antigeeni",,
1889,"Li-Listeria, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600858,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Listeria, vasta-aineet",,
1890,"Mask, species determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600859,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mato, lajimääritys",,
1891,"U -Methadone, screening (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600860,LABfi Level 0,Measurement,2004-01-01,2007-12-31,,,"U -Metadoni, seulonta (kval)",,
1892,"U-Methadone, Confirmation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036180,Methadone [Presence] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600861,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Metadoni, varmistus",,
1893,"Microsporidia, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600862,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Microsporidia, värjäys",,
1894,S -Midazolam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600863,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Midatsolaami,,
1895,S -Mirtazapine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600864,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Mirtatsapiini,,
1896,S -Moclobemide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600865,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Moklobemidi,,
1897,"Li-Mycoplasma pneumoniae, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3002823,Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600866,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Mycoplasma pneumoniae, IgG-vasta-aineet",,
1898,"Nephronoftis, deletion mutation, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600867,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Nefronoftiisi, deleetiogeenivirhe, DNA-tutkimus",,
1899,"S -Nocardia, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600868,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Nokardia, vasta-aineet",,
1900,S -Olanzapin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3040370,OLANZapine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600869,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Olantsapiini,,
1901,"U -Opiater, screeing (kval)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600870,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"U -Opiaatit, seulonta (kval)",,
1902,"U -Opiatrist, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600871,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Opiaatit, varmistus",,
1903,"S -Paracoccidioidomyces, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600872,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Paracoccidioidomyces, vasta-aineet",,
1904,"Parainfluenza 1 virus, antigen",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3010464,Parainfluenza virus 1 Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600873,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Parainfluenssa 1 -virus, antigeeni",,
1905,"Li-Parainfluenza 1 Virus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600874,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Parainfluenssa 1 -virus, IgG-vasta-aineet",,
1906,"S -Parainfluenza 1 virus, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600875,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parainfluenssa 1 -virus, IgG-vasta-aineet",,
1907,"Parainfluenza 2 virus, antigen",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3021578,Parainfluenza virus 2 Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600876,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Parainfluenssa 2 -virus, antigeeni",,
1908,"Parainfluenza 3 virus, antigen",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3005880,Parainfluenza virus 3 Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600877,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Parainfluenssa 3 -virus, antigeeni",,
1909,"Li-Parainfluenza 3 Virus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600878,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Parainfluenssa 3 -virus, IgG-vasta-aineet",,
1910,"S -Parainfluenza 3 virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600879,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parainfluenssa 3 -virus, vasta-aineet",,
1911,Ts-Parasites (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600880,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Parasiitit (kval),,
1912,Sk-Parasites (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600881,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sk-Parasiitit (kval),,
1913,S -Paroxetine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600882,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Paroksetiini,,
1914,"S-Mumps virus, IgM antibodies (parotitis virus)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600883,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sikotautivirus, IgM-vasta-aineet",,
1915,"Li-Mumps virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600884,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Sikotautivirus, vasta-aineet",,
1916,"S -Parvovirus, Antibodies, Avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600885,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parvovirus, vasta-aineet, aviditeetti",,
1917,"Picornavirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600886,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pikornavirus, nukleiinihappo (kval)",,
1918,"Northern Epilepsy (EPMP), DNA Test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600887,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pohjoinen epilepsia (EPMP), DNA-tutkimus",,
1919,"Progressive myoclonus epilepsy, DNA examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600888,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Progressiivinen myoklonusepilepsia, DNA-tutkimus",,
1920,"B -Prothrombene gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600889,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Protrombiinigeeni, DNA-tutkimus",,
1921,"Li-Puumalavirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600890,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Puumala-virus, IgG-vasta-aineet",,
1922,"Li-Puumalavirus, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600891,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Puumala-virus, IgM-vasta-aineet",,
1923,"S -Puumalavirus, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012447,Hantavirus puumala IgG Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000600892,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puumala-virus, IgG-vasta-aineet",,
1924,"Li-Puumalavirus, Antibodies, Avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600893,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Puumala-virus, vasta-aineet, aviditeetti",,
1925,"Li-TBE virus, IgM antibodies (tick-borne encephalitis virus)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42868415,European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600894,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Puutiaisaivokuumevirus, IgM-vasta-aineet",,
1926,"Li-TBE virus, antibodies (tick-borne encephalitis virus)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42868415,European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600895,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Puutiaisaivokuumevirus, vasta-aineet",,
1926,"Li-TBE virus, antibodies (tick-borne encephalitis virus)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42868418,European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600895,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Puutiaisaivokuumevirus, vasta-aineet",,
1927,"S -Pyruvate Dehydrogenase (PDH), Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600896,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Pyruvaattidehydrogenaasi (PDH), vasta-aineet",,
1928,P -Reptilastid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600897,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Reptilaasiaika,,
1929,"Li-RS virus, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600898,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-RS-virus, IgG-vasta-aineet",,
1930,S -Risperidone,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3038864,risperiDONE [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600899,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Risperidoni,,
1931,"Li-Rotavirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600900,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Rotavirus, IgG-vasta-aineet",,
1932,"S -Rotavirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600901,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Rotavirus, IgG-vasta-aineet",,
1933,"Li-Rubella virus, IgG antibodies (Red dog virus)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600902,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Vihurirokkovirus, IgG-vasta-aineet",,
1934,"Li-Rubella virus, antibodies (Red dog virus)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600903,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Vihurirokkovirus, vasta-aineet",,
1935,"Li-Rubella virus, antibodies, avidity (Red dog virus)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600904,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Vihurirokkovirus, vasta-aineet, aviditeetti",,
1936,U-Schistosoma (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600905,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Schistosoma (kval),,
1937,S -Sertraline,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3013676,Sertraline [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600906,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sertraliini,,
1938,"B -Swamp, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600907,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Sieni, viljely",,
1939,"S -Sindbis virus, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600908,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sindbis-virus, IgG-vasta-aineet",,
1940,U -Cells,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3029287,Urinalysis microscopic panel [#/volume] - Urine by Automated count,Measurement,MAPS_TO,,HUS,1596153600000,,2000600909,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Solut,,
1941,"U -Cells, differential calculus",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40761539,Cells [Type] in Urine sediment by Light microscopy,Measurement,MAPS_TO,,tays,1630368000000,,2000600910,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Solut, erittelylaskenta",,
1942,"S-Sporothrix, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600911,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sporothrix, vasta-aineet",,
1943,"S -Strongyloides stercoralis, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600912,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Strongyloides stercoralis, vasta-aineet",,
1944,S -Teicoplanin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600913,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Teikoplaniini,,
1945,"S -Toxocara canis / cati, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015350,Toxocara sp Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000600914,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Toxocara canis/cati, vasta-aineet",,
1946,"Li-Toxoplasma, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023835,Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600915,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Toxoplasma, IgG-vasta-aineet",,
1947,"Li-Toxoplasma, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3022577,Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000600916,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Toxoplasma, IgM-vasta-aineet",,
1948,"Li-Toxoplasma, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600917,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Toxoplasma, vasta-aineet",,
1949,"S Transferrin receptor, soluble",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3015399,Transferrin receptor.soluble [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600918,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Transferriinireseptori, liukoinen",,
1950,S -Transferrin receptor-ferritin-index,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600919,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Transferriinireseptori-ferritiini-indeksi,,
1951,"Trichomonas, Sensitivity Determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600920,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Trichomonas, herkkyysmääritys",,
1952,Trichinella spiralis (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600921,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Trichinella spiralis (kval),,
1953,"Li-Treponema pallidum, FTA-absorption",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600922,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Treponema pallidum, FTA-absorptio",,
1954,"S -Trypanosoma brucei, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600923,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Trypanosoma brucei, vasta-aineet",,
1955,"S -Trypanosoma cruzi, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600924,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Trypanosoma cruzi, vasta-aineet",,
1956,"U-Zopiclone, screening (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600925,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Tsopikloni, seulonta (kval)",,
1957,"Li-Varicella-Zoster Virus, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40761849,Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600926,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Vesirokkovirus, IgG-vasta-aineet",,
1958,S -Venlafaxine,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3045519,Venlafaxine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600927,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Venlafaksiini,,
1959,"P -von Willebrand factor, F VIII binding capacity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600928,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -von Willebrand-tekijä, F VIII sitomiskyky",,
1960,"X-linked retinoschis, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600929,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"X-koromosomin periytyvä retinokiisi, DNA-tutkimus",,
1984,U-Jodid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600930,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Jodidi,,
1988,B -Cadmium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600931,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Kadmium,,
1989,U -Cadmium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600932,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kadmium,,
1991,Af-Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600933,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Kalium,,
1992,As-Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600934,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Kalium,,
1993,Di-Kalium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600935,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Kalium,,
1994,dU-Potassium,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3016330,Potassium [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600936,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kalium,,
1995,E -Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600937,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Kalium,,
1996,F -Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600938,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Kalium,,
1997,Gj-Kalium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600939,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Kalium,,
1998,Li-Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600940,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Kalium,,
1999,P -Potassium,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3023103,Potassium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600941,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kalium,,
2000,Pd-Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600942,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Kalium,,
2001,S -Potassium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023103,Potassium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600943,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kalium,,
2002,Sa-Kalium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600944,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Kalium,,
2003,Sw-Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600945,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sw-Kalium,,
2004,U -Potassium,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3016038,Potassium [Moles/volume] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000600946,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kalium,,
2005,"Pt-Potassium, interchangeable",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600947,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Kalium, vaihtuva",,
2006,dU-Calcitonin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600948,LABfi Level 0,Measurement,2004-01-01,2013-12-31,,,dU-Kalsitoniini,,
2007,fP -Calcitonin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600949,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP -Kalsitoniini,,
2008,fS-Calcitonin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3018840,Calcitonin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000600950,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kalsitoniini,,
2009,"S -Calcitonin, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600951,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kalsitoniini, vasta-aineet",,
2010,Pt-Tubular reabsorption of calcium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600952,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Kalsiumin tubulaarinen reabsorptio,,
2011,dU-Calcium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3010838,Calcium [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000600953,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kalsium,,
2012,F -Calcium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600954,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Kalsium,,
2013,S -Calcium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3015377,Calcium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000600955,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kalsium,,
2014,Li-Calcium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600956,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Kalsium,,
2015,Sa-Calcium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600957,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Kalsium,,
2016,U -Calcium,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3018133,Calcium [Moles/volume] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600958,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kalsium,,
2019,"S -Calcium, ionized",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3021347,Calcium.ionized [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600959,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kalsium, ionisoitunut",,
2020,"dU-Calcium, ionized",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600960,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Kalsium, ionisoitunut",,
2021,"F -Campylobacter, culture",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006418,Campylobacter sp identified in Tissue by Organism specific culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000600961,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Campylobacter, viljely",,
2023,"Pt-Capnography, arterial-end-tidal-pCO2",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600962,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Kapnografia, arteria-end-tidal-pCO2",,
2024,Pt-Capnography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600963,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Kapnografia,,
2026,Li-Carbamazepine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600964,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Karbamatsepiini,,
2027,S -Carbamazepine,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3018980,carBAMazepine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600965,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Karbamatsepiini,,
2028,Pt-Pressure measurement of esophagus and cardia,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600966,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Esofaguksen ja kardian painemittaus,,
2029,Pt-pH measurement of esophagus and cardia,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600967,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Esofaguksen ja kardian pH-mittaus,,
2030,"Pt-Cardia and esophagus, reflux",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600968,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Kardia ja esofagus, refluksi",,
2031,"S -Cardiolipin, Antibodies (VDRL)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3029634,Reagin Ab [Titer] in Serum by VDRL,Measurement,MAPS_TO,,HUS,1596153600000,,2000600969,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kardiolipiini, vasta-aineet (VDRL)",,
2032,U -Karnitin (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600970,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Karnitiini (kval),,
2033,fS-Carotene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600971,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Karoteenit,,
2034,S -Carcinoembryonic antigen,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3003785,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600972,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Karsinoembryonaalinen antigeeni,,
2035,fS Growth Hormone,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3046904,Somatotropin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000600973,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kasvuhormoni,,
2036,S -Releasing hormone for growth hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600974,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kasvuhormonin vapauttajahormoni,,
2037,Ts-Releasing Hormone Releasing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600975,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Kasvuhormonin vapauttajahormoni,,
2038,"S -Growth hormone, 24h curve",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600976,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kasvuhormoni, 24h-käyrä",,
2039,F -Katalas (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600977,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Katalaasi (kval),,
2040,fS-Chenodeoxycholate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600978,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kenodeoksikolaatti,,
2041,S -Ceruloplasmin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3022756,Ceruloplasmin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600979,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Keruloplasmiini,,
2042,"Pt-Central blood circulation, color dilution",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600980,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Keskeisverenkierto, värilaimennus",,
2043,"Pt-Central blood circulation, ear densitometry",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600981,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Keskeisverenkierto, korvadensitometri",,
2050,Pt-Total lung resistance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600982,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,Pt-Keuhkojen kokonaisvastus,,
2051,Pt Lungs Maximum Exhalation Pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600983,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Keuhkojen maksimaalinen uloshengityspaine,,
2052,Pt Lungs Maximum Inhalation Pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600984,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Keuhkojen maksimaalinen sisäänhengityspaine,,
2053,F -Enterobius vermicularis (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600985,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Enterobius vermicularis (kval),,
2054,S -Kinidine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600986,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kinidiini,,
2055,Sewing Crystals (Qual),-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3050238,Crystals [Presence] in Synovial fluid by Light microscopy,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600987,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Kiteet (kval),,
2056,Bi-Stone Analysis (Concrement),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600988,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bi-Kivianalyysi,,
2057,Gi-Stone Analysis (Concrement),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600989,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gi-Kivianalyysi,,
2058,U-Stone Analysis (Concretion),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600990,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kivianalyysi,,
2059,"Chlamydia trachomatis, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600991,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Chlamydia trachomatis, viljely",,
2060,"S-Chlamydia, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600992,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia, vasta-aineet",,
2061,"Pt-Clinical stress test, special examination, anamnestic circumstances",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600993,LABfi Level 0,Measurement,2004-01-01,2008-12-31,,,"Pt-Kliininen rasituskoe, erikoistutkimus, anamnestiset olosuhteet",,
2062,"Pt-Clinical load test, other load",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600994,LABfi Level 0,Measurement,2004-01-01,2008-12-31,,,"Pt-Kliininen rasituskoe, muu rasitus",,
2063,"Pt-Clinical load test, pulse-based, cycling ergometry",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600995,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Kliininen rasituskoe, pulssijohteinen, pyöräergometri",,
2064,"Pt-Clinical load test, heart rate based, treadmill",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600996,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Kliininen rasituskoe, pulssijohteinen, juoksumatto",,
2065,"Pt-Clinical load test, spiroergometry",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600997,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Kliininen rasituskoe, spiroergometria",,
2068,"Pt-Clinical load test, work-based, bicycle ergometry",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4094501,Cardiovascular stress test using bicycle ergometer,Measurement,MAPS_TO,,TYKS,1631577600000,,2000600998,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Kliininen rasituskoe, työjohteinen, pyöräergometri",,
2069,"Pt-Clinical load test, work-based, treadmill",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000600999,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Kliininen rasituskoe, työjohteinen, juoksumatto",,
2070,"Pt-Clinical load test, free load",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601000,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Kliininen rasituskoe, vapaa rasitus",,
2072,Gj-hydrochloric acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601001,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Kloorivetyhappo,,
2073,Off-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601002,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Kloridi,,
2074,As-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601003,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Kloridi,,
2075,Gj-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601004,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Kloridi,,
2076,Di-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601005,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Kloridi,,
2077,dU-Chloride,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006567,Chloride [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601006,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kloridi,,
2078,F-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601007,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Kloridi,,
2079,Li-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601008,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Kloridi,,
2080,P-Chloride,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3014576,Chloride [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601009,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kloridi,,
2081,Pd-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601010,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Kloridi,,
2082,S-Chloride,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014576,Chloride [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601011,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kloridi,,
2083,Sa-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601012,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Kloridi,,
2084,Sw-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601013,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sw-Kloridi,,
2085,Sy-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601014,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Kloridi,,
2086,U-Chloride,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007733,Chloride [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601015,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kloridi,,
2087,S -Chloroquine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601016,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klorokiini,,
2089,B-Coagulation Retraction,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601017,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,B -Koageliretraktio,,
2090,fS-Cholat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601018,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kolaatti,,
2092,S -Cholecystokinin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601019,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kolekystokiniini,,
2093,S -Cholecystokinintest,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601020,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Kolekystokiniini-koe,,
2094,"F -Vibrio cholerae, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601021,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Vibrio cholerae, viljely",,
2095,fS-Cholesterol,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019900,Cholesterol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601022,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kolesteroli,,
2096,fS-Cholesterol Esters,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601023,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kolesteroliesterit,,
2097,"fS-Cholesterol, high density lipoproteins",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023602,Cholesterol in HDL [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601024,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-kolesteroli, high density lipoproteiinit",,
2098,"fS-Cholesterol, chylomicrons",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601025,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-kolesteroli, kylomikronit",,
2099,"fS-Cholesterol, low density lipoproteins",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001308,Cholesterol in LDL [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601026,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-kolesteroli, low density lipoproteiinit",,
2100,"fS-Cholesterol, very low density lipoproteins",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601027,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-kolesteroli, very low density lipoproteiinit",,
2101,S -Colinesterase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601028,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Koliiniesteraasi,,
2102,S -Colinesterase (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601029,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Koliiniesteraasi (kval),,
2103,S -Colloidosmotic pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601030,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kolloidiosmoottinen paine,,
2104,U -Colloidosmotic pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601031,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kolloidiosmoottinen paine,,
2106,S -Complement C3,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000620,Complement C3 [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601032,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Komplementti C3,,
2107,S -Complement C4,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017766,Complement C4 [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601033,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Komplementti C4,,
2108,Pt-Lung compliance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601034,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,Pt-Keuhkojen komplianssi,,
2110,Pt-Measurement of Respiratory Work,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601035,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Hengitystyön mittaus,,
2113,S -Conglutinin-bound immune complexes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601036,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Konglutiiniiniin sitoutuneet immunokompleksit,,
2114,T -Contractile Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601037,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,T -Kontraktiili proteiini,,
2115,F -Coproporphyrin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601038,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Koproporfyriini,,
2116,dU-Coproporphyrin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601039,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Koproporfyriini,,
2117,B -Coproporphyrin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601040,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Koproporfyriini,,
2119,Bm-Coproporphyrinogen oxidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601041,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-Koproporfyrinogeenioksidaasi,,
2120,E -Coproporphyrinogen oxidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601042,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Koproporfyrinogeenioksidaasi,,
2121,dU-Coriongonadotropin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601043,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Koriongonadotropiini,,
2122,S -Coriongonadotropin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3018171,Choriogonadotropin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601044,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Koriongonadotropiini,,
2123,U -Coriongonadotropin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601045,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Koriongonadotropiini,,
2124,U -Coriongonadotropin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023511,Choriogonadotropin [Units/volume] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000601046,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Koriongonadotropiini (kval),,
2125,dU-Chorionic gonadotropin-B subunit,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601047,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Koriongonadotropiini-B-alayksikkö,,
2126,B -Coriongonadotropin-B subunit,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601048,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Koriongonadotropiini-B-alayksikkö,,
2128,P -Cortisol,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036481,Cortisol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601049,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kortisoli,,
2129,S -Cortisol,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3036481,Cortisol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601050,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kortisoli,,
2130,"dU-Cortisol, free",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020911,Cortisol [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601051,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Kortisoli, vapaa",,
2131,dU-Creatine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3025549,Creatine [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601052,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kreatiini,,
2132,S -Creatin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006442,Creatine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601053,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kreatiini,,
2133,U -Creatine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022689,Creatine [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601054,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kreatiini,,
2134,S -Kreatinkinas,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007220,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601055,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kreatiinikinaasi,,
2135,"S -Creatin kinase, MB subunit",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3029790,Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601056,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kreatiinikinaasi, MB-alayksikkö",,
2136,"Li-Creatine kinase, isoenzymes",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601057,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Kreatiinikinaasi, isoentsyymit",,
2137,"S -Creatin kinase, isoenzyme",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036604,Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis,Measurement,MAPS_TO,,HUS,1596153600000,,2000601058,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kreatiinikinaasi, isoentsyymit",,
2138,Am-Creatinine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601059,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Kreatiniini,,
2139,As-Creatinine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601060,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Kreatiniini,,
2140,Di-Creatinine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601061,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Kreatiniini,,
2141,dU-Creatinine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3025549,Creatine [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601062,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kreatiniini,,
2142,fP-Creatinine,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3020564,Creatinine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601063,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Kreatiniini,,
2143,fS-Creatinine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020564,Creatinine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601064,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kreatiniini,,
2144,Pd-Creatinine,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3037441,Creatinine [Moles/volume] in Peritoneal dialysis fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000601065,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Kreatiniini,,
2145,U -Creatinine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009508,Creatinine [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601066,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kreatiniini,,
2146,Pt-Creatininclearance,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40771922,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood",Measurement,MAPS_TO,,HUS,1596153600000,,2000601067,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Kreatiniinin poistuma,,
2147,B -Krom,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601068,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Kromi,,
2148,S -Krom,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601069,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kromi,,
2149,U -Krom,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601070,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kromi,,
2150,Am-Chromosome Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601071,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Kromosomitutkimus,,
2151,B -Chromosome examination,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40765089,Chromosome analysis panel - Blood by G-banded,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601072,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Kromosomitutkimus,,
2152,Bm -Chromosome examination,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,21494434,Karyotype in Bone marrow,Measurement,MAPS_TO,,HUS,1596153600000,,2000601073,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-Kromosomitutkimus,,
2153,L -Chromosome examination,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601074,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,L -Kromosomitutkimus,,
2154,Sk-Chromosome Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601075,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sk-Kromosomitutkimus,,
2155,P -Cryofibrinogen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601076,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kryofibrinogeeni,,
2156,P -Cryoglobulin (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601077,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kryoglobuliini (kval),,
2157,S -Cryoglobulin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601078,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kryoglobuliini (kval),,
2158,P -Cryoprecipitation Analysis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601079,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Kryopresipitaatin analyysi,,
2159,S -Cryoprecipitation Analysis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601080,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kryopresipitaatin analyysi,,
2160,"S -Cryptococcus neoformans, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601081,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Cryptococcus neoformans, vasta-aineet",,
2161,Pt-K Vitamin Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601082,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-K-vitamiinikoe,,
2162,Li-Xantochrome (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601083,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Ksantokromia (kval),,
2163,U-Xanthurenate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601084,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Ksanturenaatti,,
2164,U -Xanthurenate (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601085,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Ksanturenaatti (kval),,
2165,Pt-Xylostest,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601086,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Ksyloosi-koe,,
2166,Ly-Tissue Antigen,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3034614,HLA Ag [Interpretation],Measurement,MAPS_TO,,tays,1630368000000,,2000601087,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ly-Kudosantigeeni,,
2167,S -Gold,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601088,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kulta,,
2168,U -Gold,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601089,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kulta,,
2169,dU-Copper,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3033942,Copper [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601090,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kupari,,
2170,S -Coppers,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001186,Copper [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601091,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kupari,,
2171,U -Coppers,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3045177,Copper [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601092,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kupari,,
2173,S -Coldagglutinins,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001686,Cold agglutinin [Titer] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601093,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kylmähemagglutiniinit,,
2174,E -Call hemolysis (Donath-Landsteiner),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601094,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,E -Kylmähemolyysi (Donath-Landsteiner),,
2175,fS-Chylomicrons (Qual),-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3020132,Chylomicrons [Presence] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601095,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kylomikronit (kval),,
2176,Dj-Kymotrypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601096,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Dj-Kymotrypsiini,,
2177,F -Kymotrypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601097,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Kymotrypsiini,,
2178,Pa-Kymotrypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601098,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pa-Kymotrypsiini,,
2180,"Fly caterpillar, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601099,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Kärpästoukka, natiivivalmiste",,
2182,Ts-Laktas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601100,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Laktaasi,,
2183,B-Lactate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3047181,Lactate [Moles/volume] in Blood,Measurement,MAPS_TO,,tays,1630368000000,,2000601101,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Laktaatti,,
2184,fP-Lactate,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3014111,Lactate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601102,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Laktaatti,,
2186,Li-Lactate,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3035999,Lactate [Moles/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601103,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Laktaatti,,
2187,"S-Lactate dehydrogenase, isoenzymes",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009347,Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601104,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Laktaattidehydrogenaasi, isoentsyymit",,
2188,"S-Lactate dehydrogenase, heat stable",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601105,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Laktaattidehydrogenaasi, lämpöstabiili",,
2190,Lactate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601106,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Laktaattidehydrogenaasi,,
2191,E-Lactate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601107,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Laktaattidehydrogenaasi,,
2192,Li-Lactate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601108,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Laktaattidehydrogenaasi,,
2193,Pf-Lactate dehydrogenase,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40763082,Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction,Measurement,MAPS_TO,,HUS,1596153600000,,2000601109,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Laktaattidehydrogenaasi,,
2194,S-Lactate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601110,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Laktaattidehydrogenaasi,,
2195,U-Lactate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601111,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Laktaattidehydrogenaasi,,
2196,S-Placental lactogen hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601112,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Laktogeeninen hormoni, istukkaperäinen",,
2197,Pt-Lactose Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601113,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Laktoosi-koe,,
2198,"S -Langerhans cell islands, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3019628,Pancreatic islet cell Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601114,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Langerhansin saareke, vasta-aineet",,
2199,S-Lanosterol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601115,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Lanosteroli,,
2200,"Pt-Venous Reflux, Plethysmography",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601116,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Laskimovirtaus, plethysmografia",,
2201,"Pt-Venous reflux, Doppler measurement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601117,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Laskimovirtaus, doppler-mittaus",,
2202,"Pt-Venous reflux, pressure, bloody",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601118,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Laskimovirtaus, -paine, verinen",,
2203,B -Sink,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3013707,Erythrocyte sedimentation rate by Westergren method,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601119,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lasko,,
2205,"S -Legionella, Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3050794,Legionella sp Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601120,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Legionella, vasta-aineet",,
2206,"Legionella, cultivation",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3037692,Legionella sp identified in Specimen by Organism specific culture,Measurement,MAPS_TO,,tays,1630368000000,,2000601121,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Legionella, viljely",,
2207,"S -Comilk, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601122,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Lehmänmaito, vasta-aineet",,
2209,Leishmania (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601123,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Leishmania (kval),,
2210,"Leishmania, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601124,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Leishmania, viljely",,
2211,"S -Leptospira, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601125,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Leptospira, vasta-aineet",,
2213,Am-Lecithin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601126,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Lesitiini,,
2214,The Am-Lecithin / Sphingomyelin Ratio,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601127,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Lesitiini/sfingomyeliini -suhde,,
2215,Af-Leukocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601128,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Leukosyytit,,
2216,As-Leukocyte,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601129,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Leukosyytit,,
2217,Ex-Leukocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601130,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ex-Leukosyytit,,
2218,fB-Leukocytes,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3010813,Leukocytes [#/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601131,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fB-Leukosyytit,,
2219,Li-Leukocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016543,Leukocytes [#/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601132,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Leukosyytit,,
2220,Pf leukocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023199,Leukocytes [#/volume] in Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601133,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Leukosyytit,,
2221,U-Leukocytes,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3018095,Leukocytes [#/volume] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601134,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Leukosyytit,,
2223,U-Leukocytes (Qual),-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3045414,Leukocytes [Presence] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601135,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Leukosyytit (kval),,
2224,"Af-Leukocytes, differential calculus",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601136,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Af-Leukosyytit, erittelylaskenta",,
2225,"B -Leucocytes, differential calculus",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42870588,"Differential panel, method unspecified - Blood",Measurement,MAPS_TO,,HUS,1596153600000,,2000601137,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Leukosyytit, erittelylaskenta",,
2226,"Dj Leukocytes, Differential Calculus",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601138,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Dj-Leukosyytit, erittelylaskenta",,
2227,"Gj-Leukocytes, differential calculus",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601139,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Gj-Leukosyytit, erittelylaskenta",,
2228,"Li-Leukocytes, Differential Calculus",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016018,Differential panel - Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601140,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Leukosyytit, erittelylaskenta",,
2229,"L-Leukocytes, Phagocytosis Capability",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601141,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"L -Leukosyytit, fagosytointikyky",,
2230,"S -Granulocyte, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601142,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"S -Granulosyytti, vasta-aineet",,
2231,S -Leucine-encephalin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601143,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Leusiinienkefaliini,,
2232,S -Leucine aminopeptidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601144,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Leusiiniaminopeptidaasi,,
2233,U-Leucine Aminopeptidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601145,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Leusiiniaminopeptidaasi,,
2234,Pt-Leucine Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601146,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Leusiini-koe,,
2236,S -Lidocaine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601147,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Lidokaiini,,
2238,"M -Myofibrillary, distribution",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601148,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"M -Lihassäikeet, jakauma",,
2239,"Pt-Grip strength, hand muscles",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601149,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Lihasten puristusvoima, käsi",,
2240,Pt Muscle Blood Circulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601150,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Lihasverenkierto,,
2241,dU-Lipas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601151,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Lipaasi,,
2242,fS-Lipas,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004905,Lipase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601152,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Lipaasi,,
2243,Pa-Lipas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601153,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pa-Lipaasi,,
2244,U -Lipas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601154,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Lipaasi,,
2245,fS-Lipids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601155,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Lipidit,,
2246,Li-Lipofager,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601156,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Li-Lipofagit,,
2247,"fS-Lipoprotein, apoA1",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601157,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, apo A1",,
2248,"fS-Lipoprotein, apoB",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3014791,Apolipoprotein B [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601158,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, apo B",,
2249,"fS-Lipoprotein, chylomicrons",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601159,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"fS-Lipoproteiini, kylomikronit",,
2250,"fS-Lipoprotein, pre-beta",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601160,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, pre-beeta",,
2251,fS-Lipoprotein X,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601161,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Lipoproteiini X,,
2252,"fS-Lipoprotein, Fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601162,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, fraktiot",,
2253,Sy-Lipoproteins,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601163,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Lipoproteiinit,,
2254,"fS-Lipoprotein, ultracentrifugation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601164,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, ultrasentrifugointi",,
2255,fP-Lipoprotein lipase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601165,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Lipoproteiinilipaasi,,
2256,"S -Listeria, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3029612,Listeria sp Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601166,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Listeria, vasta-aineet",,
2257,"Listeria, cultivation",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020356,Listeria sp identified in Specimen by Organism specific culture,Measurement,MAPS_TO,,tays,1630368000000,,2000601167,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Listeria, viljely",,
2258,"S-Adrenal gland, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3011628,Adrenal Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601168,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Lisämunuainen, vasta-aineet",,
2259,Li-Lithium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601169,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Litium,,
2260,S -Lithium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024666,Lithium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601170,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Litium,,
2261,U -Lithium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3038195,Lithium [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601171,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Litium,,
2262,fS-Litocholate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601172,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Litokolaatti,,
2263,Pt-LRH-test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601173,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-LRH-koe,,
2264,dU-Luteinizing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601174,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Luteinisoiva hormoni,,
2265,S -Luteinizing hormone,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3009214,Lutropin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601175,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Luteinisoiva hormoni,,
2266,U-Luteinizing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601176,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Luteinisoiva hormoni,,
2267,S -Releasing hormone for luteinizing hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601177,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Luteinisoivan hormonin vapauttajahormoni,,
2269,"Bm-Bone marrow examination, MGG and iron staining",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3042111,Morphology [Interpretation] in Bone marrow Narrative,Measurement,MAPS_TO,,HUS,1596153600000,,2000601178,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bm-Luuydintutkimus, MGG- ja rautavärjäys",,
2271,B -Bly,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003577,Lead [Moles/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601179,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lyijy,,
2272,dU-Bly,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001317,Lead [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601180,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Lyijy,,
2273,Ha-Bly,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601181,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ha-Lyijy,,
2274,U -Bly,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002480,Lead [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601182,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Lyijy,,
2275,"B -Lymphocytes, differential calculus",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601183,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Lymfosyytit, erittely",,
2276,"Ts-Lymphocytes, Differential Counting",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601184,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Ts-Lymfosyytit, erittely",,
2277,BA Lymphocyte ConA Stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601185,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyyttien ConA-stimulaatio,,
2278,B -Lymphocytes' PHA Stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601186,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyyttien PHA-stimulaatio,,
2280,B -Lymphocytes' PWM Stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601187,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyyttien PWM-stimulaatio,,
2281,Ly-Lymphocyte-mediated lysis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601188,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ly-Lymfosyyttivälitteinen lyysi,,
2282,P -Lysinvasopressin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601189,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Lysiinivasopressiini,,
2283,P -Lysosomal acid hydrolase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601190,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Lysosomaalinen hapan hydrolaasi,,
2284,dU-Lysozyme,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601191,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Lysotsyymi,,
2285,Fl-Lysozyme,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601192,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Fl-Lysotsyymi,,
2286,Lf-Lysozyme,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601193,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Lf-Lysotsyymi,,
2287,Li-Lysozyme,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40759057,Lysozyme [Mass/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601194,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Lysotsyymi,,
2288,Pf-Lysozyme,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40758047,Lysozyme [Mass/volume] in Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601195,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Lysotsyymi,,
2289,S -Lysozyme,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3012110,Lysozyme [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601196,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Lysotsyymi,,
2290,U-Lysozyme,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008343,Lysozyme [Mass/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601197,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Lysotsyymi,,
2291,U -Lysozyme (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601198,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Lysotsyymi (kval),,
2292,"Bm-Lysozyme, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601199,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Lysotsyymi, värjäys",,
2293,"L -Lysozyme, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601200,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"L -Lysotsyymi, värjäys",,
2294,Gj-Läkemedelsscreening (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601201,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Lääkeaineseulonta (kval),,
2295,U -Läkemedelsscreening (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601202,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Lääkeaineseulonta (kval),,
2298,Di-Magnesium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601203,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Magnesium,,
2299,dU-Magnesium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017937,Magnesium [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601204,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Magnesium,,
2300,E -Magnesium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601205,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Magnesium,,
2301,F -Magnesium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601206,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Magnesium,,
2302,Li-Magnesium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601207,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Magnesium,,
2303,S -Magnesium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3012095,Magnesium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601208,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Magnesium,,
2304,Sp-Magnesium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601209,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sp-Magnesium,,
2305,U -Magnesium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017400,Magnesium [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601210,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Magnesium,,
2306,"Pt-Mage, acid secretion (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601211,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Maha, haponeritys (kval)",,
2307,"Pt-Mage, stimulated acid secretion, breakfast (quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601212,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Maha, haponeritys, koeaamiainen-stimulaatio (kvant)",,
2308,"Pt-Stomach, Stimulated Acid Secretion, Histamine (Quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601213,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Maha, haponeritys, histamiini-stimulaatio (kvant)",,
2309,"Pt-Stomach, Stimulated Acid Secretion, Insulin (Quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601214,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Maha, haponeritys, insuliini-stimulaatio (kvant)",,
2310,"Pt-Stomach, Stimulated Acid Secretion, Pentagastrin (Quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601215,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Maha, haponeritys, pentagastriini-stimulaatio (kvant)",,
2311,"Pt-Mage, long-term registration of pH",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601216,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Maha, pH:n pitkäaikaisrekisteröinti",,
2312,"Pt-Stomach, emptying rate",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601217,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Maha, tyhjenemisnopeus",,
2313,"S -Liver and renal microsomes, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003265,Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence,Measurement,MAPS_TO,,HUS,1596153600000,,2000601218,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Maksa- ja munuaismikrosomi, vasta-aineet",,
2315,B -Plasmodium (qual.),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3004446,Plasmodium sp identified in Blood by Light microscopy,Measurement,MAPS_TO,,tays,1630368000000,,2000601219,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Plasmodium (kval),,
2316,E -Plasmodium (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601220,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Plasmodium (kval),,
2317,"S -Plasmodium, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40760087,Plasmodium sp Ab [Presence] in Serum by Immunofluorescence,Measurement,MAPS_TO,,tays,1630368000000,,2000601221,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Plasmodium, vasta-aineet",,
2318,Ts-Maltas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601222,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Ts-Maltaasi,,
2319,Pt-Maltostest,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601223,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Maltoosi-koe,,
2320,U -Mandelat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601224,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Mandelaatti,,
2321,dU-Manganese,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601225,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Mangaani,,
2322,P -Mangan,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601226,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Mangaani,,
2323,U -Mangan,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601227,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Mangaani,,
2324,Li-Mastix Reaction,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601228,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Mastixreaktio,,
2325,S -Mexiletin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601229,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Meksiletiini,,
2326,U -Melanin (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601230,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Melaniini (kval),,
2327,Ts-Melanostatin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601231,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Melanosyyttejä stimuloivan hormonin eritystä estävä hormoni,,
2328,S -Melanocyte Stimulating Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601232,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Melanosyyttejä stimuloiva hormoni,,
2329,S -Melatonin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601233,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Melatoniini,,
2330,"S -Neisseria meningitidis, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3016732,Neisseria meningitidis Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601234,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Neisseria meningitidis, vasta-aineet",,
2332,U -Meprobamat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601235,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Meprobamaatti,,
2333,U -Meprobamat (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601236,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Meprobamaatti (kval),,
2334,U -Methadon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601237,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metadoni,,
2335,U -Methadone (qual.),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028707,Methadone [Presence] in Urine by Screen method,Measurement,MAPS_TO,,HUS,1596153600000,,2000601238,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metadoni (kval),,
2336,dU-Metanephrine,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3033923,Metanephrine [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601239,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Metanefriini,,
2337,dU-Metanephrine and Normethanephrine,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3000213,Normetanephrine [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601240,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Metanefriini ja normetanefriini,,
2337,dU-Metanephrine and Normethanephrine,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3033923,Metanephrine [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601240,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Metanefriini ja normetanefriini,,
2338,S -Methanephrine and Normethanephrine,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009340,Metanephrine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601241,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Metanefriini ja normetanefriini,,
2338,S -Methanephrine and Normethanephrine,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3026179,Normetanephrine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601241,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Metanefriini ja normetanefriini,,
2338,S -Methanephrine and Normethanephrine,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3030408,3-Methoxytyramine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601241,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Metanefriini ja normetanefriini,,
2339,B -Methanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601242,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Metanoli,,
2340,S -Methanol,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3008402,Methanol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601243,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Metanoli,,
2341,S -Methemalbumin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601244,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Methemalbumiini,,
2342,B-Methemoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007930,Methemoglobin/Hemoglobin.total in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601245,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Methemoglobiini,,
2343,B -Methemoglobin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601246,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Methemoglobiini (kval),,
2344,S -Metioninencephalin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601247,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Metioniinienkefaliini,,
2345,dU-Methoxyhydroxymandelate,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3012403,Metanephrines [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601248,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Metoksihydroksimandelaatti,,
2346,S -Metotrexate,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3017115,Methotrexate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601249,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Metotreksaatti,,
2347,Pt-Metyrapontest,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601250,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Metyraponi-koe,,
2348,dU-Methyl malonate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601251,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Metyylimalonaatti,,
2349,S-Mianserin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601252,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Mianseriini,,
2350,B -Microfilaria,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601253,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Mikrofilariat,,
2351,"Pt-Hjärtat's minute volume, Ficks method",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601254,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sydämen minuuttitilavuus, Fickin menetelmä",,
2353,"Pt-Hjärtat's minute volume, heat dilution",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601255,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sydämen minuuttitilavuus, lämpölaimennus",,
2355,"Pt-Heart's Minute Volume, Color Dilution",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601256,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sydämen minuuttitilavuus, värilaimennus",,
2357,"S-mitochondria, antibodies",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3034770,Mitochondria Ab [Titer] in Serum,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601257,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Mitokondria, vasta-aineet",,
2358,"S-Mononucleosis, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601258,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Mononukleoosi, vasta-aineet",,
2359,"S-Mononucleosis, Antibodies, Absorbed",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601259,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Mononukleoosi, vasta-aineet, absorboitu",,
2360,"S-Mononucleosis, antibodies (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3048929,Epstein Barr virus Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601260,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Mononukleoosi, vasta-aineet (kval)",,
2361,P -Motilin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601261,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Motiliini,,
2362,"S-Ovarian, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601262,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Munasarja, vasta-aineet",,
2364,Off-Mucin Reaction (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601263,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Musiinireaktio (kval),,
2365,Sy-Mucin Reaction (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601264,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Musiinireaktio (kval),,
2366,"Mycobacterium, typing",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,36659890,Mycobacterial identification panel - Specimen by Molecular genetics method,Measurement,MAPS_TO,,tays,1630368000000,,2000601265,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycobacterium, tyypitys",,
2367,"S -Mycoplasma pneumoniae, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3027545,Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601266,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Mycoplasma pneumoniae, vasta-aineet",,
2368,"Mycoplasma, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601267,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycoplasma, viljely",,
2369,S -Myoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005895,Myoglobin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601268,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Myoglobiini,,
2370,U -Myoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3011066,Myoglobin [Mass/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601269,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Myoglobiini,,
2371,U -Myoglobin (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601270,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Myoglobiini (kval),,
2372,Off-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601271,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Natrium,,
2373,As-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601272,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Natrium,,
2374,Di-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601273,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Natrium,,
2375,Dj-Natrium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601274,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Dj-Natrium,,
2376,dU-Sodium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002079,Sodium [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601275,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Natrium,,
2377,E-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601276,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Natrium,,
2378,F-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601277,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Natrium,,
2379,Gj-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601278,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Natrium,,
2380,Li-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601279,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Natrium,,
2381,Pd-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601280,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Natrium,,
2382,S-Sodium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019550,Sodium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601281,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Natrium,,
2383,Sa-Natrium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601282,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Natrium,,
2384,Sw-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601283,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sw-Natrium,,
2385,Sy-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601284,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Natrium,,
2386,U-Sodium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003181,Sodium [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601285,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Natrium,,
2387,"Pt-Sodium, interchangeable",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601286,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Natrium, vaihtuva",,
2388,L -Examination of leukocyte phagocytosis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601287,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,L -Leukosyyttien fagosytoositutkimus,,
2391,S -Cyclosporin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601288,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Syklosporiini,,
2392,U -Neuraminides,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601289,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Neuraminidaasi,,
2393,S -Neurotensin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601290,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Neurotensiini,,
2394,L -Neutrophil grananolucytes chemotaxis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601291,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,L -Neutrofiilisten granulosyyttien kemotaksis,,
2395,Ex-Neutrophils,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601292,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ex-Neutrofiilit,,
2396,Ns-Neutrophils,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601293,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ns-Neutrofiilit,,
2397,U -Nickel,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601294,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Nikkeli,,
2398,S -Nitrazepam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601295,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Nitratsepaami,,
2399,Pt-Examination of nitrogen leaching,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601296,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Typen uloshuuhtoutumistutkimus,,
2400,"Pt-Nitrography, single breath",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601297,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Nitrografia, single breath",,
2403,"Nokardia, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601298,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Nokardia, viljely",,
2404,dU-Noradrenaline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601299,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Noradrenaliini,,
2405,P -Noradrenaline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601300,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Noradrenaliini,,
2406,dU-Normetanefrin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3000213,Normetanephrine [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601301,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Normetanefriini,,
2407,S -Normethanephrine,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3026179,Normetanephrine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601302,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Normetanefriini,,
2408,S -Nortriptyline,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3026926,Nortriptyline [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601303,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Nortriptyliini,,
2410,S -Nucleotides (5-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601304,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Nukleotidaasi (5-),,
2411,"Pt-Catheterization of the Right Part of the Heart, Containing Various Measurements",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601305,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sydämen katetrisaatio, oikea puoli, sisältää erilaiset mittaukset",,
2419,Pt-Catheterization and Angiography of the Right Part of the Heart,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601306,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sydämen katetrisaatio ja angiografia, oikea puoli",,
2420,Pt-Synchronization of the Atrium of the Heart,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601307,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Sydämen eteistahdistus,,
2421,dU-Oxalate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3027570,Oxalate [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000601308,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Oksalaatti,,
2422,U -Oxalat (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601309,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Oksalaatti (kval),,
2423,S -Oxazepam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601310,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Oksatsepaami,,
2424,"Pt-Oximetry, short-term",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601311,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Oksimetria, lyhytaikainen",,
2426,"Pt-Oximetry, long-term registration",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601312,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Oksimetria, pitkäaikrekisteröinti",,
2429,"Pt-Oxygen Partial Pressure, Transcutaneous",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601313,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Happiosapaine, transkutaaninen",,
2434,S -Oxytocin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601314,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Oksitosiini,,
2435,U -Opiater (kval),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027008,Opiates [Presence] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601315,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Opiaatit (kval),,
2436,dU-Organic Acids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601316,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Orgaaniset hapot,,
2437,U -Organic acids (qualifiers),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601317,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Orgaaniset hapot (kval),,
2438,S-Ornitine carbamyltransferase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601318,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Ornitiinikarbamyylitransferaasi,,
2440,Pt-Orthostatic Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601319,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Ortostaattinen koe,,
2441,dU-Osmolality,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601320,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Osmolaliteetti,,
2442,nU-Osmolality,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601321,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,nU-Osmolaliteetti,,
2443,S -Osmolality,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3008295,Osmolality of Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601322,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Osmolaliteetti,,
2444,U-Osmolality,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3026782,Osmolality of Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601323,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Osmolaliteetti,,
2445,Pt fasting test (glucose + insulin),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601324,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Paastotutkimus (glukoosi + insuliini),,
2450,Pt-Para-aminohippuratclearance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601325,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Para-aminohippuraatin poistuma,,
2451,S -Paracetamol,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020485,Acetaminophen [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601326,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Parasetamoli,,
2452,S -Paracetamol (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601327,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Parasetamoli (kval),,
2453,U -Paracetamol (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601328,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Parasetamoli (kval),,
2454,B -Parasites (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601329,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Parasiitit (kval),,
2455,F -Parasites (qual.),-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3003327,Ova and parasites identified in Stool by Light microscopy,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601330,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Parasiitit (kval),,
2456,Parasites (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601331,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Parasiitit (kval),,
2457,fS-Parathormon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601332,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Parathormoni,,
2458,Pt-Parathormon Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601333,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Parathormoni-koe,,
2459,"S -Parietal Cell, Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3008717,Parietal cell Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601334,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parietaalisolu, vasta-aineet",,
2460,Bm-PAS dyeing,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601335,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-PAS-värjäys,,
2461,L -PAS staining,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601336,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,L -PAS-värjäys,,
2462,"S-Pasteurella, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601337,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Pasteurella, vasta-aineet",,
2463,"F -Sugar, reducing (qualifying)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601338,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Sokerit, pelkistävät (kval)",,
2464,fS-Pepsinogen I,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3033888,Pepsinogen I [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601339,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Pepsinogeeni I,,
2465,fS-Pepsinogen II,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601340,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Pepsinogeeni II,,
2466,B-Perchlorethylene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601341,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Perkloorietyleeni,,
2467,Pt-Perchlorate Certificate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601342,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Perkloraatti-koe,,
2468,Am-Peroxidas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601343,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Am-Peroksidaasi,,
2469,"Bm-Peroxidase, Dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601344,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Peroksidaasi, värjäys",,
2470,"L -Peroxidase, Dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601345,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"L -Peroksidaasi, värjäys",,
2471,"S -Bordetella pertussis, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3025018,Bordetella pertussis Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601346,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Bordetella pertussis, vasta-aineet",,
2472,"Bordetella pertussis, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601347,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bordetella pertussis, viljely",,
2473,B -Small blood picture,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40761511,CBC panel - Blood by Automated count,Measurement,MAPS_TO,,HUS,1596153600000,,2000601348,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Perusverenkuva,,
2474,B -Small blood count and platelets,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40761511,CBC panel - Blood by Automated count,Measurement,MAPS_TO,,HUS,1596153600000,,2000601349,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Perusverenkuva ja trombosyytit,,
2475,"B -Small blood count, mechanical differential count of leukocytes, cell distribution, platelets",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40758558,Short blood count panel - Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601350,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Perusverenkuva, leukosyyttien erittelylaskenta koneella, solujakauma, trombosyytit",,
2476,"S -Rickettsia, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601351,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Rickettsia, vasta-aineet",,
2477,Am-Surface Voltage,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601352,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Am-Pintajännitys,,
2480,Pt-Plasma Volume,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601353,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Plasman tilavuus,,
2481,"S -Streptococcus pneumoniae, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3006358,Streptococcus pneumoniae Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601354,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Streptococcus pneumoniae, vasta-aineet",,
2482,"Pneumocystis carinii, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601355,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pneumocystis jirovecii, värjäys",,
2483,"S -Cross-banded muscle, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601356,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Poikkijuovalihas, vasta-aineet",,
2484,"S -Poliovirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601357,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Poliovirus, vasta-aineet",,
2485,dU-Porfobilinogen,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020207,Porphobilinogen [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000601358,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Porfobilinogeeni,,
2486,U -Porphobilinogen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601359,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Porfobilinogeeni,,
2487,U -Porphobilinogen (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601360,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Porfobilinogeeni (kval),,
2488,dU-Porphyrins,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3039542,Porphyrins [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000601361,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Porfyriinit,,
2489,F -Porphyrins,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40759632,Porphyrins [Mass/mass] in Stool,Measurement,MAPS_TO,,tays,1630368000000,,2000601362,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Porfyriinit,,
2490,U -Porphyrins,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042628,Porphyrins [Moles/volume] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000601363,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Porfyriinit,,
2492,F -Porphyrins (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601364,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Porfyriinit (kval),,
2493,U -Porphyrins (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601365,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Porfyriinit (kval),,
2494,S -Prealbumin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013742,Prealbumin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601366,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prealbumiini,,
2495,dU-Pregnandiol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601367,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Pregnandioli,,
2496,U -Pregnandiol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601368,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Pregnandioli,,
2497,dU-Pregnantriol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601369,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Pregnantrioli,,
2498,U -Pregnantriol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601370,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Pregnantrioli,,
2499,S -Primidon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601371,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Primidoni,,
2500,P -Coagulation factor V,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005757,Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601372,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hyytymistekijä V,,
2501,dU-Progesterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601373,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Progesteroni,,
2502,S -Progesterone,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3005082,Progesterone [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601374,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Progesteroni,,
2503,"fS-C peptide, proinsulin",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3032836,C peptide [Moles/volume] in Serum or Plasma --fasting,Measurement,MAPS_TO,,tays,1630368000000,,2000601375,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-C-peptidi, proinsuliinin",,
2504,P -Procainamide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601376,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Prokaiiniamidi,,
2505,S-Procainamide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601377,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prokaiiniamidi,,
2506,P -Coagulation factor VII,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3011547,Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601378,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hyytymistekijä VII,,
2507,S -Prolactin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021387,Prolactin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601379,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prolaktiini,,
2508,S -inhibitory hormone for prolactin secretion,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601380,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prolaktiinierityksen estäjähormoni,,
2509,P -Prostaglandin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601381,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Prostaglandiini,,
2510,P -Protamine Sulfate Reaction,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601382,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,P -Protamiinisulfaattireaktio,,
2511,Off-Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601383,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Proteiini,,
2512,As-Protein,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3002331,Protein [Mass/volume] in Peritoneal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000601384,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Proteiini,,
2513,dU-Protein,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020876,Protein [Mass/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601385,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Proteiini,,
2514,Li-Protein,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019473,Protein [Mass/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601386,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Proteiini,,
2515,Pf-Protein,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003434,Protein [Mass/volume] in Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601387,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Proteiini,,
2516,S-Protein,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3020630,Protein [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601388,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Proteiini,,
2517,Se-Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601389,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Se-Proteiini,,
2518,Sy-Protein,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3036670,Protein [Mass/volume] in Synovial fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601390,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Proteiini,,
2519,U -Protein,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3037121,Protein [Mass/volume] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601391,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Proteiini,,
2520,dU Protein Electrophoresis,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,21494890,Protein electrophoresis panel - 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601392,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Proteiini, fraktiot",,
2521,Li-Protein Electrophoresis,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004268,Protein electrophoresis panel - Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601393,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Proteiini, fraktiot",,
2522,S -Protein electrophoresis,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004588,Protein electrophoresis panel - Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601394,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proteiini, fraktiot",,
2523,U -Protein Electrophoresis,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044927,Protein electrophoresis panel - Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601395,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Proteiini, fraktiot",,
2524,"Li-Protein, Fractions, Immunoelectrophoresis",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004268,Protein electrophoresis panel - Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601396,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Proteiini, fraktiot, immunoelektroforeesi",,
2525,"S -Protein, fractions, immunoelectrophoresis",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004588,Protein electrophoresis panel - Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601397,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,"S -Proteiini, fraktiot, immunoelektroforeesi",,
2526,"U-Protein, fractions, immunoelectrophoresis",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044927,Protein electrophoresis panel - Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601398,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,"U -Proteiini, fraktiot, immunoelektroforeesi",,
2527,Af-Protein (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601399,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Proteiini (kval),,
2528,Li-Protein (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601400,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Proteiini (kval),,
2529,U -Protein (kval),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021601,Nitrite [Presence] in Urine by Test strip,Measurement,MAPS_TO,,HUS,1596153600000,,2000601401,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Proteiini (kval),,
2530,"S -Protein-bound radioiodine, 2 h",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601402,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proteiiniin sitoutunut radiojodi, 2 h",,
2531,"S -Protein-bound radioiodine, 24 h",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601403,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proteiiniin sitoutunut radiojodi, 24 h",,
2532,"S -Protein-bound radioiodine, 48 h",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601404,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proteiiniin sitoutunut radiojodi, 48 h",,
2533,"S -Protein bound radioiodine, 72 h",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601405,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proteiiniin sitoutunut radiojodi, 72 h",,
2536,F -Protoporphyrin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601406,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Protoporfyriini,,
2537,B -Protoporphyrin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601407,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Protoporfyriini,,
2538,F -Protoporphyrin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601408,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Protoporfyriini (kval),,
2539,E -Protoporphyrin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601409,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Protoporfyriini (kval),,
2540,Ly-Protoporphyrinogen Oxidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601410,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ly-Protoporfyrinogeenioksidaasi,,
2541,S -Protriptyline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601411,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Protriptyliini,,
2542,P -Prothrombin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005353,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601412,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Protrombiini,,
2543,"P -prothrombin, consumption",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601413,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Protrombiinin konsumptio,,
2544,Pt-Proteinclearance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601414,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Proteiinin poistuma,,
2547,P -Coagulation factor XI,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001850,Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601415,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hyytymistekijä XI,,
2548,"Pt-pulse curve, external, apex cardiography",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601416,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Pulssikäyrä, ulkoinen, apexkardiografia",,
2549,"Pt-pulse curve, external, carotid",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601417,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Pulssikäyrä, ulkoinen, carotis",,
2550,"Pt-Pulskurva, extern, jugularis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601418,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Pulssikäyrä, ulkoinen, jugularis",,
2551,"Pt-pulse curve, external, peripheral, artery",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601419,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Pulssikäyrä, ulkoinen, perifeerinen,valtimo",,
2552,"S -TBE virus, IgG antibodies (tick-borne encephalitis virus)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42868417,European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601420,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puutiaisaivokuumevirus, IgG-vasta-aineet",,
2553,"S -TBE virus, IgM antibodies (tick-borne encephalitis virus)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42868414,European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601421,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puutiaisaivokuumevirus, IgM-vasta-aineet",,
2554,B -Pyruvate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3011048,Pyruvate [Moles/volume] in Blood,Measurement,MAPS_TO,,tays,1630368000000,,2000601422,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Pyruvaatti,,
2555,P -Pyruvate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601423,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Pyruvaatti,,
2556,E -Pyruvatkinas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601424,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Pyruvaattikinaasi,,
2557,"S -Coxiella burnetii, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3019768,Coxiella burnetii Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601425,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Coxiella burnetii, vasta-aineet",,
2560,dF-Fatty acids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601426,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dF-Rasvahapot,,
2561,"fS-Fatty acids, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601427,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Rasvahapot, vapaat",,
2562,"F -Fats, microscopic examination (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601428,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Rasvat, mikroskooppinen tutkimus (kval)",,
2563,Pt Iron Absorption Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601429,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Raudan absorptio-koe,,
2565,fS-Iron binding capacity,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601430,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Raudansitomiskyky,,
2566,fS-Iron,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022948,Iron [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601431,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Rauta,,
2567,U-Iron,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3043701,Iron [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601432,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Rauta,,
2568,"Pt-Iron, organ incorporation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601433,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Rauta, elinkertymä",,
2569,"E-Iron, incorporation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601434,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Rauta, inkorporaatio",,
2570,"E-Iron, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601435,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Rauta, värjäys",,
2571,"Pt-Iron, interchangeable",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601436,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Rauta, vaihtuva",,
2573,P -Recalcification time,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601437,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,P -Rekalsifikaatioaika,,
2574,fS-Renin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601438,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Reniini,,
2575,Ts-Receptor Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601439,LABfi Level 0,Measurement,2004-01-01,2013-12-31,,,Ts-Reseptoritutkimus,,
2579,Antigen from respiratory viruses,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3001684,Respiratory syncytial virus Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601440,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Respiratoristen virusten antigeeni,,
2579,Antigen from respiratory viruses,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3007625,Streptococcus pneumoniae Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601440,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Respiratoristen virusten antigeeni,,
2579,Antigen from respiratory viruses,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3027146,Parainfluenza virus 1+2+3 Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601440,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Respiratoristen virusten antigeeni,,
2579,Antigen from respiratory viruses,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,21492987,Influenza virus A and B Ag panel - Upper respiratory specimen by Rapid immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601440,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Respiratoristen virusten antigeeni,,
2579,Antigen from respiratory viruses,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,36304958,Adenovirus Ag [Presence] in Nasopharynx by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601440,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Respiratoristen virusten antigeeni,,
2579,Antigen from respiratory viruses,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40763480,Human metapneumovirus Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601440,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Respiratoristen virusten antigeeni,,
2580,"S -Reticulin, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601441,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Retikuliini, IgA-vasta-aineet",,
2581,B -Reticulocytes,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3023520,Reticulocytes [#/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601442,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Retikulosyytit,,
2582,E -Reticulocytes,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3027945,Reticulocytes/100 erythrocytes in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601443,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Retikulosyytit,,
2583,S -Retinol Binding Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601444,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Retinolia sitova proteiini,,
2585,"S -Rheumafaktor, Waaler-Rose",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601445,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Reumafaktori, Waaler-Rose",,
2587,"E -Rh, D-antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601446,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"E -Rh, D-antigeeni",,
2588,"E -Rh, antigen typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601447,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Rh, antigeenityypitys",,
2593,"S -Ribonucleic acid, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601448,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ribonukleiinihappo, vasta-aineet",,
2594,"F -Rotavirus, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601449,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Rotavirus, antigeeni",,
2597,"Pt-Matstrupe, peristaltik",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601450,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Ruokatorvi, peristaltiikka",,
2598,"Pt-Matstrupe, pH + pressure measurement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601451,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Ruokatorvi, pH + painemittaus",,
2599,Off-Sediment,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601452,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Sakka,,
2601,Ts-Sackaras,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601453,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Sakkaraasi,,
2602,E -Sucrose Hemolysis Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601454,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Sakkaroosi-hemolyysikoe,,
2603,Pt-Sucrose Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601455,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Sakkaroosikoe,,
2604,S -Salicylates,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3017950,Salicylates [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601456,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Salisylaatit,,
2605,U -Salicylates,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601457,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Salisylaatit,,
2606,U -Salicylates (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601458,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Salisylaatit (kval),,
2607,"S-Salmonella, Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3036071,Salmonella sp Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601459,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Salmonella, vasta-aineet",,
2608,"F -Salmonella, cultivation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004716,Salmonella sp identified in Stool by Organism specific culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000601460,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Salmonella, viljely",,
2609,"S -Bile duct, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601461,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Sappitiehyt, vasta-aineet",,
2610,"S-Schistosomas, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3032642,Schistosoma sp Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601462,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Schistosoma, vasta-aineet",,
2611,Schistosoma (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601463,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Schistosoma (kval),,
2612,Secretary-Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601464,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sekreettori-tutkimus,,
2613,P -Secretin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601465,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Sekretiini,,
2614,Pt Secret Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601466,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Sekretiini-koe,,
2615,dU-Selenium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601467,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Seleeni,,
2616,S -Selen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601468,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Seleeni,,
2617,U -Selen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601469,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Seleeni,,
2618,Am-Sphingomyelin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601470,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Sfingomyeliini,,
2619,"S -Shigella, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601471,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Shigella, vasta-aineet",,
2620,"F -Shigella, cultivation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42529406,Shigella sp [Presence] in Stool by Culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000601472,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Shigella, viljely",,
2621,U -Sialic acid (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601473,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Sialiinihappo (kval),,
2624,F - Connective tissue pieces (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601474,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Sidekudoskappaleet (kval),,
2625,Li-Siderofager,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601475,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Siderofaagit,,
2626,"S -Sperm, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601476,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Siittiö, vasta-aineet",,
2627,"Pt-Sperm Survey, Limited",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601477,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Siemennestetutkimus, suppea",,
2628,"Pt-Sperm Survey, Comprehensive",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4038314,"Semen analysis, post vasectomy",Measurement,MAPS_TO,,TYKS,1631577600000,,2000601478,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Siemennestetutkimus, laaja",,
2629,"Pt-Sperm Survey, Extensive with Additional Surveys",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601479,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Siemennestetutkimus, laaja lisätutkimuksin",,
2630,"Mushrooms, native preparations",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601480,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sieni, natiivivalmiste",,
2631,"Mushrooms, cultivation",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3000494,Fungus identified in Specimen by Culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601481,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sieni, viljely",,
2632,"Mushrooms, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601482,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sieni, värjäys",,
2633,"S -Parotite virus, antibodies (mumps virus)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601483,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sikotautivirus, vasta-aineet",,
2634,"S -Smooth muscle, antibodies",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3007566,Smooth muscle Ab [Titer] in Serum,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601484,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sileälihas, vasta-aineet",,
2636,B -Zinc,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020717,Zinc [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601485,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Sinkki,,
2637,dU-Zinc,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3018730,Zinc [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601486,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Sinkki,,
2638,Li-Zinc,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601487,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Sinkki,,
2639,P -Zinc,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020717,Zinc [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601488,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Sinkki,,
2640,Sp-Zinc,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601489,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sp-Sinkki,,
2643,B -Morphological examination of cells,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000093,Morphology [Interpretation] in Blood Narrative,Measurement,MAPS_TO,,HUS,1596153600000,,2000601490,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Solujen morfologinen tarkastelu,,
2644,"F -Sugar, fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601491,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Sokerit, fraktiot",,
2645,"S -Sugar, fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601492,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sokerit, fraktiot",,
2646,"U -Sugar, fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601493,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Sokerit, fraktiot",,
2648,U -Socker (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601494,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Sokerit (kval),,
2649,U-Cell Secretion Rate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601495,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Solujen eritysnopeus,,
2650,Af-Cells,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601496,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Solut,,
2651,As-Celler,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044007,Cell count panel - Peritoneal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601497,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Solut,,
2652,Dj-Celler,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601498,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Dj-Solut,,
2653,Ex-Cells,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601499,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ex-Solut,,
2654,Gj-Celler,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601500,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Solut,,
2655,Li-Celler,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044290,Cell count panel - Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601501,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Solut,,
2656,Ns cells,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601502,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ns-Solut,,
2657,Pf cells,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3045788,Cell count panel - Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601503,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Solut,,
2658,Sy-Celler,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044941,Cell count panel - Synovial fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601504,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Solut,,
2659,P -Somatomedin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601505,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,P -Somatomediini,,
2660,S-Somatomedin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601506,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Somatomediini,,
2661,S-Somatostatin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601507,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Somatostatiini,,
2662,S -Sorbitol dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601508,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sorbitolidehydrogenaasi,,
2663,Am-Spectrum (320-640 nm),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601509,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Spektri (320-640 nm),,
2664,Li-Spectrum (320-640 nm),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601510,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Spektri (320-640 nm),,
2665,"Leptospira, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601511,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Leptospira, natiivivalmiste",,
2666,"Leptospira, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601512,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Leptospira, viljely",,
2667,"Leptospira, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601513,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Leptospira, värjäys",,
2669,"Pt-Spirometry, standard dynamic time-volume measurement",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4133840,Spirometry,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601514,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Pt-Spirometria, tavallinen dynaaminen aikatilavuusmittaus",,
2670,"Pt-Short-term maximum ventilation, spirometry",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601515,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Lyhytaikainen maksimiventilaatio, spirometri",,
2671,Pt-Time volume spirometry and bronchodilation test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601516,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,Pt-Aika-tilavuusspirometria ja bronkodilaatiokoe,,
2672,Pt-Time volume pyrometry in connection with provocation tests,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601517,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Aika-tilavuusspirometria provokaatiokokeen yhteydessä,,
2676,"Pt-Measurement of lung volumes with a spirometer, gas dilution",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601518,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Pt-Keuhkotilavuuksien mittaus spirometrilla, kaasulaimennus",,
2680,Pt-Flow-volume spirometry and provocation test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601519,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Virtaustilavuus-spirometria, sisältää lausunnon",,
2682,Pt Flow Volume Spirometry and Bronchodilation Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601520,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Virtaustilavuus-spirometria ja bronkodilaatiokoe,,
2684,Pt-Flow-volume-spirometry and provocation test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601521,LABfi Level 0,Measurement,2004-01-01,2008-12-31,,,Pt-Virtaustilavuus-spirometria ja provokaatiokoe,,
2697,"Staphylococcus, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601522,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Staphylococcus, viljely",,
2698,Sterilization control,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601523,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sterilointikontrolli,,
2699,"Streptococcus, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601524,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Streptococcus, antigeeni",,
2700,"S-Streptococcus DNAase, Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3001475,Streptococcal DNAse B [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601525,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Streptococcus DNAasi, vasta-aineet",,
2701,"S -Streptococcus exoenzyme, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601526,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Streptococcus eksoentsyymi, vasta-aineet",,
2703,"Ps-Streptococcus, culture (hemolytic streptococci)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024135,Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000601527,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ps-Streptococcus, viljely (hemolyyttiset streptokokit)",,
2704,P -Coagulation factor X,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004409,Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601528,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hyytymistekijä X,,
2705,S-Substance P,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601529,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Substanssi P,,
2706,"Bm-Sudan black B, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601530,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-Sudanblack-B -värjäys,,
2707,"L -Sudan black B, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601531,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,L -Sudanblack-B -värjäys,,
2708,Off-Relative Density,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601532,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Suhteellinen tiheys,,
2709,As-Relative density,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601533,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Suhteellinen tiheys,,
2710,dU-Relative density,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601534,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Suhteellinen tiheys,,
2711,Li-Relative Density,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601535,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Suhteellinen tiheys,,
2712,nU-Relative density,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601536,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,nU-Suhteellinen tiheys,,
2713,Pf-Relative density,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601537,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Suhteellinen tiheys,,
2714,Sewing-Relative Density,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601538,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Suhteellinen tiheys,,
2715,U -Relative density,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019150,Specific gravity of Urine by Refractometry,Measurement,MAPS_TO,,HUS,1596153600000,,2000601539,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Suhteellinen tiheys,,
2716,Sex chromatin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601540,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sukukromatiini,,
2717,B -Sulfmethemoglobin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601541,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Sulfmethemoglobiini,,
2718,S-Sulfonamides,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601542,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sulfonamidit,,
2720,U -Cyanide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601543,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Syanidi,,
2721,"S-Cardiac muscle, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601544,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sydänlihas, vasta-aineet",,
2722,dU-Cyclic AMP,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601545,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Syklinen AMP,,
2723,P -Cyclic AMP,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601546,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Syklinen AMP,,
2724,U -Cyclic AMP,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601547,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Syklinen AMP,,
2725,"S -Potid Gland, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601548,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Sylkirauhanen, vasta-aineet",,
2726,Pt-Systolic Time Intervals,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601549,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Systoliset aikaintervallit,,
2727,"S -Cytomegalovirus, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3010130,Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601550,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Cytomegalovirus, vasta-aineet",,
2727,"S -Cytomegalovirus, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3015635,Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601550,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Cytomegalovirus, vasta-aineet",,
2727,"S -Cytomegalovirus, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,21492711,Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601550,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Cytomegalovirus, vasta-aineet",,
2728,"U -Cytomegalovirus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601551,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Cytomegalovirus, viljely",,
2729,L -Cytotoxicity Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601552,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,L -Sytotoksisuustesti,,
2730,Sarcoptes scabie (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601553,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sarcoptes scabie (kval),,
2731,S -Tallium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601554,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tallium,,
2732,"S -Teiconic acid, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3026480,Teichoate Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601555,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Teikkohappo, vasta-aineet",,
2733,S-Theophylline,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3018851,Theophylline [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601556,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Teofylliini,,
2735,S -Testosterone,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017446,Testosterone [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601557,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Testosteroni,,
2736,"S -Testosterone, free",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3018301,Testosterone Free [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601558,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Testosteroni, vapaa",,
2737,S-Sex hormone-binding globulin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3004248,Sex hormone binding globulin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601559,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sukupuolihormoneja sitova globuliini,,
2738,"S -Clostridium tetani, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3035407,Clostridium tetani toxoid Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601560,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Clostridium tetani, vasta-aineet",,
2743,S-Thiocyanate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3014171,Thiocyanate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601561,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tiosyanaatti,,
2744,S-Tobramycin (determination of content),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3035509,Tobramycin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601562,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tobramysiini,,
2749,"S-Toxoplasma, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3024995,Toxoplasma gondii IgG Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601563,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Toxoplasma, IgG-vasta-aineet",,
2750,"S-Toxoplasma, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3034844,Toxoplasma gondii IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601564,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Toxoplasma, IgM-vasta-aineet",,
2751,"Toxoplasma, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601565,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Toxoplasma, viljely",,
2753,Pt-Tolbutamide test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601566,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Tolbutamidi-koe,,
2754,F -Larver,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601567,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Toukat,,
2755,dU-Transferrin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,44816868,Transferrin [Mass/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601568,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Transferriini,,
2756,fS-Transferrin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004789,Transferrin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601569,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Transferriini,,
2757,U -Transferrin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007886,Transferrin [Mass/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601570,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Transferriini,,
2758,S -Corticosteroid-binding globulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601571,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kortikosteroideja sitova globuliini,,
2759,"S -Treponema pallidum, hemagglutination",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3019539,Treponema pallidum Ab [Titer] in Serum by Hemagglutination,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601572,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Treponema pallidum, hemagglutinaatio",,
2762,"Pt-TRH test, limited study",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601573,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Tyreotropiinin vapauttajahormoni-koe,suppea",,
2763,"Pt-TRH test, comprehensive examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601574,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Tyreotropiinin vapauttajahormoni-koe, laaja",,
2764,"Fl-Trichomonas and yeast, native preparations",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601575,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Fl-Trichomonas ja hiiva, natiivivalmiste",,
2765,"Fl-Trichomonas, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601576,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Trichomonas, natiivivalmiste",,
2766,"Fl-Trichomonas and yeast, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601577,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Fl-Trichomonas ja hiiva, viljely",,
2769,As-Triglycerides,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601578,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Triglyseridit,,
2770,fS-Triglycerides,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3025839,Triglyceride [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601579,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Triglyseridit,,
2771,Pf-Triglycerides,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042010,Triglyceride [Moles/volume] in Pleural fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000601580,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Triglyseridit,,
2772,S -Tryodtyronine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008304,Triiodothyronine (T3) [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601581,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Trijodityroniini,,
2773,"Pt-triiodothyronine, suppression test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601582,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Trijodityroniini, suppressiokoe",,
2774,"S -Tryodtyronine, reverse",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601583,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Trijodityroniini, käänteinen",,
2775,"S -Tryodtyronine, frit",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3026989,Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601584,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Trijodityroniini, vapaa",,
2776,"S -Triiodtyronine, binding test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601585,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Trijodityroniini, sitoutumiskoe",,
2777,"S -Trichinella spiralis, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3002814,Trichinella spiralis Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601586,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Trichinella spiralis, vasta-aineet",,
2778,U -Trichloroacetate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601587,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Triklooriasetaatti,,
2779,U -Trichloroacetate (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601588,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Triklooriasetaatti (kval),,
2780,U -Trichloroethanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601589,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Trikloorietanoli,,
2781,E -Triosphosphatisomerase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601590,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Trioosifosfaatti-isomeraasi,,
2782,P -Thrombin time,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036489,Thrombin time,Measurement,MAPS_TO,,HUS,1596153600000,,2000601591,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Trombiiniaika,,
2783,"P-Thromboplastin time, activated, partial",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3018677,aPTT in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601592,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Tromboplastiiniaika, aktivoitu, partiaalinen",,
2791,B-Thrombocytes,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3007461,Platelets [#/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601593,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Trombosyytit,,
2795,"Pt platelets, half-life",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601594,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Trombosyytit, puoliintumisaika",,
2796,"B-Thrombocyte Antibodies, Typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601595,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Trombosyyttivasta-aineet, tyypitys",,
2801,B -Trypanosoma (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601596,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Trypanosoma (kval),,
2802,"S -Trypanosoma, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601597,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Trypanosoma, vasta-aineet",,
2803,"Trypanosoma, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601598,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Trypanosoma, natiivivalmiste",,
2804,Dj-Trypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601599,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Dj-Trypsiini,,
2805,dU-Trypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601600,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Trypsiini,,
2806,fS-Trypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601601,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Trypsiini,,
2807,Pa-Trypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601602,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pa-Trypsiini,,
2808,F -Trypsin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601603,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Trypsiini (kval),,
2810,"Mycobacterium tuberculosis, susceptibility determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601604,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycobacterium tuberculosis, herkkyysmääritys",,
2812,"Mycobacterium tuberculosis, culture",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3014162,Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601605,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycobacterium tuberculosis, viljely",,
2813,"Mycobacterium tuberculosis, staining",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3042631,Mycobacterium sp identified in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601606,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycobacterium tuberculosis, värjäys",,
2814,"S -Basal membrane in tubule, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601607,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tubulustyvikalvo, vasta-aineet",,
2815,"S -Measure virus, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042683,Measles virus Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601608,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tuhkarokkovirus, vasta-aineet",,
2816,"Francisella tularensis, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3036048,Francisella tularensis Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601609,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Francisella tularensis, vasta-aineet",,
2818,"Francisella tularensis, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601610,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Francisella tularensis, viljely",,
2819,"S -Kernel, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3037522,Nuclear Ab [Titer] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000601611,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tuma, vasta-aineet",,
2821,"Pt-Thermo test, Measurement of threshold values ​​for the temperature sense",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601612,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Terminen tuntokynnysmittaus,,
2823,Pt-Combined Measurement of Sensing Threshold,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601613,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Yhdistetty tuntokynnysmittaus,,
2824,Pt-Measurement of Vibration Threshold,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601614,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Värinätuntokynnyksen mittaus,,
2825,S -Tymol Reaction,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601615,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Tymolireaktio,,
2826,"dU-Nitrogen, total",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601616,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Typpi, kokonais",,
2827,"U -Nitrogen, total",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601617,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Typpi, kokonais",,
2828,S -Tyreoglobulin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3007446,Thyroglobulin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601618,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyreoglobuliini,,
2829,"S -Tyreoglobulin, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3025547,Thyroglobulin Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601619,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tyreoglobuliini, vasta-aineet",,
2830,"S -thyreoglobulin, Ig class antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601620,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Tyreoglobuliini, vasta-aineet Ig-luokitus",,
2831,"S -thyroid microsome, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601621,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tyreoideamikrosomi, vasta-aineet",,
2832,S -Tyreotropin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009201,Thyrotropin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601622,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyreotropiini,,
2833,S -Tyrothropin-releasing hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601623,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyreotropiinin vapauttajahormoni,,
2834,S -Tyroxine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014620,Thyroxine (T4) [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601624,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyroksiini,,
2835,S -Tyroxine Binding Globulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036566,Thyroxine binding globulin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601625,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyroksiinia sitova globuliini,,
2836,"S -thyroxine, free",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3008486,Thyroxine (T4) free [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601626,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tyroksiini, vapaa",,
2837,"S -Tyroxine, binding test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601627,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tyroksiini, sitoutumiskoe",,
2838,S -Tyrosine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601628,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyrosiini,,
2840,Pt Starch Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601629,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Tärkkelys-koe,,
2841,F - Starch (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601630,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Tärkkelysjyväset (kval),,
2842,Pt-Installation of cardiac pacemakers,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601631,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Sydämen tahdistimen asennus,,
2843,Off-Appearance (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601632,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Ulkonäkö (kval),,
2844,As-Appearance (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601633,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Ulkonäkö (kval),,
2845,F - Appearance (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601634,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Ulkonäkö (kval),,
2846,Gj-Appearance (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601635,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Ulkonäkö (kval),,
2847,Li-Appearance (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023410,Appearance of Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601636,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Ulkonäkö (kval),,
2848,Pf-Appearance (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014891,Appearance of Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601637,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Ulkonäkö (kval),,
2849,Sy-Appearance (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024263,Appearance of Synovial fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601638,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Ulkonäkö (kval),,
2850,U-Appearance (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601639,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Ulkonäkö (kval),,
2852,Pt Exhalation Peak Flow,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601640,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Uloshengityksen huippuvirtaus,,
2853,Pt-Allergen provocation of the airways (spirometry or PEF),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601641,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Hengityksen allergeenialtistus (spirometria tai PEF),,
2854,"Pt-Bronchodilation test, spirometry or PEF",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601642,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Pt-Bronkodilaatiokoe, spirometria tai PEF",,
2855,"Pt-Histamine provocation test, bronchi",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601643,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Histamiinialtistuskoe, keuhkoputket",,
2856,Pt-Cold air load for study of asthma reaction,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601644,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Kylmäilma-altistus astmareaktion tutkimiseksi,,
2857,"Pt-Methacholine provocation test, bronchi",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601645,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Metakoliinialtistuskoe, keuhkoputket",,
2858,"Pt-Exhalation peak flow, series measurement, long-term follow-up",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601646,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Uloshengityksen huippuvirtaus, sarjamittaus, pitkäaikaisseuranta",,
2859,"Pt-Exhalation peak flow, serial measurement, stress test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601647,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Pt-Uloshengityksen huippuvirtaus, sarjamittaus, rasituskoe",,
2860,"Pt-Exhalation peak flow, series measurement in the workplace",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601648,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Uloshengityksen huippuvirtaus, sarjamittaus työpaikalla",,
2861,"Pt-Exhalation peak flow, series measurement, day",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601649,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Uloshengityksen huippuvirtaus, sarjamittaus, vuorokausi",,
2862,"F -Fecus, microscopic examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601650,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Uloste, mikroskooppinen tutkimus",,
2883,dU-Urat,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028714,Urate [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601651,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Uraatti,,
2884,S -Urat,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3026493,Urate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601652,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Uraatti,,
2885,Sy-Urat,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3042301,Urate [Moles/volume] in Synovial fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601653,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Uraatti,,
2886,U -Urat,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027874,Urate [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601654,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Uraatti,,
2887,dU-Urea,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036525,Urea [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601655,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Urea,,
2888,fS-Urea,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020779,Urea [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601656,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Urea,,
2889,Sa-Urea,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601657,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Urea,,
2890,U-Urea,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3012898,Urea [Moles/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601658,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Urea,,
2892,Pt-Ureaclearance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601659,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Urean poistuma,,
2893,F -Urobilin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601660,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Urobiliini,,
2894,U-Urobilin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601661,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Urobiliini,,
2895,F -Urobilin (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601662,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Urobiliini (kval),,
2896,U -Urobilin (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601663,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Urobiliini (kval),,
2897,dU-Urobilinogen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601664,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Urobilinogeeni,,
2898,F -Urobilinogen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601665,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Urobilinogeeni,,
2899,F -Urobilinogen (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601666,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Urobilinogeeni (kval),,
2900,U -Urobilinogen (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601667,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Urobilinogeeni (kval),,
2901,U-uropepsinogen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601668,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Uropepsinogeeni,,
2902,dU-Uroporphyrin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601669,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Uroporfyriini,,
2903,U-Uroporphyrin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601670,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Uroporfyriini (kval),,
2905,E -Porfobilinogendeaminas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601671,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Porfobilinogeenideaminaasi,,
2906,"S-Vaccinia virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601672,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vaccinia-virus, vasta-aineet",,
2907,"B -Lymphocytes, vacuolized",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40763527,Lymphocytes.vacuolated [Presence] in Blood by Light microscopy,Measurement,MAPS_TO,,tays,1630368000000,,2000601673,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Lymfosyytit, vakuolisoituneet",,
2908,"S -Valproate, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601674,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Valproaatti, vapaa",,
2909,"Pt arterial pressure, auscultatory",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601675,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Valtimopaine, auskultoiden",,
2910,"Pt-Arterial pressure and blood flow, plethysmography",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601676,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Valtimopaine ja verenvirtaus, pletysmografi",,
2912,"Pt-arterial pressure, Doppler measurement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601677,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Valtimopaine, dopplermittaus",,
2914,"Pt-arterial pressure, direct catheter measurement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601678,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Valtimopaine, suora katetrimittaus",,
2916,"Pt-arterial flow, peripheral, plethysmography, provocation test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601679,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Valtimovirtaus, perifeerinen, pletysmografi, provokaatiokoe",,
2918,"Pt-arterial pressure, cold provocation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601680,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Valtimopaine, kylmäprovokaatio",,
2919,"Pt-arterial pressure, long-term measurement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601681,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Valtimopaine, pitkäaikaismittaus",,
2922,"Varicella-Zoster virus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601682,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Vesirokkovirus, viljely",,
2923,"S -Varicella-Zoster virus, antibodies",-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3016065,Varicella zoster virus IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,tyks,1631577600000,,2000601683,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vesirokkovirus, vasta-aineet",,
2923,"S -Varicella-Zoster virus, antibodies",-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3022575,Varicella zoster virus IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tyks,1631577600000,,2000601683,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vesirokkovirus, vasta-aineet",,
2924,"Pt-Catheterization of the left part of the heart, various measurements included",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601684,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sydämen katetrisaatio, vasen puoli, sisältää erilaiset mittaukset",,
2925,Pt-Catheterization and ventriculo- or aortography of the left part of the heart,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601685,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sydämen katetrisaatio ja ventikulo- tai aortografia, vasen puoli",,
2926,Pt-Coronary angiography with measurements,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601686,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Koronaariangiografia mittauksineen,,
2932,fP-Vasoactive intestinal peptide,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3051252,Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601687,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Vasoaktiivinen intestinaalinen peptidi,,
2934,Pt Vector Cardiography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601688,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Vektorikardiografia,,
2935,B -Blood Compatibility Test,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002529,ABO group [Type] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601689,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Veren sopivuuskoe,,
2935,B -Blood Compatibility Test,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004592,Major crossmatch [Interpretation],Measurement,MAPS_TO,,HUS,1596153600000,,2000601689,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Veren sopivuuskoe,,
2935,B -Blood Compatibility Test,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044640,Blood type and Crossmatch panel - Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601689,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Veren sopivuuskoe,,
2938,Pt-Blood Circulation Time,-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,4047231,"Circulation time, one test",Procedure,MAPS_TO,,tyks,1631577600000,,2000601690,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Verenkiertoaika,,
2939,Pt Blood Pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601691,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Verenpaine,,
2940,Pt-Blood Volume,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601692,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Veren tilavuus,,
2941,Of-Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601693,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Veri (kval),,
2942,As-Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601694,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Veri (kval),,
2944,Li-Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601695,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Veri (kval),,
2945,Pf-Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601696,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Veri (kval),,
2946,Sy-Blod (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601697,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Veri (kval),,
2947,U -Blod (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601698,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Veri (kval),,
2950,"​​""E -Blood group antigen typing""",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601699,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Veriryhmä antigeenityypitys,,
2951,"E -Blood Group, ABO and Rh",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3003694,ABO and Rh group [Type] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601700,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Veriryhmä, ABO ja Rh",,
2952,"S -Blood group, isoagglutinins",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601701,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Veriryhmä, isoagglutiniinit",,
2953,"S -Blgroup antibodies, screening (qualification)",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3001079,Blood group antibody screen [Presence] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601702,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Veriryhmävasta-aineet, seulonta (kval)",,
2955,"B -Blood group, antibodies, identification",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019601,Blood group antibody investigation [Interpretation] in Plasma or RBC,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601703,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Veriryhmä, vasta-aineet, tunnistus",,
2956,"P -Blood group, isoagglutinins, IgG",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601704,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Veriryhmä, isoagglutiniinit, IgG",,
2957,"S -Blood group, isoagglutinins",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601705,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Veriryhmä, isoagglutiniinit, IgM",,
2958,Pt Water Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601706,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Vesi-koe,,
2959,Water Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601707,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Vesitutkimus,,
2960,"S -Rubella virus (Red dog virus), antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3010937,Rubella virus Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601708,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vihurirokkovirus, vasta-aineet",,
2961,"S -Rubella virus (Red dog virus), IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601709,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vihurirokkovirus, IgM-vasta-aineet",,
2962,"S -Rubella virus (Red dog virus), IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601710,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vihurirokkovirus, IgG-vasta-aineet",,
2966,"Virus, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601711,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Virus, antigeeni",,
2967,"S -Virus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601712,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Virus, vasta-aineet",,
2972,"S -Virus, IgG Antibodies, Specific",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601713,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Virus, IgG vasta-aineet, spesifinen",,
2973,"S -Virus, IgM Antibodies, Specific",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601714,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Virus, IgM vasta-aineet, spesifinen",,
2975,"Virus, culture",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3028433,Virus identified in Specimen by Culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601715,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Virus, viljely",,
2976,"Virus, native preparation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601716,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Virus, natiivivalmiste",,
2977,B -Viscosity,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028652,Viscosity of Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601717,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Viskositeetti,,
2978,P -Viscosity,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024316,Viscosity of Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601718,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Viskositeetti,,
2979,S -Viscosity,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3010493,Viscosity of Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000601719,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Viskositeetti,,
2980,Sewing Viscosity,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3040771,Viscosity of Synovial fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601720,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Viskositeetti,,
2982,"Pt-Bleeding Time, Ivy",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601721,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Pt-Vuotoaika, Ivy",,
2983,Pt Concentration Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601722,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Väkevöimiskoe,,
2985,"S-Yersinia, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3038981,Yersinia enterocolitica O:3 Ab [Titer] in Serum by Agglutination,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601723,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Yersinia, vasta-aineet",,
2985,"S-Yersinia, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3040926,Yersinia pseudotuberculosis 1 Ab [Titer] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601723,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Yersinia, vasta-aineet",,
2985,"S-Yersinia, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3040944,Yersinia pseudotuberculosis 3 Ab [Titer] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601723,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Yersinia, vasta-aineet",,
2985,"S-Yersinia, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3052636,Yersinia enterocolitica O:9 Ab [Titer] in Serum by Agglutination,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601723,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Yersinia, vasta-aineet",,
2986,"S-Yersinia, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601724,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Yersinia, IgA-vasta-aineet",,
2987,"S-Yersinia, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601725,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Yersinia, IgG-vasta-aineet",,
2988,"S-Yersinia, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601726,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Yersinia, IgM-vasta-aineet",,
2989,"F -Yersinia, cultivation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014765,Yersinia sp identified in Stool by Organism specific culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000601727,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Yersinia, viljely",,
2990,Af-Adenosindeaminas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601728,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Adenosiinideaminaasi,,
2991,S -Adenosindeaminas,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3052649,Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601729,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Adenosiinideaminaasi,,
2992,U-Adenosine triphosphate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601730,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Adenosiinitrifosfaatti,,
2993,P -Adrenaline + noradrenaline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601731,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Adrenaliini + noradrenaliini,,
2994,"S -Albumin, glycerate",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601732,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Albumiini, glykoitunut",,
2996,S -Alpha-1-fetoprotein (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601733,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alfa-1-fetoproteiini (kval),,
2997,Di-Aluminum,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601734,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Alumiini,,
2998,S -Aluminium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601735,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alumiini,,
2999,S-Amphetamine (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601736,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Amfetamiini (kval),,
3000,S -Amacacin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,21494227,Amikacin free [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601737,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Amikasiini,,
3003,S -Amobarbital (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601738,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Amobarbitaali (kval),,
3004,"S -Amylase, macro",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601739,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Amylaasi, makro",,
3006,"S-aspartate aminotransferase, mitochondrial",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601740,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Aspartaattiaminotransferaasi, mitokondriaalinen",,
3007,"S -Aspartata aminotransferase, cytoplasmic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601741,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Aspartaattiaminotransferaasi, sytoplasmaattinen",,
3008,Am-Beta-2-microglobulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601742,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Beeta-2-mikroglobuliini,,
3009,Sa-Beta-2-microglobulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601743,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Beeta-2-mikroglobuliini,,
3010,Pt-Beta-2-microglobulin clearance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601744,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Beeta-2-mikroglobuliinin poistuma,,
3011,dU-Betatromboglobulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601745,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,dU-Beetatromboglobuliini,,
3012,P-Betatromboglobulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601746,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Beetatromboglobuliini,,
3013,S -Butabarbital (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601747,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Butabarbitaali (kval),,
3014,S -C1-Esteras,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601748,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -C1-Esteraasi,,
3015,"E -Coombs, direct (mono- or polyspecific antiserum) (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40758895,Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells,Measurement,MAPS_TO,,HUS,1596153600000,,2000601749,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Coombs, suora (mono- tai polyspesifinen antiseerumi) (kval)",,
3015,"E -Coombs, direct (mono- or polyspecific antiserum) (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40758897,Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells,Measurement,MAPS_TO,,HUS,1596153600000,,2000601749,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"E -Coombs, suora (mono- tai polyspesifinen antiseerumi) (kval)",,
3017,S -Diazepam (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601750,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Diatsepaami (kval),,
3018,S -Phenytoin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601751,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fenytoiini (kval),,
3019,B-Digoxin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3027456,Digoxin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601752,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Digoksiini,,
3020,Ts-Digoxin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601753,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Digoksiini,,
3021,U -Disulfiram (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601754,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Disulfiraami (kval),,
3022,"S -Kernel, soluble antigens, antibodies",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3013293,Extractable nuclear Ab [Presence] in Serum,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601755,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tuma, liukoiset antigeenit, vasta-aineet",,
3023,S -Antibodies to enterobacterial antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601756,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Enterobakteerien antigeenin vasta-aineet,,
3024,dU-Epiandrosterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601757,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Epiandrosteroni,,
3025,dU-Epitestosterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601758,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Epitestosteroni,,
3026,dU-Estron + estradiol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601759,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Estroni + estradioli,,
3027,nU-Estron + estradiol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601760,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,nU-Estroni + estradioli,,
3028,S -Etambutol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601761,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Etambutoli,,
3029,S -Ethanol (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601762,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Etanoli (kval),,
3030,U -Ecchlorvynol (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601763,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,U -Etklorvynoli (kval),,
3031,S -Phenobarbital (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601764,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fenobarbitaali (kval),,
3032,S -Fencyclidine (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601765,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fensyklidiini (kval),,
3033,As-Fibrinkoagel (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601766,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,As-Fibriinihyytymä (kval),,
3034,Pf-Fibrinkoagel (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601767,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Pf-Fibriinihyytymä (kval),,
3035,Sy-Fibrinkoagel (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601768,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Sy-Fibriinihyytymä (kval),,
3036,β -Fibrinopeptide A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601769,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Fibrinopeptidi A,,
3037,β -Fibrinopeptide B,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601770,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Fibrinopeptidi B,,
3038,S -Flurazepam (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601771,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fluratsepaami (kval),,
3041,Li-Glycine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601772,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Glysiini,,
3042,"B -Hemoglobin, isoelectric focusing",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032868,Hemoglobin electrophoresis panel in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601773,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hemoglobiini, isoelektrinen fokusointi",,
3044,S -Heroin (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601774,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Heroiini (kval),,
3047,Pt-Immunoglobulin G clearance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601775,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Immunoglobuliini G:n poistuma,,
3048,Ts-Immunoglobulin and Supplement C3,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601776,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Immunoglobuliini ja komplementti C3,,
3049,"S-Immunoglobulin A, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601777,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini A, vasta-aineet",,
3050,"S-Immune Complex, Circulating",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601778,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunokompleksit, kiertävät",,
3051,Tf-Immunkomplex,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601779,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Tf-Immunokompleksit,,
3052,"P -Insulin, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601780,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Insuliini, vapaa",,
3053,"Cytological examination, other",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3043405,Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601781,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Irtosolututkimus, muu",,
3054,S-Isoniazid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601782,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Isoniatsidi,,
3055,Pt-Isoniazid test (acetylation),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601783,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Isoniatsidi-koe (asetylaatio),,
3056,U -Isoniazide (Qual),-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3041184,Isoniazid [Presence] in Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601784,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Isoniatsidi (kval),,
3057,B-Isopropanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601785,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Isopropanoli,,
3058,"S -Campylobacter, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601786,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Campylobacter, vasta-aineet",,
3059,S-Thyroid Stimulating Antibodies,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601787,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyreoideaa stimuloivat vasta-aineet,,
3060,S -Clonazepam,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3005067,clonazePAM [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000601788,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klonatsepaami,,
3061,S -Clonazepam (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601789,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klonatsepaami (kval),,
3063,U-Chloral hydrate (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601790,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,U -Kloraalihydraatti (kval),,
3064,S -Clordiazepoxide (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601791,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klordiatsepoksidi (kval),,
3066,"P -Complement C3, activation products",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601792,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Komplementti C3, aktivaatiotuotteet",,
3067,"P -Complement C4, activation products",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601793,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Komplementti C4, aktivaatiotuotteet",,
3068,Tf Complement C3,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601794,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Tf-Komplementti C3,,
3069,Tf Complement C4,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601795,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Tf-Komplementti C4,,
3070,S -Codein (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601796,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kodeiini (kval),,
3071,"S -Creatin kinase, B-subunit",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601797,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kreatiinikinaasi, B-alayksikkö",,
3072,"S -Creatin kinase, M-subunit",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601798,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kreatiinikinaasi, M-alayksikkö",,
3073,S -Xylos,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601799,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Ksyloosi,,
3074,U -Xylos,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601800,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Ksyloosi,,
3075,Ly-Tissue Antigen B27,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008898,HLA-B27 [Presence],Measurement,MAPS_TO,,HUS,1596153600000,,2000601801,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ly-Kudosantigeeni B27,,
3076,"S-Lactate dehydrogenase, isoenzyme 1",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601802,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Laktaattidehydrogenaasi, isoentsyymi 1",,
3077,"S-Lactate dehydrogenase, isoenzyme 5",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601803,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Laktaattidehydrogenaasi, isoentsyymi 5",,
3078,Me-Lanugohår (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601804,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Me-Lanugokarvat (kval),,
3079,"B -Sink, micro",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601805,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Lasko, mikro",,
3080,Sy Leukocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000475,Leukocytes [#/volume] in Synovial fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601806,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Leukosyytit,,
3082,"fS-Lipoprotein, apo C",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601807,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, apo C",,
3083,S -Lorazepam (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601808,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Loratsepaami (kval),,
3084,Ts-Releasing Hormone for Luteinizing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601809,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Luteinisoivan hormonin vapauttajahormoni,,
3085,B -Lymphoblasts' surface markers,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601810,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -Lymfoblastien pintamarkkerit,,
3086,Bm-Lymphoblasts' surface markers,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601811,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-Lymfoblastien pintamarkkerit,,
3087,Ly-Lymphocyte B subclasses,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601812,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ly-Lymfosyytti B-alaluokat,,
3088,Ly-Lymphocyte T-subclasses,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601813,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ly-Lymfosyytti T-alaluokat,,
3089,"B -Lymphocytes, mixed culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601814,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Lymfosyytit, sekaviljelmä",,
3090,B -Lymphocytes PPD Stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601815,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyyttien PPD-stimulaatio,,
3092,S -Methamphetamine (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601816,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Metamfetamiini (kval),,
3093,S -Nitrazepam (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601817,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Nitratsepaami (kval),,
3094,U -Nitrite (qual),-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3042812,Nitrite [Presence] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601818,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Nitriitti (kval),,
3095,"B -NK cells, cell-mediated lysis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601819,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -NK-solut, soluvälitteinen lyysi",,
3097,S -Oxcarbazepine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601820,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Okskarbatsepiini,,
3098,S -Pentobarbital (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601821,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Pentobarbitaali (kval),,
3099,S -Perfenazine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601822,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Perfenatsiini,,
3100,S -Plasminogen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601823,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Plasminogeeni,,
3102,S -Propranolol (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601824,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Propranololi (kval),,
3103,P -Prostaglandin 6-Keto F1A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601825,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Prostaglandiini 6-Keto F1A,,
3104,P -Prostaglandin E2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601826,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Prostaglandiini E2,,
3105,P -Prostaglandin F2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601827,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Prostaglandiini F2,,
3107,Gj-Järn (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601828,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Rauta (kval),,
3108,S -Secobarbital (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601829,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sekobarbitaali (kval),,
3109,S -Rifampicin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601830,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Rifampisiini,,
3110,S -Sulfate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601831,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sulfaatti,,
3111,Pt-Sulfonamide Test (Acetylation),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601832,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Sulfonamidi-koe (asetylaatio),,
3112,dU-Cyclic GMP,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601833,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Syklinen GMP,,
3113,P -Cyclic GMP,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601834,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Syklinen GMP,,
3114,U -Cyclic GMP,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601835,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Syklinen GMP,,
3115,Pt-Cyclic AMP clearance,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601836,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Syklisen AMP:n poistuma,,
3116,S -Theophylline (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601837,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Teofylliini (kval),,
3117,S -Tiopental,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601838,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tiopentaali,,
3118,S-Thioridazine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601839,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tioridatsiini,,
3119,P -thiocyanate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601840,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Tiosyanaatti,,
3122,P -Tromboxan B2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601841,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Tromboksaani B2,,
3123,"B-Thromboplastin time, activated, partial",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601842,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Tromboplastiiniaika, aktivoitu, partiaalinen",,
3125,"B Platelets, Functional Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601843,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Trombosyytit, funktiotutkimus",,
3126,S -Tyroxine Binding Albumin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601844,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyroksiinia sitova albumiini,,
3127,S -Tyroxine-binding prealbumin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601845,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyroksiinia sitova prealbumiini,,
3129,"Sewing Leukocytes, Differential Counting",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021788,Differential panel - Synovial fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601846,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sy-Leukosyytit, erittelylaskenta",,
3130,S -Salicylates (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601847,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Salisylaatit (kval),,
3132,Pt-CRH-test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601848,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Adrenokortikotropiini-vapauttajahormonikoe,,
3133,As-Albumin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3026692,Albumin [Mass/volume] in Peritoneal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000601849,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Albumiini,,
3134,dU-Albumin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027035,Albumin [Mass/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601850,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Albumiini,,
3135,P-alpha-fucosidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601851,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Alfa-fukosidaasi,,
3136,β-Alpha-galactosidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601852,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Alfa-galaktosidaasi,,
3137,β-Alpha-glucosidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601853,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Alfa-glukosidaasi,,
3138,"β-Alpha-mannosidase, isoenzymes",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601854,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Alfa-mannosidaasi, isoentsyymit",,
3139,dU-Amino Acids (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601855,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Aminohapot (kval),,
3140,dU-Ammoniumjon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601856,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Ammonium-ioni,,
3141,Pf-Amylase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601857,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Amylaasi,,
3142,"S-Amylase, immunoglobulin complex",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601858,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Amylaasi, immunoglobuliinikompleksi",,
3143,"S-Amyloid, A-protein",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601859,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Amyloidi, A-proteiini",,
3144,"S-Amyloid, A-protein, low molecular weight",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601860,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Amyloidi, A-proteiini, pieni molekyylipaino",,
3145,Pt-Anorectal Manometry,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601861,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Anorektaalimanometria,,
3146,dU-Antranilat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601862,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Antranilaatti,,
3147,dU-Aromatic hydrocarbons,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601863,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Aromaattiset hiilivedyt,,
3148,dU-Arsenic,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601864,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Arseeni,,
3149,P -Arylsulfatase A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601865,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Aryylisulfataasi A,,
3150,S -Acetazolamide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601866,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Asetatsoliamidi,,
3153,Vitamin dU-B12,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601867,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-B12-vitamiini,,
3154,"U -Bacteria, culture on slides",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601868,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Bakteeri, aluslasiviljely",,
3155,dU-Barbiturates,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601869,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Barbituraatit,,
3156,"dU barbiturates, fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601870,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Barbituraatit, fraktiot",,
3157,B-Basophilic leukocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006315,Basophils [#/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601871,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Basofiiliset leukosyytit,,
3158,β-Beta-galactosidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601872,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Beeta-galaktosidaasi,,
3159,P-Beta-glucuronidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601873,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Beeta-glukuronidaasi,,
3160,dU-Beta-2-microglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022097,Beta-2-Microglobulin [Mass/time] in 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000601874,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Beeta-2-mikroglobuliini,,
3161,dU-Bromide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601875,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Bromidi,,
3162,F -Clostridium difficile -toxin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3044936,Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601876,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Clostridium difficile -toksiini,,
3163,"Vitamin S-D-1,25-OH",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42529188,25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000601877,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -D-vitamiini-1,25-OH",,
3164,Vitamin S-D3-25-OH,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024390,25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601878,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -D3-vitamiini-25-OH,,
3165,"Vitamin S-D-24,25-OH",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601879,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -D-vitamiini-24,25-OH",,
3166,"S -Dehydroepiandrosterone, sulfate",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3016616,Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601880,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Dehydroepiandrosteroni, sulfaatti",,
3168,S -Doxepin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601881,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Doksepiini,,
3169,Vitamin fS-E,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000208,Alpha tocopherol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601882,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-E-Vitamiini,,
3170,dU-Mercury,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601883,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Elohopea,,
3171,Pt-Estradiol test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601884,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Estradioli-koe,,
3172,U -Eethylene glycol (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601885,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Etyleeniglykoli (kval),,
3173,dU-Fluoride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601886,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Fluoridi,,
3174,dU-Folate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601887,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Folaatti,,
3175,"U -glycoprotein, Tamm-Horsfall",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601888,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Glykoproteiini, Tamm-Horsfall",,
3176,P -Surge phosphates,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601889,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hapan fosfataasi,,
3177,dU-Acids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601890,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Hapot,,
3178,"aB-Syre, volymandel",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40762366,Oxygen capacity [Volume Fraction] in Arterial blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601891,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"aB-Happi, tilavuusosuus",,
3179,"vB-Syre, volymandel",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601892,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"vB-Happi, tilavuusosuus",,
3181,F -Hemoglobin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601893,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Hemoglobiini (kval),,
3182,"Pt carbon dioxide partial pressure, transcutaneous",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601894,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Hiilidioksidiosapaine, transkutaaninen",,
3187,dU-Hippurat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601895,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Hippuraatti,,
3189,Pf-Hyaluronic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601896,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Hyaluronihappo,,
3190,Sy-Hyaluronic Acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601897,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Hyaluronihappo,,
3191,Li-Hydroxy-indolylacetate (5-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601898,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Hydroksi-indolyyliasetaatti (5-),,
3192,"S-Immunoglobulin-G, subclasses",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024139,IgG subclass 3 [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000601899,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokat",,
3192,"S-Immunoglobulin-G, subclasses",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024980,IgG subclass 4 [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000601899,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokat",,
3192,"S-Immunoglobulin-G, subclasses",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027135,IgG subclass 1 [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000601899,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokat",,
3192,"S-Immunoglobulin-G, subclasses",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028192,IgG subclass 2 [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000601899,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokat",,
3192,"S-Immunoglobulin-G, subclasses",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3050039,IgG subclass panel [Mass/volume] - Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000601899,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokat",,
3193,"Li-immunoglobulin, monoclonal",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601900,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Immunoglobuliini, monoklonaalinen",,
3194,"Li-immunoglobulin, oligoclonal",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601901,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Immunoglobuliini, oligoklonaalinen",,
3197,dU-Jodid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601902,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Jodidi,,
3198,dU-Cadmium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601903,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kadmium,,
3199,Se-Kalium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601904,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Se-Kalium,,
3200,dU-Kallikrein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601905,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kallikreiini,,
3201,Di-Calcium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601906,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Kalsium,,
3202,"fS-Calcium, ultrafiltered",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601907,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Kalsium, ultrafiltroituva",,
3203,S -Carbamazepine oxide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601908,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Karbamatsepiiniepoksidi,,
3205,Pt-Clomiphene Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601909,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Klomifeeni-koe,,
3206,Se-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601910,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Se-Kloridi,,
3207,Pf-Cholesterol,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3041918,Cholesterol [Moles/volume] in Pleural fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000601911,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Kolesteroli,,
3208,"S -cholesterol, high density lipoprotein 2",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601912,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -kolesteroli, high density lipoproteiini 2",,
3209,"S -cholesterol, high density lipoprotein 3",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601913,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -kolesteroli, high density lipoproteiini 3",,
3210,Pt-Koriongonadotropin Test 1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601914,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Koriongonadotropiini-koe 1,,
3211,"S -Cortisol, binding capacity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601915,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Kortisoli, sitoutumiskapasiteetti",,
3212,"S -Creatin kinase, MB-immunoglobulin complex",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601916,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kreatiinikinaasi, MB-immunoglobuliinikompleksi",,
3213,dU-Krom,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601917,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kromi,,
3214,dU-Xanthurenic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601918,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Ksanturenaatti,,
3215,dU-Gold,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601919,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Kulta,,
3216,Off-Lactate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601920,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Af-Laktaatti,,
3217,Sy-Lactate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009015,Lactate [Moles/volume] in Synovial fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000601921,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Laktaatti,,
3218,As-lactate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601922,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Laktaattidehydrogenaasi,,
3219,"Legionella pneumophila, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601923,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Legionella pneumophila, värjäys",,
3220,S -Liverlipas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601924,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Lipaasi, maksaperäinen",,
3221,S -Lipoproteinlipas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601925,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Lipoproteiinilipaasi,,
3222,dU-Lithium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601926,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Litium,,
3223,B -Lymphocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019198,Lymphocytes [#/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601927,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyytit,,
3224,S -Läkemedelsscreening (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601928,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Lääkeaineseulonta (kval),,
3225,dU-Mandelat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601929,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Mandelaatti,,
3226,S -Maprotilin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601930,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Maprotiliini,,
3227,U-Methoxyhydroxymandelate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601931,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metoksihydroksimandelaatti,,
3228,dU-Methylhippurate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601932,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Metyylihippuraatti,,
3229,U -Methylhippurate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601933,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metyylihippuraatti,,
3230,B -Monocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001604,Monocytes [#/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601934,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Monosyytit,,
3231,"Li-Myelin Protein, Basic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601935,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Myeliiniproteiini, emäksinen",,
3232,β -N-acetyl-alpha-glucosaminidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601936,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -N-asetyyli-alfa-glukosaminidaasi,,
3233,β -N-acetyl-beta-glucosaminidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601937,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -N-asetyyli-beta-glukosaminidaasi,,
3234,"β -N-acetyl-beta-glucosaminidase, isoenzyme",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601938,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -N-asetyyli-beta-glukosaminidaasi, isoentsyymi",,
3235,Se-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601939,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Se-Natrium,,
3236,S -Netilmycin (determination of content),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601940,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Netilmysiini (pitoisuusmääritys),,
3238,B -Neutrophils,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3017732,Neutrophils [#/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000601941,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Neutrofiilit,,
3239,dU-Nickel,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601942,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Nikkeli,,
3240,aB-Oxyhemoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014007,Fractional oxyhemoglobin in Arterial blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000601943,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,aB-Oksihemoglobiini,,
3241,vB-Oxyhemoglobin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601944,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,vB-Oksihemoglobiini,,
3242,"S-Penicillin G, IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3037297,Penicillin G IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601945,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Penisilliini G, IgE-vasta-aineet",,
3243,"S-Penicillin V, IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3026029,Penicillin V IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601946,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Penisilliini V, IgE-vasta-aineet",,
3244,"S -Procainamide, N-acetyl-",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601947,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Prokaiiniamidi, N-asetyyli-",,
3245,"dU-Protein, fractions, immunoelectrophoresis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601948,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,"dU-Proteiini, fraktiot, immunoelektroforeesi",,
3246,dU-Iron,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601949,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Rauta,,
3248,dU-Sialic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601950,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Sialiinihappo,,
3249,S -Sisomycin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601951,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sisomysiini,,
3250,Di-Celler,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601952,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Solut,,
3252,S-Somatomedin-A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601953,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Insuliinin kaltainen kasvutekijä 2,,
3253,S -Insulin-like growth factor 1,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3014326,Insulin-like growth factor-I [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000601954,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Insuliinin kaltainen kasvutekijä 1,,
3254,Ts-Sudanblack B-dyeing,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601955,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Sudanblack-B -värjäys,,
3255,S -Sultiamin?,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601956,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sultiaami,,
3256,dU-Cyanide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601957,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Syanidi,,
3257,S -T3 antibodies,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042934,Triiodothyronine (T3) Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601958,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -T3, vasta-aineet",,
3258,S -T3R Antibodies,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3051822,Thyroxine (T4) Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601959,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -T3R, vasta-aineet",,
3259,S -T4 Antibodies,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601960,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -T4, vasta-aineet",,
3260,"Bm-Terminaltransferas, dyeing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601961,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Terminaalitransferaasi, värjäys",,
3261,"L -Terminal transfer, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601962,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"L -Terminaalitransferaasi, värjäys",,
3262,Pt-Testosterone Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601963,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Testosteroni-koe,,
3263,"Li-Treponema pallidum, hemagglutination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601964,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Treponema pallidum, hemagglutinaatio",,
3264,dU-Trichloroacetate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601965,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Triklooriasetaatti,,
3265,dU-Trichloroethanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601966,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Trikloorietanoli,,
3266,S -Trimipramine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601967,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Trimipramiini,,
3268,U-Urine Survey 1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601968,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Virtsatutkimus 1,,
3269,U-Urine Survey 2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601969,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Virtsatutkimus 2,,
3270,U-Urine Survey 3,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601970,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Virtsatutkimus 3,,
3271,S-Thyroid Inhibitory Antibodies,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601971,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tyreoideaa estävät vasta-aineet,,
3272,S -Antibodies to Thyroid Hormones,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601972,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tyreoideahormonit, vasta-aineet",,
3275,S -Looks (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601973,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Ulkonäkö (kval),,
3277,S -Vancomycin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005715,Vancomycin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000601974,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Vankomysiini,,
3278,"S -Actin, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601975,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Aktiini, vasta-aineet",,
3279,"S-Brucella, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3028704,Brucella sp IgG Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601976,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Brucella, IgG-vasta-aineet",,
3280,"S-Brucella, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3024051,Brucella sp IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601977,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Brucella, IgM-vasta-aineet",,
3281,S -C3-Nephrite factor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601978,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -C3-Nefriittitekijä,,
3283,E-Erythrocytes C3b Receptor Assay,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601979,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,E -Erytrosyyttien C3b reseptori määritys,,
3284,"S -Glomerulus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601980,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Glomerulus, vasta-aineet",,
3285,"S -Neisseria gonorrhoeae, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601981,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Neisseria gonorrhoeae, IgG-vasta-aineet",,
3286,"S-Neisseria gonorrhoeae, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601982,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Neisseria gonorrhoeae, IgM-vasta-aineet",,
3287,"Haemophilus influenzae (b), antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601983,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Haemophilus influenzae (b), antigeeni",,
3288,"S-Immunoglobulin A, secretory",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601984,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini A, sekretorinen",,
3289,"Se-Immunoglobulin A, Secretory",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601985,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Se-Immunoglobuliini A, sekretorinen",,
3290,"Li-Immunoglobulin G and albumin, relation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007798,IgG/Albumin [Mass Ratio] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000601986,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Immunoglobuliini G:n ja albumiinin suhde,,
3291,"Li-Immunoglobulin E and albumin, relation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601987,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Immunoglobuliini E:n ja albumiinin suhde,,
3292,"S -Campylobacter, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601988,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Campylobacter, IgG-vasta-aineet",,
3293,"S -Campylobacter, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601989,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Campylobacter, IgM-vasta-aineet",,
3294,"Chlamydia trachomatis, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601990,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Chlamydia trachomatis, antigeeni",,
3295,Li-Complement C3,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601991,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Komplementti C3,,
3296,Pf-Complement C3,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601992,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Komplementti C3,,
3297,Li-Complement C4,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601993,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Komplementti C4,,
3298,Pf-Complement C4,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601994,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Komplementti C4,,
3299,"Li-Complement, total hemolytic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601995,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Li-Komplementti, kokonaishemolyyttinen",,
3300,"Pf-Complement, total hemolytic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601996,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Pf-Komplementti, kokonaishemolyyttinen",,
3301,"Tf-Complement, total hemolytic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000601997,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Tf-Komplementti, kokonaishemolyyttinen",,
3303,"S-Legionella, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3032743,Legionella sp IgG Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601998,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Legionella, IgG-vasta-aineet",,
3304,"S-Legionella, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,21494567,Legionella sp IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000601999,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Legionella, IgM-vasta-aineet",,
3305,"S -Listeria, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602000,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Listeria, IgG-vasta-aineet",,
3306,"S -Listeria, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602001,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Listeria, IgM-vasta-aineet",,
3307,B -Lymphocytes' oidiomycin stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602002,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyyttien oidiomysiini -stimulaatio,,
3308,B -Lymphocytes' protein A stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602003,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyyttien proteiini A -stimulaatio,,
3310,"Neisseria meningitidis, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602004,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Neisseria meningitidis, antigeeni",,
3311,"S -Bordetella pertussis, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602005,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Bordetella pertussis, IgA-vasta-aineet",,
3312,"S -Bordetella pertussis, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3007732,Bordetella pertussis IgG Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602006,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Bordetella pertussis, IgG-vasta-aineet",,
3313,"S -Bordetella pertussis, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602007,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Bordetella pertussis, IgM-vasta-aineet",,
3314,"S -Rheumatoid Factor, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602008,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Reumafaktori, IgA-vasta-aineet",,
3315,"S -Rheumatoid Factor, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602009,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Reumafaktori, IgG-vasta-aineet",,
3316,"S-Rheumatoid Factor, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602010,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Reumafaktori, IgM-vasta-aineet",,
3317,"S -Ribonucleoprotein, Nuclear, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006999,Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602011,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ribonukleoproteiini, nukleaarinen, vasta-aineet",,
3318,"S-Salmonella, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602012,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Salmonella, IgG-vasta-aineet",,
3319,"S-Salmonella, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602013,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Salmonella, IgM-vasta-aineet",,
3320,"S -Shigella, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3047301,Shigella sp Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602014,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Shigella, IgG-vasta-aineet",,
3321,"S -Shigella, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602015,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Shigella, IgM-vasta-aineet",,
3322,"S -Sjögren's syndrome, A (Ro) antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023939,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602016,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sjögrenin syndroma, A (Ro)-vasta-aineet",,
3323,"S -Sjögren's syndrome, B (La) antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027450,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602017,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sjögrenin syndroma, B (La)-vasta-aineet",,
3324,"S -Sm (Smith), Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016921,Smith extractable nuclear Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602018,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sm (Smith), vasta-aineet",,
3325,Streptococcus agalactiae (B) antigen,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3022008,Streptococcus agalactiae Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602019,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Streptococcus agalactiae (B) antigeeni,,
3326,"Streptococcus pneumoniae, antigen",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3011363,Streptococcus pneumoniae Ag [Presence] in Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602020,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Streptococcus pneumoniae, antigeeni",,
3330,"S -Francisella tularensis, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602021,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Francisella tularensis, IgG-vasta-aineet",,
3331,"S -Francisella tularensis, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602022,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Francisella tularensis, IgM-vasta-aineet",,
3340,Pf-Albumin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3011544,Albumin [Mass/volume] in Pleural fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000602023,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Albumiini,,
3341,F-Alpha-1-antitrypsin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003101,Alpha 1 antitrypsin [Mass/mass] in Stool,Measurement,MAPS_TO,,HUS,1596153600000,,2000602024,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Alfa-1-antitrypsiini,,
3342,"Pf-Alpha-1-glycoprotein, acidic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602025,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pf-Alfa-1-glykoproteiini, hapan",,
3344,Pt-Glucagon test (growth hormone andcortisol determination),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602026,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Glukagoni-koe (kasvuhormoni- ja kortisolimääritys),,
3346,"S -Hepatitis A virus, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3016650,Hepatitis A virus Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602027,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti A -virus, vasta-aineet",,
3347,"S -Hepatitis B virus, c-antigen, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013527,Hepatitis B virus core IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602028,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti B -virus, c-antigeeni, IgM-vasta-aineet",,
3355,P -Examination of bleeding tendency,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602029,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Vuototaipumuksen selvittely,,
3356,Bf-Immunoglobulin A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602030,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bf-Immunoglobuliini A,,
3357,Bf-Immunoglobulin G,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602031,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bf-Immunoglobuliini G,,
3358,Bf-Immunoglobulin M,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602032,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bf-Immunoglobuliini M,,
3362,"Li-Cardiolipin, Antibodies (VDRL)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602033,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Kardiolipiini, vasta-aineet (VDRL)",,
3363,Sy-Complement C3,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602034,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Komplementti C3,,
3364,Sy-Complement C4,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602035,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Komplementti C4,,
3365,S -Lanatoside-C,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602036,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Lanatosidi-C,,
3366,Fl-Leukocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602037,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Fl-Leukosyytit,,
3367,"Li-Lymphocytes, Differential Counting",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602038,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Lymfosyytit, erittely",,
3377,Reumafaktor (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602039,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Reumafaktori (kval),,
3379,S -Ballic acids,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3034274,Bile acid [Moles/volume] in Serum --fasting,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602040,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sappihapot,,
3380,"Pt-Secret Test, gastrin",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602041,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sekretiini-koe, gastriini",,
3388,Pt-Night Polygraphy in a Sleep Laboratory,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602042,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Yöpolygrafia unilaboratoriossa,,
3389,U -Vanadin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602043,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Vanadiini,,
3390,Pt-Examination of tremors,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602044,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Vapinatutkimus,,
3394,"Li-Virus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602045,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Virus, vasta-aineet",,
3395,P -Hemoglobin (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602046,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Hemoglobiini (kval),,
3396,P-Dopamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602047,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Dopamiini,,
3397,Pf-Antistreptolysin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602048,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Antistreptolysiini,,
3398,"S -Complement, total hemolytic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602049,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Komplementti, kokonaishemolyyttinen",,
3399,"S -Gliadin, IgA Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3017317,Gliadin IgA Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602050,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Gliadiini, IgA-vasta-aineet",,
3400,"S -Gliadin, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3017830,Gliadin IgG Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602051,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Gliadiini, IgG-vasta-aineet",,
3401,S -Immunfixation,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3037756,Immunofixation for Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602052,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Immunofiksaatiotutkimus,,
3402,U-Immunofixation,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017704,Immunofixation for Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000602053,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Immunofiksaatiotutkimus,,
3403,dU-Immunfixation,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3047189,Immunofixation for 24 hour Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000602054,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Immunofiksaatiotutkimus,,
3404,Li-Immunfixation,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019529,Immunofixation for Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000602055,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Immunofiksaatiotutkimus,,
3409,B -Lithium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602056,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Litium,,
3410,E -Lithium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602057,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Litium,,
3411,nU-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602058,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,nU-Glukoosi,,
3412,S -CA 19-9 antigen,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3022914,Cancer Ag 19-9 [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602059,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -CA 19-9 antigeeni,,
3413,Sy-Antistreptolysin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602060,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Antistreptolysiini,,
3414,S -CA 12-5 antigen,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3037551,Cancer Ag 125 [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602061,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -CA 12-5 antigeeni,,
3415,S -CA 50 antigen,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044042,Cancer Ag 50 [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602062,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -CA 50 antigeeni,,
3416,B -Cellodling,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602063,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Soluviljely,,
3417,Bm-Cellodling,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602064,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-Soluviljely,,
3418,Hydrogen Pt Exhalation Gas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602065,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Uloshengityskaasun vety,,
3419,"Hydrogen Pt Exhalation Gas, Intestinal Test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602066,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Uloshengityskaasun vety, suolistokoe",,
3420,aB Acid Treatment Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602067,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,aB-Happihoitokoe,,
3421,"Pt-Blood Circulation, Penis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602068,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Verenkierto, penis",,
3422,Pt Magnetocardiography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602069,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Magnetokardiografia,,
3423,"Pt-Heart's minute volume, CO2 rebreathing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602070,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sydämen minuuttitilavuus, CO2-rebreathing",,
3424,"Pt-Breathing movement, long-term registration",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602071,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Hengitysliike, pitkäaikaisrekisteröinti",,
3425,"dU-Albumin, microalbuminuria",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602072,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Albumiini, mikroalbuminuria",,
3426,Li-Angiotensin-1-convert,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009991,Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000602073,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Angiotensiini-1-konvertaasi,,
3427,"S-Acetylcholine Receptor, Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3006257,Acetylcholine receptor Ab [Moles/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602074,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Asetyylikoliinireseptori, vasta-aineet",,
3428,Vitamin fS-B1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602075,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-B1-vitamiini,,
3429,Vitamin S-B6,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3042585,Pyridoxine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602076,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -B6-vitamiini,,
3430,U-ethylene glycol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602077,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Etyleeniglykoli,,
3431,S- Phospholipase-A2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602078,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fosfolipaasi-A2,,
3433,S- Myoglobin (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602079,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Myoglobiini (kval),,
3434,S- Neuron-specific enolas,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3028531,Enolase.neuron specific [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602080,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Neuronispesifinen enolaasi,,
3435,P- Protein C,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020287,Protein C actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602081,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Proteiini C,,
3436,S -Sialic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602082,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sialiinihappo,,
3437,E -Glutation peroxidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602083,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Glutationiperoksidaasi,,
3438,S -Oxazepam (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602084,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Oksatsepaami (kval),,
3439,"B-Thrombocytes, aggregation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602085,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Trombosyytit, aggregaatio",,
3440,Pf-Angiotensin-1-convert,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3040491,Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000602086,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Angiotensiini-1-konvertaasi,,
3441,"Bacteria, anaerobic MIC determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602087,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, anaerobinen MIC-määritys",,
3442,"F -Bacteria, culture 1 (Salmonella, Shigella, Yersinia, Campylobacter)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3025941,Bacteria identified in Stool by Culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000602088,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Bakteeri, viljely 1 (Salmonella, Shigella, Yersinia, Campylobacter)",,
3443,"F -Bacteria, culture 2 (Clostridium difficile, Staphylococcus aureus, Candida)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3010991,Clostridioides difficile [Presence] in Specimen by Organism specific culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602089,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Bakteeri, viljely 2 (Clostridium difficile, Staphylococcus aureus, candida)",,
3443,"F -Bacteria, culture 2 (Clostridium difficile, Staphylococcus aureus, Candida)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3012167,Candida sp identified in Stool by Organism specific culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602089,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Bakteeri, viljely 2 (Clostridium difficile, Staphylococcus aureus, candida)",,
3444,"F -Cryptosporidium, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602090,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Cryptosporidium, värjäys",,
3445,"U-Phenoxyacetic acid, (2,4-dichloro)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602091,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Fenoksietikkahappo, (2,4 -dikloori)",,
3446,"U-Phenoxyacetic acid, (4-chloro)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602092,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Fenoksietikkahappo, (4-kloori)",,
3447,E -Glyceraldehyde phosphate dehydrogenase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602093,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Glyseraldehydifosfaattidehydrogenaasi,,
3448,"U -Hexandion, 2,5-",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602094,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Heksaanidioni, 2,5-",,
3449,S -Coriongonadotropin (Qual),-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3003191,Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602095,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Koriongonadotropiini (kval),,
3450,"Li-Immunoglobulin G, index",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4027681,Cerebrospinal fluid IgG ratio and IgG index,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602096,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Immunoglobuliini G, indeksi",,
3451,"U-Immunoglobulin G, index",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602097,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Immunoglobuliini G, indeksi",,
3452,"S-Immunoglobulin G and albumin, ratio",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021492,IgG/Albumin [Mass Ratio] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602098,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Immunoglobuliini G:n ja albumiinin suhde,,
3453,"B -Fathership examination, blood group determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602099,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Isyystutkimus, veriryhmämääritys",,
3454,"B -Fathership examination, DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602100,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Isyystutkimus, DNA-tutkimus",,
3455,U -Cannabis (qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028300,Cannabinoids [Presence] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000602101,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kannabis (kval),,
3456,U -Cobalt,-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3044336,Cobalt [Moles/volume] in Urine,Measurement,MAPS_TO,,tyks,1631577600000,,2000602102,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Koboltti,,
3457,Se Leukocytes,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3010813,Leukocytes [#/volume] in Blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602103,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Se-Leukosyytit,,
3458,"Pu Leukocytes, Differential Calculus",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602104,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Pu-Leukosyytit, erittelylaskenta",,
3459,"fS-Lipoprotein, apo A2",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602105,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, apo A2",,
3460,"U-Lead, alkyl",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602106,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Lyijy, alkyyli",,
3461,dU-oligosaccharides,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602107,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Oligosakkaridit,,
3462,"dU-Oligosaccharides, screening (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602108,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Oligosakkaridit, seulonta (kval)",,
3464,U -Pentachlorophenol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602109,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Pentakloorifenoli,,
3465,"F -Poliovirus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602110,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Poliovirus, viljely",,
3466,B -N-Propanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602111,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Propanoli-N,,
3467,"S-Rabies virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602112,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Rabiesvirus, vasta-aineet",,
3468,"Cytomegalovirus, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602113,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cytomegalovirus, antigeeni",,
3469,U-Tetrachlorophenol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602114,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Tetrakloorifenoli,,
3470,B -Toluene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602115,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Tolueeni,,
3471,"HI virus, antigen (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602116,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"HI-virus, antigeeni (kval)",,
3472,"B -HI virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602117,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HI-virus, vasta-aineet",,
3473,"S -HI virus, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3011325,HIV 1+2 Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602118,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -HI-virus, vasta-aineet",,
3474,"HI virus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602119,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"HI-virus, viljely",,
3475,Gj-Blood from gastric juice (qualifier),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602120,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Gj-Veri mahanesteestä (kval),,
3476,E -Transketolas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602121,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Transketolaasi,,
3477,"B -Trichloroethane, (1,1,1-)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602122,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Trikloorietaani, (1,1,1-)",,
3478,"S -Protein, glycerate",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602123,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proteiini, glykoitunut",,
3479,"fS-Fatty acids, fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602124,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Rasvahapot, fraktiot",,
3487,"B Platelets, Antibodies (Qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3018291,Platelet Ab [Presence] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602125,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Trombosyytit, vasta-aineet (kval)",,
3488,"Bacteria, aerobic MBC determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602126,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, aerobinen MBC-määritys",,
3490,"Bacteria, anaerobic species determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602127,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, anaerobinen lajimääritys",,
3491,"Pu-Bacteria, culture 1 (anaerobic + aerobic culture, was from deep wound)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3042936,Bacteria identified in Isolate by Culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000602128,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pu-Bakteeri, viljely 1 (anaerobi + aerobiviljely, syvämärkä)",,
3492,"Pu-Bacteria, culture 2 (aerobic culture, surfaces from wounds)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007853,Bacteria identified in Skin by Aerobe culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000602129,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pu-Bakteeri, viljely 2 (aerobiviljely, pintamärkä)",,
3493,"Ex-Bacteria, culture",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023419,Bacteria identified in Sputum by Culture,Measurement,MAPS_TO,,tays,1630368000000,,2000602130,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ex-Bakteeri, viljely",,
3494,"F -Clostridium difficile, cultivation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013566,Clostridioides difficile [Presence] in Stool by Organism specific culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000602131,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Clostridium difficile, viljely",,
3495,"Corynebacterium diphtheriae, species identification",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602132,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Corynebacterium diphtheriae, lajimääritys",,
3496,"F -Escherichia coli, enteropathogen, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602133,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Escherichia coli, enteropatogeeninen, tyypitys",,
3497,"S -Treponema pallidum, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602134,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Treponema pallidum, IgM-vasta-aineet",,
3498,"Ps-Neisseria gonorrhoeae, swallow cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602135,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ps-Neisseria gonorrhoeae, nieluviljely",,
3499,"Haemophilus influenzae, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602136,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Haemophilus influenzae, tyypitys",,
3500,S -Klomipramine,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3014345,clomiPRAMINE [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602137,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klomipramiini,,
3501,"Legionella, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602138,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Legionella, tyypitys",,
3502,B -Lymphocytes' tularemia antigen stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602139,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyyttien tularemia-antigeeni -stimulaatio,,
3503,"Neisseria meningitidis, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602140,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Neisseria meningitidis, tyypitys",,
3504,S -Antibody test in connection with the MPR vaccination,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602141,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -MPR-rokotukseen liittyvä vasta-ainetutkimus,,
3505,"Streptococcus pneumoniae, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602142,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Streptococcus pneumoniae, tyypitys",,
3506,"Fungi, species identification",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602143,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sieni, lajimääritys",,
3508,"Pu-Mushroom, cultivation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000494,Fungus identified in Specimen by Culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000602144,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pu-Sieni, viljely",,
3509,"Sk-Mushroom, cultivation",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000494,Fungus identified in Specimen by Culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000602145,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sk-Sieni, viljely",,
3510,"Staphylococcus aureus, phage typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602146,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Staphylococcus aureus, faagityypitys",,
3511,"Treponema pallidum, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602147,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Treponema pallidum, antigeeni",,
3513,"Yersinia, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602148,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Yersinia, tyypitys",,
3514,"Mm-Hygiene test, cultivation (breast milk)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3003157,Bacteria [#/volume] in Mother's milk,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602149,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mm-Hygienianäyte, viljely (äidinmaito)",,
3515,"Sp-Sperm, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602150,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sp-Siittiö, vasta-aineet",,
3516,"Cf-Sperm, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602151,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cf-Siittiö, vasta-aineet",,
3517,Cf-Postcoital-test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602152,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Cf-Postkoitaali-koe,,
3518,"Cf-Sperm Secretion Penetration, Capillary Tube Test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602153,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cf-Siittiöiden limapenetraatio, kapillaarikoe",,
3519,"Sp-Sperm Oocyte Penetration, Hamster Test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602154,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sp-Siittiöiden oosyyttipenetraatio,hamsterikoe",,
3520,"S -Dengue virus, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009677,Dengue virus Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602155,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Denguevirus, vasta-aineet",,
3521,"S -Hepatitis D virus, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3004347,Hepatitis D virus Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602156,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti D -virus, vasta-aineet",,
3522,"S-Chlamydia psittaci, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602157,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia psittaci, vasta-aineet",,
3523,"S-Chlamydia trachomatis, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602158,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia trachomatis, IgM-vasta-aineet",,
3525,"S-Influenza virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602159,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Influenssavirus, vasta-aineet",,
3526,"S -Incoovirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602160,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Inkoo-virus, vasta-aineet",,
3527,"S -Sindbis virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602161,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sindbis-virus, vasta-aineet",,
3528,"S -Puumalavirus, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42868544,Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602162,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puumala-virus, IgM-vasta-aineet",,
3529,Varicella-Zoster virus (chickenpox virus) antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602163,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Vesirokkovirus, antigeeni",,
3532,Pt-Electroneurography (ENG) special technology,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602164,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Elektroneurografia (ENG) erikoistekniikka,,
3533,"Pt-Electroneurography (ENG), examination of several problems",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602165,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroneurografia (ENG), usean ongelman tutkimus",,
3534,Pt-Electroretinography (ERG) with Corneal Electrodes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602166,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Elektroretinografia (ERG) korneaalisilla elektrodeilla,,
3541,Pt-Motor Transcranial Magnetic Stimulation Examination (MEP),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602167,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Motorinen herätevastetutkimus magneettistimulaatiolla,,
3542,Pt-Sleep Polygraphy in a Sleep Laboratory,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602168,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Unipolygrafia unilaboratoriossa,,
3543,Pt-Sömnpolygrafi specialregistrering,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602169,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Unipolygrafia erityisrekisteröinnein,,
3544,Pt-Bulbocavernosus reflex,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602170,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Bulbokavernosusheijaste,,
3545,Pt Masseter Reflex,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602171,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Masseterheijaste,,
3546,"The Pt-Blinkreflexen, basic examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602172,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Räpäysheijaste, perustutkimus",,
3548,"S -Histon, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000636,Histone Ab [Presence] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602173,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Histoni, vasta-aineet",,
3550,"S -Rheumatoid factor, determination",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3021614,Rheumatoid factor [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602174,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Reumafaktori, määritys",,
3551,See-Detection of cerebrospinal fluid (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602175,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Se-Selkäydinnesteen osoitus (kval),,
3552,"S -Borrelia, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008230,Borrelia burgdorferi IgM Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602176,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Borrelia, vasta-aineet",,
3552,"S -Borrelia, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016888,Borrelia burgdorferi IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602176,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Borrelia, vasta-aineet",,
3553,"S -Allergen, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602177,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Allergeeni, IgG-vasta-aineet",,
3554,Pt-Sample,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602178,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Pistokoe,,
3557,cU-Albumin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602179,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Albumiini,,
3558,Sa-Progesterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602180,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Progesteroni,,
3559,Sa-Amylas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602181,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Amylaasi,,
3560,Sa-Acidity,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602182,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Happamuusaste,,
3561,"Sa-Acidity, Stimulated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602183,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sa-Happamuusaste, stimuloitu",,
3562,Sa-Lysozyme,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602184,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Lysotsyymi,,
3563,"Sa-Amylase, Stimulated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602185,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sa-Amylaasi, stimuloitu",,
3564,"Sa-Streptococcus mutans, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602186,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sa-Streptococcus mutans, viljely",,
3565,Pt Saliva Secretion Rate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602187,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Syljen eritysnopeus,,
3566,"Pt Saliva Secretion Rate, Stimulated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602188,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Syljen eritysnopeus, stimuloitu",,
3567,"Sa-Immunoglobulin A, Stimulated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602189,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sa-Immunoglobuliini A, stimuloitu",,
3568,"Sa-Immunoglobulin G, Stimulated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602190,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sa-Immunoglobuliini G, stimuloitu",,
3569,"Sa-Immunoglobulin M, Stimulated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602191,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sa-Immunoglobuliini M, stimuloitu",,
3570,"Sa-Lactobacillus, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602192,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sa-Lactobacillus, viljely",,
3571,Sa-Buffer Capacity,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602193,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Puskurikapasiteetti,,
3572,"Sa-Buffer Capacity, Stimulated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602194,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sa-Puskurikapasiteetti, stimuloitu",,
3573,Sa-Hydroxyprogesterone (17-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602195,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Hydroksiprogesteroni (17-),,
3574,Sa-Testosterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602196,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Testosteroni,,
3577,"P -Protein S, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3037201,Protein S Ag actual/normal in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602197,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Proteiini S, antigeeni",,
3578,P -Lupusanticoagulant,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,46235128,Lupus anticoagulant aPTT and dRVVT screening panel W Reflex,Measurement,MAPS_TO,,HUS,1596153600000,,2000602198,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Lupusantikoagulantti,,
3579,vB-Syrehalt,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602199,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,vB-Happisisältö,,
3580,zB-Syrehalt,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602200,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,zB-Happisisältö,,
3581,"cB-Syre, volymandel",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602201,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"cB-Happi, tilavuusosuus",,
3582,"zB-Syre, volymandel",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602202,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"zB-Happi, tilavuusosuus",,
3583,Pt-Measurement of Cardiac Pacemaker Functionality,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602203,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Sydämen tahdistimen toiminnan mittaus,,
3584,"F -Bacteria, culture 3 (culture 1 + Bacillus cereus, Clostridium perfringens, Staphylococcus aureus)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602204,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Bakteeri, viljely 3 (viljely 1 + Bacillus cereus, Clostridium perfringens, Staphylococcus aureus)",,
3585,"S-Haemophilus influenzae (b), antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3044398,Haemophilus influenzae B Ag [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602205,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Haemophilus influenzae (b), vasta-aineet",,
3586,"Chlamydia pneumoniae, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602206,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,"Chlamydia pneumoniae, vasta-aineet",,
3587,S -CA 15-3 antigen,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3006588,Cancer Ag 15-3 [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602207,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -CA 15-3 antigeeni,,
3588,U -Dolikol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602208,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Dolikoli,,
3589,"fS-Lipoprotein, apo E",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602209,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, apo E",,
3590,dF-Fetter,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602210,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dF-Rasvat,,
3591,F -Fetter,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602211,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Rasvat,,
3592,S -Tumor Associated Trypsin Inhibitor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602212,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tuumoriin liittyvä trypsiini-inhibiittori,,
3593,U -Tumor-Associated Trypsin Inhibitor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602213,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Tuumoriin liittyvä trypsiini-inhibiittori,,
3594,S -Osteocalcin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028772,Osteocalcin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602214,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Osteokalsiini,,
3595,Pt-Cardiovascular Reflex,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602215,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Kardiovaskulaariheijaste,,
3596,Pt-Cardiovascular reflex combined with blood pressure provocations,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602216,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Kardiovaskulaariheijaste verenpaineprovokaatiohin yhdistettynä,,
3597,Pt-Sympathetic skin reaction,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602217,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Sympaattinen ihoreaktio,,
3599,Pt-Other Reflex Investigations,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602218,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Muu refleksitutkimus,,
3600,"Pt-pH measurement of esophagus and cardia, long-term registration",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602219,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Esofaguksen ja kardian pH-mittaus, pitkäaikaisrekisteröinti",,
3601,Pt-Examination of the Autonomic Nervous System,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602220,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Autonomisen hermoston tutkiminen,,
3602,"Pt-Respiration Regulation, Other Methods",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602221,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Hengityksen säätely, muut menetelmät",,
3603,fP-Renin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602222,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Reniini,,
3604,"Salmonella, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602223,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Salmonella, tyypitys",,
3605,"Shigella, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602224,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Shigella, tyypitys",,
3606,B -Cyclosporin A,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3010375,cycloSPORINE [Mass/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602225,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Syklosporiini A,,
3607,"S -Phospholipid, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3018658,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602226,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Fosfolipidi, vasta-aineet",,
3607,"S -Phospholipid, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3035544,Cardiolipin IgG Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602226,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Fosfolipidi, vasta-aineet",,
3607,"S -Phospholipid, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,46235128,Lupus anticoagulant aPTT and dRVVT screening panel W Reflex,Measurement,MAPS_TO,,HUS,1596153600000,,2000602226,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Fosfolipidi, vasta-aineet",,
3608,"S -Cardiolipin, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602227,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kardiolipiini, IgA-vasta-aineet",,
3609,"S -Cardiolipin, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3028333,Cardiolipin IgG Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602228,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kardiolipiini, IgG-vasta-aineet",,
3610,"S -Cardiolipin, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3006441,Cardiolipin IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000602229,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kardiolipiini, IgM-vasta-aineet",,
3612,"S -Neutrophils' cytoplasmic antigen, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3049804,Myeloperoxidase IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602230,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Neutrofiilien sytoplasma-antigeeni, vasta-aineet",,
3612,"S -Neutrophils' cytoplasmic antigen, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3052912,Proteinase 3 IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602230,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Neutrofiilien sytoplasma-antigeeni, vasta-aineet",,
3613,Sw-Osmolality,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602231,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sw-Osmolaliteetti,,
3614,Di-Acidity,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602232,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Happamuusaste,,
3615,U-Ethanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602233,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Etanoli,,
3616,cB-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602234,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cB-Glukoosi,,
3617,"S -Carbamazepine, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602235,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Karbamatsepiini, vapaa",,
3618,fP-Corticosterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602236,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Kortikosteroni,,
3619,F -Leucocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602237,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,F -Leukosyytit,,
3620,Li-Methotrexate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602238,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Metotreksaatti,,
3621,S - Determination of microbleaching agents,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602239,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Mikrobilääkkeen pitoisuusmääritys,,
3622,P-Sodium,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019550,Sodium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602240,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Natrium,,
3623,dU-Neopterin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602241,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Neopteriini,,
3625,"Poliovirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602242,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Poliovirus, vasta-aineet",,
3626,Pregnenolon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602243,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pregnenoloni,,
3627,"fP-Renin, landscape",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602244,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fP-Reniini, makuu",,
3628,"fP-Renin, ascending",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3049149,Renin [Mass/volume] in Plasma --upright,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602245,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fP-Reniini, pysty",,
3629,U -Amylas (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602246,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Amylaasi (kval),,
3630,"Cytomegalovirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602247,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cytomegalovirus, vasta-aineet",,
3631,"Li measles virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602248,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Tuhkarokkovirus, vasta-aineet",,
3632,"Li-Varicella-Zoster Virus (Chickenpox Virus), Antibodies",-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3012561,Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,tyks,1631577600000,,2000602249,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Vesirokkovirus, vasta-aineet",,
3632,"Li-Varicella-Zoster Virus (Chickenpox Virus), Antibodies",-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,42868421,Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,tyks,1631577600000,,2000602249,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Vesirokkovirus, vasta-aineet",,
3634,Ts-Ribonucleic Acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602250,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Ribonukleiinihappo,,
3635,"Ps-Streptococcus pyogenes (A), antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602251,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ps-Streptococcus pyogenes (A), antigeeni",,
3637,"Li-HI virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602252,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-HI-virus, vasta-aineet",,
3638,"Li-Puumalavirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602253,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Puumala-virus, vasta-aineet",,
3639,"S -Squamous cell carcinoma, antigen",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3005411,Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602254,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Squamous cell carsinoma, antigeeni",,
3640,"S -Proatriopeptide, C-terminal",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602255,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proatriopeptidi, C-terminaalinen",,
3641,Resume Chromosome Survey,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40765091,Chromosome analysis panel - Chorionic villus sample by G-banded,Measurement,MAPS_TO,,tays,1630368000000,,2000602256,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Cv-Kromosomitutkimus,,
3642,S -Prostataspecific Antigen,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3013603,Prostate specific Ag [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602257,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prostataspesifinen antigeeni,,
3643,"Gardnerella vaginalis, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602258,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Gardnerella vaginalis, viljely",,
3644,"Ureaplasma urealyticum, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602259,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ureaplasma urealyticum, viljely",,
3647,"aB-Blood gas analysis (pO2, pCO2, pH, calculation)",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019060,Gas panel - Arterial blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602260,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"aB-Verikaasuanalyysi (pO2,pCO2,pH,laskenta)",,
3648,"cB Blood Gas Analysis (pO2, pCO2, pH, Calculation)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602261,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"cB-Verikaasuanalyysi (pO2,pCO2,pH,laskenta)",,
3649,"vB Blood Gas Analysis (pO2, pCO2, pH, Calculation)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3000991,Gas panel - Venous blood,Measurement,MAPS_TO,,tays,1630368000000,,2000602262,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"vB-Verikaasuanalyysi (pO2,pCO2,pH,laskenta)",,
3650,"eg Blood gas analysis (pO2, pCO2, pH, calculation)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602263,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"zB-Verikaasuanalyysi (pO2,pCO2,pH,laskenta)",,
3652,"S-Centers, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602264,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sentromeeri, vasta-aineet",,
3653,Li-Neuron Specific Enolas,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3042779,Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000602265,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Neuronispesifinen enolaasi,,
3654,S -Tymidinkinas,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3045066,Thymidine kinase [Enzymatic activity/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602266,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tymidiinikinaasi,,
3655,Pf-Carcinoembryonic antigen,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009804,Carcinoembryonic Ag [Mass/volume] in Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000602267,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Karsinoembryonaalinen antigeeni,,
3656,S -Cryoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,21491868,Cryoglobulin [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602268,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kryoglobuliini,,
3657,S -Hyaluronic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602269,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hyaluronihappo,,
3658,fS-Proinsulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602270,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Proinsuliini,,
3659,Mm-Iron,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602271,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Mm-Rauta,,
3660,B -Porphyrins,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3033915,Coproporphyrin [Moles/volume] in Red Blood Cells,Measurement,MAPS_TO,,HUS,1596153600000,,2000602272,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Porfyriinit,,
3660,B -Porphyrins,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3040632,Protoporphyrin [Moles/volume] in Red Blood Cells,Measurement,MAPS_TO,,HUS,1596153600000,,2000602272,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Porfyriinit,,
3661,Li-Adenosindeaminas,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3034552,Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000602273,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Adenosiinideaminaasi,,
3662,Pf-Adenosindeaminas,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3036428,Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602274,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Adenosiinideaminaasi,,
3663,cU-Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602275,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Proteiini,,
3664,"Pf Leukocytes, Differential Calculus",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3012441,Differential panel - Pleural fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000602276,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pf-Leukosyytit, erittelylaskenta",,
3665,"As-Leukocytes, Differential Calculus",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3033799,Differential panel - Peritoneal fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000602277,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"As-Leukosyytit, erittelylaskenta",,
3666,"S -Pneumocystis jirovecii, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602278,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Pnemocystis jirovecii, vasta-aineet",,
3667,U -Surgency (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602279,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Happamuusaste (kval),,
3669,uS-Thyrotropin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42870560,Thyrotropin [Units/volume] in Cord blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000602280,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,uS-Tyreotropiini,,
3670,S -Propranolol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602281,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Propranololi,,
3671,"S -HI virus, antigen",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3031067,HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000602282,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -HI-virus, antigeeni",,
3672,S -Bensodiazepines (qual.),-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3051596,Benzodiazepines [Presence] in Serum or Plasma by Screen method,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602283,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Bentsodiatsepiinit (kval),,
3673,"P -Calcium, ionized",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021347,Calcium.ionized [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602284,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Kalsium, ionisoitunut",,
3674,S -Tricyclic antidepressants (qual.),-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3025478,Tricyclic antidepressants [Presence] in Serum or Plasma,Measurement,MAPS_TO,,tyks,1631577600000,,2000602285,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Trisykliset antidepressantit (kval),,
3675,E-uroporphyrinogen decarboxylase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602286,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,E -Uroporfyrinogeenidekarboksylaasi,,
3676,"S -Growth Hormone, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602287,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kasvuhormoni, vasta-aineet",,
3677,"S-Beta-1-glycoprotein, pregnancy specific",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602288,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Beeta-1-glykoproteiini, raskausspesifinen",,
3678,S -Hydroxybutyric acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602289,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hydroksivoihappo,,
3679,U-Thiosulfate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602290,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Tiosulfaatti,,
3680,"S -Reticulin, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602291,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Retikuliini, IgG-vasta-aineet",,
3681,S-Valproate,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009466,Valproate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602292,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Valproaatti,,
3682,S- Procollagen III: amino-terminal propeptide,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42869547,Procollagen type III.N-terminal propeptide [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602293,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prokollageeni III:n aminoterminaalinen propeptidi,,
3683,"fS- Lipoprotein, apo A",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602294,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Lipoproteiini, apo A",,
3684,Pf-Beta-2-microglobulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602295,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Beeta-2-mikroglobuliini,,
3685,S- Triazolam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602296,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Triatsolaami,,
3686,S -Zopiclone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602297,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tsopikloni,,
3687,S -Desdiazepam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602298,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Desdiatsepaami,,
3688,S -Destrimipramine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602299,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Destrimipramiini,,
3689,S -Lorazepam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602300,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Loratsepaami,,
3691,P -Nickel,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008214,Nickel [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602301,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Nikkeli,,
3692,S -Orotat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602302,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Orotaatti,,
3693,"S-Leishmania, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602303,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Leishmania, vasta-aineet",,
3694,S -Penotyping of alpha-1-antitrypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602304,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alfa-1-antitrypsiinin fenotyypitys,,
3695,"B -Small blood count, minidiff, platelets (erythrocytes, Hb, leukocytes, 2-3 leukocyte groups)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3007461,Platelets [#/volume] in Blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602305,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Perusverenkuva, minidiffi, trombosyytit (erytrosyytit, Hb, leukosyytit, 2-3 leukosyyttiryhmää)",,
3695,"B -Small blood count, minidiff, platelets (erythrocytes, Hb, leukocytes, 2-3 leukocyte groups)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40758558,Short blood count panel - Blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602305,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Perusverenkuva, minidiffi, trombosyytit (erytrosyytit, Hb, leukosyytit, 2-3 leukosyyttiryhmää)",,
3696,B -Complete blood picture,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602306,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Täydellinen verenkuva,,
3698,"Pt-Cyclic AMP, nephrogenic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602307,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Syklinen AMP, nefrogeeninen",,
3699,S -Bupivacain,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602308,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Bupivakaiini,,
3700,S -Dexametason,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602309,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Deksametasoni,,
3701,S -Etidocaine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602310,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Etidokaiini,,
3702,S -Flekainide,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017461,Flecainide [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602311,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Flekainidi,,
3703,S -Medroxyprogesterone acetate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602312,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Medroksiprogesteroniasetaatti,,
3704,S -Megestrol acetate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602313,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Megestroliasetaatti,,
3705,"S -Methylprednisolone, 6-alpha",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602314,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Metyyliprednisoloni, 6-alfa",,
3706,S -Prednisolone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602315,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prednisoloni,,
3707,S -Prednison,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602316,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prednisoni,,
3708,S -Tocaine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602317,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tokainidi,,
3709,S -Blood Antibody,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602318,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Punasoluvasta-aine,,
3712,Pt bromocript test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602319,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Bromokriptiini-koe,,
3713,"Pt-Dexamethasone test, hirsutism",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602320,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Deksametasoni-koe, hirsutismi",,
3714,Pt-Desmopressin test (+ waterproof),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602321,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Desmopressiini-koe (+ vesipaasto),,
3715,"Pt-Glucose Test, Hypoglycaemia",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602322,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Glukoosi-koe, hypoglykemia",,
3716,"Pt-Glucose Test, Growth Hormone",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602323,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Glukoosi-koe, kasvuhormoni",,
3718,"Pt-Lactose test, ethanol3719, Pt-Pentagastrin test, subcutaneous",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602324,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Laktoosi-koe, etanoli",,
3719,"Pt-Pentagastrin test, subcutaneous",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602325,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Pentagastriini-koe, subkutaaninen",,
3720,"Pt-Pentagastrine test, intravenous",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602326,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Pentagastriini-koe, intravenöösi",,
3721,Pt-Bile Acid Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602327,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Sappihappokoe,,
3723,Sp-adenosine triphosphate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602328,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sp-Adenosiinitrifosfaatti,,
3724,Kl-Albumin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602329,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Kl-Albumiini,,
3726,"Sy-Bacteria, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602330,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sy-Bakteeri, viljely",,
3727,Di-Bicarbonate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602331,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Bikarbonaatti,,
3728,Pu-C reactive protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602332,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pu-C-reaktiivinen proteiini,,
3729,"S -Endomysium, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602333,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Endomysium, vasta-aineet",,
3732,Sy-Erythrocytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3010144,Erythrocytes [#/volume] in Synovial fluid,Measurement,MAPS_TO,,HUS,1596153600000,,2000602334,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sy-Erytrosyytit,,
3733,S -Fructose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602335,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fruktoosi,,
3734,fP-Hydroxycorticosterone (18-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602336,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Hydroksikortikosteroni (18-),,
3735,"S-Immunoglobulin A, subclasses",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602337,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini A, alaluokat",,
3736,dF-Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602338,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dF-Kalium,,
3737,Kl-Kalium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602339,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Kl-Kalium,,
3738,Mm-Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602340,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Mm-Kalium,,
3739,Mm-Calcium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602341,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Mm-Kalsium,,
3740,dF-Chloride,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602342,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dF-Kloridi,,
3741,Ts Chromosome Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602343,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Kromosomitutkimus,,
3742,B -Xylos,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602344,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Ksyloosi,,
3743,Di-Leukocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602345,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Leukosyytit,,
3744,"B -Immunphenotyping, blood disease",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602346,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Immunofenotyypitys, veritauti",,
3745,"Bm -Immunphenotyping, blood disease",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602347,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bm-Immunofenotyypitys, veritauti",,
3746,"Ts -Immunphenotyping, blood disease",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602348,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Immunofenotyypitys, veritauti",,
3747,Sy-Lymphocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602349,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Sy-Lymfosyytit,,
3748,B -Mangan,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602350,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Mangaani,,
3749,dF-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602351,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dF-Natrium,,
3750,Kl-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602352,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Kl-Natrium,,
3751,Mm-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602353,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Mm-Natrium,,
3753,"cU-C peptide, proinsulin",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602354,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"cU-C-peptidi, proinsuliinin",,
3754,Di-Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602355,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Di-Proteiini,,
3755,Mm-Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602356,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Mm-Proteiini,,
3756,"S -TBE virus (tick-borne encephalitis virus), antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42868414,European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602357,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puutiaisaivokuumevirus, vasta-aineet",,
3756,"S -TBE virus (tick-borne encephalitis virus), antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42868417,European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602357,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puutiaisaivokuumevirus, vasta-aineet",,
3757,cU-Sulfonamides,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602358,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Sulfonamidit,,
3759,Pt-Test for Growth Hormone Releasing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602359,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Kasvuhormonin vapauttajahormonikoe,,
3761,"S-Skin Epithelial Basal Membrane, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602360,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ihon epiteelin tyvikalvo, IgA-vasta-aineet",,
3762,"S-Skin Epithelial Basal Membrane, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602361,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ihon epiteelin tyvikalvo, IgG-vasta-aineet",,
3763,S -Procollagen I: carboxy-terminal propeptide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602362,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prokollageeni I:n karboksiterminaalinen propeptidi,,
3764,"S-Laminin, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602363,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Laminiini, vasta-aineet",,
3765,"S -Scleroderma 70, Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3025245,SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602364,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Skleroderma 70, vasta-aineet",,
3767,"S-Polymyocyte 1, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602365,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Polymyosiitti 1, vasta-aineet",,
3768,S -Proliferative Cell Nuclear Antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602366,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Jakautuvien solujen tuma-antigeeni,",,
3769,"S -Ribosome P protein, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602367,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ribosomi P-proteiini, vasta-aineet",,
3770,"S Cell Nucleus, Antibodies, Granulocyte Specific",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602368,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tuma, vasta-aineet, granulosyyttispesifiset",,
3771,"B-Apolipoprotein B, gene mutation, polymorphism, DNA testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602369,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Apolipoproteiini B, geenin mutaatio, polymorfia, DNA-tutkimus",,
3772,"B -Aspartylglucosaminidase gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602370,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Aspartylglukosaminidaasigeeni, DNA-tutkimus",,
3773,"Am-Aspartyl Glucosaminidase Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602371,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Am-Aspartylglukosaminidaasigeeni, DNA-tutkimus",,
3774,"P1-Aspartyl Glucosaminidase Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602372,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pl-Aspartylglukosaminidaasigeeni, DNA-tutkimus",,
3775,"Ts-Aspartyl Glucosaminidase Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602373,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Aspartylglukosaminidaasigeeni, DNA-tutkimus",,
3776,Vitamin fE-B2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602374,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fE-B2-vitamiini,,
3777,"U -Bacteria, still growing",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3026008,Bacteria identified in Urine by Culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000602375,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Bakteeri, jatkoviljely",,
3778,B -BCR / ABL gene translocation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602376,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -BCR/ABL geenin translokaatio,,
3779,Bm-BCR / ABL gene translocation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602377,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-BCR/ABL geenin translokaatio,,
3780,Ts-BCR / ABL gene translocation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602378,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ts-BCR/ABL geenin translokaatio,,
3781,B -BCR / ABL Merger Transcript Study,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028956,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000602379,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -BCR/ABL fuusiolähetin tutkimus,,
3782,Bm-BCR / ABL fusion transcript study,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42529040,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Bone marrow by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000602380,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-BCR/ABL fuusiolähetin tutkimus,,
3783,Ts-BCR / ABL Merger Transcript Study,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602381,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-BCR/ABL fuusiolähetin tutkimus,,
3784,"Bl-Broncoalveolar lavage sample, group examination whose content varies according to hospital",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602382,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bl-Bronkoalveolaarinen lavaationäyte sairaalakohtainen ryhmätutkimus, jonka sisältö vaihtelee",,
3785,"B -Buffy coat, leukocyte enrichment, staining",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602383,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Buffy-coat, leukosyyttirikaste, värjäys",,
3786,"S-Chlamydia psittaci, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602384,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia psittaci, IgG-vasta-aineet",,
3787,Fl-Clueceller (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602385,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Fl-Clue-solut (kval),,
3788,S-D2-vitamin-25-OH,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602386,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -D2-vitamiini-25-OH,,
3790,B -DNA fingerprint,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602387,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -DNA fingerprint,,
3791,Bm-DNA fingerprint,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602388,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-DNA fingerprint,,
3792,Ts-DNA fingerprint,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602389,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-DNA fingerprint,,
3797,"The B-Dystrophen gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602390,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Dystrofiinigeeni, DNA-tutkimus",,
3798,"The Am-Dystrophen gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602391,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Am-Dystrofiinigeeni, DNA-tutkimus",,
3799,"The F1 Dystrophen gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602392,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Fl-Dystrofiinigeeni, DNA-tutkimus",,
3800,"F -Escherichia coli, vero-cell, enterotoxigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602393,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Escherichia coli, verosolu, enterotoksigeeninen",,
3804,"S -Factor B, phenotyping",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602394,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Faktori B, fenotyypitys",,
3805,S-Fluoxetine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602395,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fluoksetiini,,
3806,S -Flucytosine (determination of content),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602396,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Flusytosiini (pitoisuusmääritys),,
3807,Bl-Phospholipids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602397,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bl-Fosfolipidit,,
3811,"Neisseria gonorrhoeae, still growing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602398,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Neisseria gonorrhoeae, jatkoviljely",,
3812,vB-Oxygen Saturation (Hemoglobin),-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3004529,Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602399,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,vB-Happikyllästeisyys (hemoglobiini),,
3813,"F -Hemoglobin, human (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016251,Hemoglobin.gastrointestinal [Presence] in Stool,Measurement,MAPS_TO,,HUS,1596153600000,,2000602400,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Hemoglobiini, ihmisen (kval)",,
3815,"S -Hepatitis C virus, antibodies",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3017143,Hepatitis C virus Ab [Presence] in Serum,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602401,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti C -virus, vasta-aineet",,
3816,P -Histamine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3045759,Histamine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602402,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Histamiini,,
3817,Point mutation of the B -HRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602403,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -HRAS geenin pistemutaatio,,
3818,Point mutation of the Bm-HRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602404,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-HRAS geenin pistemutaatio,,
3819,Point mutation of the Ts-HRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602405,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ts-HRAS geenin pistemutaatio,,
3820,B -HRAS gene expression,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602406,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -HRAS geenin ekspressio,,
3821,Expression of the Bm-HRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602407,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-HRAS geenin ekspressio,,
3822,Expression of the Ts-HRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602408,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ts-HRAS geenin ekspressio,,
3828,P -Antifactor X activity (heparin inhibition of activated coagulation factor X),-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3020427,Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602409,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Antifactori X-aktiivisuus (hepariinin estovaikutus aktivoituneeseen hyytymistekijä X),,
3830,"S-Immunoglobulin, light chains, Kappa",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602410,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,"S -Immunoglobuliini, kevyet ketjut, Kappa",,
3831,"S-Immunoglobulin, light chains, Lambda",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602411,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,"S -Immunoglobuliini, kevyet ketjut, Lambda",,
3832,"dU-Immunoglobulin, light chains, Kappa",-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3004269,Kappa light chains [Mass/time] in 24 hour Urine,Measurement,MAPS_TO,,tyks,1631577600000,,2000602412,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Immunoglobuliini, kevyet ketjut, Kappa",,
3833,"dU-Immunoglobulin, light chains, Lambda",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3017831,Lambda light chains [Mass/volume] in 24 hour Urine,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602413,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Immunoglobuliini, kevyet ketjut, Lambda",,
3834,"S-Immunoglobulin E, bass screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602414,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini E, perusseulonta",,
3835,"S-Immunoglobulin E, Specific Screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602415,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini E, suunnattu seulonta",,
3836,"S -Allergen, IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,36660136,Multiplex allergen panel - Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602416,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Allergeeni, IgE-vasta-aineet",,
3837,The B-Immunoglobulin Genes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017312,HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602417,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Immunoglobuliinigeenit,,
3838,The Bm Immunoglobulin Gene,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40763629,HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602418,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-Immunoglobuliinigeenit,,
3839,The Ts Immunoglobulin Gene,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017312,HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602419,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Immunoglobuliinigeenit,,
3847,"S -Insulin, autoimmune antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602420,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Insuliini, autoimmuunivasta-aineet",,
3848,S -Isopropanol,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015616,Isopropanol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602421,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Isopropanoli,,
3849,B -Calcitoningenen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602422,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Kalsitoniinigeeni,,
3850,Bm-Calciton Engines,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602423,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-Kalsitoniinigeeni,,
3851,Ts-Calcite Tons,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602424,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Kalsitoniinigeeni,,
3852,Sa-Karbamazepine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602425,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sa-Karbamatsepiini,,
3853,S -Karnitin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3033882,Carnitine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602426,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Karnitiini,,
3854,S -Clobazam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602427,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klobatsaami,,
3855,"S -Complement C4, fenotpning",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602428,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Komplementti C4, fenotyypitys",,
3856,"S -Complement, total hemolytic, classical pathway",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602429,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Komplementti, kokonaishemolyyttinen, klassinen tie",,
3857,"S -Complement, total hemolytic, alternative route",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,44817194,Complement alternate pathway AH50 actual/normal in Serum by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602430,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Komplementti, kokonaishemolyyttinen, vaihtoehtonen tie",,
3858,Point mutation of the B -KRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602431,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -KRAS geenin pistemutaatio,,
3859,Point mutation of the Bm-KRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602432,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-KRAS geenin pistemutaatio,,
3860,Point mutations of the Ts-KRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602433,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-KRAS geenin pistemutaatiot,,
3861,Expression of the B -KRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602434,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -KRAS geenin ekspressio,,
3862,Expression of the Bm-KRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602435,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-KRAS geenin ekspressio,,
3863,Expression of the Ts-KRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602436,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ts-KRAS geenin ekspressio,,
3864,cU-Creatinine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602437,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Kreatiniini,,
3865,"B -LDL Receptor Gene Mutation, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602438,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -LDL-reseptorigeenin mutaatio, DNA-tutkimus",,
3866,Pt Exposure Test on Mucosa,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602439,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Limakalvoaltistuskoe,,
3872,U -Metabolic screening,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602440,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Metabolinen seulonta,,
3873,dU-Metoxityramine (3-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602441,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Metoksityramiini (3-),,
3874,dU-Methylhistamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602442,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Metyylihistamiini,,
3875,cU-Methylhistamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602443,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Metyylihistamiini,,
3876,Li-content determination of microbleaching agents,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602444,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Mikrobilääkkeen pitoisuusmääritys,,
3877,"Mycoplasma pneumoniae, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602445,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Mycoplasma pneumoniae, antigeeni",,
3878,cU-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602446,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Natrium,,
3879,"B -Neurofibromatosis gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602447,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Neurofibromatoosigeeni, DNA-tutkimus",,
3880,"Am-Neurofibromatosis Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602448,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Am-Neurofibromatoosigeeni, DNA-tutkimus",,
3881,"The P1 Neurofibromatosis Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602449,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pl-Neurofibromatoosigeeni, DNA-tutkimus",,
3882,Point mutation of the B -NRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602450,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -NRAS geenin pistemutaatio,,
3883,Point mutation of the Bm-NRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602451,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-NRAS geenin pistemutaatio,,
3884,Point mutation of the Ts-NRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602452,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ts-NRAS geenin pistemutaatio,,
3885,Expression of the B -NRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602453,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -NRAS geenin ekspressio,,
3886,Expression of the Bm-NRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602454,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-NRAS geenin ekspressio,,
3887,Expression of the Ts-NRAS gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602455,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ts-NRAS geenin ekspressio,,
3888,"Papillomavirus, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602456,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Papilloma virus, antigeeni",,
3889,"Papillomavirus (HPV), culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602457,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Papilloma virus (HPV), viljely",,
3890,Pt-Hereditary disease,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602458,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Perinnöllinen sairaus,,
3894,S -Propafenone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602459,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Propafenoni,,
3895,S -Propanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602460,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Propanoli,,
3896,S-Pseudokolinesterase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602461,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Pseudokoliinesteraasi,,
3898,"Mm-Fats, breast milk",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602462,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mm-Rasvat, äidinmaito",,
3899,"S -Reticulin, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602463,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Retikuliini, vasta-aineet",,
3900,S-Ciprofloxacin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602464,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Siprofloksasiini,,
3901,Sp-Citrate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602465,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sp-Sitraatti,,
3902,Assessment of Cell Morphology,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602466,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Solujen morfologinen tarkastelu,,
3903,S -Streptomycin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602467,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Streptomysiini,,
3904,B -T cell receptor genes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017962,TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602468,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -T-solureseptorigeenit,,
3905,Bm-T cell receptor genes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40763634,TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602469,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-T-solureseptorigeenit,,
3906,Ts-T cell receptor genes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017962,TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602470,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-T-solureseptorigeenit,,
3907,"S -Toxoplasma, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014959,Toxoplasma gondii IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602471,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Toxoplasma, vasta-aineet",,
3908,"S-Toxoplasma, IgA Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3018921,Toxoplasma gondii IgA Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602472,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Toxoplasma, IgA-vasta-aineet",,
3909,"S -Toxoplasma, antibodies, avidity",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40760109,Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602473,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Toxoplasma, vasta-aineet, aviditeetti",,
3910,"Pt-Tolbutamide test, oral",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602474,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Tolbutamidi-koe, peroraalinen",,
3911,"Pt-Tolbutamide test, intravenous",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602475,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Tolbutamidi-koe, intravenöösi",,
3912,"S -Trophoblast, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602476,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Trofoblasti, vasta-aineet",,
3913,Pt Platelet Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602477,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Trombosyytti-koe,,
3914,"Pt-Blood pressure, long-term registration (24 h)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602478,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Verenpaine, pitkäaikaisrekisteröinti (24 h)",,
3915,S -Verpamil,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602479,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Verpamiili,,
3920,S -Alprazolam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602480,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alpratsolaami,,
3921,U -Aluminium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602481,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Alumiini,,
3922,S-Amiodarone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602482,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Amiodaroni,,
3923,"S -Amylase, from pancreas (pancreas)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016417,Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602483,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Amylaasi, haimaperäinen",,
3924,"U -Amylase, from pancreas (pancreas)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019396,Amylase.pancreatic [Enzymatic activity/volume] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000602484,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Amylaasi, haimaperäinen",,
3925,"S -Amylase, inhibited",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602485,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Amylaasi, inhiboitu",,
3926,"S -Androstenediol glucuronide, 3 alpha",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602486,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Androstendioliglukuronidi, 3 alfa",,
3927,fS-Beta-carotene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602487,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Beetakarotiini,,
3928,B -Benzene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602488,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Bentseeni,,
3929,"S-Chlamydia psittaci, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602489,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia psittaci, IgM-vasta-aineet",,
3931,B -DNA coupling assay,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602490,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -DNA kytkentäanalyysi,,
3932,Pt High Resolution ECG,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602491,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, suurresoluutiotutkimus",,
3935,"The Amagene for Coagulation Factor VIII, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602492,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Am-Hyytymistekijä VIII geeni, DNA-tutkimus",,
3936,"B -Gene for Coagulation Factor VIII, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602493,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Hyytymistekijä VIII geeni, DNA-tutkimus",,
3937,"The P1 Gene for Coagulation Factor VIII, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602494,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Pl-Hyytymistekijä VIII geeni, DNA-tutkimus",,
3938,U -Phenol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602495,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Fenoli,,
3939,P -Fibrin D D-Dimers (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602496,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Fibriinin D-dimeerit (kval),,
3940,"The Am Fibrillation Gene, DNA Examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602497,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Am-Fibrilliinigeeni, DNA-tutkimus",,
3941,"The B -Fibrillation Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602498,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Fibrilliinigeeni, DNA-tutkimus",,
3942,"The P1 Fibrillation Gene, DNA Examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602499,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pl-Fibrilliinigeeni, DNA-tutkimus",,
3943,"The Ts-Fibrillation Gene, DNA Examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602500,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Fibrilliinigeeni, DNA-tutkimus",,
3945,U -Formiat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602501,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Formiaatti,,
3946,S -Gamma-vinyl-gamma-aminobutyric acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602502,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Gamma-vinyyli-gamma-aminovoihappo,,
3947,"The B -Gelsol gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602503,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Gelsoliinigeeni, DNA-tutkimus",,
3948,U-Glyphosate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602504,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Glyfosaatti,,
3949,S -Haloperidol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602505,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Haloperidoli,,
3950,"S -Helicobacter pylori, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602506,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Helicobacter pylori, vasta-aineet",,
3951,"S -Helicobacter pylori, antibodies (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602507,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Helicobacter pylori, vasta-aineet (kval)",,
3952,"F -Helicobacter pylori, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013139,Helicobacter pylori Ag [Presence] in Stool,Measurement,MAPS_TO,,HUS,1596153600000,,2000602508,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Helicobacter pylori, antigeeni",,
3953,"S -Helicobacter pylori, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602509,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Helicobacter pylori, IgA-vasta-aineet",,
3954,"S -Helicobacter pylori, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027696,Helicobacter pylori Ab [Titer] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602510,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Helicobacter pylori, IgG-vasta-aineet",,
3955,"S -Helicobacter pylori, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602511,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Helicobacter pylori, IgM-vasta-aineet",,
3956,"Ts-HLADr, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602512,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Ts-HLADr, tyypitys",,
3957,S -Hydroxycarbazepine (10-),-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3048469,10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602513,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hydroksikarbatsepiini (10-),,
3958,U -Hydroxymethylformamide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602514,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Hydroksimetyyliformamidi,,
3959,S -Hydroxytryptamine (5-),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3022725,Serotonin [Moles/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602515,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Hydroksitryptamiini (5-),,
3960,Ts-Interleukin 2 receptor (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602516,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Interleukin 2-reseptori (kval),,
3962,U-Chlorophenols,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602517,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kloorifenolit,,
3963,S-Chlorpromazine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602518,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klooripromatsiini,,
3964,S -Klozapin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000081,cloZAPine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602519,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klotsapiini,,
3965,B -Cobalt,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602520,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,B -Koboltti,,
3966,S -Collagen I: carboxy-terminal telopeptide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602521,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kollageeni I:n karboksiterminaalinen telopeptidi,,
3969,U -Kotinin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602522,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kotiniini,,
3975,"Li-Borrelia, Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3011166,Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602523,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Borrelia, vasta-aineet",,
3977,U-Naphthol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602524,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Naftoli,,
3982,S -Nordiazepam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602525,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Nordiatsepaami,,
3984,S -Norfluoxetine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602526,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Norfluoksetiini,,
3985,S -Norklobazam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602527,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Norklobatsaami,,
3986,S -Norklomipramine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602528,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Norklomipramiini,,
3987,S -Nortrimipramine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602529,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Nortrimipramiini,,
3990,Ts-Examination of Fine Needle Biopsy,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3043109,Cytology report of Tissue fine needle aspirate Cyto stain,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602530,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Ohutneulabiopsiatutkimus,,
3991,S -Pentobarbital,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602531,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Pentobarbitaali,,
3994,P -Tissue Plasminogen Activator,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602532,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Plasminogeenin kudosaktivaattori,,
3995,P-Inhibitor of Tissue Plasminogen Activator,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602533,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Plasminogeenin kudosaktivaattorin inhibiittori,,
3996,S -Platina,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602534,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Platina,,
3997,"F -Plesiomonas shigelloides, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602535,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Plesiomonas shigelloides, viljely",,
3998,"-Pneumocystis jirovecii, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602536,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pneumocystis jirovecii, antigeeni",,
3999,fS-Polychlorinated Biphenyls,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602537,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Polyklooratut bifenyylit,,
4000,"P -Protein S, antigen, free",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020629,Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602538,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Proteiini S, antigeeni, vapaa",,
4002,"Am-Retinoblastoma Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602539,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Am-Retinoblastoomageeni, DNA-tutkimus",,
4003,"B -Retinoblastoma gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602540,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Retinoblastoomageeni, DNA-tutkimus",,
4004,"The P1 Retinoblastoma Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602541,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pl-Retinoblastoomageeni, DNA-tutkimus",,
4009,Pt-Study of the autonomic nervous system of the heart and blood circulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602542,LABfi Level 0,Measurement,2004-01-01,2006-12-31,,,Pt-Sydämen ja verenkierron autonomisen hermoston tutkiminen,,
4010,Pt-Pulse Variation at Rest,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602543,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Sykevariaatio lepotilassa,,
4011,"Pt-Pulse Variation, Long-Term Registration",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602544,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Sykevariaatio, pitkäaikaisrekisteröinti",,
4012,Ts-Cyclosporin A (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602545,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Syklosporiini A (kval),,
4014,"Cytomegalovirus, immediate early antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602546,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cytomegalovirus, immediate early antigen",,
4015,U -Tallium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602547,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Tallium,,
4019,S -Temazepam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602548,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tematsepaami,,
4020,U-Thiotiazolidine-4-carboxylic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602549,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Tiotiatsolidiinikarboksylaatti,,
4021,"Toxoplasma, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602550,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Toxoplasma, antigeeni",,
4022,B-Fluorotrichloromethane (Freon 11),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602551,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Fluoritrikloorimetaani (Freon 11),,
4023,B-Fluorotrichloroethane (Freon 113),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602552,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Fluoritrikloorietaani (Freon 113),,
4024,U -Trichlorophenol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602553,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,U -Trikloorifenoli,,
4025,P - Investigation of thrombosis system,-1,,0,APPROVED,UNREVIEWED,Auto-remapping using OHDSI release 2024-08-29,1727395200000,4195642,Thrombophilia screening test,Measurement,MAPS_TO,,TYKS,1727395200000,,2000602554,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Tromboositaipumuksen selvittely,,
4026,S -Trazodon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602555,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Tratsodoni,,
4027,"Ex-Mycobacterium tuberculosis, culture",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3036432,Mycobacterium tuberculosis genotype [Identifier] in Isolate,Measurement,MAPS_TO,,tays,1630368000000,,2000602556,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ex-Mycobacterium tuberculosis, viljely",,
4028,"S -thyroid apoxidase, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027238,Thyroperoxidase Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602557,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tyreoideaperoksidaasi, vasta-aineet",,
4031,"P-by Willebrand factor, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036035,von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602558,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -von Willebrand-tekijä, antigeeni",,
4032,"P -von Willebrand factor, ristocetin cofactor",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602559,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -von Willebrand-tekijä, ristosetiinikofaktori",,
4034,"Ts-Dissection of Tissue, Abortion",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602560,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Aborttikudoksen dissektiotutkimus,,
4035,Ts-Amyloid (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602561,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Amyloidi (kval),,
4036,Ts-Acetylcholinesterase (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602562,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Asetyylikoliiniesteraasi (kval),,
4037,As-Cytological Examination of Peritoneal Fluid,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4281824,"Cell count and differential, peritoneal fluid",Measurement,MAPS_TO,,TYKS,1631577600000,,2000602563,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Peritoneaalinesteen irtosolututkimus,,
4038,"Bl-Broncoalveolar lavage test, cell examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602564,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bl-Bronkoalveolaarinen huuhtelunäyte, solututkimus",,
4039,"Bl-Broncoalveolar lavage test, quantification of asbestos",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602565,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bl-Bronkoalveolaarinen huuhtelunäyte, asbestin kvantitoiminen",,
4040,Bf-Cytological examination of bronchial secretions,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3030694,Cytology report of Bronchial brush Cyto stain,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602566,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bf-Bronkuseritteen irtosolututkimus,,
4040,Bf-Cytological examination of bronchial secretions,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3033034,Cytology report of Bronchoalveolar lavage Cyto stain,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602566,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bf-Bronkuseritteen irtosolututkimus,,
4041,"Ts-DNA, Flow Cytometry",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602567,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-DNA, virtaussytometria",,
4042,He-Histological Examination of Endomyocardium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602568,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,He-Endomyocardiumin histologinen tutkimus,,
4043,Ts-Histological examination of gastroscopy samples,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40768797,Stomach Pathology biopsy report,Measurement,MAPS_TO,,HUS,1596153600000,,2000602569,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Gastroskopianäytteiden histologinen tutkimus,,
4044,Pt-Examination of gynecological cell sample,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4206982,Sampling of female genital tract for smear,Procedure,MAPS_TO,,TYKS,1631577600000,,2000602570,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Gynekologinen irtosolututkimus,,
4045,"Pt-Examination of gynecological cell sample, screening",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3050380,Cytology report of Cervical or vaginal smear or scraping Cyto stain,Measurement,MAPS_TO,,HUS,1596153600000,,2000602571,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Gynekologinen irtosolututkimus, seulonta",,
4046,Ne-Histological Examination of Nerve,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602572,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ne-Hermon histologinen tutkimus,,
4047,"Sk-Skin, Immunofluorescence Examination",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3037320,Microscopic observation [Identifier] in Specimen by Immunofluorescence,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602573,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sk-Iho, immunofluoresenssitutkimus",,
4047,"Sk-Skin, Immunofluorescence Examination",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40768443,Skin Pathology biopsy report,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602573,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sk-Iho, immunofluoresenssitutkimus",,
4049,Ln-Histological examination of lymph node,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40768795,Lymph node Pathology biopsy report,Measurement,MAPS_TO,,tays,1630368000000,,2000602574,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ln-Imusolmukkeen histologinen tutkimus,,
4050,Pt-Pathological consultation,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40763624,Pathology Consult note,Note,MAPS_TO,,TYKS,1631577600000,,2000602575,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Patologian konsultaatio,,
4051,"Ts-Tissue Samples, Rapid Preparation",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,37311796,Tissue frozen section technique,Procedure,MAPS_TO,,TYKS,1631577600000,,2000602576,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Kudoksen pikaleiketutkimus,,
4052,"Ts-Tissue Samples, Electron Microscopic Examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602577,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäyte, elektronimikroskooppinen tutkimus",,
4053,"Tissue Tests, Immunofluorescence Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602578,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäyte, immunofluoresenssitutkimus",,
4054,"Ts-Histological examination of tissue samples, 1-3 specific small samples from the same whole",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,40768804,Tissue Pathology biopsy report,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602579,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäytteen histologinen tutkimus, 1-3 eriteltyä pientä näytettä, samaan kokonaisuuteen kuuluvia",,
4055,"Ts-Histological examination of tissue samples, 4 or more samples",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602580,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäytteen histologinen tutkimus, 4 tai useampia eriteltyjä pieniä näytteitä",,
4056,"Ts-Histological examination of tissue samples, limited surgical specimen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002256,Pathology report gross observation,Measurement,MAPS_TO,,HUS,1596153600000,,2000602581,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäytteen histologinen tutkimus, suppea leikkauspreparaatti",,
4057,M -Histological examination of muscle,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602582,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,M -Lihaksen histologinen tutkimus,,
4059,Li-Cytological examination of cerebrospinal fluid,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012320,Pathologist interpretation of Cerebral spinal fluid tests,Measurement,MAPS_TO,,tays,1630368000000,,2000602583,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Likvorin irtosolututkimus,,
4060,Bo-Histological examination of bone or hard tissue,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602584,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bo-Luun tai kovakudoksen histologinen tutkimus,,
4061,Bm-Histological examination of bone marrow,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3045142,Bone marrow Pathology biopsy report,Measurement,MAPS_TO,,HUS,1596153600000,,2000602585,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bm-Luuytimen histologinen tutkimus,,
4062,St-Cytological examination of the stomach,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602586,LABfi Level 0,Measurement,2004-01-01,2013-12-31,,,St-Mahalaukun irtosolututkimus,,
4064,Lr-Histological examination of liver,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,43531140,Microscopic examination of specimen from liver,Procedure,MAPS_TO,,TYKS,1631577600000,,2000602587,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Lr-Maksan histologinen tutkimus,,
4065,"Ki-Kidney, Electron Microscopic Examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602588,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ki-Munuainen, elektronimikroskooppinen tutkimus",,
4066,"Ki-Kidney, Immunofluorescence Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602589,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ki-Munuainen, immunofluorenssitutkimus",,
4067,Ki-Histological examination of kidney,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40768446,Kidney Pathology biopsy report,Measurement,MAPS_TO,,tays,1630368000000,,2000602590,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ki-Munuaisen histologinen tutkimus,,
4068,Ns-Cytological examination of the nose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602591,LABfi Level 0,Measurement,2004-01-01,2013-12-31,,,Ns-Nenän irtosolututkimus,,
4069,"Pt-Autopsy, adult",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4162299,Autopsy examination,Procedure,MAPS_TO,,TYKS,1631577600000,,2000602592,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Obduktio, aikuinen",,
4070,"Pt-Autopsy, children",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602593,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Obduktio, lapsi",,
4071,"Pt-Autopsy, neuropathological",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602594,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Obduktio, neuropatologinen",,
4072,"Pt-Autopsy, microbiological",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602595,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Obduktio, mikrobiologinen",,
4075,"Papillomavirus, Nucleic Acid (Qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3029511,Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000602596,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Papilloomavirus, nukleiinihappo (kval)",,
4076,Pf-Cytological examination of pleural fluid,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40768806,Pleura Pathology biopsy report,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602597,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Pleuranesteen irtosolututkimus,,
4077,Mf-Cytological examination of mammary gland secretions,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602598,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Mf-Rintarauhaseritteen irtosolututkimus,,
4078,U -Cytological examination of urine,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3049717,Cytology report of Urine Cyto stain,Measurement,MAPS_TO,,HUS,1596153600000,,2000602599,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Virtsan irtosolututkimus,,
4080,Ex-Cytological Examination of Cough,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602600,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ex-Ysköksen irtosolututkimus,,
4082,"Pt-Adrenocorticotropin test, enzyme deficiency of cortisol synthesis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602601,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Adrenokortikotropiini-koe, kortisolisynteesin entsyymipuute",,
4083,Adrenocorticotropin-like peptide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602602,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Adrenokortikotrooppisen hormonin kaltainen peptidi,,
4084,"cU-Albumin, microalbuminuria",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602603,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"cU-Albumiini, mikroalbuminuria",,
4085,"S -Alpha-Androstane (5) -3alpha, 17 betadiolglucurone",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602604,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"S -Alfa-Androstan(5)-3alfa, 17 beetadioliglukuron",,
4088,"Amoeba, staining (trophozoites)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602605,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ameeba, värjäys (trofozoiitit)",,
4090,As-Angiotensin-1-convert,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602606,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Angiotensiini-1-konvertaasi,,
4091,"S-Apolipoprotein E, Phenotyping",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602607,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Apolipoproteiini E, fenotyypitys",,
4092,"B-Apolipoprotein E, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602608,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Apolipoproteiini E, DNA-tutkimus",,
4093,"B -Bacteria, still growing",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023368,Bacteria identified in Blood by Culture,Measurement,MAPS_TO,,HUS,1596153600000,,2000602609,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Bakteeri, jatkoviljely",,
4094,"Pp-Bacteria, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602610,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pp-Bakteeri, viljely",,
4095,"S -Borrelia, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016888,Borrelia burgdorferi IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602611,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Borrelia, IgG-vasta-aineet",,
4096,"S -Borrelia, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008230,Borrelia burgdorferi IgM Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602612,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Borrelia, IgM-vasta-aineet",,
4097,"Borrelia, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602613,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Borrelia, viljely",,
4098,"S -C1-Esterase Inhibitor, Activity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602614,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -C1-Esteraasin inhibiittori, aktiivisuus",,
4099,Li-CA 12-5 antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602615,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-CA 12-5 antigeeni,,
4100,"S-Chlamydia trachomatis, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602616,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia trachomatis, IgG-vasta-aineet",,
4101,S -Desialotransferrin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003031,Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602617,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Desialotransferriini,,
4102,Ts-Examination of Mutations in Mitochondrial DNA,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602618,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-DNA:n Mitokondriaalinen rakennemuutosanalyysi,,
4103,"F -Escherichia coli, enterohemorrhagic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602619,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Escherichia coli, enterohemorrhaginen",,
4104,Vitamin Sp-E,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602620,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Sp-E-Vitamiini,,
4105,"S -Elastase, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602621,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Elastaasi, vasta-aineet",,
4106,"B - Mercury, inorganic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602622,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Elohopea, epäorgaaninen",,
4107,"B - Mercury, organic",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602623,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Elohopea, orgaaninen",,
4108,S -Eosinophilic cationic protein,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005791,Eosinophil cationic protein (ECP) [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602624,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Eosinofiilisten granulosyyttien kationinen proteiini,,
4109,"S-Epstein-Barr virus, nuclear antigen, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602625,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epstein-Barrin virus, tuma-antigeeni, vasta-aineet",,
4110,Ts-Examination of Estrogen Receptor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602626,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Ts-Estrogeenireseptoritutkimus,,
4111,S -Estrone sulfate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602627,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Estronisulfaatti,,
4112,"B -Fragile-X, -FMR1 gene, DNA test",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,21494429,FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,tays,1630368000000,,2000602628,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Fragiili-X,-FMR1-geenin DNA-tutkimus",,
4113,P -Dibrin D-dimers,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3051714,Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602629,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Fibriinin D-dimeerit,,
4114,"S -Phosphatidylserine, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602630,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Fosfatidyylseriini, IgG-vasta-aineet",,
4115,"S -Phosphatidylserine, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602631,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Fosfatidyylseriini, IgM-vasta-aineet",,
4116,"S-Ganglioside, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602632,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Gangliosidi, vasta-aineet",,
4117,"Ts-Helicobacter pylori, culture",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,36306090,Helicobacter pylori [Presence] in Tissue by Organism specific culture,Measurement,MAPS_TO,,tays,1630368000000,,2000602633,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Helicobacter pylori, viljely",,
4118,"Ts-HER-2-neu, oncoprotein, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602634,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-HER-2-neu, onkoproteiini, DNA-tutkimus",,
4119,"S-Human T-lymphotrophic virus, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40758292,HTLV I+II Ab panel - Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602635,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Human T-cell leukemiavirus, vasta-aineet",,
4120,"S-Interferon-alpha, neutralizing antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602636,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Interferoni-alfa, neutraloivat vasta-aineet",,
4121,Pt-Captopril Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602637,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Kaptopriili-koe,,
4122,Li-Carcinoembryonic Antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602638,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Karsinoembryonaalinen antigeeni,,
4124,"S -Cathepsin-G, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602639,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Katepsiini-G, vasta-aineet",,
4125,"S -Keratin, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602640,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Keratiini, vasta-aineet",,
4126,"S -Testicle, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602641,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kives, vasta-aineet",,
4127,S -Cocaine (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013632,Cocaine [Presence] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602642,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kokaiini (kval),,
4128,U -Cocaine (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016879,Cocaine [Presence] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000602643,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kokaiini (kval),,
4129,Pt-Clinical physiological consultation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602644,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Kliinisen fysiologian konsultaatio,,
4130,Pt-Clinical Chemical Consultation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602645,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Kliinisen kemian konsultaatio,,
4132,Pt-Clinical microbiological consultation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602646,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Kliinisen mikrobiologian konsultaatio,,
4133,"Pt-Statement on neurophysiological examination, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602647,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Lausunto neurofysiologisesta tutkimuksesta, vaativa",,
4136,Li-Koriongonadotropin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602648,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Koriongonadotropiini,,
4137,"Pt-Koriongonadotropin test 2, prepubertal",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602649,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Koriongonadotropiini-koe 2, prepubertaalinen",,
4138,"Pt-Coriongonadotropin Test 3, Puberty",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602650,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Koriongonadotropiini-koe 3, pubertaalinen",,
4139,"Ts chromosome analysis, immunomorphological",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602651,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Ts-Kromosomianalyysi, immunologismorfologinen",,
4141,"The Helsinki Mutation of the B -LDL Receptor Gene, DNA Examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602652,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -LDL-reseptorigeenin Helsinki-mutaatio, DNA-tutkimus",,
4142,"B -LDL Receptor Gene North Karelia Mutation, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602653,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -LDL-reseptorigeenin Pohjois-Karjala-mutaatio, DNA-tutkimus",,
4143,"S-Lactoferrin, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602654,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Laktoferriini, vasta-aineet",,
4144,fS-Lipoprotein (a),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602655,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Lipoproteiini (a),,
4145,B -Lymphocyte CD4 subclass,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602656,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Lymfosyytti CD4-alaluokka,,
4146,"S -Lysozyme, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602657,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Lysotsyymi, vasta-aineet",,
4147,S -Methylmalonate,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016426,Methylmalonate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602658,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Metyylimalonaatti,,
4148,"S-Myeloperoxidase, Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3016080,Myeloperoxidase Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602659,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Myeloperoksidaasi, vasta-aineet",,
4149,"S-Myeloperoxidase, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3049804,Myeloperoxidase IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602660,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Myeloperoksidaasi, IgG-vasta-aineet",,
4150,"S -Mycoplasma pneumoniae, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3018387,Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602661,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Mycoplasma pneumoniae, IgG-vasta-aineet",,
4151,"S -Mycoplasma pneumoniae, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3010521,Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602662,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Mycoplasma pneumoniae, IgM-vasta-aineet",,
4154,Onchocerca (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602663,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Onchocerca (kval),,
4155,P -Parathormone-like peptide,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3033670,Parathyrin related protein [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602664,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Parathormonin kaltainen peptidi,,
4156,"S -Parvovirus, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006120,Parvovirus B19 IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602665,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parvovirus, vasta-aineet",,
4156,"S -Parvovirus, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008321,Parvovirus B19 IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602665,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parvovirus, vasta-aineet",,
4157,uB-Small blood count and platelets,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602666,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,uB-Perusverenkuva ja trombosyytit,,
4158,Ts-Progestin Receptor Examination,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602667,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Ts-Progestiinireseptoritutkimus,,
4160,"S-Proteinase 3, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009445,Proteinase 3 Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602668,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proteinaasi 3, vasta-aineet",,
4161,"fS-Fatty acids, free, fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602669,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Rasvahapot, vapaat, fraktiot",,
4162,"fS-Fatty acids, very long hydrocarbon chain (22 C)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602670,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Rasvahapot, hyvin pitkäketjuiset (22 C)",,
4163,fP-Renin substrate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602671,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Reniinisubstraatti,,
4165,"S-Salmonella, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602672,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Salmonella, IgA-vasta-aineet",,
4166,dU-Citrate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012989,Citrate [Moles/time] in 24 hour Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000602673,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Sitraatti,,
4167,"Streptococcus, continued cultivation (screened sample)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042975,Streptococcus sp identified in Isolate by Organism specific culture,Measurement,MAPS_TO,,tays,1630368000000,,2000602674,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Streptococcus, jatkoviljely (seulottu näyte)",,
4168,"S-Cytomegalovirus, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3010130,Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602675,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Cytomegalovirus, IgG-vasta-aineet",,
4169,"S -Cytomegalovirus, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3015635,Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602676,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Cytomegalovirus, IgM-vasta-aineet",,
4170,"P -Transcobalamines, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602677,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Transkobalamiinit, vapaat",,
4171,"S -Treponema pallidum, FTA-absorption",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602678,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Treponema pallidum, FTA-absorptio",,
4172,S -Trypsinogen 1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602679,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Trypsinogeeni 1,,
4173,S -Trypsinogen 2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602680,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Trypsinogeeni 2,,
4174,U -Trypsinogen 1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602681,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Trypsinogeeni 1,,
4175,U -Trypsinogen 2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602682,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Trypsinogeeni 2,,
4176,Li-Tumor-Associated Trypsin Inhibitor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602683,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Tuumoriin liittyvä trypsiini-inhibiittori,,
4177,uS-Tyroxin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602684,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,uS-Tyroksiini,,
4178,"UV blood gas analysis, umbilical vein blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602685,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"uV-Verikaasuanalyysi, napalaskimoveri",,
4179,"UA Blood Gas Analysis, Umbilical Arterial Blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602686,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"uA-Verikaasuanalyysi, napavaltimoveri",,
4180,"B -Blood group, antibodies, identification, extended",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602687,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Punasoluvasta-aineet, tunnistus, laajennettu",,
4181,"B -Blood group, antibodies, identification, panagglutinin",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602688,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Punasoluvasta-aineet, tunnistus, panagglutiniini",,
4183,Pi-Histological examination of the pituitary gland,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602689,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pi-Aivolisäkkeen histologinen tutkimus,,
4184,Sk-Histological examination of skin rash,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602690,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Sk-Ihottumanäytteen histologinen tutkimus,,
4185,"Cytological test, immunohistochemical examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602691,LABfi Level 0,Measurement,2004-01-01,2013-12-31,,,"Irtosolunäyte, immunohistokemiallinen tutkimus",,
4186,"Cytological test, in situ hybridization",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602692,LABfi Level 0,Measurement,2004-01-01,2013-12-31,,,"Irtosolunäyte, in situ-hybridisaatiotutkimu",,
4187,"Cn-Special Neuropathological Examination of the Central Nervous System, Autopsy Test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602693,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cn-Keskushermoston erillinen neuropatologinen tutkimus, obduktionäyte",,
4188,Lu-Histological examination of lung,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602694,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Lu-Keuhkon histologinen tutkimus, parenkyymitaudin selvittely",,
4189,Out-Cytological Examination of the Uterus (Uterus),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602695,LABfi Level 0,Measurement,2004-01-01,2013-12-31,,,Ut-Kohdun irtosolututkimus,,
4190,"Ts-Tissue Test, Enzyme Histochemical Examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602696,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäyte, entsyymihistokemiallinen tutkimus",,
4191,"Ts-Tissue Test, Immunohistochemical Examination",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,4035726,Immunohistochemistry procedure,Measurement,MAPS_TO,,HUS,1596153600000,,2000602697,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäyte, immunohistokemiallinen tutkimus",,
4192,"Ts-Tissue Samples, In Situ Hybridization",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3049539,Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal,Measurement,MAPS_TO,,tays,1630368000000,,2000602698,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäyte, in situ-hybridisaatiotutkimus",,
4193,"Ts-Tissue Test, Suspected Storage Disease",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602699,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäyte, kertymätautiepäily",,
4194,"Ts-Histological examination of tissue samples, comprising surgical specimens",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602700,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kudosnäytteen histologinen tutkimus, laaja leikkauspreparaatti",,
4195,Bo-Histomorphometric analysis of bone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602701,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bo-Luun histomorfometrinen tutkimus,,
4196,B -Alcohols,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602702,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Alkoholit,,
4197,U -Alcohols,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602703,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Alkoholit,,
4198,"Af-Amylase, from pancreas (pancreas)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602704,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Af-Amylaasi, haimaperäinen",,
4199,"As-Amylase, from pancreas (pancreas)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602705,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"As-Amylaasi, haimaperäinen",,
4200,"Li-Borrelia, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42529197,Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602706,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Borrelia, IgG-vasta-aineet",,
4201,"Li-Borrelia, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3011050,Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602707,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Borrelia, IgM-vasta-aineet",,
4202,"Borrelia, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3030429,Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602708,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Borrelia, nukleiinihappo (kval)",,
4203,U -Buprenorphine (qual.),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,1001926,Buprenorphine [Presence] in Urine by Screen method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602709,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Buprenorfiini (kval),,
4204,"S-Chlamydia pneumoniae, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,1175715,Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602710,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia pneumoniae, IgM-vasta-aineet",,
4205,"Chlamydia trachomatis, immunofluorescence",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602711,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Chlamydia trachomatis, immunofluoresenssi",,
4206,"U-Chlamydia trachomatis, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024950,Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000602712,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"U -Chlamydia trachomatis, nukleiinihappo (kval)",,
4207,S-Desipramine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602713,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Desipramiini,,
4208,S-Desmethylclozapine,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3008832,Norclozapine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602714,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Desmetyyliklotsapiini,,
4209,"DNA, isolation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602715,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"DNA, eristys",,
4210,"U-erythrocytes, dysmorphs",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40761545,Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy,Measurement,MAPS_TO,,tays,1630368000000,,2000602716,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Erytrosyytit, dysmorfiset",,
4211,"P -Coagulation factor IX, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602717,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Hyytymistekijä IX, vasta-aineet",,
4212,U -Fibrin D D-Dimers (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602718,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,U -Fibriinin D-dimeerit (kval),,
4213,U -Fibrine D-Dimers,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602719,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,U -Fibriinin D-dimeerit,,
4214,P -Fibrinolytic Capacity,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602720,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Fibrinolyyttinen kapasiteetti,,
4215,M -Phosphofructokinase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602721,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,M -Fosfofruktokinaasi,,
4216,"M -Phosphorylase, aktiv",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602722,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"M -Fosforylaasi, aktiivinen",,
4217,"M -Phosphorylase, total",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602723,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"M -Fosforylaasi, kokonais",,
4218,"P -Heparin, Logiparin",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602724,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"P -Hepariini, Logiparin",,
4219,"P -Heparin, Klexane",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602725,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"P -Hepariini, Klexane",,
4221,U -Drugscreening (kval),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3011288,Drugs identified in Urine by Screen method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602726,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Huumeseulonta (kval),,
4223,S -Imipenem,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602727,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Imipeneemi,,
4224,"Immunoglobulin E, targeted screening and specification",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602728,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini E, suunnattu seulonta ja erittely",,
4225,"S-Immunoglobulin G, subclass 1",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3027135,IgG subclass 1 [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602729,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokka 1",,
4226,"S-Immunoglobulin G, subclass 2",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028192,IgG subclass 2 [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602730,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokka 2",,
4227,"S-Immunoglobulin G, subclass 3",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024139,IgG subclass 3 [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602731,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokka 3",,
4228,"S-Immunoglobulin G, subclass 4",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024980,IgG subclass 4 [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602732,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G, alaluokka 4",,
4229,dU-Carnitine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602733,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Karnitiini,,
4230,M -Carnitinpalmityltransferase 1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602734,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,M -Karnitiinipalmityylitransferaasi 1,,
4231,M -Carnitinpalmityltransferase 2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602735,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,M -Karnitiinipalmityylitransferaasi 2,,
4232,As-Carcinoembryonic antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602736,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,As-Karsinoembryonaalinen antigeeni,,
4233,S -Kefalosporin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602737,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Kefalosporiini,,
4234,S -Coriongonadotropin-A Subunit,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602738,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Koriongonadotropiini-A-alayksikkö,,
4235,"S -Coriongonadotropin-A subunit, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602739,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Koriongonadotropiini-B-alayksikkö, vapaa",,
4236,"S -Creatin kinase, MB subunit, mass",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602740,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Kreatiinikinaasi, MB-alayksikkö, massa",,
4237,Legionella (kval),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3046861,Legionella sp Ag [Presence] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000602741,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Legionella (kval),,
4238,B -Aimmunocytochemical analysis of leukocyte phenotype,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602742,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -Leukosyyttien fenotyypin immunosytokemia,,
4239,Bm Immunocytochemical Analysis of Leukocyte Phenotype,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602743,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Bm-Leukosyyttien fenotyypin immunosytokemia,,
4240,"Ly-Lymphocytes, Proportion of T-helper Cells",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014037,CD3+CD4+ (T4 helper) cells/100 cells in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000602744,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ly-Lymfosyytit, T-auttajasolujen osuus",,
4241,"Ly-Lymphocytes, Proportion of T-suppressor Cells",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007449,CD3+CD8+ (T8 suppressor) cells/100 cells in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000602745,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Ly-Lymfosyytit, T-estäjäsolujen osuus",,
4242,"B -Lymphocytes, proportion of cells with CD25 expression",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602746,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Lymfosyytit, CD25-ekpressoivien solujen määrä",,
4243,"B -Lymphocytes, proportion of cells with D54 expression",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602747,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Lymfosyytit, D54-ekpressoivien solujen määrä",,
4244,"Mycobacterium, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3035109,Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602748,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycobacterium, nukleiinihappo (kval)",,
4245,"Mycobacterium, susceptibility determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602749,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycobacterium, herkkyysmääritys",,
4246,M -Myoadenylate deaminase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602750,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,M -Myoadenylaattideaminaasi,,
4247,B -NK cells,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3025271,CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000602751,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -NK-solut,,
4248,U -Orotat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602752,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Orotaatti,,
4249,"S -Parvovirus, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006120,Parvovirus B19 IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602753,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parvovirus, IgG-vasta-aineet",,
4250,"S -Parvovirus, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3026515,Parvovirus B19 IgM Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602754,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parvovirus, IgM-vasta-aineet",,
4251,"S -Sindbis virus, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602755,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sindbis-virus, IgM-vasta-aineet",,
4252,"B -Porphyria, acute intermittent, DNA examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602756,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Porfyria, akuutti intermittoiva, DNA-tutkimus",,
4253,"S -Prostatase-specific antigen, complex",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602757,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Prostataspesifinen antigeeni, kompleksi",,
4254,"S -Prostat-specific antigen, free",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3005013,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602758,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Prostataspesifinen antigeeni, vapaa",,
4255,"Sy-Rheumatoid Factor, Waaler-Rose",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602759,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Sy-Reumafaktori, Waaler-Rose",,
4256,Pt-Secretin-cerulein-test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602760,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Sekretiini-keruleeni-koe,,
4257,"Fungi, Sensitivity Determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602761,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sieni, herkkyysmääritys",,
4258,S -Citalopram,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3021367,Citalopram [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602762,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sitalopraami,,
4259,"US-Tyroxin, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602763,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"uS-Tyroksiini, vapaa",,
4260,Pt-Vasopressin Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602764,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Pt-Vasopressiini-koe,,
4261,"Pt-von Willebrandfaktor, undertypning",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602765,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-von Willebrand-tekijä, alatyypitys",,
4262,"P -von Willebrandfaktor, multimerer",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023693,von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot,Measurement,MAPS_TO,,HUS,1596153600000,,2000602766,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -von Willebrand-tekijä, multimeerit",,
4263,Pt-Measurement of pressure in muscle lungs,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602767,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Lihasaitiopaineen mittaus,,
4264,S -Granulocyte Growth Factor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602768,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Granulosyyttikasvutekijä,,
4265,S -Granulocyte-macrophage growth factor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602769,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Granulosyyttimakrofaagikasvutekijä,,
4266,"Ly-HLADP, typing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602770,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Ly-HLADP, tyypitys",,
4267,"B -HLA-DQB, typing, DNA testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602771,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-DQB, DNA-tutkimus",,
4268,"B -Immunthrombopenia Examination, Newborns",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602772,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Immuunitrombosytopenia-tutkimus, vastasyntyneen",,
4269,S-Interleukin 2 receptor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602773,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Interleukin 2-reseptori,,
4270,S -Chloroprotixes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602774,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Klooriprotikseeni,,
4272,"S -Leucocyte Antibodies, IgG, Screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602775,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Leukosyyttivasta-aineet, IgG, seulonta",,
4273,"S -Phyroid, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602776,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Lisäkilpirauhanen, vasta-aineet",,
4274,"B -Lymphocyte Stimulation Assay, Antigen-Specific",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602777,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Lymfosyyttistimulaatiokoe, antigeenispesifinen",,
4276,B -Alloantigen typing of platelets,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602778,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Trombosyyttien alloantigeenityypitys,,
4277,"B -Alloantigen typing of platelets, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602779,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Trombosyyttien alloantigeenityypitys, DNA-tutkimus",,
4278,S -Troponin T,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3019800,Troponin T.cardiac [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602780,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Troponiini T,,
4279,"Nucleus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602781,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Tuma, vasta-aineet",,
4280,"F -Tumor necrosis factor, alpha",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602782,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Tuumorinekroositekijä, alfa",,
4281,"Li-Tumor Necrosis Factor, Alpha",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602783,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Tuumorinekroositekijä, alfa",,
4282,"S -Tumor necrosis factor, alpha",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004282,Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602784,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tuumorinekroositekijä, alfa",,
4283,"B -Adrenoleukodystrophy, DNA examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602785,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Adrenoleukodystrofia, DNA-tutkimus",,
4284,Pd-Albumin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3041198,Albumin [Mass/volume] in Peritoneal dialysis fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000602786,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Albumiini,,
4285,S -Alcohols,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020191,Ethanol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602787,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alkoholit,,
4285,S -Alcohols,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3008402,Methanol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602787,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alkoholit,,
4285,S -Alcohols,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015616,Isopropanol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602787,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alkoholit,,
4285,S -Alcohols,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3027318,Ethylene glycol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000602787,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Alkoholit,,
4286,"S -Amylase, from salivary gland",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602788,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Amylaasi, sylkiperäinen",,
4287,dU-Aspartylglucosamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602789,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Aspartyyliglukoosiamiini,,
4288,"B -Angelman's Syndrome, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602790,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Angelmanin oireyhtymä, DNA-tutkimus",,
4289,"Li-Bacteria, continued cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602791,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Bakteeri, jatkoviljely",,
4290,"Ps-Bacteria, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602792,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ps-Bakteeri, viljely",,
4291,S-Biotinidas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602793,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Biotinidaasi,,
4292,"S -Blastomyces, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602794,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Blastomyces, vasta-aineet",,
4293,S-Busulfan,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005069,Busulfan [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602795,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Busulfaani,,
4294,"S-Chlamydia pneumoniae, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3038769,Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602796,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia pneumoniae, IgG-vasta-aineet",,
4295,"Chlamydia pneumoniae, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602797,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Chlamydia pneumoniae, viljely",,
4296,"F -Clostridium difficile, antigen",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3032057,Clostridioides difficile [Presence] in Stool,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602798,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Clostridium difficile, antigeeni",,
4297,"S-Coxsackie B5 virus, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602799,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Coxsackie B5 -virus, IgG-vasta-aineet",,
4298,"S -Coxsackie B5 virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602800,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Coxsackie B5 -virus, vasta-aineet",,
4299,U -Dextromethorphan,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602801,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Dekstrometorfaani,,
4300,S-Desmethylcitalopram,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602802,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Desmetyylisitalopraami,,
4301,"Echo 22 virus, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602803,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Echo 22-virus, IgG-vasta-aineet",,
4302,"Enterovirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602804,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Enterovirus, IgG-vasta-aineet",,
4303,"Enterovirus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602805,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Enterovirus, viljely",,
4304,Ns-Eosinophilic Cationic Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602806,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ns-Eosinofiilisten granulosyyttien kationinen proteiini,,
4305,S -Ethanol,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3020191,Ethanol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602807,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Etanoli,,
4306,"Ts-Fragile-X, FMR1 gene, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602808,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Fragiili-X, FMR1-geenin DNA-tutkimus",,
4307,"B -Fragile-X, chromosome examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602809,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Fragiili-X, kromosomitutkimus",,
4308,Examination of Fragile-X Syndrome,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602810,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,Fragiili-X oireyhtymän tutkiminen,,
4309,"dU-Glycosaminoglycans, fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602811,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Glykosaminoglykaanit, fraktiot",,
4310,"dU-Glycolipids, Fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602812,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Glykolipidit, fraktiot",,
4311,F -Surgency,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602813,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,F -Happamuusaste,,
4312,"S -Hepatitis B virus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3022058,Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602814,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti B -virus, nukleiinihappo (kval)",,
4313,"S -Hepatitis E Virus, Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3006922,Hepatitis E virus Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602815,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti E -virus, vasta-aineet",,
4314,"S -Hepatitis C virus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3021125,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000602816,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hepatiitti C -virus, nukleiinihappo (kval)",,
4315,"B -HLADr Typing, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602817,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -HLADr-tyypitys, DNA-tutkimus",,
4316,B -Hypohidrotic ectodermal dysplasia,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602818,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Hypohidroottinen ektodermaalidysplasia,,
4317,U-Isopropanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602819,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Isopropanoli,,
4318,"S -Japanese encephalitis virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602820,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Japanin enkefaliittivirus, vasta-aineet",,
4319,M -Karnitin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602821,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,M -Karnitiini,,
4321,"U -Coriongonadotropin, fragment",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602822,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Koriongonadotropiini, fragmentit",,
4322,"B -Corioidemigen, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602823,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Korioideremiageeni, DNA-tutkimus",,
4323,Bm Chromosome Translocation 14:18 at the BCL2 Gene,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3031888,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Bone marrow by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000602824,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bm-Kromosomien 14:18 translokaatio BCL2-geenin kohdalla, DNA-tutkimus",,
4324,Ts chromosome translocation 14:18 at the BCL2 gene,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020893,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000602825,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kromosomien 14:18 translokaatio BCL2-geenin kohdalla, DNA-tutkimus",,
4325,Pl Chromosome Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602826,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Pl-Kromosomitutkimus,,
4326,UB Chromosome Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602827,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,uB-Kromosomitutkimus,,
4327,Ts-Copper,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602828,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Kupari,,
4328,S -Lamotrigine,-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3037826,lamoTRIgine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tyks,1631577600000,,2000602829,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Lamotrigiini,,
4329,Pd-Leukocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602830,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Leukosyytit,,
4330,"B-Leukocytes, CD34 subclass",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602831,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Leukosyytit, CD34 alaluokka",,
4331,"Bm Leukocytes, CD34 subclass",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602832,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Bm-Leukosyytit, CD34 alaluokka",,
4332,"Pd Leukocytes, Differential Calculation",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3040562,Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count,Measurement,MAPS_TO,,tays,1630368000000,,2000602833,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pd-Leukosyytit, erittelylaskenta",,
4333,S -Levomepromazine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602834,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Levomepromatsiini,,
4334,Pd-Lipas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602835,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Lipaasi,,
4335,cU-Luteinizing Hormone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602836,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Luteinisoiva hormoni,,
4336,Ly-Lymphoblast Transformation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602837,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,Ly-Lymfoblastitransformaatio,,
4337,"B -Lymphocytes, stimulation test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602838,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Lymfosyytit, stimulaatiokoe",,
4338,"B -Lymphocytes' borrelia antigen, stimulation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602839,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"B -Lymfosyyttien borrelia-antigeeni, stimulaatio",,
4339,"fP-Magnesium, ionized",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602840,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fP-Magnesium, ionisoitunut",,
4340,"B -Multiple endocrine neoplasia, type 1, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602841,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Multippeli endokriininen neoplastia, tyyppi 1, DNA-tutkimus",,
4341,Ex-Myeloperoxidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602842,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ex-Myeloperoksidaasi,,
4342,S-Myeloperoxidase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602843,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Myeloperoksidaasi,,
4343,"B -Osteogenesis imperfecta IV, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602844,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Osteogenesis imperfekta IV, DNA-tutkimus",,
4344,"S -Parvovirus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015822,Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000602845,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Parvovirus, nukleiinihappo (kval)",,
4345,"Bordetella pertussis, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012477,Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000602846,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bordetella pertussis, nukleiinihappo (kval)",,
4346,S -Plasmin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602847,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,S -Plasmiini,,
4347,"B -Polycystic kidney disease, adult, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602848,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Polykystinen munuaistauti, aikuisiän, DNA-tutkimus",,
4348,"B-Prader-Willi Syndrome, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602849,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Prader Willin oireyhtymä, DNA-tutkimus",,
4349,Pd-Protein,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3033926,Protein [Mass/volume] in Peritoneal dialysis fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000602850,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Proteiini,,
4350,"RS virus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602851,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"RS virus, viljely",,
4351,"RS virus, antigen",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3001684,Respiratory syncytial virus Ag [Presence] in Specimen,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602852,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"RS virus, antigeeni",,
4352,"dU-Sialic acid, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602853,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Sialihappo, vapaa",,
4353,"Sp-Sperm, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602854,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sp-Siittiö, IgA-vasta-aineet",,
4354,"Sp-Sperm, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602855,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sp-Siittiö, IgG-vasta-aineet",,
4355,Pd cells,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,40763641,Cell count and Differential panel - Peritoneal dialysis fluid,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602856,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Solut,,
4356,Cellodling,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602857,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Soluviljely,,
4357,"B -Spinocerebellar ataxia, type 1, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602858,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Spinocerebellar ataxia, tyyppi 1, DNA-tutkimus",,
4358,"Staphylococcus aureus, methicillin-resistant odling",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019902,Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602859,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Staphylococcus aureus, metisilliiniresistenssi viljely",,
4359,"Cytomegalovirus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020229,Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000602860,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Cytomegalovirus, nukleiinihappo (kval)",,
4360,B -Tacrolimus,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3026250,Tacrolimus [Mass/volume] in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602861,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Tacrolimus,,
4361,S -Troponin I,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3021337,Troponin I.cardiac [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602862,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Troponiini I,,
4363,fS-Ubikinon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602863,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Ubikinoni,,
4364,Pd-Urea,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3040661,Urea [Moles/volume] in Peritoneal dialysis fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000602864,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pd-Urea,,
4368,"Adenovirus, antigen",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3016845,Adenovirus Ag [Presence] in Specimen by Immunofluorescence,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602865,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Adenovirus, antigeeni",,
4369,"Ps adenovirus, antigen (NPS test)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602866,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ps-Adenovirus, antigeeni (NPS-näyte)",,
4370,B -Examination of quinidine-induced thrombocytopenia,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602867,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Kin(id)iinitrombosytopeniatutkimus,,
4371,"S-Adenovirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602868,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Adenovirus, IgG-vasta-aineet",,
4372,"Li-Adenovirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602869,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Adenovirus, IgG-vasta-aineet",,
4373,"Adenovirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602870,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Adenovirus, vasta-aineet",,
4374,"F -Aeromonas, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602871,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Aeromonas, viljely",,
4375,"Amoeba, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602872,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ameeba, viljely",,
4377,"P-Antithrombin III, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003771,Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602873,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Antitrombiini III, antigeeni",,
4378,P -APC resistance,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008561,Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602874,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -APC-resistenssi,,
4378,P -APC resistance,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3015816,F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602874,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -APC-resistenssi,,
4379,S -Arabinotol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602875,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Arabinotoli,,
4381,"Bacteria, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40769539,Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602876,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bakteeri, nukleiinihappo (kval)",,
4382,S-Bilirubinglucuronides,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602877,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,S -Bilirubiiniglukuroniidit,,
4384,"Chlamydia pneumoniae, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3031478,Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602878,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Chlamydia pneumoniae, nukleiinihappo (kval)",,
4385,"S -RS virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602879,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -RS-virus, vasta-aineet",,
4386,"S-Coxsackie B4 virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602880,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Coxsackie B4 -virus, vasta-aineet",,
4388,"Li-Cytomegalovirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602881,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Cytomegalovirus, IgG-vasta-aineet",,
4389,"Li-Cytomegalovirus, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602882,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Cytomegalovirus, IgM-vasta-aineet",,
4390,"S -Endomysium, IgA Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020961,Endomysium IgA Ab [Titer] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602883,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Endomysium, IgA-vasta-aineet",,
4391,"S -Endomysium, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032773,Endomysium IgG Ab [Titer] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602884,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Endomysium, IgG-vasta-aineet",,
4392,"Enterovirus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3016881,Enterovirus RNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602885,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Enterovirus, nukleiinihappo (kval)",,
4393,Ts-Enzyme,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602886,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Ts-Entsyymi,,
4394,"S-Epstein-Barr virus, early antigen, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602887,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epstein-Barrin virus, varhaisantigeeni, vasta-aineet",,
4395,S -Fibrin D D-Dimers (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602888,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Fibriinin D-dimeerit (kval),,
4397,"S-Ganglioside (Gm1), IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602889,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Gangliosidi(Gm1), IgG-vasta-aineet",,
4398,"S-Ganglioside (Gm1), IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602890,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Gangliosidi(Gm1), IgM-vasta-aineet",,
4399,B -Examination of heparin-induced thrombocytopenia,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40760871,Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602891,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Hepariinitrombosytopeniatutkimus,,
4400,"S -Glutamate decarboxylase (GAD), antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020148,Glutamate decarboxylase 65 Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602892,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Glutamaattidekarboksylaasi (GAD), vasta-aineet",,
4401,"Herpes simplex virus, rapid culture",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3010254,Herpes simplex virus identified in Specimen by Organism specific culture,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602893,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Herpes simplex -virus, pikaviljely",,
4402,"Li-Herpes simplex virus, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3025927,Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602894,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Herpes simplex -virus, IgG-vasta-aineet",,
4403,"Li-Herpes simplex virus, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3044212,Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602895,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Herpes simplex -virus, IgM-vasta-aineet",,
4404,"Li-Herpes simplex virus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3008733,Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602896,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Herpes simplex -virus, nukleiinihappo (kval)",,
4405,"S-Herpes simplex virus, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3041365,Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602897,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Herpes simplex -virus, IgG-vasta-aineet",,
4406,"S-Herpes simplex virus, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3041145,Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602898,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Herpes simplex -virus, IgM-vasta-aineet",,
4407,"Li-Herpes simple virus, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3043525,Herpes simplex virus Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602899,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Herpes simplex -virus, vasta-aineet",,
4409,"S -Human herpesvirus-6, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602900,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Human herpes -virus 6, vasta-aineet",,
4410,"B -Coagulation factor V gene, DNA test",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3015816,F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000602901,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hyytymistekijä V geeni, DNA-tutkimus",,
4411,P -Coagulation factor XIII,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019250,Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602902,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hyytymistekijä XIII,,
4412,"P -Coagulation factor VIII, pig, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602903,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"P -Hyytymistekijä VIII, sika, vasta-aineet",,
4413,"S-Immunoglobulin G3, GM allotype determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602904,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Immunoglobuliini G3, GM-allotyypin määritys",,
4415,"Influenza A virus, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002523,Influenza virus A Ag [Presence] in Specimen,Measurement,MAPS_TO,,HUS,1596153600000,,2000602905,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Influenssa A -virus, antigeeni",,
4416,"Influenza B virus, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003740,Influenza virus B Ag [Presence] in Specimen,Measurement,MAPS_TO,,HUS,1596153600000,,2000602906,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Influenssa B -virus, antigeeni",,
4417,"Li-Influenza A Virus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602907,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Influenssa A -virus, IgG-vasta-aineet",,
4419,"S-Influenza A Virus, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042885,Influenza virus A IgG Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602908,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Influenssa A -virus, IgG-vasta-aineet",,
4420,"S-Influenza B virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602909,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Influenssa B -virus, vasta-aineet",,
4421,"Sewing-Cytological examination, synovial fluid",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602910,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Sy-Irtosolututkimus, nivelneste",,
4422,"Ma-Cytological examination, sinus",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602911,LABfi Level 0,Measurement,2004-01-01,2013-12-31,,,"Ma-Irtosolututkimus, poskiontelo",,
4423,"Co-cytological examination, conjunctiva of the eye (conjunctiva)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602912,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ko-Irtosolututkimus, silmän sidekalvo",,
4424,Pl-Histological examination of the placenta (placenta),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602913,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pl-Istukan histologinen tutkimus,,
4425,"P -Lupusanticoagulant, dRVVT",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602914,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Lupusantikoagulantti, dRVVT",,
4426,"P -Lupusanticoagulant, PTT",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3048518,aPTT.lupus sensitive actual/normal (normalized LA screen),Measurement,MAPS_TO,,TYKS,1631577600000,,2000602915,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Lupusantikoagulantti, PTT",,
4427,"S -Langerhans islets, complement-binding antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602916,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Langerhansin saareke, komplementtia sitovat vasta-aineet",,
4428,"Legionella pneumophila, nucleic acid (qual.)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3020565,Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602917,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Legionella pneumophila, nukleiinihappo (kval)",,
4429,B -Compatibility test for leukocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602918,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Leukosyyttien sopivuuskoe,,
4431,S -Man-Binding Lectin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602919,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Mannaaniin sitoutuva lektiini,,
4432,T -Membrane Glycoproteins,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602920,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,T -Membraaniglykoproteiinit,,
4433,"Li Measles Virus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602921,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Tuhkarokkovirus, IgG-vasta-aineet",,
4434,"Li measles virus, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602922,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Tuhkarokkovirus, IgM-vasta-aineet",,
4435,"S -Measure virus, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602923,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tuhkarokkovirus, IgG-vasta-aineet",,
4436,"S -Measure virus, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602924,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tuhkarokkovirus, IgM-vasta-aineet",,
4437,"Mycobacterium, special culture",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3005702,Mycobacterium sp identified in Specimen by Organism specific culture,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602925,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycobacterium, erikoisviljely",,
4438,"B -Mycobacterium, special culture",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015479,Mycobacterium sp identified in Blood by Organism specific culture,Measurement,MAPS_TO,,tays,1630368000000,,2000602926,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Mycobacterium, erikoisviljely",,
4439,"Mycoplasma pneumoniae, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3002482,Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602927,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycoplasma pneumoniae, nukleiinihappo (kval)",,
4440,"Li-Mycoplasma pneumoniae, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3035929,Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602928,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Mycoplasma pneumoniae, vasta-aineet",,
4442,"S -Nucleolus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602929,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Nukleolus, vasta-aineet",,
4445,"P -Tissue plasminogen activator, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602930,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Plasminogeenin kudosaktivaattori, antigeeni",,
4446,"-Pneumocystis jirovecii, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009595,Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000602931,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pneumocystis jirovecii, nukleiinihappo (kval)",,
4447,"S -Proatriopeptide, N-terminal",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602932,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Proatriopeptidi, N-terminaalinen",,
4448,"P -Protein C, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002022,Protein C Ag actual/normal in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602933,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Proteiini C, antigeeni",,
4449,P -Protein S,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3036669,Protein S actual/normal in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,HUS,1596153600000,,2000602934,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Proteiini S,,
4452,"P -Prothrombin, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602935,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Protrombiini, antigeeni",,
4453,"S -Puumalavirus, Antibodies, Avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602936,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puumala-virus, vasta-aineet, aviditeetti",,
4455,"RS virus, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602937,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"RS virus, IgG-vasta-aineet",,
4457,"S -Rickettsia conorii, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3026657,Rickettsia conorii Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602938,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Rickettsia conorii, vasta-aineet",,
4458,"S -Rickettsia typhi, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3027540,Rickettsia typhi Ab [Titer] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000602939,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Rickettsia typhi, vasta-aineet",,
4459,"F -Virus, Detection with Electron Microscope",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3007147,Virus identified in Stool by Electron microscopy,Measurement,MAPS_TO,,tays,1630368000000,,2000602940,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Virus, osoitus elektronimikroskopialla",,
4460,"Strongyloides, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602941,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Strongyloides, viljely",,
4461,"Li-TBE virus (tick-borne encephalitis virus), IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42868418,European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602942,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Puutiaisaivokuumevirus, IgG-vasta-aineet",,
4464,P -Troponin T (kval),-1,,0,APPROVED,UNREVIEWED,tyks,1631577600000,3019800,Troponin T.cardiac [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tyks,1631577600000,,2000602943,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Troponiini T (kval),,
4467,"S -Varicella-Zoster virus, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3003220,Varicella zoster virus IgG Ab [Titer] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602944,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Vesirokkovirus, IgG-vasta-aineet",,
4468,"Li-Varicella-Zoster Virus, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42868421,Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602945,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Vesirokkovirus, IgM-vasta-aineet",,
4469,"B - Blood group antibodies, during pregnancy",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602946,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Veriryhmävasta-aineet, raskaudenaikaiset",,
4470,"Virus, electron microscope detection",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602947,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Virus, osoitus elektronimikroskopialla",,
4471,"Pt-Bleeding Time, Duke",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602948,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"Pt-Vuotoaika, Duke",,
4472,S -Zuklopentixol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602949,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Zuklopentiksoli,,
4475,"Pt-Helicobacter pylori, urea test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602950,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Helicobacter pylori, ureakoe",,
4476,"Pt-ECG, long-term recording, symptom-based",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602951,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti, oirejohteinen",,
4477,U - Collagen I amino terminal telopeptide,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3014038,Collagen crosslinked N-telopeptide [Moles/volume] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000602952,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Kollageeni I:n aminoterminaalinen telopeptidi,,
4478,"fS-Apolipoprotein A-4, phenotyping",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602953,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Apolipoproteiini A-4, fenotyypitys",,
4479,Bf-Eosinophilic Cationic Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602954,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Bf-Eosinofiilisten granulosyyttien kationinen proteiini,,
4480,Lf-Eosinophilic Cationic Protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602955,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Lf-Eosinofiilisten granulosyyttien kationinen proteiini,,
4481,Sa-Teofyllin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602956,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,Sa-Teofylliini,,
4482,"Pt-ECG, includes statement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602957,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-EKG, sisältää lausunnon",,
4483,"Ts-Helicobacter pylori, ureas (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602958,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Helicobacter pylori, ureaasi (kval)",,
4484,"HI virus-1, nucleic acid (quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602959,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"HI-virus-1, nukleiinihappo (kvant)",,
4485,"HI virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602960,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"HI-virus, nukleiinihappo (kval)",,
4486,"Pt-Skin Test 1, Limited, 1-5 Antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602961,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Ihokoe 1, suppea, 1-5 antigeenia",,
4487,"Pt-Skin Test 2, limited, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602962,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Ihokoe 2, suppea, vaativa",,
4488,"Pt-Skin Test 3, Comprehensive, 6-20 Antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602963,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,"Pt-Ihokoe 3, laaja, 6-20 antigeenia",,
4489,"Pt-Skin Test 4, comprehensive, demanding, over 20 antigens or specialty chemicals",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602964,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Ihokoe 4, laaja, vaativa, yli 20 antigeenia tai erikoiskemikaalit",,
4490,"Mycobacterium tuberculosis, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014162,Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000602965,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Mycobacterium tuberculosis, nukleiinihappo (kval)",,
4496,S -Collagen I amino terminal propeptide,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3049714,Procollagen type I.N-terminal propeptide [Mass/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000602966,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Prokollageeni I:n aminoterminaalinen propeptidi,,
4497,"S-Chlamydia pneumoniae, IgA antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3044802,Chlamydophila pneumoniae IgA Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602967,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia pneumoniae, IgA-vasta-aineet",,
4498,"S-Chlamydia trachomatis, IgA antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602968,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Chlamydia trachomatis, IgA-vasta-aineet",,
4499,"S -Campylobacter, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602969,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Campylobacter, IgA-vasta-aineet",,
4500,B -Genotyping of alpha-1-antitrypsin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602970,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Alfa-1-antitrypsiinin genotyypitys, DNA-tutkimus",,
4501,B-Chromosome translocation 14:18 at the BCL2 gene,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020893,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000602971,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Kromosomien 14:18 translokaatio BCL2-geenin kohdalla, DNA-tutkimus",,
4502,"S -Alkaline phosphatase, bone specific",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602972,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Alkalinen fosfataasi, luuspesifinen",,
4503,S -Insulin-like growth factor binding protein 3,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602973,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Insuliinin kaltaista kasvutekijää sitova proteiini 3,,
4504,fS-Chromogranin A,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3006407,Chromogranin A [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602974,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Kromograniini A,,
4505,"S -Kernel, antibodies, typing",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3004616,Nuclear Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602975,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Tuma, vasta-aineet, tyypitys",,
4506,S -Cytofragment 21-1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602976,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Sytofragmentti 21-1,,
4507,P -Cystatin C,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3030366,Cystatin C [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602977,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kystatiini C,,
4508,S -Disialotransferrin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602978,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Disialotransferriini,,
4509,B-Methadone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602979,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Metadoni,,
4510,"S -Mycoplasma pneumoniae, IgA antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602980,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Mycoplasma pneumoniae, IgA-vasta-aineet",,
4511,U -Albumin-Creatinine Ratio,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020682,Albumin/Creatinine [Ratio] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000602981,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Albumiinin ja kreatiniinin suhde,,
4512,P -Troponin I (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602982,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Troponiini I (kval),,
4513,"P -Hydroxybutyric acid4514, fP-Calcium",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3003985,Beta hydroxybutyrate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000602983,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Hydroksivoihappo,,
4514,fP-Calcium,-1,,0,APPROVED,UNREVIEWED,TAYS,1596153600000,3015377,Calcium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS,1596153600000,,2000602984,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Kalsium,,
4515,fP-Cholesterol,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019900,Cholesterol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602985,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Kolesteroli,,
4516,"fP-Cholesterol, high density lipoprotein",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3023602,Cholesterol in HDL [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602986,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fP-kolesteroli, high density lipoproteiinit",,
4517,P -Kreatinkinas,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3007220,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602987,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kreatiinikinaasi,,
4518,"P -Creatin kinase, B subunit",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602988,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Kreatiinikinaasi, B-alayksikkö",,
4519,"P -Creatin kinase, M subunit",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602989,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Kreatiinikinaasi, M-alayksikkö",,
4520,"P-Thromboplastin time, INR response",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3022217,INR in Platelet poor plasma by Coagulation assay,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602990,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Tromboplastiiniaika, INR-tulostus",,
4521,"S -Puumalavirus, IgM Antibodies (Qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,42868544,Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence,Measurement,MAPS_TO,,tays,1630368000000,,2000602991,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Puumala-virus, IgM-vasta-aineet (kval)",,
4522,U -Lysergic acid diethylamide (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602992,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Lysergihappodietyyliamidi (kval),,
4523,"U -Lysergic acid diethylamide, confirmation test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602993,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Lysergihappodietyyliamidi, varmistustesti",,
4524,"P -Creatin kinase, MB subunit",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3029790,Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602994,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Kreatiinikinaasi, MB-alayksikkö",,
4525,"P -Creatin kinase, MB subunit, pulp",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005785,Creatine kinase.MB [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602995,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Kreatiinikinaasi, MB-alayksikkö, massa",,
4526,β-Lactate dehydrogenase,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3022250,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602996,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Laktaattidehydrogenaasi,,
4527,P -Lithium,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024666,Lithium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000602997,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Litium,,
4528,P -Methanol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000602998,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Metanoli,,
4529,fP -Iron,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3022948,Iron [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000602999,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Rauta,,
4530,P -Triglycerides,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3025839,Triglyceride [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603000,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Triglyseridit,,
4531,P -Troponin I,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3021337,Troponin I.cardiac [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603001,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Troponiini I,,
4532,P -Troponin T,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3019800,Troponin T.cardiac [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603002,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Troponiini T,,
4533,P -Urat,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3026493,Urate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603003,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Uraatti,,
4534,P -Urea,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3020779,Urea [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603004,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Urea,,
4536,"B -HLA-DQA, DNA Assay, Specified",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3010841,HLA-DQ alpha [Type],Measurement,MAPS_TO,,HUS,1596153600000,,2000603005,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-DQA, DNA-tutkimus, tarkennettu",,
4537,"B -HLA-DQB, DNA Assay, Specified",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40763590,HLA-DQ beta [Type],Measurement,MAPS_TO,,HUS,1596153600000,,2000603006,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-DQB, DNA-tutkimus, tarkennettu",,
4538,"B -HLA-DPB, DNA Assay, Specified",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3013862,HLA-DP [Type],Measurement,MAPS_TO,,HUS,1596153600000,,2000603007,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-DPB, DNA-tutkimus, tarkennettu",,
4539,"B -HLA-A, DNA Assay",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3024471,HLA-A [Type],Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603008,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-A, DNA-tutkimus",,
4541,"B -HLA-C, DNA Assay",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3025311,HLA-B [Type],Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603009,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-B, DNA-tutkimus",,
4541,"B -HLA-C, DNA study",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3026777,HLA-C [Type],Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603010,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-C, DNA-tutkimus",,
4542,"B -HLA-DRB, DNA Assay, Specified",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024932,HLA-DR beta [Type],Measurement,MAPS_TO,,HUS,1596153600000,,2000603011,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-DRB, DNA-tutkimus, tarkennettu",,
4543,P -Plasminogen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603012,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Plasminogeeni,,
4544,P -Fibrin Polymerization,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603013,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Fibriinin polymerisaatio,,
4545,P -Complement C3,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000620,Complement C3 [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603014,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Komplementti C3,,
4546,P -Complement C4,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017766,Complement C4 [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603015,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Komplementti C4,,
4547,P -Man-Binding Lectin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603016,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Mannaaniin sitoutuva lektiini,,
4548,"S -Screening of developmental disorder, first trimester",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3050129,First trimester maternal screen panel - Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603017,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sikiön kehityshäiriöiden seulonta, ensimmäinen trimesteri",,
4549,"S -Plasmaprotein A, during pregnancy",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3051741,Pregnancy associated plasma protein A [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603018,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Plasmaproteiini A, raskauteen liittyvä",,
4550,"S -Screening of developmental disorder, second trimester",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603019,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sikiön kehityshäiriöiden seulonta, toinen trimesteri",,
4551,"B -Chromosome examination, haematological",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40765096,Chromosome analysis panel by Banding,Measurement,MAPS_TO,,HUS,1596153600000,,2000603020,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Kromosomitutkimus, hematologinen",,
4552,"Ts chromosome examination, hematological",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40765096,Chromosome analysis panel by Banding,Measurement,MAPS_TO,,HUS,1596153600000,,2000603021,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kromosomitutkimus, hematologinen",,
4553,"Fuorescence in situ hybridization, haematological",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603022,LABfi Level 0,Measurement,2004-01-01,2012-12-31,,,"Fluoresenssi in situ hybridisaatiotutkimus, hematologinen",,
4556,"FISH examination, embryonic cell",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603023,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Fluoresenssi in situ hybridisaatiotutkimus, alkiosolu",,
4557,P -Netilmycin (determination of content),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603024,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Netilmysiini,,
4558,dU-Netilmycin (determination of content),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603025,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,dU-Netilmysiini,,
4559,Li-Netilmycin (determination of content),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603026,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Li-Netilmysiini,,
4560,fP-Parathormon,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,36303407,Parathyrin.intact goal [Mass/volume] Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603027,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Parathormoni,,
4561,"P -Proatriopeptide, C-terminal",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603028,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Proatriopeptidi, C-terminaalinen",,
4562,"P -Proatriopeptide, N-terminal",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603029,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Proatriopeptidi, N-terminaalinen",,
4563,P-Pseudokolinesterase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603030,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Pseudokoliinesteraasi,,
4564,P -Selen,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3010015,Selenium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603031,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Seleeni,,
4565,fP-Zinc,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603032,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Sinkki,,
4566,B-Cyclosporin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603033,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,B -Syklosporiini,,
4567,fP-Transferrin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3004789,Transferrin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603034,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Transferriini,,
4568,fP-Triglycerides,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3048773,Triglyceride [Moles/volume] in Serum or Plasma --fasting,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603035,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Triglyseridit,,
4569,B - Investigation of thrombotic tendency,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603036,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Tromboositaipumuksen selvittely,,
4571,"P -Tumor necrosis factor, alpha",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603037,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Tuumorinekroositekijä, alfa",,
4572,"Bacillus anthracis, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603038,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Bacillus antracis, nukleiinihappo (kval)",,
4573,fP-Urea,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3020779,Urea [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603039,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fP-Urea,,
4574,"P -Blood group, isoagglutinins, IgG",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603040,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"P -Veriryhmä, isoagglutiinit, IgG",,
4575,"P -Blood group, isoagglutinins, IgM",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603041,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,"P -Veriryhmä, isoagglutiinit, IgM",,
4576,P -Blood Group Antibodies,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603042,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,P -Punasoluvasta-aineet,,
4577,"P -Blood group antibodies, screening (qualification)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603043,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Punasoluvasta-aineet, seulonta (kval)",,
4578,B -Fibrin D D-Dimers,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603044,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -Fibriinin D-dimeerit,,
4579,"Li-Human Herpesvirus-6, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3043257,Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000603045,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Human herpesvirus-6, IgG-vasta-aineet",,
4580,"S-Human Herpesvirus-6, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603046,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Human herpesvirus-6, IgG-vasta-aineet",,
4581,"Li-Human Herpesvirus-6, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3034368,Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000603047,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Human herpesvirus-6, IgM-vasta-aineet",,
4582,"S -Human Herpesvirus-6, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603048,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Human herpesvirus-6, IgM-vasta-aineet",,
4583,"S -Human Herpesvirus-6, Antibodies, Avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603049,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Human herpesvirus-6, vasta-aineet, aviditeetti",,
4584,"Li-Human Herpesvirus-7, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603050,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Human herpesvirus-7, vasta-aineet",,
4585,"S -Human Herpesvirus-7, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603051,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Human herpesvirus-7, vasta-aineet",,
4586,P -Albumin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3024561,Albumin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603052,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Albumiini,,
4587,P-Alkaline phosphatase,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3035995,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603053,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Alkalinen fosfataasi,,
4589,P -Amylase,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3016771,Amylase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603054,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Amylaasi,,
4590,"P -Amylase, from pancreas (pancreas)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016417,Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603055,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Amylaasi, haimaperäinen",,
4591,P-Aspartate aminotransferase,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3013721,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603056,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Aspartaattiaminotransferaasi,,
4592,P -Bilirubin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3006140,Bilirubin.total [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603057,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Bilirubiini,,
4593,P -Bilirubinkonjugat,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005772,Bilirubin.conjugated [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603058,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Bilirubiinikonjugaatit,,
4594,P -C-reactive protein,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3020460,C reactive protein [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603059,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -C-reaktiivinen proteiini,,
4595,"P -Phosphate, inorganic",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003458,Phosphate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603060,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Fosfaatti, epäorgaaninen",,
4596,P -Glucose (load),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603061,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,P -Glukoosi (rasitus),,
4597,P -Glutamyltransferase,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3026910,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603062,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Glutamyylitransferaasi,,
4598,P -Calcium,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3015377,Calcium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603063,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kalsium,,
4599,"fP-Cholesterol, low density lipoprotein",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3001308,Cholesterol in LDL [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603064,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fP-kolesteroli, low density lipoproteiinit",,
4600,P -Creatinine,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3020564,Creatinine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603065,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Kreatiniini,,
4601,P -Magnesium,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3012095,Magnesium [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603066,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Magnesium,,
4602,P -Myoglobin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005895,Myoglobin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603067,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Myoglobiini,,
4603,P -Nucleotides (5-),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603068,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Nukleotidaasi (5-),,
4606,The Iron Saturation of the Transferrin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40763571,Iron/Transferrin [Ratio] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603069,LABfi Level 0,Measurement,2004-12-31,2030-12-31,,,Transferriinin rautakyllästeisyys,,
4607,"P -Orthopoxvirus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603070,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Ortopox-virus, viljely",,
4608,"Orthopoxvirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603071,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ortopox-virus, nukleiinihappo (kval)",,
4609,"S -Orthopoxvirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603072,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ortopox-virus, vasta-aineet",,
4610,"S -Orthopoxvirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603073,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ortopox-virus, IgG-vasta-aineet",,
4611,"S -Orthopoxvirus, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603074,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Ortopox-virus, IgM-vasta-aineet",,
4612,"U-Gamma-hydroxybutyrate, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603075,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Gammahydroksibutyraatti, varmistus",,
4613,P -Ethanol,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020191,Ethanol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603076,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Etanoli,,
4614,"B-Lactose Intolerance, DNA Testing",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,43534045,MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603077,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Laktoosi-intoleranssi, DNA-tutkimus",,
4615,B-Acetylcholinesterase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603078,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Asetyylikoliiniesteraasi,,
4616,"S -Natriuretic peptide, B-type (32-)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603079,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Natriureettinen peptidi, B-tyypin (32-)",,
4617,"S -Natriuretic peptide, B-type N-terminal propeptide",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3029187,Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603080,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Natriureettinen peptidi, B-tyypin N-terminaalinen propeptidi",,
4618,P -Prealbumin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3013742,Prealbumin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603081,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Prealbumiini,,
4619,S-Protein S100,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3051671,S100 calcium binding protein B [Mass/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000603082,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Proteiini S100,,
4620,"Parvovirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603083,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Parvovirus, nukleiinihappo (kval)",,
4621,"Li-Parotitic Virus, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603084,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Sikotautivirus, IgM-vasta-aineet",,
4622,"Li-Parotitic Virus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603085,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Sikotautivirus, IgG-vasta-aineet",,
4623,"Li-Mycoplasma pneumoniae, IgM antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3037677,Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603086,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Mycoplasma pneumoniae, IgM-vasta-aineet",,
4624,"Ts-Papillomavirus, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603087,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Papilloomavirus, nukleiinihappo (kval)",,
4625,"Hepatitis C virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603088,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Hepatiitti C -virus, nukleiinihappo (kval)",,
4626,"S-Epstein-Coniferous virus, antibodies, avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603089,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Epstein-Barrin virus, vasta-aineet, aviditeetti",,
4627,"S-Dengue virus, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603090,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Denguevirus, IgG-vasta-aineet",,
4628,fS-Peptide from pancreas (pancreas),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40758355,Pancreatic polypeptide [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603091,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,fS-Haimaperäinen peptidi,,
4629,B -Organophosphates,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603092,LABfi Level 0,Measurement,2004-01-01,2009-12-31,,,B -Organofosfaatit,,
4630,S -Gabapentin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3026906,Gabapentin [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603093,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Gabapentiini,,
4631,S -Ketiapine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603094,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Ketiapiini,,
4632,"U-Legionella, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603095,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Legionella, antigeeni",,
4633,"S-Leptospira, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3014720,Leptospira sp IgG Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000603096,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Leptospira, IgG-vasta-aineet",,
4634,"S-Leptospira, IgM Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015869,Leptospira sp IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000603097,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Leptospira, IgM-vasta-aineet",,
4635,"F -Cryptosporidium, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603098,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Cryptosporidium, antigeeni",,
4636,"F -Giardia, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603099,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"F -Giardia, antigeeni",,
4637,"S -Prostatase-specific antigen, free, proportion",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603100,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Prostataspesifinen antigeeni, vapaa, osuus",,
4638,"S-Gastrin, 17-fragment",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603101,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Gastriini, 17-fragmentti",,
4639,"fS-Gastrin, 17-fragment",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603102,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"fS-Gastriini, 17-fragmentti",,
4640,"B -HLA Disease Association in Celiac Disease, DNA Testing",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3045683,HLA typing for celiac disease panel - Blood or Tissue,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603103,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Keliakia, HLA-tautiassosiaatio, DNA-tutkimus",,
4641,"B -APECED Syndrome, DNA Examination of the Most Common Mutations (Ruler Mutations) in the AIRE Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603104,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -APECED-oireyhtymä, AIRE-geenin valtamutaatioiden DNA-tutkimus",,
4642,"Ts-APECED Syndrome, DNA Examination of the Most Common Mutations (Ruler Mutations) in the AIRE Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603105,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-APECED-oireyhtymä, AIRE-geenin valtamutaatioiden DNA-tutkimus",,
4643,B -Gene for Cystic Fibrosis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603106,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Kystisen fibroosin geeni, DNA-tutkimus",,
4644,"B-Juvenile neuronal ceroid lipofuscinosis (JNCL), DNA examination of the most common mutations in the CLN3 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603107,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Juveniili neuronaalinen seroidilipofuskinoosi (JNCL), CLN3-geenin valtamutaatioiden DNA-tutkimus",,
4645,"Ts-Juvenile Neuronal Ceroid Lipofuscinosis (JNCL), DNA Examination of the Most Common Mutations in the CLN3 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603108,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Juveniili neuronaalinen seroidilipofuskinoosi (JNCL), CLN3-geenin valtamutaatioiden DNA-tutkimus",,
4646,"B -Variant late infantile neuronal ceroid lipofuscinosis (vLINCL), DNA examination of the most common mutation in the CLN5 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603109,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Variantti myöhäisinfantiili neuronaalinen seroidilipofuskinoosi (vLINCL), CLN5-geenin valtamutaation DNA-tutkimus",,
4647,"Ts-Variant Late Infantile Neuronal Ceroid Lipofuscinosis (vLINCL), DNA Examination of the Most Common Mutation in the CLN5 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603110,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Variantti myöhäisinfantiili neuronaalinen seroidilipofuskinoosi (vLINCL), CLN5-geenin valtamutaation DNA-tutkimus",,
4648,"B -Myotonic dystrophy type 1 (DM1), expansion of DMPK geneeven repetitive sequence, DNA testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603111,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Myotoninen dystrofia tyyppi 1 (DM1), DMPK-geenin toistojakson ekspansion DNA-tutkimus",,
4649,"Ts-Myotonic dystrophy type 1 (DM1), expansion of the repetitive sequence of the DMPK gene, DNA examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603112,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Myotoninen dystrofia tyyppi 1 (DM1), DMPK-geenin toistojakson ekspansion DNA-tutkimus",,
4650,"B -Family Adenomatotic Polyposis (FAP), DNA Examination of Individual APC Gene Mutations",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603113,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Familiaalinen adenomatoottinen polypoosi (FAP), yksittäisen APC-geenin mutaation DNA-tutkimus",,
4651,"B -Family Adenomatotic Polyposis (FAP), Extensive Mutational Search of the APC Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603114,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Familiaalinen adenomatoottinen polypoosi (FAP), laaja APC-geenin mutaatiohaku",,
4652,B - DNA Examination of the Most Common Mutation in the FSH Receptor Gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603115,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -FSH-reseptorigeenin valtamutaation DNA-tutkimus,,
4653,"B -Hereditary non-polyposis colorectal cancer (HNPCC), comprehensive mutation search in the MLH1, MSH2 or MSH6 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603116,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Periytyvä ei-polypoottinen paksusuolisyöpä (HNPCC), MLH1-, MSH2- tai MSH6-geenin laaja mutaatiohaku",,
4654,"B -Hereditary non-polyposis colorectal cancer (HNPCC), DNA examination of the three most common mutations in the MLH1 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603117,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Periytyvä ei-polypoottinen paksusuolisyöpä (HNPCC), kolmen MLH1-geenin valtamutaation DNA-tutkimus",,
4655,"B -Hereditary non-polyposis colorectal cancer (HNPCC), DNA examination of individual mutations in the MLH1, MSH2 or MSH6 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603118,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Periytyvä ei-polypoottinen paksusuolisyöpä (HNPCC), MLH1-, MSH2- tai MSH6-geenin yksittäisen mutaation DNA-tutkimus",,
4656,"B -Huntington's disease, expansion of the repetitive sequence of the ITI5 gene, DNA testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603119,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Huntingtonin tauti, ITI5-geenin toistojakson ekspansion DNA-tutkimus",,
4657,"B-Infantile neuronal ceroid lipofuscinos (INCL), DNA test of the most common mutation in the PPT gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603120,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Infantiili neuronaalinen seroidilipofuskinoosi (INCL), PPT-geenin valtamutaation DNA-tutkimus",,
4658,"Ts-Infantile Neuronal Ceroid Lipofuscinos (INCL), DNA Examination of the Most Common Mutation in the PPT Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603121,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Infantiili neuronaalinen seroidilipofuskinoosi (INCL), PPT-geenin valtamutaation DNA-tutkimus",,
4659,"B -Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD), DNA test of the most common mutation in the HADHA gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603122,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Long chain 3- hydroxyacyl CoA dehydrogenaasin puutos (LCHAD), HADHA-geenin valtamutaation DNA-tutkimus",,
4660,"Ts-Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD), DNA test of the most common mutation in the HADHA gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603123,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Long chain 3- hydroxyacyl CoA dehydrogenaasin puutos (LCHAD), HADHA-geenin valtamutaation DNA-tutkimus",,
4661,"B -Medium chain acyl-CoA dehydrogenase deficiency (MCAD), DNA test of the most common mutation in the ACADM gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603124,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Medium chain acyl CoA dehydrogenaasin puutos (MCAD), ACADM-geenin valtamutaation DNA-tutkimus",,
4662,"Ts-Medium chain acyl-CoA dehydrogenase deficiency (MCAD), DNA test of the most common mutation in the ACADM gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603125,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Medium chain acyl CoA dehydrogenaasin puutos (MCAD), ACADM-geenin valtamutaation DNA-tutkimus",,
4663,"B -Rett Syndrome, Methyl CpG Binding Protein 2 Gene (MECP2) Gene Error",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603126,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Rettin oireyhtymä, Methyl-CpG binding proteiini 2-geenin (MECP2) geenivirhe",,
4664,"B -MELAS syndrome, examination of the most common mutations in mitochondrial DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603127,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -MELAS-oireyhtymä, mitokondriaalisen DNA:n valtamutaatioiden tutkimus",,
4665,"Ts-MELAS syndrome, examination of the most common mutations in mitochondrial DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603128,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-MELAS-oireyhtymä, mitokondriaalisen DNA:n valtamutaatioiden tutkimus",,
4666,"B -NARP syndrome, examination of the most common mutation in mitochondrial DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603129,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -NARP-oireyhtymä, mitokondriaalisen DNA:n valtamutaation tutkimus",,
4667,"Ts-NARP Syndrome, Examination of the Most Common Mutochondrial DNA Mutation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603130,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-NARP-oireyhtymä, mitokondriaalisen DNA:n valtamutaation tutkimus",,
4668,"B -MERRF syndrome, examination of the most common mutations in mitochondrial DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603131,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -MERRF-oireyhtymä, mitokondriaalisen DNA:n valtamutaatioiden tutkimus",,
4669,"Ts-MERRF Syndrome, Examination of the Most Common Mutochondrial DNA Mutations",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603132,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-MERRF-oireyhtymä, mitokondriaalisen DNA:n valtamutaatioiden tutkimus",,
4670,"B -Hypertrophic cardiomyopathy, examination of the most common mutations in mitochondrial DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603133,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Hypertrofinen kardiomyopatia, mitokondriaalisen DNA:n valtamutaatioiden tutkimus",,
4671,"Ts-Hypertrophic Cardiomyopathy, Examination of the Most Common Mutochondrial DNA Mutations",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603134,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Hypertrofinen kardiomyopatia, mitokondriaalisen DNA:n valtamutaatioiden tutkimus",,
4672,"B-Leber's optic atrophy, examination of the most common mutations in mitochondrial DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603135,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Leberin optikusatrofia, mitokondriaalisen DNA:n valtamutaatioiden tutkimus",,
4673,"Ts-Leber's optic atrophy, examination of the most common mutations in mitochondrial DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603136,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Leberin optikusatrofia, mitokondriaalisen DNA:n valtamutaatioiden tutkimus",,
4674,"B -Mulibrey nanism, DNA test of the most common mutation in the MUL gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603137,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Mulibrey-nanismi, MUL-geenin valtamutaation DNA-tutkimus",,
4675,"Ts-Mulibrey nanism, DNA examination of the most common mutation in the MUL gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603138,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Mulibrey-nanismi, MUL-geenin valtamutaation DNA-tutkimus",,
4676,"B -Congenital Nephrosis (CNF), DNA Examination of the Two Most Common Mutations in the NPHS1 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603139,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Kongenitaali nefroosi (CNF), kahden NPHS1-geenin valtamutaation DNA-tutkimus",,
4677,"Ts-Congenital Nephrosis (CNF), DNA Examination of the Two Most Common Mutations in the NPHS1 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603140,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kongenitaali nefroosi (CNF), kahden NPHS1-geenin valtamutaation DNA-tutkimus",,
4678,"B -Plasminogen activator inhibitor, study of promoter nucleotide variation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603141,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Plasminogeeniaktivaattorin inhibiittori, promoottorin nukleotidivariaation tutkimus",,
4679,B -DNA Examination of the Exon 9 Deletion of the Presenilin 1 Gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603142,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Preseniliini1-geenin eksoni 9:n deleetion DNA-tutkimus,,
4680,Ts-DNA Examination of Exon 9 Deletion of the Presenilin 1 Gene,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603143,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Ts-Preseniliini1-geenin eksoni 9:n deleetion DNA-tutkimus,,
4681,"B -RET- proto-oncogene, mutation search",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603144,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -RET- proto-Onkogeeni, mutaatiohaku",,
4682,"B-Cartilage-Hair Hypoplasia, DNA Examination of the Most Common Mutations in the RHH Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603145,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Rusto-hiushypoplasia, RHH-geenin valtamutaatioiden DNA-tutkimus",,
4683,"B-Cartilage-hair hypoplasia, extensive mutation search in the RHH gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603146,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Rusto-hiushypoplasia RHH-geenin laaja mutaatiohaku,,
4684,"Ts-Cartilage-Hair Hypoplasia, DNA Examination of the Most Common Mutations in the RHH Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603147,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Rusto-hiushypoplasia, RHH-geenin valtamutaatioiden DNA-tutkimus",,
4685,"Ts-cartilage-hair hypoplasia, extensive mutation search in the RHH gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603148,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Rusto-hiushypoplasia, RHH-geenin laaja mutaatiohaku",,
4686,"B -Salla's disease, DNA test of the most common mutation in the SLC17A5 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603149,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Sallan taudi, SLC17A5-geenin valtamutaation DNA-tutkimus",,
4687,"Ts-Salla's Disease, DNA Examination of the Most Common Mutation in the SLC17A5 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603150,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Sallan taudi, SLC17A5-geenin valtamutaation DNA-tutkimus",,
4688,"B-Usher Syndrome, Type 3, DNA Examination of the Most Common Mutations in the USH-3 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603151,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Usherin oireyhtymä, tyyppi 3, USH-3-geenin valtamutaatioiden DNA-tutkimus",,
4689,"Ts-Usher Syndrome, Type 3, DNA Examination of the Most Common Mutations in the USH-3 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603152,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Usherin oireyhtymä, tyyppi 3, USH-3-geenin valtamutaatioiden DNA-tutkimus",,
4690,"Ts-Congenital Chloride Diarrhea (CCD), DNA Examination of the Most Common Mutation in the DRA Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603153,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Kongenitaalinen kloridiripuli (CCD), DRA-geenin valtamutaation DNA-tutkimus",,
4691,"Ts-Northern Epilepsy (EPMR), DNA Examination of the Most Common Mutation in the CLN8 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603154,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Pohjoinen epilepsia (EPMR), CLN8-geenin valtamutaation DNA-tutkimus",,
4692,"Ts-Diastrophic Dysplasia, DNA Examination of the Most Common Mutations in the SLC26A2 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603155,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Diastrofisen dysplasia, SLC26A2-geenin valtamutaatioiden DNA-tutkimus",,
4693,"Ts-Progressive Myoclonus Epilepsy (EPM1), Expansion of the Repeat Sequence of the CSTB Gene, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603156,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Progressiivinen myoklonusepilepsia (EPM1), CSTB-geenin toistojakson ekspansion DNA-tutkimus",,
4694,"B -Progressive Myoclonus Epilepsy, DNA Examination of the Most Common Mutations in the CSTB Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603157,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Progressiivinen myoklonusepilepsia, CSTB-geenin valtamutaatioiden DNA-tutkimus",,
4695,"Ts-Progressive Myoclonus Epilepsy, DNA Examination of the Most Common Mutations in the CSTB Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603158,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Progressiivinen myoklonusepilepsia, CSTB-geenin valtamutaatioiden DNA-tutkimus",,
4697,"B -Argininosuccinaturi (ASA-uri), DNA examination of the most common mutation in the ASL gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603159,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Arginosukkinaattiuria (ASA-uria), ASL-geenin valtamutaation DNA-tutkimus",,
4698,"Ts-Argininosuccinaturi (ASA-uri), DNA examination of the most common mutation in the ASL gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603160,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Arginosukkinaattiuria (ASA-uria), ASL-geenin valtamutaation DNA-tutkimus",,
4699,"B -Choen's Syndrome, DNA Examination of the Most Common Mutation in the COH1 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603161,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Cohenin oireyhtymä, COH1-geenin valtamutaation DNA-tutkimus",,
4700,"Ts-Cohen Syndrome, DNA Examination of the Most Common Mutation in the COH1 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603162,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Cohenin oireyhtymä, COH1-geenin valtamutaation DNA-tutkimus",,
4702,B -Examination of the most common mutations in the HFE gene associated with hereditary hemochromatosis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603163,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Periytyvään hemokromatoosiin liittyvien HFE-geenin valtamutaatioiden tutkimus,,
4703,"B -Muscle-eye-brain-sendometriosis (MEB), DNA examination of the most common mutation in the POMGT1 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603164,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Lihas-silmä-aivo-oireyhtymä (MEB), POMGT1-geenin valtamutaation DNA-tutkimus",,
4704,"Ts-Muscle-Eye-Brain Syndrome (MEB), DNA Examination of the Most Common Mutation in the POMGT1 Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603165,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Lihas-silmä-aivo-oireyhtymä (MEB), POMGT1-geenin valtamutaation DNA-tutkimus",,
4705,"Ts-Nefronoftis, Examination of Chromosome 2q13 Deletion",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603166,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Nefronoftiisi, kromosomi 2q13 deleetion DNA-tutkimus",,
4706,"Ts-X chromosome-bound retinoschis, DNA examination of the most common mutations in the XLRS1 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603167,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-X-kromosomissa periytyvä retinoskiisi, XLRS1-geenin valtamutaatioiden DNA-tutkimus",,
4707,Pf-Neuron-specific enolas,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603168,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pf-Neuronispesifinen enolaasi,,
4708,Am-erythropoietin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603169,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Am-Erytropoietiini,,
4709,"P -Natriuretic peptide, B-type (32-)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3011960,Natriuretic peptide B [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603170,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Natriureettinen peptidi, B-tyypin (32-)",,
4710,"S-Acid phosphatase, tartrate resistant 5b",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603171,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Hapan fosfataasi, tartraattiresistentti 5b",,
4712,U -Protein and Creatinine Ratio,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3045462,Protein/Creatinine [Ratio] in Urine,Measurement,MAPS_TO,,HUS,1596153600000,,2000603172,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Proteiinin ja kreatiniinin suhde,,
4720,"β -Transferrin receptor, soluble",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3015399,Transferrin receptor.soluble [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603173,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Transferriinireseptori, liukoinen",,
4721,"Ts-HER-2 Gene Amplification, ISH Examination",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,44816752,ERBB2 gene copy number/nucleus in Tissue by FISH,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603174,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-HER-2, onkogeeni, ISH-tutkimus",,
4723,"B -Congenital chloride diarrhea (CCD), DNA examination of the most common mutation in the DRA gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603175,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Kongenitaalinen kloridiripuli (CCD), DRA-geenin valtamutaation DNA-tutkimus",,
4724,"B -North Epilepsy (EPMR), DNA examination of the most common mutation in the CLN8 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603176,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Pohjoinen epilepsia (EPMR), CLN8-geenin valtamutaation DNA-tutkimus",,
4725,"B -Diastrophic dysplasia, DNA examination of the most common mutations in the SLC26A2 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603177,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Diastrofisen dysplasia, SLC26A2-geenin valtamutaatioiden DNA-tutkimus",,
4726,"B-Progressive Myoclonus Epilepsy (EPM1), Expansion of the Repeat Sequence of the CSTB Gene, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603178,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Progressiivinen myoklonusepilepsia (EPM1), CSTB-geenin toistojakson ekspansion DNA-tutkimus",,
4727,"B -Letal Neonatal Metabolic Syndrome (GRACILE), DNA Examination of the Most Common Mutation in the BCS1L Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603179,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Letaali neonataali metabolinen oireyhtymä (GRACILE), BCS1L-geenin valtamutaation DNA-tutkimus",,
4728,"Ts-Lethal Neonatal Metabolic Syndrome (GRACILE), DNA Examination of the Most Common Mutation in the BCS1L Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603180,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Letaali neonataali metabolinen oireyhtymä (GRACILE), BCS1L-geenin valtamutaation DNA-tutkimus",,
4729,"B -Letal neonatal metabolic syndrome (GRACILE), extensive mutation search in the BCS1L gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603181,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Letaali neonataali metabolinen oireyhtymä (GRACILE), BCS1L-geenin laaja mutaatiohaku",,
4730,"Ts-Lethal Neonatal Metabolic Syndrome (GRACILE), Extensive Mutational Search in the BCS1L Gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603182,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ts-Letaali neonataali metabolinen oireyhtymä (GRACILE), BCS1L-geenin laaja mutaatiohaku",,
4731,"B -Nefronoftis, Examination of Chromosome 2q13 Deletion",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603183,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -Nefronoftiisi, kromosomi 2q13 deleetion DNA-tutkimus",,
4732,"B -X chromosome-bound retinoschis, DNA examination of the most common mutations in the XLRS1 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603184,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -X-kromosomissa periytyvä retinoskiisi, XLRS1-geenin valtamutaatioiden DNA-tutkimus",,
4733,S -Buprenorphine,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3004982,Buprenorphine [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603185,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,S -Buprenorfiini,,
4734,B -Buprenorphine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603186,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,B -Buprenorfiini,,
4735,"S -Phenytoin, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603187,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Fenytoiini, vapaa",,
4736,B -Tissue antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603188,LABfi Level 0,Measurement,2004-01-01,2011-12-31,,,B -Kudosantigeeni,,
4737,"B -HLA-C, DNA Assay, Specified",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,46236302,HLA-C [Type] by High resolution typing,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603189,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-C, DNA-tutkimus, tarkennettu",,
4738,"B -HLA-B, DNA Assay, Specified",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,40760410,HLA-B [Type] by High resolution,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603190,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-B, DNA-tutkimus, tarkennettu",,
4739,"B -HLA-A, DNA Assay, Specified",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,40760409,HLA-A [Type] by High resolution,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603191,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"B -HLA-A, DNA-tutkimus, tarkennettu",,
4740,Pt-Urine Flow Measurement (Flow) and Residual Urine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603192,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Virtsa virtaaman (flow) ja jäännösvirtsan mittaus,,
4741,"Pt-Urodynamic examination 1 (cystometry, pressure flow measurement and EMG examination of the shutter muscle)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603193,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Urodynamiikan tutkimus 1 (kystometria, painevirtaamamittaus ja sulkijalihaksen EMG-tutkimus)",,
4742,"Pt-Urodynamic examination 2 (cystometry, pressure flow measurement, EMG examination of the shutter muscle, static pressure measurement of the urethra and ice water test)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603194,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pt-Urodynamiikan tutkimus 2 (kystometria, painevirtaamamittaus, sulkijalihaksen EMG-tutkimus, virtsaputken staattinen painemittaus ja jäävesitestaus)",,
4743,Pt-Examination of Urinary Incontinence with Urethrocystometry,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603195,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,Pt-Virtsatieinkontinenssin tutkiminen uretrokystometrialla,,
4744,"S -Citrulinated peptide, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3041942,Cyclic citrullinated peptide Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000603196,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"S -Sitrulliinipeptidi, vasta-aineet",,
4746,"Influenza A and B viruses, antigen",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024891,Influenza virus A+B Ag [Presence] in Specimen,Measurement,MAPS_TO,,HUS,1596153600000,,2000603197,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Influenssa A ja B -virus, antigeeni",,
4747,"Herpes simplex virus-1, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603198,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Herpes simplex -virus 1, antigeeni",,
4748,"Herpes simplex virus-2, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603199,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Herpes simplex -virus 2, antigeeni",,
4749,"Li-Cytomegalovirus, Antibodies in Capsules",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603200,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Li-Cytomegalovirus, vasta-aineet likvorista",,
4751,"cU Immunoglobulin G, Urine Collection",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603201,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Immunoglobuliini G keräysvirtsasta,,
4752,P -Galactose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603202,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,P -Galaktoosi,,
4753,"Ca-Bacteria, culture from venous cannula",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603203,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Ca-Bakteeri, viljely suonikanyylista",,
4754,"Pd-Bacteria, culture from peritoneal dialysis fluid",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40763091,Bacteria identified in Peritoneal dialysis fluid by Culture,Measurement,MAPS_TO,,tays,1630368000000,,2000603204,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Pd-Bakteeri, viljely peritoneaalidialyysinesteestä",,
4755,cU-Alpha-1-microglobulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603205,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,cU-Alfa-1-mikroglobuliini,,
4756,dU-Alpha-1-microglobulin from diurnal urine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603206,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"dU-Alfa-1-mikroglobuliini, vuorokausivirtsa",,
4757,"U-Alpha-1-microglobulin, urine sample",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3052318,Alpha-1-Microglobulin [Mass/volume] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000603207,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Alfa-1-mikroglobuliini, kertavirtsa",,
4759,"P -HI virus-1, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3013180,HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603208,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -HI-virus 1, nukleiinihappo (kvant)",,
4760,"P -Natriuretic peptide, B-type N-terminal propeptide (32-)",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3029187,Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603209,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"P -Natriureettinen peptidi, B-tyypin N-terminaalinen propeptidi",,
4761,U -Tramadol (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603210,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,U -Tramadoli (kval),,
4762,"U -Tramadol, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603211,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"U -Tramadoli, varmistus",,
4763,Ts-Histological examination of prostate biopsy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603212,LABfi Level 0,Measurement,2004-06-01,2030-12-31,,,Ts-Prostatabiopsian histologinen tutkimus,,
4764,Ts-Histological Examination of Colonoscopy Samples,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603213,LABfi Level 0,Measurement,2004-06-01,2030-12-31,,,Ts-Kolonoskopianäytteiden histologinen tutkimus,,
4765,Ln examination of sentinel node,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,45881866,Sentinel lymph node biopsy,Meas Value,MAPS_TO,,TYKS,1631577600000,,2000603214,LABfi Level 0,Measurement,2004-06-01,2030-12-31,,,Ln-Vartijaimusolmuketutkimus (sentinel node),,
4766,"Sk-Skin, Immunofluorescence Assay, IgA",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3046682,IgA [Presence] in Skin by Immunofluorescence,Measurement,MAPS_TO,,tays,1630368000000,,2000603215,LABfi Level 0,Measurement,2004-06-01,2030-12-31,,,"Sk-Iho, immunofluoresenssitutkimus, IgA",,
4767,S -Metadon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603216,LABfi Level 0,Measurement,2004-06-01,2030-12-31,,,S -Metadoni,,
4768,"U -Fluorescence in situ hybridization assay, cells in urine",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603217,LABfi Level 0,Measurement,2004-06-01,2030-12-31,,,"U -Fluoresenssi in situ hybridisaatiotutkimus, virtsan solut",,
4769,"S -Interferon-beta, neutralizing antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603218,LABfi Level 0,Measurement,2004-06-01,2030-12-31,,,"S -Interferoni-beeta, neutraloivat vasta-aineet",,
4770,B -FISH study of the microdeletions of chromosomes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603219,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,B -Kromosomien mikrodeleetioiden FISH-tutkimus,,
4771,P -Mycophenolic acid,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3027653,Mycophenolate [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603220,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,P -Mykofenolihappo,,
4772,"S -SARS coronavirus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603221,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -SARS-koronavirus, vasta-aineet",,
4773,"SARS coronavirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603222,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"SARS-koronavirus, nukleiinihappo (kval)",,
4774,"-SARS-coronavirus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603223,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"  -SARS-koronavirus, viljely",,
4775,"P-Epstein-Barr virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3043849,Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603224,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"P -Epstein-Barrin virus, nukleiinihappo (kvant)",,
4776,"Epstein-Barr virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3031321,Epstein Barr virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603225,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"Epstein-Barrin virus, nukleiinihappo (kvant)",,
4777,"P -Cytomegalovirus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055120,Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603226,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"P -Cytomegalovirus, nukleiinihappo (kvant)",,
4780,"S-Enterovirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603227,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -Enterovirus, nukleiinihappo (kval)",,
4781,"S -Phlebovirus, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603228,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -Flebovirus, vasta-aineet",,
4782,"Polyomavirus, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603229,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"Polyoomavirus, nukleiinihappo (kval)",,
4783,"S-Rhinovirus, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603230,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -Rinovirus, nukleiinihappo (kval)",,
4784,"Rhinovirus, Nucleic Acid (Qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3025023,Rhinovirus RNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603231,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"Rinovirus, nukleiinihappo (kval)",,
4785,Cytological Rapid Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603232,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,Sytologinen pikatutkimus,,
4786,"B - Detection of CD2 and CD3 lymphocytes, blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603233,LABfi Level 0,Measurement,2004-11-19,2011-12-31,,,"B -CD2 ja CD3-lymfosyyttien osoitus, veri",,
4787,"Ts Detection of CD2 and CD3 Lymphocytes, Tissue",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603234,LABfi Level 0,Measurement,2004-11-19,2011-12-31,,,"Ts-CD2 ja CD3-lymfosyyttien osoitus, kudos",,
4788,Ts-Detection of Intercellular Adhesion Molecule 1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603235,LABfi Level 0,Measurement,2004-11-19,2013-12-31,,,Ts-Intersellullaarisen adheesiomolekyyli 1:n osoitus,,
4789,Ts-Detection of Leukocyte Adhesion Molecules,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603236,LABfi Level 0,Measurement,2004-11-19,2013-12-31,,,Ts-Leukosyyttien adheesiomolekyylien osoitus,,
4790,Ts-Detection of Leukocyte Activation Molecules,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603237,LABfi Level 0,Measurement,2004-11-19,2013-12-31,,,Ts-Leukosyyttien aktivaatiomolekyylien osoitus,,
4791,"Li-Leukocyte Surface Markers, Liquors",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603238,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"Li-Leukosyyttien pintamarkkerit, likvor",,
4792,"Ly-Auxiliary Cells and Suppressor Cells, Immunophenotyping",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603239,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"Ly-Auttajasolujen ja estäjäsolujen suhde, immunofenotyypitys",,
4799,"Am-Fuorescence in situ hybridization study, aneuploidy",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603240,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"Am-Fluoresenssi in situ hybridisaatiotutkimus, aneuploidia",,
4800,"Pt-Glucose test, oral, during pregnancy",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603241,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"Pt-Glukoosi-koe, oraalinen, raskaudenaikainen",,
4801,"B -HLA Disease Association in Rheumatoid Arthritis, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603242,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"B -Reuma, HLA-tautiassosiaatio, DNA-tutkimus",,
4802,"RNA, extraction",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603243,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"RNA, eristys",,
4803,F -Calprotectin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3048689,Calprotectin [Mass/mass] in Stool,Measurement,MAPS_TO,,HUS,1596153600000,,2000603244,LABfi Level 0,Measurement,2004-12-31,2030-12-31,,,F -Kalprotektiini,,
4804,"S -Desmoglein, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40765950,Desmoglein 1 Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000603245,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -Desmogleiini, vasta-aineet",,
4804,"S -Desmoglein, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40765951,Desmoglein 3 Ab [Presence] in Serum by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000603245,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -Desmogleiini, vasta-aineet",,
4805,"S -Desmoglein 1, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603246,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -Desmogleiini 1, vasta-aineet",,
4806,"S -Desmoglein 3, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603247,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -Desmogleiini 3, vasta-aineet",,
4807,"Chlamydia trachomatis, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006093,Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603248,LABfi Level 0,Measurement,2004-01-01,2030-12-31,,,"Chlamydia trachomatis, nukleiinihappo (kval)",,
4808,"dU-Creatinine, children, diurnal urine",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603249,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"dU-Kreatiniini, lapset, vuorokausivirtsa",,
4809,Li-Phospho-tau protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603250,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,Li-Fosfo-tau proteiini,,
4810,Li-Tau protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603251,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,Li-Tau proteiini,,
4811,Li-Beta-amyloid 42 protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603252,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,Li-Beeta-amyloidi 42 proteiini,,
4812,Pt-Exhaled Gas Nitric Oxide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603253,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,Pt-Uloshengityskaasun typpioksidi,,
4813,"HI virus, antigen and antibodies, combination test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603254,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"HI-virus, antigeeni ja vasta-aineet, yhdistelmätutkimus",,
4814,"S -HI virus, antigen and antibodies, combination test",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,46235355,HIV 1 and 2 tests - Meaningful Use set,Measurement,MAPS_TO,,HUS,1596153600000,,2000603255,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"S -HI-virus, antigeeni ja vasta-aineet, yhdistelmätutkimus",,
4815,"B -Forescence in situ hybridization assay, aneuploidy",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603256,LABfi Level 0,Measurement,2004-11-19,2030-12-31,,,"B -Fluoresenssi in situ hybridisaatiotutkimus, aneuploidia",,
4816,"U -Chlamydia trachomatis and Neisseria gonorrhoeae, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003510,Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603257,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"U -Chlamydia trachomatis ja Neisseria gonorrhoeae, nukleiinihappo (kval)",,
4816,"U -Chlamydia trachomatis and Neisseria gonorrhoeae, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3024950,Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603257,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"U -Chlamydia trachomatis ja Neisseria gonorrhoeae, nukleiinihappo (kval)",,
4817,"Bacteria producing broad-spectrum beta-lactamase, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603258,LABfi Level 0,Measurement,2004-12-09,2030-12-31,,,"Bakteeri, laajakirjoista beta-laktamaasia tuottava, viljely",,
4818,"B -Complement C4 typing, DNA testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603259,LABfi Level 0,Measurement,2004-12-31,2030-12-31,,,"B -Komplementti C4-tyypitys, DNA-tutkimus",,
4819,"The Turku Mutation of the B -LDL Receptor Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603260,LABfi Level 0,Measurement,2004-12-31,2030-12-31,,,"B -LDL-reseptorigeenin Turku-mutaatio, DNA-tutkimus",,
4820,"The B -LDL receptor gene's Pori mutation, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603261,LABfi Level 0,Measurement,2004-12-31,2030-12-31,,,"B -LDL-reseptorigeenin Pori-mutaatio, DNA-tutkimus",,
4821,"B -LDL Receptor Mutation Pogosta Mutation, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603262,LABfi Level 0,Measurement,2004-12-31,2030-12-31,,,"B -LDL-reseptorigeenin Pogosta-mutaatio, DNA-tutkimus",,
4822,"Fin11 Mutation of the B -LDL Receptor Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603263,LABfi Level 0,Measurement,2004-12-31,2030-12-31,,,"B -LDL-reseptorigeenin Fin11-mutaatio, DNA-tutkimus",,
4823,"Fin12 Mutation of the B -LDL Receptor Gene, DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603264,LABfi Level 0,Measurement,2004-12-31,2030-12-31,,,"B -LDL-reseptorigeenin Fin12-mutaatio, DNA-tutkimus",,
4824,Vitamin P-B-12,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009035,Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603265,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,P -B-12-Vitamiini,,
4825,P-Digoxin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603266,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,P -Digoksiini,,
4826,P -Ferritin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3001122,Ferritin [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603267,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,P -Ferritiini,,
4827,P-Immunoglobulin A,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007164,IgA [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603268,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,P -Immunoglobuliini A,,
4828,P-Immunoglobulin G,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3005719,IgG [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603269,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,P -Immunoglobuliini G,,
4829,P-Immunoglobulin M,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3028026,IgM [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603270,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,P -Immunoglobuliini M,,
4830,β -Prolactin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3051050,Macroprolactin/Prolactin [Moles] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603271,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,P -Prolaktiini,,
4831,P -Tyreotropin,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3009201,Thyrotropin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603272,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,P -Tyreotropiini,,
4832,"P -thyroxine, free",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3008486,Thyroxine (T4) free [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603273,LABfi Level 0,Measurement,2005-02-17,2030-12-31,,,"P -Tyroksiini, vapaa",,
4833,"Mm-Ko, detection of nucleic acid, breast milk (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603274,LABfi Level 0,Measurement,2005-03-14,2030-12-31,,,"Mm-Lehmä, nukleiinihapon osoitus, äidinmaito (kval)",,
4834,P -Carbamazepine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603275,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,P -Karbamatsepiini,,
4835,Af-Immunofixation Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603276,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Af-Immunofiksaatiotutkimus,,
4836,"nU-Albumin, mikroalbuminuri",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3049506,Microalbumin [Mass/time] in Urine collected for unspecified duration,Measurement,MAPS_TO,,HUS,1596153600000,,2000603277,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"nU-Albumiini, mikroalbuminuria",,
4837,uB-acid base balance and pO2,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603278,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,uB-Happoemästase ja pO2,,
4838,cB acid base balance and pO2 (fetus),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603279,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,cB-Happoemästase ja pO2 (sikiö),,
4839,vB-Acid Base Balance and Electrolytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3000991,Gas panel - Venous blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000603280,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,vB-Happoemästase ja elektrolyytit,,
4840,CB acid base balance and electrolytes,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3022313,Gas panel - Capillary blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000603281,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,cB-Happoemästase ja elektrolyytit,,
4841,"S -Colinesterase, calculated quantity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603282,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"S -Koliiniesteraasi, laskennallinen suure",,
4842,P -Interleukin 6,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023091,Interleukin 6 [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603283,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,P -Interleukiini 6,,
4843,P -Interleukin 8,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3046594,Interleukin 8 [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603284,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,P -Interleukiini 8,,
4844,"β -Interleukin-2 receptor, soluble",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3007847,Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603285,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"P -Interleukiini-2:n reseptori, liukoinen",,
4845,uS-Erythropoietin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603286,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,uS-Erytropoietiini,,
4846,Pf-Potassium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603287,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Pf-Kalium,,
4847,Pf-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603288,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Pf-Natrium,,
4848,Gi-Kalium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603289,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Gi-Kalium,,
4849,Gi-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603290,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Gi-Natrium,,
4850,nU-Sodium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603291,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,nU-Natrium,,
4851,Bm-Comparative Genomic Hybridization Assay (CGH),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603292,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Bm-Vertaileva genominen hybridisaatiotutkimus (VGH),,
4852,U -Succinylacetone and succinylacetoacetate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603293,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,U -Sukkinyyliasetoni ja sukkinyyliasetoasetaatti,,
4853,Li-Pyruvat,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603294,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Li-Pyruvaatti,,
4854,P-Beta-hydroxybutyrate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3003985,Beta hydroxybutyrate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603295,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,P -Beeta-hydroksibutyraatti,,
4855,"U -Organic acids, semiquantitative",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3049233,Organic acids panel - Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000603296,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"U -Orgaaniset hapot, semikvantitatiivinen",,
4856,P -Anion deficit,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3045716,Anion gap in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603297,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,P -Anionivaje,,
4857,P -Osmolality,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008295,Osmolality of Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603298,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,P -Osmolaliteetti,,
4858,"Ex-Eosinophilic Cationic Protein, Induced Cough",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603299,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"Ex-Eosinofiilisten granulosyyttien kationinen proteiini, indusoitu yskös",,
4859,"Ex-Eosinophilic Cationic Protein, Spontaneous Coughing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603300,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"Ex-Eosinofiilisten granulosyyttien kationinen proteiini, spontaani yskös",,
4860,Ts-T cell receptor gamma / delta-positive cells in the small intestinal surface epithelium,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603301,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Ts-T-solureseptori gamma/delta-positiiviset solut ohutsuolen pintaepiteelissä,,
4861,U-Oligosaccharides (Qual),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3013931,Oligosaccharides [Presence] in Urine,Measurement,MAPS_TO,,tays,1630368000000,,2000603302,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,U -Oligosakkaridit (kval),,
4862,Ts-Disaccharidase activity in the intestinal mucosa (qual.),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603303,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Ts-Disakkaridaasi-aktiviteetit suolen mukosasta (kval),,
4863,Am-Phospholipids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603304,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,Am-Fosfolipidit,,
4864,"B -Ammunphenotyping, Stem Cells",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603305,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"B -Immunofenotyypitys, kantasolut",,
4865,B -Heparin Antibodies (Qual),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40760871,Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000603306,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,B -Hepariinivasta-aineet (kval),,
4866,U -Bladder tumor associated antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603307,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,U -Bladder tumor associated antigen,,
4867,cB-Bilirubin,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40757494,Bilirubin.total [Moles/volume] in Blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603308,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,cB-Bilirubiini,,
4868,"P -Prostat-specific antigen, ratio",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3001784,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603309,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"P -Prostataspesifinen antigeeni, suhde",,
4869,P -Prostatase-specific antigen,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3013603,Prostate specific Ag [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603310,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,P -Prostataspesifinen antigeeni,,
4870,P -Tumor-associated trypsin inhibitor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603311,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,P -Tuumoriin liittyvä trypsiini-inhibiittori,,
4871,F -Calprotectin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603312,LABfi Level 0,Measurement,2005-04-08,2009-12-31,,,F -Calprotectin,,
4872,"Of-Protein, Fractions",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603313,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"Af-Proteiini, fraktiot",,
4873,S -Bilirubin (foster),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603314,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,S -Bilirubiini (sikiö),,
4874,"S -Carnitine, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603315,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"S -Karnitiini, vapaa",,
4875,S -Phytanoic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603316,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,S -Fytaanihappo,,
4876,"dU-Carnitine, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603317,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"dU-Karnitiini, vapaa",,
4877,"M -Carnitine, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603318,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"M -Karnitiini, vapaa",,
4878,"U -Karnitin, fritt",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603319,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"U -Karnitiini, vapaa",,
4879,uS-C-reactive protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603320,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,uS-C-reaktiivinen proteiini,,
4880,"S -Saccharomyces cerevisiae, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3041672,Baker's yeast Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000603321,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"S -Saccharomyces cerevisiae, vasta-aineet",,
4881,"B-Narcolepsy, HLA Disease Association, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603322,LABfi Level 0,Measurement,2005-04-08,2030-12-31,,,"B -Narkolepsia, HLA-tautiassosiaatio, DNA-tutkimus",,
4884,"B -Welanders distal myopathy (WDM), DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603323,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,B -Welanderin distaalisen myopatian (WDM) DNA-tutkimus,,
4885,B -DNA Assay of the TTN Gene in Tibial Muscular Dystrophy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603324,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,B -TTN-geenin DNA-tutkimus tibiaalisessa lihasdystrofiassa,,
4886,B -Examination of Choline Acetyltransferase Gene Mutations in Congenital Myasthenia-Apnea Syndrome (CMS-EA),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603325,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,B -Koliiniasetyylitransferaasigeenin mutaatioiden tutkimus kongenitaalisessa myastenia-apnea-syndroomassa (CMS-EA),,
4887,"B -DNA study of LGMD2A pathogenic CAPN3 gene mutations (Limb-girdle muscular dystrophy type 2A, calpainopathy)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603326,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,"B -LGMD2A-tautia (Limb-girdle muscular dystrophy type 2A, kalpainopatia) aiheuttavan CAPN3-geenin mutaatioiden DNA-tutkimus",,
4888,B -DNA Examination of LGMD2I and CMD1C Disease-Causing FKRP Gene Mutations,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603327,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,B -LGMD2I-tautia ja CMD1C-tautia aiheuttavan FKRP-geenin mutaatioiden DNA-tutkimus,,
4889,"B-Dystrophy myotonica type 2 (DM2), DNA test on the allele size of the repetitive sequence of the ZNF9 gene",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3040668,CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,Measurement,MAPS_TO,,tays,1630368000000,,2000603328,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,"B -Dystrofia myotonica tyyppi 2 (DM2), ZNF9-geenin toistojakson alleelikokojen DNA-tutkimus",,
4890,"B-Dystrophy myotonica type 2 (DM2), DNA examination of mutation in the repetitive sequence of the ZNF9 gene",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603329,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,"B -Dystrofia myotonica tyyppi 2 (DM2), ZNF9-geenin toistojaksomutaation DNA-tutkimus",,
4891,B -DNA study of the most common Finnish mutation (FINmaj) in tibial muscular dystrophy (TMD),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603330,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,B -Tibiaalisen lihasdystrofian (TMD) suomalaisen valtamutaation (FINmaj) DNA-tutkimus,,
4892,"The fusion RNA of the B -PML / RARA genes (15:17), (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055239,"t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603331,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,"B -PML/RARA geenien fuusio-RNA: t(15:17), (kvant)",,
4893,"Bm-PML / RARA gene fusion RNA (15:17), (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42529039,"t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603332,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,"Bm-PML/RARA geenien fuusio-RNA: t(15:17), (kvant)",,
4894,"The fusion RNA of the B -BCR-ABL1 genes (9:22), (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3042391,"t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603333,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,"B -BCR-ABL1 -geenien fuusio-RNA: t(9:22), (kvant)",,
4895,"The fusion RNA of the Bm-BCR-ABL1 genes (9:22), (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42868452,"t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603334,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,"Bm-BCR-ABL1 -geenien fuusio-RNA: t(9:22), (kvant)",,
4896,"Influenza A virus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3044938,Influenza virus A RNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603335,LABfi Level 0,Measurement,2005-11-01,2030-12-31,,,"Influenssa A -virus, nukleiinihappo (kval)",,
4897,"Adenovirus, Nucleic Acid (Qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3040853,Adenovirus DNA [Identifier] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603336,LABfi Level 0,Measurement,2005-11-01,2030-12-31,,,"Adenovirus, nukleiinihappo (kval)",,
4898,"P-Adenovirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603337,LABfi Level 0,Measurement,2005-10-14,2030-12-31,,,"P -Adenovirus, nukleiinihappo (kval)",,
4899,"S -Prostataspecific antigen, ratio",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603338,LABfi Level 0,Measurement,2005-10-14,2011-12-31,,,"S -Prostataspesifinen antigeeni, suhde",,
4900,"P -Prostat-specific antigen, free",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3005013,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603339,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"P -Prostataspesifinen antigeeni, vapaa",,
4901,"Pt-Electroencephalography (EEC) long-term registration, additional days",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603340,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) pitkäaikaisrekisteröinti, jatkovuorokausi",,
4902,"Pt-Somatosensory Reaction Potentials (SEP), Extra Nerve, Both Sides, Stimulation Study",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603341,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Somatosensorinen herätevastetutkimus (SEP), lisähermo molemmin puolin",,
4903,"Pt-Visual Reaction Potentials (VEP), Half-Field Study, Stimulation Study",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603342,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Visuaalinen herätevastetutkimus (VEP), puolikenttätutkimus",,
4904,"Pt-Blinkreflexen, additional nerve",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603343,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Räpäysheijaste, lisähermo",,
4905,Pt-Habitation of the turn signal reflex,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603344,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Räpäysheijasteen habituaatio,,
4906,"Pt-Electroencephalography (EEC) and video monitoring, first day",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603345,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) ja videomonitorointinti, ensimmäinen vuorokausi",,
4907,"Pt-Electroencephalography (EEC) and video monitoring, additional days",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603346,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) ja videomonitorointinti, jatkovuorokausi",,
4908,"Pt-Electroencephalography (EEC), long-term outpatient registration, first day",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603347,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), ambulatorinen pitkäaikaisrekisteröinti, ensimmäinen vuorokausi",,
4909,"Pt-Electroencephalography (EEC), long-term outpatient registration, additional days",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603348,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), ambulatorinen pitkäaikaisrekisteröinti, jatkovuorokausi",,
4910,"Pt Electroencephalography (EEC), intracranial electrodes",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603349,LABfi Level 0,Measurement,2006-01-01,2020-12-31,,,"Pt-Elektroenkefalografia (EEG), kallonsisäiset elektrodit",,
4911,"Pt-Electroencephalography (EEC), special analysis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603350,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), erikoisanalyysi",,
4912,Pt-Electroencephalography (EEC) combined with imaging,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603351,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Elektroenkefalografia (EEG) kuvantamiseen yhdistettynä,,
4913,Pt-Electroencephalography at the same time as another measure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603352,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Elektroenkefalografia muun toimenpiteen aikana,,
4914,"Pt Magnetoencephalography (MEG), Limited",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603353,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Magnetoenkefalografia (MEG), suppea",,
4915,"Pt Magnetoencephalography (MEG), Common",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603354,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Magnetoenkefalografia (MEG), tavallinen",,
4916,"Pt Magnetoencephalography (MEG), comprehensive",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603355,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Magnetoenkefalografia (MEG), laaja",,
4917,"Pt Magnetoencephalography (MEG), Special Techniques",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603356,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Magnetoenkefalografia (MEG), erikoistekniikka",,
4918,"Pt-Magnetic stimulation, targeted stimulation of the brain, position determination using MRI image",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603357,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Magneettistimulaatio, MRI-kuvan avulla navigoiden kohdistettu aivojen stimulaatio",,
4919,"Pt-Sleep Polygraphy, Outpatient",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603358,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Unipolygrafia, ambulatorinen",,
4920,Pt-Measurement of the touch threshold,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603359,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Kosketustuntokynnyksen mittaus,,
4921,"Pt-Electroneuromyography (ENMG), examinationof several extremities or problems",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603360,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroneuromyografia (ENMG), usean raajan tai ongelman tutkimus",,
4922,"Pt-Electroneurography (ENG), rapid testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603361,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Elektroneurografia (ENG), pikatestaus",,
4923,"Pt-Botulin treatment using electromyography (EMG), standard",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603362,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt -Botuliinihoito elektromyografia (EMG) ohjauksessa, tavallinen",,
4924,"Pt-Neurophysiological monitoring during surgery, a method",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603363,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Leikkauksen aikainen neurofysiologinen valvonta, yksi menetelmä",,
4925,"Pt-Neurophysiological monitoring during surgery, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603364,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Leikkauksen aikainen neurofysiologinen valvonta, vaativa",,
4926,"Pt-Statement on neurophysiological examination, common",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603365,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Lausunto neurofysiologisesta tutkimuksesta, tavallinen",,
4927,Pt Muscle Biopsy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603366,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Lihasbiopsia,,
4928,Pt-Nerve Biopsy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603367,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Hermobiopsia,,
4929,Pt-Hudbiopsi,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603368,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Ihobiopsia,,
4930,Pt-Impulse Oscillometry,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603369,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Impulssioskillometria,,
4931,Pt-Long-term registration of esophageal bilirubin and pH,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603370,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Esophaguksen bilirubiinin ja pH:n pitkäaikaisrekisteröinti,,
4932,Pt-Long-term recording of esophageal pressure and pH,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603371,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Esophaguksen paineen ja pH:n pitkäaikaisrekisteröinti,,
4933,"Pt-Standing position, tolerance test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603372,LABfi Level 0,Measurement,2006-01-01,2011-12-31,,,Pt-Pystyasennon sietokoe,,
4934,Pt-Electrogastrography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603373,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Elektrogastrografia,,
4935,Pt-Ischemic muscle test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603374,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,Pt-Iskeeminen lihaskoe,,
4936,"Trichomonas, cultivation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603375,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Trichomonas, viljely",,
4937,"U-Neisseria gonorrhoeae, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003510,Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603376,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"U -Neisseria gonorrhoeae, nukleiinihappo (kval)",,
4938,"Pt-Adrenocorticotropin test, minidos",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603377,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"Pt-Adrenokortikotropiini-koe, minimiannos",,
4939,F -Dominant aerobic bacteria in feces,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603378,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,F -Ulosteen aerobinen valtakasvu,,
4940,"F -Norovirus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3008909,Norovirus RNA [Presence] in Stool by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603379,LABfi Level 0,Measurement,2006-01-01,2030-12-31,,,"F -Norovirus, nukleiinihappo (kval)",,
4941,"S -Complement, total activity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603380,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Komplementti, kokonaisaktiivisuus",,
4942,"S -Treponema pallidum, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019832,Treponema pallidum Ab [Presence] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000603381,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Treponema pallidum, vasta-aineet",,
4943,Li-Orexin A,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603382,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,Li-Oreksiini A,,
4944,U-Deoxypyridinoline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603383,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,U-Deoksipyridinoliini,,
4945,U-Pyridinoline,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603384,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,U-Pyridinoliini,,
4946,"U-Deoxypyridinoline, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603385,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"U-Deoksipyridinoliini, vapaa",,
4947,"U -Pyridinoline, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603386,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"U-Pyridinoliini, vapaa",,
4948,Vitamin B1,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3006653,Thiamine [Moles/volume] in Blood,Measurement,MAPS_TO,,HUS,1596153600000,,2000603387,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,B1-vitamiini,,
4949,"S-Immunoglobulin, light chains, free",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,40760888,Immunoglobulin light chains.free panel - Serum,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603388,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Immunoglobuliini, kevytketjut, vapaat",,
4950,"S-Immunoglobulin, light chains, lambda, free",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3047169,Lambda light chains.free [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603389,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Immunoglobuliini, kevytketjut, Lambda, vapaat",,
4951,"Bm-JAK2 gene mutation, DNA test",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,21494671,JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603390,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Bm -JAK2-geenin mutaatio, DNA-tutkimus",,
4952,"B -JAK2 gene mutation, DNA test",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,21494670,JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603391,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"B -JAK2-geenin mutaatio, DNA-tutkimus",,
4953,ESBL continued investigation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603392,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,ESBL-jatkotutkimus,,
4954,"Bacteria, species identification",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603393,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Bakteeri, lajimääritys",,
4955,"S-Chlamydia pneumoniae, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3006237,Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603394,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Chlamydia pneumoniae, vasta-aineet",,
4955,"S-Chlamydia pneumoniae, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3017558,Chlamydophila pneumoniae IgM Ab [Presence] in Serum,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603394,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Chlamydia pneumoniae, vasta-aineet",,
4956,"Li-Chlamydia pneumoniae, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603395,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Li-Chlamydia pneumoniae, vasta-aineet",,
4957,"S-Influenza Virus Type B, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603396,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S-Influenssa B -virus, IgG-vasta-aineet",,
4958,"S-Enterovirus, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603397,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Enterovirus, IgG-vasta-aineet",,
4959,"Li-Rubella Virus, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603398,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Li-Vihurirokkovirus, IgM-vasta-aineet",,
4960,"Li-Toxoplasma, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603399,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Li-Toxoplasma, IgA-vasta-aineet",,
4961,"Cytomegalovirus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603400,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Cytomegalovirus, viljely",,
4962,"B -Cytomegalovirus, culture",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603401,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"B-Cytomegalovirus, viljely",,
4963,"S-Pemphigoid, BP180 Antigen, Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40760848,Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603402,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Pemfigoidi, BP180-antigeeni, vasta-aineet",,
4964,"S -Goodpastures Syndrome, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603403,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Goodpasturen syndrooma, vasta-aineet",,
4965,"S -TSH Receptor, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017044,Thyrotropin receptor Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000603404,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -TSH-reseptori, vasta-aineet",,
4966,"S-Immunoglobulin, light chains, coat, free",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3034860,Kappa light chains.free [Mass/volume] in Serum,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603405,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Immunoglobuliini, kevytketjut, Kappa, vapaat",,
4967,Pt- Carbon monoxide content in exhaled air,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603406,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,Pt-Uloshengityskaasun hiilimonoksidipitoisuus,,
4968,"Pt Orthostatic Test (45 min, Tilt Test)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603407,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,Pt-Pystyasennon sietokoe,,
4969,Pt-Oscillometric Impedance Measurement of the Respiratory System,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603408,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,Pt-Oskillometrisen hengityselimistön impedanssi,,
4970,Pt-Oscillometric Impedance Measurement of the Respiratory System and Bronchodilation Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603409,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,Pt-Oskillometrisen hengityselimistön impedanssi ja bronkodilataatiokoe,,
4971,"Pt-Oscillometric Impedance Measurement of the Respiratory System, Exposure",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603410,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Pt-Oskillometrisen hengityselimistön impedanssi, altistus",,
4972,"P -Natriuretic peptide, B-type (32-) (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603411,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"P -Natriureettinen peptidi, B-tyypin (32-) (kval)",,
4973,"P -Creatin kinase, MB subunit, mass (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603412,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"P -Kreatiinikinaasi, MB-alayksikkö, massa (kval)",,
4974,P -Myoglobin (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603413,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,P -Myoglobiini (kval),,
4975,P -Glucagon,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023436,Glucagon [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603414,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,P -Glukagoni,,
4976,"S -Complement, activity, lektinvägen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603415,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"S -Komplementti, aktiivisuus, lektiinitie",,
4977,"dU-Immunoglobulin, light chains, Lambda, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603416,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"dU-Immunoglobuliini, kevytketjut, Lambda, vapaat",,
4978,"dU-Immunoglobulin, light chains, Kappa, free",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603417,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"dU-Immunoglobuliini, kevytketjut, Kappa, vapaat",,
4979,"Complement, total hemolytic activity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603418,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Komplementti, kokonaishemolyyttinen",,
4980,B -MxA protein,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603419,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,B -MxA -proteiini,,
4981,"Staphylococcus aureus, methicillin resistant, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603420,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Staphylococcus aureus, metisilliiniresistentti, nukleiinihappo (kval)",,
4982,"Staphylococcus aureus, methicillin resistant, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603421,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Staphylococcus aureus, metisilliiniresistentti, varmistus",,
4983,Pt-ECG long-term recording 48 h,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603422,LABfi Level 0,Measurement,2007-01-01,2008-12-31,,,EKG:n pitkäaikaisrekisteröinti 48 h,,
4984,Pt-ECG long-term recording 72 h,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603423,LABfi Level 0,Measurement,2007-01-01,2008-12-31,,,EKG:n pitkäaikaisrekisteröinti 72 h,,
4985,"Pt-Spiroergometry on treadmill (ECG, RR monitoring and measurement of exhaled gases as well as spirometry or PEF and oxymetry)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603424,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,Pt-Spiroergometria juoksumatolla,,
4986,"Pt-Clinical work-based load test on treadmill (ECG, RR follow-up, PEF-blows)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603425,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,Pt-Kliininen työjohteinen kuormituskoe juoksumatolla,,
4987,"Pt-Clinical work-based load test on a bicycle (ECG, RR follow-up, PEF-blows)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603426,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,Pt-Kliininen työjohteinen kuormituskoe polkupyörällä,,
4988,"Pt-Clinical heart rate-based load test on treadmill (ECG, RR follow-up, PEF-blows)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603427,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Pt-Kliininen pulssijohteinen kuormituskoe juoksumatolla (EKG-, RR-seuranta, PEF puhallukset)",,
4989,"Pt-Clinical heart rate-based load test on a bicycle (ECG, RR follow-up, PEF-blows)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603428,LABfi Level 0,Measurement,2007-01-01,2030-12-31,,,"Pt-Kliininen pulssijohteinen kuormituskoe polkupyörällä (EKG-, RR-seuranta, PEF puhallukset)",,
4990,B- Examination of mutations occurring in Finland in the CLCN1 gene in congenital myotonia (Myotonia congenita),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603429,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,B -CLCN1-geenin Suomessa esiintyvien mutaatioiden tutkimus synnynnäisessä myotoniassa (Myotonia congenita),,
4991,B-DNA study of VCP gene mutations causing IBMPFD disease (Inclusion body myopathy with early-onset paget disease and frontotemporal dementia),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603430,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,B -IBMPFD -tautia (Inclusion body myopathy with early-onset paget disease and frontotemporal dementia) aiheuttavan VCP-geenin mutaatioiden DNA-tutkimus,,
4992,B -DNA Assay of CPTII Gene Mutations Causing Carnitine Palmitoyltransferase Deficiency,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603431,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,B -Karnitiini palmitoyylitransferaasin puutosta aiheuttavan CPT II -geenin mutaatioiden DNA-tutkimus,,
4993,B -Examination of the most common mutation in the RAPSN gene in congenital myasthenia-apnea syndrome (CMS-EA),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603432,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,B -RAPSN-geenin valtamutaation tutkimus kongenitaalisessa myastenia-apnea-syndroomassa (CMS-EA),,
4994,"B -DNA study of the most common SGCA gene mutation causing LGMD2D disease (Limb-girdle muscular dystrophy type 2, α-sarcoglycanopathy)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603433,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"B -LGMD2D-tautia (Limb-girdle muscular dystrophy type 2, a-sarkoglykanopatia) aiheuttavan SGCA-geenin valtamutaation DNA-tutkimus",,
4995,"B -DNA study of MYOT gene mutations causing LGMD1A (Limb-girdle muscular dystrophy type 1A, myotilinopathy)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603434,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"B -LGMD1A-tautia (Limb-girdle muscular dystrophy type 1A, myotilinopatia) aiheuttavan MYOT-geenin mutaatioiden DNA-tutkimus",,
4996,B -DNA Assay of ZASP Gene Mutations Causing Myofibrillar Myopathy (ZASP-Related MFM),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603435,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,B -Myofibrillaarista myopatiaa (ZASP-related MFM) aiheuttavan ZASP-geenin mutaatioiden DNA-tutkimus,,
4997,"B -DNA study of mutations in the POLG1 gene in PEO, MIRAS and SANDO disease",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603436,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"B -PEO-, MIRAS- ja SANDO-tauteja aiheuttavan POLG1-geenin mutaatioiden DNA-tutkimus",,
4998,B -DNA study of LMNA gene mutations causing LGMD1B (Limb-girdle muscular dystrophy type 1B) disease and Emery-Dreifuss muscular dystrophy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603437,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,B -LGMD1B-tautia (Limb-girdle muscular dystrophy type 1B) ja Emery-Dreifuss lihasdystrofiaa aiheuttavan LMNA-geenin mutaatioiden DNA-tutkimus,,
4999,"Pt-Glomerulus Filtration Rate, Estimated, Cockcroft-Gault Formula",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,44806420,Estimation of glomerular filtration rate,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603438,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Pt-Glomerulussuodosnopeus, estimoitu, Cockcroftin-Gaultin kaava",,
6000,"Pt-Glomerulus filtration rate, estimated, MDRD formula (unit of measurement: ml / min / 1.73 m2)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,46236952,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",Measurement,MAPS_TO,,HUS,1596153600000,,2000603439,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Pt-Glomerulussuodosnopeus, estimoitu, MDRD-tutkimuksen kaava (mittayksikkö: ml/min/1.73 m2)",,
6001,"P -BK virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3004590,BK virus DNA [Presence] in Serum or Plasma by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000603440,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"P -BK-virus, nukleiinihappo (kvant)",,
6002,"S -Hepatitis D virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603441,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"S -Hepatiitti D -virus, nukleiinihappo (kval)",,
6003,"Hepatitis D virus, nucleic acid (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603442,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Hepatiitti D -virus, nukleiinihappo (kval)",,
6004,"Aspergillus, detection of antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603443,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Aspergillus, antigeenin osoitus",,
6005,Sc Chromosome Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603444,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Sc-Kromosomitutkimus,,
6006,Pt-Flow-volume-spirometry without statement,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3003197,Forced vital capacity [Volume] Respiratory system by Spirometry,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603445,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Virtaustilavuus-spirometria ilman lausuntoa,,
6006,Pt-Flow-volume-spirometry without statement,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3024653,FEV1,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603445,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Virtaustilavuus-spirometria ilman lausuntoa,,
6007,Pt-Flow-volume-spirometry and bronchodilation test without statement,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4010399,Spirometry for bronchospasm with prolonged evaluation after bronchodilator,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603446,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Virtaustilavuus-spirometria ja bronkodilataatiokoe ilman lausuntoa,,
6008,Pt-Maximum inhalation and exhalation pressure,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603447,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Maksimaalinen sisään- ja uloshengityspaine,,
6009,Pt Hypoxia Load Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603448,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Hypoksia-altistuskoe,,
6010,Pt-Volunteer hyperventilation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603449,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Voluntaarinen hyperventilaatio,,
6011,Pt-Orthostatic test for respiratory gas monitoring,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603450,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Ortostaattinen koe hengityskaasuseurannassa,,
6012,Pt-Long-term recording of alkaline gastroesophageal reflux,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603451,LABfi Level 0,Measurement,2008-01-01,2008-12-31,,,Pt-Alkaalisen gastroesofageaalisen refluksin pitkäaikaisrekisteröinti,,
6013,Pt-Handergometry,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603452,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Käsiergometria,,
6014,Pt-Pharmacological stress study,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603453,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,Pt-Farmakologinen rasituskoe,,
6015,Pt-Measurement of blood flow in lower limb arteries during exercis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603454,LABfi Level 0,Measurement,2008-01-01,2009-12-31,,,Pt-Alaraajavaltimoiden verenkierron mittaus rasituksen yhteydessä,,
6016,"Pt ECG, long-term recording (24 h), coupling, analysis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603455,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (24 h), kytkentä, analysointi",,
6017,"Pt-ECG, long-term recording (48 h), coupling, analysis, statement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603456,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (48 h), kytkentä, analysointi, lausunto",,
6018,"Pt ECG, long-term recording (48 h), coupling, analysis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603457,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (48 h), kytkentä, analysointi",,
6019,"Pt-ECG, long-term recording (72h), coupling, analysis, statement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603458,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (72 h), kytkentä, analysointi, lausunto",,
6020,"Pt ECG, long-term recording (72 h), coupling, analysis",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603459,LABfi Level 0,Measurement,2008-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (72 h), kytkentä, analysointi",,
6021,"Clinical load test, spiroergometry on treadmill",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603460,LABfi Level 0,Measurement,2008-01-01,2008-12-31,,,"Pt-Kliininen rasituskoe, spiroergometria juoksumatolla",,
6022,"Pp-Bacteria, culture 1 (anaerobic + aerobic culture, quantitative)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603461,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pp-Bakteeri, viljely 1 (anaerobi + aerobiviljely, kvantitatiivinen)",,
6023,"Ed-Bacteria, culture 1 (anaerobic + aerobic culture, deep wounds)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603462,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Ed-Bakteeri, viljely 1 (anaerobi + aerobiviljely, syvämärkä)",,
6025,"fP-Cholesterol, Chylomicrons",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603463,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"fP-Kolesteroli, kylomikronit",,
6026,"fP-Cholesterol, very low density lipoproteins",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603464,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"fP-Kolesteroli, very low density lipoproteiinit",,
6027,fP-Lipids,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603465,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,fP-Lipidit,,
6028,"S -Natalizumab, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603466,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Natalitsumabi, vasta-aineet",,
6029,B -DNA Examination of the Most Common FKRP Gene Mutation Causing LGMD2I Disease,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603467,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,B -LGMD2I-tautia aiheuttavan FKRP-geenin valtamutaation DNA-tutkimus,,
6030,"S -Histidyl-tRNA-synthetase, antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3036086,Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603468,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Histidyyli-tRNA -syntetaasi, vasta-aineet",,
6031,"B -MTHFR Gene Variation (677C> T), DNA Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603469,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"B -MTHFR geenin variaatio (677C>T ), DNA-tutkimus",,
6032,"S -Calcium, albumin-corrected",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603470,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Kalsium, albumiinikorjattu",,
6033,"B -DNA Assay MYH7 Gene Mutations Causing Laing Distal Myopathy (MPD1, Laing Distal Myopathy)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603471,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"B -Laing distaalista myopatiaa (MPD1, Laing distal myopathy) aiheuttavan MYH7-geenin mutaatioiden DNA-tutkimus",,
6034,B DNA Assay of SCN4A Gene Mutations Causing Paramyotonia congenita Disease,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603472,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,B -Paramyotonia congenita -tautia aiheuttavan SCN4A-geenin mutaatioiden DNA-tutkimus,,
6035,B -DNA Examination of the Allelic Size of the DMPK Gene in Dystrophy Myotonica Type 1 (DM1) Disease,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603473,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,B -Dystrofia myotonica tyyppi 1 (DM1) -taudin alleelikokojen DNA-tutkimus DMPK-geenistä,,
6036,B -DNA study of mutation in the repetitive sequence of the DMPK gene in Dystrophia myotonica type 1 (DM1) disease,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603474,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,B -Dystrofia myotonica tyyppi 1 (DM1) -taudin toistojaksomutaation DNA-tutkimus DMPK-geenistä,,
6037,"S -West Nile virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603475,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -West Nile -virus, vasta-aineet",,
6038,"S-Chikungunya virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603476,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Chikungunya-virus, vasta-aineet",,
6039,P -Mitotane (Lysodren),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603477,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,P -Mitotaani (Lysodren),,
6040,fS-Insulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603478,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,fS-Insuliini,,
6041,fP-Chromogranin A,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3014702,Chromogranin A [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603479,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,fP-Kromograniini A,,
6042,"Hepatitis B virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603480,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Hepatiitti B -virus, nukleiinihappo (kval)",,
6043,"S -Hepatitis B virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3022058,Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000603481,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Hepatiitti B -virus, nukleiinihappo (kvant)",,
6044,"Li-West Nile Viruses, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603482,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Li-West Nile -virus, vasta-aineet",,
6045,Pt-Flow-volume-spirometry with portable device,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603483,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Virtaustilavuus-spirometria kannettavalla laitteella,,
6046,Pt-Long-term recording of pH and impedance in the esophagus,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603484,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Esofaguksen pH:n ja impedanssin pitkäaikaisrekisteröinti,,
6047,"Pt-Clinical load test, spiroergometry with lactate test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603485,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-Kliininen rasituskoe, spiroergometria laktaattinäyttein",,
6048,"Pt-Measurement of pressure in muscle lungs, examination of two objects",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603486,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-Lihasaitiopaineen mittaus, kahden kohteen tutkimus",,
6049,Pt-Measurement of pressure in muscle lungs at rest,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603487,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Lihasaitiopaineen mittaus levossa,,
6050,Pt-Nonischemical Forearm Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603488,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Noniskeeminen nyrkistyskoe yläraajaan,,
6051,Pt-Ischemic Forearm Test,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603489,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Iskeeminen nyrkistyskoe yläraajaan,,
6052,"Pt ECG, long-term recording (24 h), analysis, statement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603490,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (24 h), analysointi, lausunto",,
6053,"Pt ECG, long-term recording (48 h), analysis, statement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603491,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (48 h), analysointi, lausunto",,
6054,"Pt-ECG, long-term recording (72 h), analysis, statement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603492,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (72 h), analysointi, lausunto",,
6055,"Pt-Clinical load test, spiroergometry with hand load",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603493,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-Kliininen rasituskoe, spiroergometria käsirasituksella",,
6056,Pt-pulse curve progression and measurement of the change in the rate of progression in the carotid arteries,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603494,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Pulssikäyrän eteneminen ja etenemisnopeuden muutoksen mittaus kaulavaltimoista,,
6057,Pt-Allergen provocation of the airways (spirometry or PEF) serial measurement,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603495,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-Hengityksen allergeenialtistus (spirometria tai PEF), sarjamittaus",,
6058,Pt-Measurement of blood circulation in the arteries of the lower extremities under load,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603496,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Alaraajavaltimoiden verenkierron mittaus rasituksen yhteydessä,,
6059,"Am-Trisomy, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603497,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Am-Trisomia, nukleiinihappo (kval)",,
6060,"B -Trisomy, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603498,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"B -Trisomia, nukleiinihappo (kval)",,
6061,"CV Trisomy, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603499,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Cv-Trisomia, nukleiinihappo (kval)",,
6062,"Bokavirus, Nucleic Acid (Qual)",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40765161,Human bocavirus DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603500,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Bokavirus, nukleiinihappo (kval)",,
6063,"Pt-Glucose, long-term registration",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603501,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-Glukoosi, pitkäaikaisseuranta",,
6064,"F -Clostridium difficile, culture and detection of toxin",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603502,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"F -Clostridium difficile, viljely ja toksiinin osoittaminen",,
6065,Pt-Eucapnese Voluntary Hyperventilation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603503,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Eukapninen voluntaarinen hyperventillaatio,,
6066,"S-Chickenpox Virus, Antibodies, Avidity",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603504,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Vesirokkovirus, vasta-aineet, aviditeetti",,
6067,"B -HLA study, detection of disease association",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603505,LABfi Level 0,Measurement,2009-01-01,2011-12-31,,,"B -HLA-tutkimus, tautiassosiaation osoitus",,
6068,Am-Alloan antigen typing of platelets,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603506,LABfi Level 0,Measurement,2009-01-01,2011-12-31,,,Am-Trombosyyttien alloantigeenityypitys,,
6069,"Am-Alloen antigen typing of platelets, DNA testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603507,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Am-Trombosyyttien alloantigeenityypitys, DNA-tutkimus",,
6070,"S -Rh, D-antigen, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603508,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Rh, D-antigeeni, vasta-aineet",,
6071,"P -Coagulation factor V, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603509,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"P -Hyytymistekijä V, vasta-aineet",,
6072,"B -von Willebrand's disease, type 2, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603510,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"B -von Willebrandin tauti, tyyppi 2,DNA-tutkimus",,
6073,"P -von Willebrand Factor, Collagen Binding Ability",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3029847,von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000603511,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"P -von Willebrand -tekijä, kollageenin sitomiskyky",,
6075,"Pt-Mannitol load, bronchi",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603512,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-Mannitolialtistus, keuhkoputket",,
6076,"S -Anaplasma, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603513,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Anaplasma, IgG-vasta-aineet",,
6077,"Aspergillus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603514,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Aspergillus, nukleiinihappo (kval)",,
6078,P -Aldosterone,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3001788,Aldosterone [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603515,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,P -Aldosteroni,,
6079,U -Antimon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603516,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,U -Antimoni,,
6080,Vitamin fP-B6,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603517,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,fP-B6-vitamiini,,
6081,Vitamin fS-B6,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603518,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,fS-B6-vitamiini,,
6083,"S -Prolactin, macro",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,43055514,Macroprolactin [Presence] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603519,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"S -Prolaktiini, makro",,
6084,B-Pseudokolinesterase,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603520,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,B -Pseudokoliiniesteraasi,,
6085,P -Renin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603521,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,P -Reniini,,
6086,B -Sirolimus,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3021374,Sirolimus [Mass/volume] in Blood,Measurement,MAPS_TO,,tays,1630368000000,,2000603522,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,B -Sirolimuusi,,
6087,Tumor-Related Trypsin Inhibitor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603523,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Tuumoriin liittyvä trypsiini-inhibiittori,,
6088,Bm-ETO / AML1 Fusion Fusion RNA t (8:21) from Bone Marrow (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603524,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Bm-ETO/AML1-geenien fuusio-RNA t(8:21) luuytimestä (kval),,
6089,B-ETO / AML1 Fusion Fusion RNA t (8:21) from Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603525,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,B -ETO/AML1-geenien fuusio-RNA t(8:21) verestä (kval),,
6090,"P -C1-Esterase Inhibitor, Activity",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023659,Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603526,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"P -C1-Esteraasin inhibiittori, aktiivisuus",,
6091,P -Factor B,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002568,Complement factor B [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603527,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,P -Faktori B,,
6092,"Pt-Arterial pressure and blood flow, plethysmography without utterance",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603528,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,"Pt-Valtimopaine ja verenvirtaus, pletysmografi ilman lausuntoa",,
6093,Pt-Exhalation gas nitrogen oxide without statement,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603529,LABfi Level 0,Measurement,2009-01-01,2030-12-31,,,Pt-Uloshengityskaasun typpioksidi ilman lausuntoa,,
6094,"Pt-Oxygen Partial Pressure, Transcutaneous Hyperbaric Oxygen Load",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603530,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Pt-Happiosapaine, transkutaaninen hyperbaarinen happialtistus",,
6095,"B -Blood group antibodies, in pregnancy, follow-up examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603531,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -Veriryhmävasta-aineet, raskaudenaikaiset, seurantatutkimus",,
6096,E -Penotyping,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3029396,Erythrocyte agglutination [Presence] in Blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603532,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,E -Fenotyypitys,,
6098,"S -Sulfatide, IgM Antibodies (Neuropathy Diagnostics)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603533,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"S -Sulfatidi, IgM-vasta-aineet (Neuropatiadiagnostiikka)",,
6099,"S -Aquaporin 4, Antibodies (Neuromyelitis optica Diagnostics)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3046426,Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603534,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"S -Akvaporiini 4, vasta-aineet (Neuromyelitis optican diagnostiikka)",,
6100,"S-Myelin Associated Glycoprotein, Antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3016184,Myelin associated glycoprotein Ab [Units/volume] in Serum,Measurement,MAPS_TO,,HUS,1596153600000,,2000603535,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"S -Myeliiniin assosioituva glykoproteiini, vasta-aineet",,
6101,"S -Muscle-specific tyrosine kinase, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603536,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"S -Lihasspesifinen tyrosiinikinaasi, vasta-aineet",,
6102,Bm-ETO / AML1 gene fusion RNA t (8:21) from bone marrow (quantum),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43054951,"t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603537,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-ETO/AML1 -geenien fuusio-RNA t(8,21) luuytimestä (kvant)",,
6103,B -ETO / AML1 Fusion Fusion RNA t (8:21) from blood (quantum),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43054950,"t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603538,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -ETO/AML1 -geenien fuusio-RNA t(8,21) verestä (kvant)",,
6104,Bm-BCR / ABL Fusion Fusion RNA t (9:22) from Bone Marrow (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603539,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-BCR/ABL -geenien fuusio-RNA t(9,22) luuytimestä (kval)",,
6105,B-BCR / ABL Fusion Fusion RNA t (9:22) from Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603540,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -BCR/ABL -geenien fuusio-RNA t(9,22) verestä (kval)",,
6106,Bm-CBFB / MYH11 Fusion RNA Inv (16) from Bone Marrow (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603541,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,Bm-CBFB/MYH11 -geenien fuusio-RNA inv(16) luuytimestä (kval),,
6107,Bm-CBFB / MYH11 gene fusion RNA inv (16) from bone marrow (quantum),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43054952,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603542,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,Bm-CBFB/MYH11 -geenien fuusio-RNA inv(16) luuytimestä (kvant),,
6108,B -CBFB / MYH11 Fusion RNA Inv (16) from Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603543,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,B -CBFB/MYH11 -geenien fuusio-RNA inv(16) verestä (kval),,
6109,B -CBFB / MYH11gene fusion RNA inv (16) from blood (quantum),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42868762,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603544,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,B -CBFB/MYH11-geenien fuusio-RNA inv(16) verestä (kvant),,
6110,Bone-TCF3-PBX1 gene fusion RNA t (1:19) from bone marrow (quantum),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603545,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-TCF3-PBX1 -geenien fuusio-RNA t(1,19) verestä (kvant)",,
6111,Bm-E2A / PBX1 gene fusion RNA t (1:19) from bone marrow (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603546,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-E2A/PBX1 -geenien fuusio-RNA t(1,19) luuytimestä (kval)",,
6112,B -E2A / PBX1 Fusion Fusion RNA t (1:19) from Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603547,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -E2A/PBX1 -geenien fuusio-RNA t(1,19) verestä (kval)",,
6113,B -TCF3-PBX1 Fusion RNA t (1:19) from blood (quantum),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055277,"t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603548,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -TCF3-PBX1 -geenien fuusio-RNA t(1,19) verestä (kvant)",,
6114,Bm-MLL / AF4 gene fusion RNA t (4:11) from bone marrow (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603549,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-MLL/AF4 -geenien fuusio-RNA t(4,11) luuytimestä (kval)",,
6115,B -MLL / AF4 gene fusion RNA t (4:11) from blood (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603550,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -MLL/AF4 -geenien fuusio-RNA t(4,11) verestä (kval)",,
6116,B -KMT2A-AFF4 Fusion Fusion RNA t (4:11) from blood (quantum),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055278,"t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603551,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -KMT2A-AFF4 -geenien fuusio-RNA t(4,11) verestä (kvant)",,
6117,Bm-KMT2A-AFF4 gene fusion RNA t (4:11) from bone marrow (quantum),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603552,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-KMT2A-AFF4 -geenien fuusio-RNA t(4,11) verestä (kvant)",,
6118,Bm-PML / RARA Fusion Fusion RNA t (15:17) from Bone Marrow (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603553,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-PML/RARA -geenien fuusio-RNA t(15,17) luuytimestä (kval)",,
6119,B -PML / RARA Fusion RNA t (15:17) from Blood (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603554,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -PML/RARA -geenien fuusio-RNA t(15,17) verestä (kval)",,
6120,Bm-SIL / TAL1 gene fusion RNA portion (1p32) from bone marrow (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603555,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,Bm-SIL/TAL1 -geenien fuusio-RNA del(1p32) luuytimestä (kval),,
6121,The fusion RNA portion of the Bm-STIL-TAL1 gene (1p32) from bone marrow (quantum),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603556,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,Bm-STIL-TAL1 -geenien fuusio-RNA del(1p32) verestä (kvant),,
6122,The fusion RNA portion (1p32) of the B -SIL / TAL1 genes from blood (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603557,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,B -SIL/TAL1 -geenien fuusio-RNA del(1p32) verestä (kval),,
6123,The fusion RNA portion (1p32) of the B -STIL-TAL1 genes (1p32) (quantum),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603558,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,B -STIL-TAL1 -geenien fuusio-RNA del(1p32) verestä (kvant),,
6124,Bm-TEL / AML1 gene fusion RNA t (12:21) from bone marrow (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603559,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-TEL/AML1 -geenien fuusio-RNA t(12,21) luuytimestä (kval)",,
6125,Bm-ETV6-RUNX1 gene fusion RNA t (12:21) from bone marrow (quantum),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055187,"t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603560,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bm-ETV6-RUNX1 -geenien fuusio-RNA t(12,21) verestä (kvant)",,
6126,B -TEL / AML1 gene fusion RNA t (12:21) from blood (qual)),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603561,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -TEL/AML1 -geenien fuusio-RNA t(12,21) verestä (kval)",,
6127,B -ETV6-RUNX1 Fusion RNA t (12:21) from blood (quantum),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055188,"t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method",Measurement,MAPS_TO,,HUS,1596153600000,,2000603562,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -ETV6-RUNX1 -geenien fuusio-RNA t(12,21) verestä (kvant)",,
6128,B -Hemoglobin-A1c,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3004410,Hemoglobin A1c/Hemoglobin.total in Blood,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603563,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,B -Hemoglobiini-A1c,,
6130,B -Neutrophilic gelatinase-associated lipocalin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603564,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,B -Neutrofiilin gelatinaasiin assosioitu lipokaliini,,
6131,P -Neutrophilic gelatinase-associated lipocalin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603565,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,P -Neutrofiilin gelatinaasiin assosioitu lipokaliini,,
6132,U -Neutrophilic gelatinase-associated lipocalin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603566,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,U -Neutrofiilin gelatinaasiin assosioitu lipokaliini,,
6133,"Influenza A virus, variant, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603567,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Influenssa A-virus, variantti, nukleiinihappo (kval)",,
6134,"B -Human herpesvirus-6 (HHV-6), nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3029493,Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000603568,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -Human herpesvirus-6 (HHV-6), nukleiinihappo (kvant)",,
6135,"Li-Human herpesvirus-6 (HHV-6), nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3046896,Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000603569,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Li -Human herpesvirus-6 (HHV-6), nukleiinihappo (kvant)",,
6136,"Human herpesvirus-6 (HHV-6), nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3035401,Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000603570,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Human herpesvirus-6 (HHV-6), nukleiinihappo (kvant)",,
6137,B -CD4 immunosuppression level of B -CD4 lymphocytes,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603571,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,B -CD4-lymfosyyttien immunosuppression taso,,
6138,"S -HER-2-neu, oncoprotein",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603572,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"S -HER-2-neu, onkoproteiini",,
6139,"F -Clostridium difficile, toxingen, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603573,LABfi Level 0,Measurement,2010-01-01,2011-12-31,,,"F -Clostridium difficile, toksiinigeeni, nukleiinihappo (kval)",,
6140,"P1 Fluorescence in Situ Hybridization Assay, Aneuploidy",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603574,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Pl-Fluoresenssi in situ hybridisaatiotutkimus, aneuploidia",,
6141,"F -Clostridium difficile -toxigen, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3051552,Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603575,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"F -Clostridium difficile, toksiinigeeni, nukleiinihappo (kval)",,
6142,"B -Borrelia, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603576,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"B -Borrelia, nukleiinihappo (kval)",,
6143,"Li-Borrelia, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603577,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Li-Borrelia, nukleiinihappo (kval)",,
6144,Ts-Histological examination of thick-needle biopsy on breast,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603578,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,Ts-Rinnan paksuneulabiopsian histologinen tutkimus,,
6145,"Bo-Histological examination of bone or soft tissue, comprising surgical specimens",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603579,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Bo-Luu- tai pehmytkudosnäytteen histologinen tutkimus, laaja leikkauspreparaatti",,
6146,"Br-Histological examination of breasts, comprehensive surgical specimens",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603580,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Br-Rinnan histologinen tutkimus, laaja leikkauspreparaatti",,
6147,"Gi-Histological examination of the Gi area, comprehensive surgical specimens",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603581,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Gi-Gi-alueen näytteen histologinen tutkimus, laaja leikkauspreparaatti",,
6148,"Lu-Histological examination of lung, comprehensive surgical specimens",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603582,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Lu-Keuhkonäytteen histologinen tutkimus, laaja leikkauspreparaatti",,
6149,"Ug-Histological examination of the urogenital area, comprehensive surgical preparations",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603583,LABfi Level 0,Measurement,2010-01-01,2030-12-31,,,"Ug- Urogenitaalialueen näytteen histologinen tutkimus, laaja leikkauspreparaatti",,
6150,S -Aripripazole,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603584,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,S -Aripipratsoli,,
6151,S -Hepsidin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42870325,Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603585,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,S -Hepsidiini,,
6152,U-Hepsidin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603586,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,U -Hepsidiini,,
6153,Bilirubin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603587,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,Bilirubiini,,
6154,CA 15-3 antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603588,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,CA 15-3 antigeeni,,
6155,CA 19-9 antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603589,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,CA 19-9 antigeeni,,
6156,Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603590,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,Glukoosi,,
6157,Carcinoembryonic antigen,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603591,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,Karsinoembryonaalinen antigeeni,,
6158,Lactate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603592,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,Laktaatti,,
6159,"S -Tryodothyronine, free, dialysis method",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603593,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,"S -Trijodityroniini, vapaa, dialyysimenetelmä",,
6160,"S -Tyroxine, free, dialysis method",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42868691,Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis,Measurement,MAPS_TO,,HUS,1596153600000,,2000603594,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,"S -Tyroksiini, vapaa, dialyysimenetelmä",,
6161,"B - Detection of phenylalanine, blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603595,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,"B -Fenyylialaniinin osoitus, veri",,
6162,"S -Insulin, receptor, antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3000219,Insulin receptor Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000603596,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,"S -Insuliini, reseptori, vasta-aineet",,
6163,S -Itraconazole,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603597,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,S -Itrakonatsoli,,
6164,B -Cobalt,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3026470,Cobalt [Mass/volume] in Blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603598,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,B -Koboltti,,
6165,"U -Methylenedioxypyrovalerone, confirmation, urine",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603599,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,"U -Metyleenidioksipyrovaleroni, varmistus, virtsa",,
6166,B -Titan,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40762814,Titanium [Mass/volume] in Blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603600,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,B -Titaani,,
6167,S -Voriconazole,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603601,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,S -Vorikonatsoli,,
6168,"Li-immunoglobulin G, oligoclonal",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40759883,Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603602,LABfi Level 0,Measurement,2011-01-01,2030-12-31,,,"Li-Immunoglobuliini G, oligoklonaalinen",,
6169,S -Levetiracetam,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603603,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,S -Levetirasetaami,,
6170,U -Oxicodone (qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603604,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,U -Oksikodoni (kval),,
6171,U -Methylenedioxymethamphetamine (qual.),-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3002148,Methylenedioxymethamphetamine [Presence] in Urine by Screen method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603605,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,U -Metyleenidioksimetamfetamiini (kval),,
6172,U-Methamphetamine (Qual),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603606,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,U -Metamfetamiini (kval),,
6173,"B Cells Reacting to M. Tuberculosis, Gamma Interferon, Secretion",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,36304997,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603607,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,"B -M. tuberculosis-herkistyneet solut, gammainterferoni, eritys",,
6174,"B cells reacted with M. tuberculosis, gamma interferon, reactive cells",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603608,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,"B -M. tuberculosis-herkistyneet solut, gammainterferoni, erittävät solut",,
6175,B - Redistribution of the heavy chain gene in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017312,HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603609,LABfi Level 0,Measurement,2012-01-01,2014-12-31,,,B- Immunoglobuliinin raskaan ketjun geenin uudelleenjärjestymä,,
6176,Bm - Redistribution of the heavy chain gene in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40763629,HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603610,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Bm -Immunoglobuliinin raskaan ketjun geenin uudelleenjärjestymä,,
6177,Ts - Redistribution of the heavy chain gene in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017312,HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603611,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Ts -Immunoglobuliinin raskaan ketjun geenin uudelleenjärjestymä,,
6178,B - Redistribution of the kappa chain in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017829,Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603612,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,B -Immunoglobuliinin kappaketjun geenin uudelleenjärjestymä,,
6179,Bm - Redistribution of the kappa chain in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017829,Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603613,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Bm -Immunoglobuliinin kappaketjun geenin uudelleenjärjestymä,,
6180,Ts - Redistribution of the kappa chain in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017829,Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603614,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Ts -Immunoglobuliinin kappaketjun geenin uudelleenjärjestymä,,
6181,B - Redistribution of the lambda chain gene in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004674,Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603615,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,B -Immunoglobuliinin lambdaketjun geenin uudelleenjärjestymä,,
6182,Bm - Redistribution of the lambda chain gene in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004674,Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603616,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Bm -Immunoglobuliinin lambdaketjun geenin uudelleenjärjestymä,,
6183,Ts - Redistribution of the gene for the lambda chain in immunoglobulin,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3004674,Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603617,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Ts -Immunoglobuliinin lambdaketjun geenin uudelleenjärjestymä,,
6184,B - Redistribution of the gamma chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017962,TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603618,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,B -T-solureseptorin gammaketjun geenin uudelleenjärjestymä,,
6185,Bm - Redistribution of the gamma chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40763634,TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603619,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Bm -T-solureseptorin gammaketjun geenin uudelleenjärjestymä,,
6186,Ts - Redistribution of the gamma chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017962,TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603620,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,T s -T-solureseptorin gammaketjun geenin uudelleenjärjestymä,,
6187,B - Redistribution of the delta chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017425,TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603621,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,B -T-solureseptorin deltaketjun geenin uudelleenjärjestymä,,
6188,Bm - Redistribution of the delta chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017425,TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603622,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Bm -T-solureseptorin deltaketjun geenin uudelleenjärjestymä,,
6189,Ts - Redistribution of the delta chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3017425,TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603623,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Ts -T-solureseptorin deltaketjun geenin uudelleenjärjestymä,,
6190,B - Redistribution of the beta chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008423,TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603624,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,B -T-solureseptorin betaketjun geenin uudelleenjärjestymä,,
6191,Bm - Redistribution of the beta chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40763637,TCRB gene rearrangements [Presence] in Bone marrow by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603625,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Bm -T-solureseptorin betaketjun geenin uudelleenjärjestymä,,
6192,Ts - Redistribution of the beta chain gene in the T cell receptor,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008423,TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603626,LABfi Level 0,Measurement,2012-01-01,2030-12-31,,,Ts -T-solureseptorin betaketjun geenin uudelleenjärjestymä,,
6193,"Influenza A and B viruses, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603627,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Influenssa A ja B-virus, nukleiinihappo (kval)",,
6194,"Influenza B virus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3038288,Influenza virus B RNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603628,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Influenssa B-virus, nukleiinihappo (kval)",,
6195,"Mycoplasma genitalium, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603629,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Mycoplasma genitalium, nukleiinihappo (kval)",,
6196,"Mycoplasma genitalium, sensitivity determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603630,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Mycoplasma genitalium, herkkyysmääritys",,
6197,"P -HI virus-1, tropism",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603631,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"P -HI-virus-1, tropismi",,
6198,"RS virus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3043924,Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603632,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"RS-virus, nukleiinihappo (kval)",,
6199,"Parainfluenza 1 virus, nucleic acid (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603633,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Parainfluenssa 1-virus, nukleiinihappo (kval)",,
6200,"Parainfluenza 2 virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603634,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Parainfluenssa 2-virus, nukleiinihappo (kval)",,
6201,"Parainfluenza 3 virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603635,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Parainfluenssa 3-virus, nukleiinihappo (kval)",,
6202,"Parainfluenza 4 virus, nucleic acid (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603636,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Parainfluenssa 4-virus, nukleiinihappo (kval)",,
6203,"Human metapneumoviruss, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042194,Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000603637,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Humaani metapneumovirus, nukleiinihappo (kval)",,
6204,"Coronavirus, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042596,Human coronavirus RNA [Presence] in Specimen by NAA with probe detection,Measurement,MAPS_TO,,tays,1630368000000,,2000603638,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Koronavirus, nukleiinihappo (kval)",,
6205,"Am-Rh genotyping, DNA testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603639,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Am-RH-genotyypitys, DNA-tutkimus",,
6206,"B -hypersensitivity to abacavir, HLA association, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603640,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B -Abacavir-yliherkkyys, HLA-assosiaatio, DNA-tutkimus",,
6207,"B - Hypersensitivity to allopurinol, HLA association, DNA test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603641,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B-Allopurinoli-yliherkkyys, HLA-assosiaatio, DNA-tutkimus",,
6208,"B -Hematological fluorescence in situ hybridization, blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603642,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B -Hematologinen fluoresenssi in situ hybridisaatio, veri",,
6209,"Bm -Hematological fluorescence in situ hybridization, bone marrow",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603643,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Bm-Hematologinen fluoresenssi in situ hybridisaatio, luuydin",,
6210,"Ts -Hematological fluorescence in situ hybridization, tissue",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603644,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Ts-Hematologinen fluoresenssi in situ hybridisaatio, kudos",,
6211,"B -Fluorescence in situ hybridization, detection of MRD (minimal residual disease), blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603645,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B-Fluoresenssi in situ hybridisaatio, jäännöstaudin osoittaminen, veri",,
6212,"Bm -Fluorescence in situ hybridization, detection of MRD (minimal residual disease), bone marrow",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603646,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Bm-Fluoresenssi in situ hybridisaatio, jäännöstaudin osoittaminen, luuydin",,
6213,"Ts-Fluorescence in situ hybridization, detection of MRD (minimal residual disease), tissue",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603647,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Ts-Fluoresenssi in situ hybridisaatio, jäännöstaudin osoittaminen, kudos",,
6214,"B -Fluorescence in situ hybridization, 24 color, blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603648,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B-Fluoresenssi in situ hybridisaatio, 24 väri, veri",,
6215,"Bm -Fluorescence in situ hybridization, 24 color, bone marrow",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603649,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Bm-Fluoresenssi in situ hybridisaatio, 24 väri, luuydin",,
6216,"Ts-Fluorescence in situ hybridization, 24 color, tissue",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603650,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Ts-Fluoresenssi in situ hybridisaatio, 24 väri, kudos",,
6217,"P1-FISH study of microdeletions in chromosomes, placenta",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603651,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pl-Kromosomien mikrodeleetioiden FISH-tutkimus, istukka",,
6218,"Am-FISH study of microdeletions in chromosomes, amniotic fluid (amniotic fluid)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603652,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Am-Kromosomien mikrodeleetioiden FISH-tutkimus, lapsivesi",,
6219,"Ts-Molecular karyotyping, congenital anomalies (array)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603653,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Ts-Molekyylikaryotyypitys, synnynnäiset poikkeavuudet (array)",,
6220,"B-Molecular karyotyping, congenital anomalies (array)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603654,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B -Molekyylikaryotyypitys, synnynnäiset poikkeavuudet (array)",,
6221,"Bm-Molecular karyotyping, congenital anomalies (array)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603655,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Bm-Molekyylikaryotyypitys, synnynnäiset poikkeavuudet (array)",,
6222,"Ts-Molecular karyotyping, congenital anomalies (array)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603656,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Ts-Molekyylikaryotyypitys, synnynnäiset poikkeavuudet (array)",,
6223,Am-Directed Trisomy and Microdeletion Examination of Cells in Amnion Fluid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603657,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Am-Kohdennettu trisomia- ja mikrodeleetiotutkimus lapsiveden soluista,,
6224,B-Directed Trisomy and Microdeletion Examination of Blood Cells,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603658,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B-Kohdennettu trisomia- ja mikrodeleetiotutkimus verisoluista,,
6225,CV-Directed Trisomy and Microdeletion Examination of Placental Cells,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603659,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Cv-Kohdennettu trisomia- ja mikrodeleetiotutkimus istukan soluista,,
6226,Ts-Directed Trisomy and Microdeletion Examination of Tissue Cells,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603660,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Ts-Kohdennettu trisomia- ja mikrodeleetiotutkimus kudoksen soluista,,
6227,"S -Antibodies to leukocytes, cytotoxic, screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603661,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S-Leukosyyttivasta-aineet, sytotoksiset, seulonta",,
6228,"S -Compatibility test for leukocytes, cytotoxic antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603662,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S -Leukosyyttien sopivuuskoe, sytotoksiset vasta-aineet",,
6229,"S -Compatibility Test for Leukocytes, IgG and IgM, Flow Cytometry",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603663,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S-Leukosyyttien sopivuuskoe, IgG ja IgM, virtaussytometria",,
6230,"S -Antibodies to leukocytes, panel reactive, IgG",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603664,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S- Leukosyyttivasta-aineet, paneelireaktiiviset, IgG",,
6231,"S -Antibodies to leukocytes, class I, IgG, identification",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603665,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S -Leukosyyttivasta-aineet, luokka I, IgG, tunnistus",,
6232,"S-Antibodies to Leukocytes, Class II, IgG, Identification",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603666,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S -Leukosyyttivasta-aineet, luokka II, IgG, tunnistus",,
6233,B - Detection of Hereditary Spherocytosis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603667,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B -Perinnöllisen sferosytoosin osoitus,,
6234,"S -Examination of heparin-induced thrombocytopenia, functional",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603668,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S-Hepariinitrombosytopeniatutkimus, funktionaalinen",,
6235,"P -Dabigatran, functional concentration (inhibitory effect on thrombin time)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055459,Dabigatran [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603669,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"P-Dabigatraani, funktionaalinen konsentraatio (estovaikutus trombiiniaikaan)",,
6236,"Li-Immunophenotyping, Blood Disease",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603670,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Li-Immunofenotyypitys, veritauti",,
6237,"Immunophenotyping, Blood Disease",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603671,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Af-Immunofenotyypitys, veritauti",,
6238,"E-Immunophenotyping, PNH",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603672,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"E-Immunofenotyypitys, PNH",,
6239,"L -Immunophenotyping, PNH",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603673,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"L-Immunofenotyypitys, PNH",,
6240,"Bm Immunophenotyping, Stem Cells (CD34 +)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603674,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Bm-Immunofenotyypitys, kantasolut",,
6241,"La Immunophenotyping, Stem Cells (CD34 +)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603675,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"La-Immunofenotyypitys, kantasolut",,
6242,"B -Protein C mutation W380G, DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603676,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B-Proteiini C mutaatio W380G, DNA",,
6243,"Am-Protein C mutation W380G, DNA",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603677,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Am-Proteiini C mutaatio W380G, DNA",,
6244,"P -Coagulation factor VIII, recombinant",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603678,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"P-Hyytymistekijä VIII, rekombinantti",,
6245,B -Gammahydroxybutyrate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603679,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B-Gammahydroksibutyraatti,,
6246,"U -Tricyclic antidepressant, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603680,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"U -Trisykliset antidepressantit, varmistus",,
6247,B-Tricyclic antidepressant,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603681,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B-Trisykliset antidepressantit,,
6248,B -Opiater,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603682,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B-Opiaatit,,
6249,B -Cocaine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603683,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B-Kokaiini,,
6250,B -Cannabis,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603684,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B-Kannabis,,
6251,B-Benzodiazepines,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603685,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B-Bentsodiatsepiinit,,
6252,S-Amphetamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603686,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,S-Amfetamiini,,
6253,B -Drugscreening (kval),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603687,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,B-Huumeseulonta (kval),,
6254,"B -Rh genotyping of fetus, DNA test, sample from mother",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603688,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B-Sikiön RH-genotyypitys, DNA-tutkimus, äidin näyte",,
6255,"P -Lupus anticoagulant, aPTT, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603689,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"P -Lupusantikoagulantti, aPTT, varmistus",,
6256,"P -Lupus anticoagulant, dRVVT, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603690,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"P -Lupusantikoagulantti, dRVVT, varmistus",,
6257,"S -Examination of heparin-induced thrombocytopenia, immunological",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603691,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S-Hepariinitrombosytopeniatutkimus, immunologinen",,
6258,"B-Immunophenotyping, B-memory cells",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603692,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B -Immunofenotyypitys, B-muistisolut",,
6259,"B -Blood group examinations, father",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603693,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"B-Veriryhmätutkimukset, isä",,
6260,"U-Immunoglobulin, Light Chains, Coat",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3035082,Kappa light chains [Mass/volume] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603694,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"U-Immunoglobuliini, kevyet ketjut, Kappa",,
6261,"U-Immunoglobulin, light chains, Lambda",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3006969,Lambda light chains [Mass/volume] in Urine,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603695,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"U-Immunoglobuliini, kevyet ketjut, Lambda",,
6262,S -Hydroxyindolylacetate (5-),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3030136,5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603696,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,S-Hydroksi-indolyyliasetaatti (5-),,
6263,Ts-Ubikinon,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603697,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Ts-Ubikinoni,,
6264,S -Methoxyhydroxymandelate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603698,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,S-Metoksihydroksimandelaatti,,
6265,S -Homovanillinate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603699,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,S-Homovanillinaatti,,
6266,"P -Rivaroxaban, inhibitory effect on coagulation factor Xa",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055458,Rivaroxaban [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603700,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"P -Rivaroksabaani, estovaikutus hyytymistekijä Xa:han",,
6267,Sa-Melatonin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603701,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Sa-Melatoniini,,
6268,U-Melatonin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603702,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,U-Melatoniini,,
6269,"Rubella virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603703,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Vihurirokkovirus, nukleiinihappo (kval)",,
6270,"S-Morbillivirus, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603704,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"S-Tuhkarokkovirus, nukleiinihappo (kval)",,
6271,"U -Morbillivirus, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603705,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"U -Tuhkarokkovirus, nukleiinihappo (kval)",,
6272,"Morbillivirus, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603706,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Tuhkarokkovirus, nukleiinihappo (kval)",,
6273,"Parotitic virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603707,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Sikotautivirus, nukleiinihappo (kval)",,
6274,Ts-Histological examination of coarse needle biopsy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603708,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Ts-Paksuneulabiopsian histologinen tutkimus,,
6275,"Ts-Histological examination of the head and neck region, comprehensive surgical specimens",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603709,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Ts-Pään ja kaulan alueen histologinen tutkimus, laaja leikkauspreparaatti",,
6276,"Pt-Electroencephalography (EEC), sleep deprivation, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603710,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), unideprivaatio, vaativa",,
6277,"Pt-Electroencephalography (EEC), sleep deprivation, very demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603711,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), unideprivaatio, erittäin vaativa",,
6278,"Pt-Electroencephalography (EEG) and video monitoring, 3-4 hours, standard",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603712,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) ja videomonitorointi, 3-4 tuntia, tavallinen",,
6279,"Pt-Electroencephalography (EEC) and video monitoring, 5-8 hours, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603713,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) ja videomonitorointi, 5-8 tuntia, vaativa",,
6280,"Pt-Electroencephalography (EEC), demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603714,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), vaativa",,
6281,"Pt-Electroencephalography (EEC), very demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603715,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), erittäin vaativa",,
6282,"Pt electroencephalography (EEG), amplitude integrated",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603716,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), amplitudi-integroitu",,
6283,"Pt-Neurophysiological consultation, made by caregivers",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603717,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Neurofysiologinen konsultaatio, hoitajan tekemä",,
6284,"Pt-Botulin therapy using electromyography (EMG), demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603718,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Botuliinihoito elektromyografia (EMG) ohjauksessa, vaativa",,
6285,"Pt-Botulin treatment by electromyography (EMG), very demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603719,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Botuliinihoito elektromyografia (EMG) ohjauksessa, erittäin vaativa",,
6286,"Pt-Electroneuromyography (ENMG), examination of ion channel diseases",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603720,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Elektroneuromyografia (ENMG), ionikanavatautien tutkimus",,
6287,"Pt-Registration of movement activity, actigraphy, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603721,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Liikeaktiviteettirekisteröinti, aktigrafia, vaativa",,
6288,"Pt-Sleep Polygraphy in a Sleep Laboratory, Demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603722,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Unipolygrafia unilaboratoriossa, vaativa",,
6289,Pt-Investigation of Event-Related Potential (ERP),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603723,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Pt-Tapahtumasidonnainen herätevastetutkimus,,
6290,Pt-Treatment with Magnetic Stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603724,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Pt-Magneettistimulaatiohoito,,
6291,"Pt-Visual Reaction Potentials (VEP), Flashing Stimulation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603725,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,Pt-Visuaalinen herätevaste (VEP) välkestimulaatiolla,,
6292,"Pt-Neurophysiological Surveillance During Surgery (IOM), very demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603726,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Leikkauksenaikainen neurofysiologinen valvonta, erittäin vaativa",,
6293,"Pt Statement on Neurophysiological Undesearch, very demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603727,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Lausunto neurofysiologisesta tutkimuksesta, erittäin vaativa",,
6294,"Pt-Thermal Reaction Potentials (CHEP), Contact Stimulation Assay, Regular",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603728,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Terminen herätevastetutkimus, tavallinen                                                                                                                       ",,
6295,"Pt-Thermal Reaction Potentials (CHEP), Contact Stimulation Assay, Comprehensive",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603729,LABfi Level 0,Measurement,2013-01-01,2030-12-31,,,"Pt-Terminen herätevastetutkimus, laaja ",,
6296,"S -Streptococcus pneumoniae, not conjugate vaccine serotypes, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603730,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Streptococcus pneumoniae, ei-konjugaattirokoteserotyypit, vasta-aineet",,
6297,"S -Streptococcus pneumoniae, conjugate vaccine serotypes, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603731,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Streptococcus pneumoniae, konjugaattirokoteserotyypit, vasta-aineet",,
6298,"S -Gliadin Peptides, Deamidated, Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40766183,Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603732,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Gliadiinipeptidit, deamidoidut, vasta-aineet",,
6298,"S -Gliadin Peptides, Deamidated, Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40766189,Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603732,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Gliadiinipeptidit, deamidoidut, vasta-aineet",,
6299,"S -Gliadin Peptides, Deamidated, IgG Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40766189,Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603733,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Gliadiinipeptidit, deamidoidut, IgG-vasta-aineet",,
6300,"S -Gliadin Peptides, Deamidated, IgA Antibodies",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,40766183,Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603734,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Gliadiinipeptidit, deamidoidut, IgA-vasta-aineet",,
6301,"Ts-Histological examination of the CNS, samples from surgery",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603735,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"Ts-Keskushermoston histologinen tutkimus, kirurginen näyte",,
6302,Li-Neuronal Antibodies,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3006804,Neuronal Ab [Presence] in Cerebral spinal fluid,Measurement,MAPS_TO,,tays,1630368000000,,2000603736,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,Li-Neuronaaliset vasta-aineet,,
6303,S -Neuronal Antibodies,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3024869,Neuronal Ab [Presence] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000603737,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,S -Neuronaaliset vasta-aineet,,
6304,Pt-Nasal nitric oxide measurement,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603738,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,Pt-Nasaalinen typpidioksidimittaus,,
6305,"Pt-Thermal stimulus response study, standard",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603739,LABfi Level 0,Measurement,2014-01-01,2018-09-30,,,"Pt-Terminen herätevastetutkimus, tavallinen",,
6306,"Pt-Thermal arousal response study, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603740,LABfi Level 0,Measurement,2014-01-01,2018-09-30,,,"Pt-Terminen herätevastetutkimus, vaativa",,
6307,"Trichomonas vaginalis, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603741,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"Trichomonas vaginalis, nukleiinihappo (kval)",,
6308,"Trichomonas vaginalis, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603742,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"Trichomonas vaginalis, antigeeni",,
6310,S -Antimulatory hormone (AMH),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603743,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,S -Anti-Muller hormoni,,
6311,S -Methoxytramine (3-) from serum,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3030408,3-Methoxytyramine [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603744,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,S -Metoksityramiini (3-) seerumista,,
6312,"Haemophilus ducreyi, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603745,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Haemophilus ducreyi, nukleiinihappo (kval)",,
6313,"Treponema pallidum, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603746,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Treponema pallidum, nukleiinihappo (kval)",,
6314,"Helicobacter pylori, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603747,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Helicobacter pylori, nukleiinihappo (kval)",,
6315,"Mycoplasma pneumoniae, sensitivity determination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603748,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Mycoplasma pneumoniae, herkkyysmääritys",,
6316,"β-Adenovirus, nucleic acid (quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603749,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"P -Adenovirus, nukleiinihappo (kvant)",,
6317,"S -Hepatitis E virus, nucleic acid (quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603750,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"S -Hepatiitti E-virus, nukleiinihappo (kvant)",,
6318,"P -JC virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032185,JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603751,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"P -JC-virus, nukleiinihappo (kvant)",,
6319,"Li-JC virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032492,JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603752,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Li-JC-virus, nukleiinihappo (kvant)",,
6320,"U -JC virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032390,JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603753,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"U -JC-virus, nukleiinihappo (kvant)",,
6321,"U -Polyomavirus, nucleic acid (quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603754,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"U -Polyoomavirus, nukleiinihappo (kvant)",,
6322,"U -BK virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3034629,BK virus DNA [#/volume] (viral load) in Urine by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603755,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"U -BK-virus, nukleiinihappo (kvant)",,
6323,"Li-BK virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3032995,BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603756,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Li-BK-virus, nukleiinihappo (kvant)",,
6324,"BK virus, nucleic acid (quantum)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3050099,BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603757,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"BK-virus, nukleiinihappo (kvant)",,
6325,"S -Parechovirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603758,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"S -Parechovirus, nukleiinihappo (kval)",,
6326,"Li-Parechovirus, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603759,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Li-Parechovirus, nukleiinihappo (kval)",,
6327,"Parechovirus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603760,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Parechovirus, nukleiinihappo (kval)",,
6328,"Li-Enterovirus, Nucleic Acid (Qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603761,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Li-Enterovirus, nukleiinihappo (kval)",,
6329,"S -JC virus, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,42868647,JC virus Ab [Presence] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000603762,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"S -JC-virus, vasta-aineet",,
6330,"nU-Porfobilinogen, natturin (morgonurin)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603763,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"nU-Porfobilinogeeni, yövirtsasta (aamuvirtsasta)",,
6331,"nU-Delta-aminolevulinate, natturin (morgonurin)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603764,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"nU-Delta-aminolevulinaatti, yövirtsasta (aamuvirtsasta)",,
6332,"nU-Porphyrins, natturin (morgonurin)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603765,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"nU-Porfyriinit, yövirtsasta (aamuvirtsasta)",,
6333,"Mu-Lactose Intolerance, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603766,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"Mu-Laktoosi-intoleranssi, DNA-tutkimus",,
6334,"P -von the Willebrand factor, activity (binding to GPIb)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,40770918,von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000603767,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"P -von Willebrand -tekijä, aktiivisuus (GPIb sitoutuminen)",,
6335,"B -immunophenotyping, fetal hemoglobin",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603768,LABfi Level 0,Measurement,2014-07-01,2030-12-31,,,"B -Immunofenotyypitys, fetaalihemoglobiini",,
6336,fP-Aldosterone,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603769,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,fP-Aldosteroni,,
6338,"fP-Renin, concentration",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603770,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"fP-Reniini, konsentraatio",,
6339,"P -Renine, concentration",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3011985,Renin [Units/volume] in Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603771,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"P -Reniini, konsentraatio",,
6341,"cB-Thromboplastin time, sampling from skin prick",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603772,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,cB-Tromboplastiiniaika ihopistosnäytteestä,,
6342,"B -Variation c.617C> G (I148M) in the PNPLA3 gene, DNA test of blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603773,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"B -PNPLA3-geenin c.617C>G (I148M) variaatio, DNA-tutkimus verestä",,
6343,"B -Gene Variations VKORC1 and CYP2C9 Affecting the Individual Dosage of Warfarin, DNA Examination of Blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603774,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"B -Varfariinin yksilölliseen annostukseen liittyvät VKORC1- ja CYP2C9-geenivariaatiot, DNA-tutkimus verestä",,
6344,"B -Variation c.512T> C in the SLCO1B1 gene, DNA examination of blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603775,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"B -SLCO1B1-geenin c.512T>C variaatio, DNA-tutkimus verestä",,
6345,"B -Cytochrome P450 2D6, Variations of the CYP2D6 gene, DNA testing of blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603776,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"B -Sytokromi P450 2D6, CYP2D6-geenin variaatiot, DNA-tutkimus verestä",,
6346,"B -Cytochrome P450 2C19, alleles * 2 and * 17 of the CYP2C19 gene, DNA test of blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603777,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"B -Sytokromi P450 2C19, CYP2C19-geenin alleelit *2 ja *17, DNA-tutkimus verestä",,
6347,"P -Fondaparinux, inhibitory effect on coagulation factor Xa",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603778,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"P -Fondaparinuksi, estovaikutus hyytymistekijä Xa:han",,
6348,"P-Apixaban, inhibitory effect on coagulation factor Xa",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,43055442,Apixaban [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603779,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"P -Apiksabaani, estovaikutus hyytymistekijä Xa:han",,
6349,Bm-Percentage of bone marrow blasts based on morphological assessment,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3009992,Blasts/100 cells in Bone marrow,Measurement,MAPS_TO,,HUS,1596153600000,,2000603780,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,Bm-Blastiosuus morfologisesti arvioituna luuytimestä,,
6350,"Bm-Immunophenotyping, MRD examination, blood diseases",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603781,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"Bm-Immunofenotyypitys, jäännöstautitutkimus, veritaudit",,
6351,"B -Ammunphenotyping, MRD examination, blood diseases",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603782,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"B -Immunofenotyypitys, jäännöstautitutkimus, veritaudit",,
6352,"Bm-Immunophenotyping, MRD examination, blood diseases (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603783,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,B -Sikiön trisomia- ja mikrodeleetiotutkimus äidin verinäytte,,
6353,"B -Ammunphenotyping, MRD examination, blood diseases (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603784,LABfi Level 0,Measurement,2015-01-01,2030-12-31,,,"B -Immunofenotyypitys, jäännöstautitutkimus veritaudit (kval)",,
6354,"Pt-Glomerular Filtration Rate, Estimated",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,40764999,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603785,LABfi Level 0,Measurement,2020-07-01,2030-12-31,,,"Pt-Glomerulussuodosnopeus, estimoitu ",,
6355,S -Copeptin,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,21491866,Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000603786,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,S -Kopeptiini,,
6356,P -Copeptin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603787,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,P -Kopeptiini,,
6357,"B -Screening of Newborns, Control of 17-OHP",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603788,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,"B -Vastasyntyneiden seulonta, 17-OHP-kontrolli",,
6358,Sa-Cortisol in Saliva,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603789,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,Sa-Syljen kortisoli,,
6359,Pt-Treatment with Transcranial DC Stimulation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603790,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,Pt-Aivojen tasavirtastimulaatiohoito,,
6360,"Ts-EGFR Genes, Mutation Assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603791,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,Ts-EGFR-geenin mutaatiotutkimus,,
6361,"Ts-BRAF genes, mutation assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603792,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,Ts-BRAF-geenin mutaatiotutkimus,,
6362,"P -Triiodtyronine, frit",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3026989,Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603793,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,"P -Trijodityroniini, vapaa",,
6363,P -Carcinoembryonic antigen,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003785,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603794,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,P -Karsinoembryonaalinen antigeeni,,
6364,P -CA 12-5 antigen,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3037551,Cancer Ag 125 [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603795,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,P -CA 12-5 antigeeni,,
6365,P -CA 15-3 antigen,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42529200,Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603796,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,P -CA 15-3 antigeeni,,
6366,P -CA 19-9 antigen,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42529201,Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603797,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,P -CA 19-9 antigeeni,,
6367,P -Luteinizing hormone,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,3009214,Lutropin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603798,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,P -Luteinisoiva hormoni,,
6368,P -Follicle Stimulating Hormone,-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,42529215,Follitropin [Units/volume] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603799,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,P -Follikkelia stimuloiva hormoni,,
6369,"fP-C peptide, proinsulin",-1,,0,APPROVED,UNREVIEWED,TYKS,1631577600000,4229110,Insulin C-peptide measurement,Measurement,MAPS_TO,,TYKS,1631577600000,,2000603800,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,"fP-C-peptidi, proinsuliinin",,
6370,"Pt-ECG long-term training (over 3 days), analysis, statement",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603801,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,"Pt-EKG, pitkäaikaisrekisteröinti (yli 3 vrk), analysointi, lausunto",,
6371,"Dermatophytes, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603802,LABfi Level 0,Measurement,2016-01-01,2030-12-31,,,"Dermatofyytit, nukleiinihappo, kval",,
6372,"Pp-Bacteria, nucleic acid (quantum), tooth pocket",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603803,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"Pp-Bakteeri, nukleiinihappo (kvant), ientasku                                                                          ",,
6373,B - The fetus' trisomy examination from the mother's blood sample,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603804,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,B -Sikiön trisomiatutkimus äidin verinäytteestä,,
6374,B - Fetal trisomy and microdeletion examination from the mother's blood sample,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603805,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,B -Sikiön trisomia- ja mikrodeleetiotutkimus äidin verinäytteestä,,
6375,"F -Parasites, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603806,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"F -Parasiitit, nukleiinihappo (kval)",,
6376,Thyroglobulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603807,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,Tyreoglobuliini,,
6377,"B -KRAS gene, mutation assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603808,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"B -KRAS-geenin mutaatiotutkimus, solunulkoinen (free) DNA",,
6378,"B -EGFR gene, mutation assay",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603809,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"B -EGFR-geenin mutaatiotutkimus, solunulkoinen (free) DNA",,
6379,S -Antibodies to adalimumab,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603810,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"S -Adalimumabi, vasta-aineet",,
6380,S -Antibodies to infliximab,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,1175556,inFLIXimab Ab [Units/volume] in Serum by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000603811,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"S -Infliksimabi, vasta-aineet",,
6381,S -Infliximab,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3042299,inFLIXimab [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603812,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,S -Infliksimabi,,
6382,S -Adalimumab,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,44786774,Adalimumab [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603813,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,S -Adalimumabi,,
6383,"F1-Streptococcus agalactiae (B), nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603814,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"Fl-Streptococcus agalactiae (B), nukleiinihappo (kval)",,
6384,"P -Calcium, albumin-corrected",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020059,Calcium [Moles/volume] corrected for albumin in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603815,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"P -Kalsium, albumiinikorjattu",,
6385,"Ps-Streptococcus pyogenes (A), nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603816,LABfi Level 0,Measurement,2017-01-01,2030-12-31,,,"Ps-Streptococcus pyogenes (A), nukleiinihappo (kval)",,
6386,"P -Fatty acids, essential",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603817,LABfi Level 0,Measurement,2017-07-01,2030-12-31,,,"P -Rasvahapot, välttämättömät",,
6387,Pt-Clinical pathological treatment of patient cases,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603818,LABfi Level 0,Measurement,2017-07-01,2030-12-31,,,Pt-Potilastapauksen kliinispatologinen käsittely,,
6388,Ts-Histological Examination of Colposcopy Biopsy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603819,LABfi Level 0,Measurement,2017-07-01,2030-12-31,,,Ts-Kolposkopianäytteiden histologinen tutkimus,,
6389,Ts-Examination of Biopsy from Uterine Mucosa,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603820,LABfi Level 0,Measurement,2017-07-01,2030-12-31,,,Ts-Kohdun limakalvon histologisen materiaalin tutkimus,,
6390,Se-Triglycerides,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603821,LABfi Level 0,Measurement,2017-07-01,2030-12-31,,,Se-Triglyseridit,,
6391,"Pf Natriuretic Peptide, B-Type N-Terminal Propeptide",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,46236287,Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay,Measurement,MAPS_TO,,tays,1630368000000,,2000603822,LABfi Level 0,Measurement,2017-07-01,2030-12-31,,,"Pf-Natriureettinen peptidi, B-tyypin N-terminaalinen propeptidi",,
6392,"S-Epstein-Barr virus, nuclear antigen, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3007080,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000603823,LABfi Level 0,Measurement,2017-07-01,2030-12-31,,,"S -Eppstein-Barrin virus, tuma-antigeeni, IgG-vasta-aineet",,
6393,"Ly-Immunophenotyping, T-cell subclasses, comprehensive",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603824,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"Ly-Immunofenotyypitys, T-solut alaluokat, laaja",,
6394,"Ly Immunophenotyping, B-cell subclasses, comprehensive",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603825,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"Ly-Immunofenotyypitys, B-solut alaluokat, laaja",,
6395,"P -C peptide from proinsulin, postprandial",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40759040,C peptide [Moles/volume] in Serum or Plasma --post meal,Measurement,MAPS_TO,,tays,1630368000000,,2000603826,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"P -C-peptidi, proinsuliinin, aterianjälkeinen",,
6396,"S -C peptide from proinsulin, postprandial",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603827,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"S -C-peptidi, proinsuliinin, aterianjälkeinen",,
6397,S -Epididymalprotein 4 (HE4),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603828,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,S Epididymaalinen antigeeni 4 (HE4),,
6398,P -Epididymalprotein 4 (HE4),-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40758310,Human epididymis protein 4 [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603829,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,P -Epididymaalinen antigeeni 4 (HE4),,
6399,Am-Lamellar Bodies,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603830,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,Am-Lamellaarikappaleet,,
6400,B-Beta-hydroxybutyrate,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603831,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,B -Beeta-hydroksibutyraatti,,
6401,Vitamin P-D-25-OH,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,40771025,25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603832,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,P -D-vitamiini-25-OH,,
6402,P -Ethanol,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020191,Ethanol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603833,LABfi Level 0,Measurement,2018-01-01,2020-02-07,,,P -Etanoli,,
6403,P -Coriongonadotropyn,-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3018171,Choriogonadotropin [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603834,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,P -Koriongonadotropiini,,
6404,"P -Rheumatism factor, determination",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3021614,Rheumatoid factor [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603835,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"P -Reumafaktori, määritys",,
6405,"P -Citrullinated Peptide, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603836,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"P -Sitrulliinipeptidi, vasta-aineet",,
6406,"P -thyroid apoxidase, antibodies",-1,,0,APPROVED,UNREVIEWED,TAYS ja HUS,1596153600000,3027238,Thyroperoxidase Ab [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,TAYS ja HUS,1596153600000,,2000603837,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"P -Tyreoideaperoksidaasi, vasta-aineet",,
6407,"fP-Lipoprotein, apo A1",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603838,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"fP-Lipoproteiini, apo A1",,
6408,"fP-Lipoprotein, apo B",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603839,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"fP-Lipoproteiini, apo B",,
6409,"fP-Apolipoproteins, ApoA1, ApoB and ApoB / A1",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603840,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"fB-Apolipoproteiinit ApoA1, ApoB ja ApoB/A1",,
6410,"fS-Apolipoproteins, ApoA1, ApoB and ApoB / A1",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603841,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"fS-Apolipoproteiinit ApoA1, ApoB ja ApoB/A1",,
6411,"Ts-Immunophenotyping, refractory celiac disease",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603842,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"Ts-Immunofenotyypitys, refraktaarikeliakia",,
6412,"Lu-Investigation of parenchymal disease in the lung, biopsy",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603843,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"Lu-Keuhkon parenkyymitaudin selvittely, biopsianäyte",,
6413,Sk-Skin Nerve Examination,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603844,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,Sk-Ihohermotutkimus,,
6414,"S -Myositis Assay, Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,43055089,Myosin Ab [Presence] in Serum or Plasma by Immunoblot,Measurement,MAPS_TO,,tays,1630368000000,,2000603845,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,"S -Myosiittitutkimus, vasta-aineet",,
6415,U-Methylenediphenyl diisocyanate (MDI),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603846,LABfi Level 0,Measurement,2018-01-01,2030-12-31,,,U -Metyleenidifenyylidi-isosyanaatti (MDI),,
6416,U -Trimethylamine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603847,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,U -Trimetyyliamiini,,
6417,"P -Peroxisomal diseases, screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603848,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,P -Peroksisomien toimintahäiriöiden seulonta,,
6418,S -Sterols,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603849,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,S -Sterolit ,,
6419,"P -CDG syndrome, screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603850,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,P -Synnynnäisten glykosylaatiohäiriöiden seulonta  ,,
6420,"S -CDG syndrome, screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603851,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,S -Synnynnäisten glykosylaatiohäiriöiden seulonta   ,,
6421,P -Oxysterols,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,37019495,Oxysterols panel - Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603852,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,P -Oksisterolit ,,
6422,B-Acyl Carnitine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603853,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,B -Asyylikarnitiini,,
6423,P -Insulin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603854,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,P -Insuliini,,
6424,Li -CXCL13 Chemokine Content in Cerebrospinal Fluid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603855,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,Li-CXCL13 -kemokiinipitoisuus,,
6425,Di-Urea,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603856,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,Di-Urea,,
6426,Se-Creatinine,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603857,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,Se-Kreatiniini,,
6427,S -Triglycerides,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603858,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,S -Triglyseridit,,
6428,S -cholesterol,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019900,Cholesterol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603859,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,S -Kolesteroli,,
6429,P -cholesterol,-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3019900,Cholesterol [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603860,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,P -Kolesteroli,,
6430,"S -cholesterol, high density lipoproteins",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023602,Cholesterol in HDL [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603861,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"S -Kolesteroli, high density lipoproteiinit",,
6431,"P -cholesterol, high density lipoproteins",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3023602,Cholesterol in HDL [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603862,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"P -Kolesteroli, high density lipoproteiinit",,
6432,"S -cholesterol, low density lipoproteins",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001308,Cholesterol in LDL [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603863,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"S -Kolesteroli, low density lipoproteiinit",,
6433,"P -cholesterol, low density lipoproteins",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3001308,Cholesterol in LDL [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603864,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"P -Kolesteroli, low density lipoproteiinit",,
6434,S -Lipider,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603865,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,S -Lipidit,,
6435,P -Lipider,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603866,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,P -Lipidit,,
6436,"S -Lipoprotein, apo A1",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008364,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603867,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"S -Lipoproteiini, apo A1",,
6437,"S -Lipoprotein, apo B",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014791,Apolipoprotein B [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603868,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"S -Lipoproteiini, apo B",,
6438,"S -Lipoprotein, apo C",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3003969,Apolipoprotein C [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603869,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"S -Lipoproteiini, apo C",,
6439,"P -Lipoprotein, apo A1",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3008364,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603870,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"P -Lipoproteiini, apo A1",,
6440,"P -Lipoprotein, apo B",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3014791,Apolipoprotein B [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603871,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,"P -Lipoproteiini, apo B",,
6441,Se-Urea,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603872,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,Se-Urea,,
6442,Pd-Glucose,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603873,LABfi Level 0,Measurement,2018-07-01,2030-12-31,,,Pd-Glukoosi,,
6443,U-S-phenylmercapturic acid,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603874,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,U -S-fenyylimerkaptuurihappo,,
6444,"Papillomavirus, genotyping",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603875,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,"Papilloomavirus, genotyypin määritys",,
6445,"Papillomavirus, nucleic acid, high risk (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603876,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,"Papilloomavirus, nukleiinihappo, suuren riskin (kval)",,
6446,"Papillomavirus, screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603877,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,"Papilloomavirus, seulonta",,
6447,S -The ratio of S -sFlt-1 to S -PlGF,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603878,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,S -Endoteelikasvutekijän liukoisen reseptorin (S -sFlt-1) ja plasentaalisen kasvutekijän (S -PlGF) suhde,,
6448,S -Soluble Vascular Endothelial Cell Growth Factor Receptor-1,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603879,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,S -Endoteelikasvutekijän liukoinen reseptori,,
6449,S -Placental growth factor,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603880,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,S -Plasentaalinen kasvutekijä          ,,
6450,S-Inhibin B,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3045781,Inhibin B [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603881,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,S -Inhibiini B,,
6451,"S -Testosterone, free, calculated",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,3018301,Testosterone Free [Moles/volume] in Serum or Plasma,Measurement,MAPS_TO,,HUS,1596153600000,,2000603882,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,"S -Testosteroni, vapaa, laskettu",,
6452,S -Topiramate,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3025481,Topiramate [Mass/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603883,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,S -Topiramaatti,,
6453,"Thyroglobulin, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603884,LABfi Level 0,Measurement,2019-01-01,2030-12-31,,,"Tyreoglobuliini, vasta-aineet",,
6454,"F -Hemoglobin, human, screening",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603885,LABfi Level 0,Measurement,2019-07-01,2030-12-31,,,"F-Hemoglobiini, ihmisen, seulontatutkimus",,
6455,"F -Hemoglobin, human",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603886,LABfi Level 0,Measurement,2019-07-01,2030-12-31,,,"F -Hemoglobiini, ihmisen (kvant)",,
6456,"Ps-Streptococcus, nucleic acid (qual.)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603887,LABfi Level 0,Measurement,2019-07-01,2030-12-31,,,"Ps-Streptococcus, nukleiinihappo (kval)",,
6457,P-Immunoglobulin D,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603888,LABfi Level 0,Measurement,2019-07-01,2030-12-31,,,P -Immunoglobuliini D,,
6458,P-Immunoglobulin E,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3005322,IgE [Units/volume] in Serum or Plasma,Measurement,MAPS_TO,,tays,1630368000000,,2000603889,LABfi Level 0,Measurement,2019-07-01,2030-12-31,,,P -Immunoglobuliini E,,
6459,"P -Edoxaban, inhibitory effect on coagulation factor Xa",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,36660577,Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method,Measurement,MAPS_TO,,HUS,1596153600000,,2000603890,LABfi Level 0,Measurement,2019-07-01,2030-12-31,,,"P -Edoksabaani, estovaikutus hyytymistekijä Xa:han   ",,
6460,"Antithrombin P73L Mutation, DNA Testing",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603891,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"B -Antitrombiini P73L -mutaatio, DNA-tutkimus",,
6461,S -C-peptide,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603892,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,S -C-peptidi,,
6462,P -Procalcitonin,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603893,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,P -Prokalsitoniini,,
6463,"Li-Cryptococcus neoformans, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603894,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"Li-Cryptococcus neoformans, antigeeni",,
6464,"S -Cryptococcus neoformans, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603895,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Cryptococcus neoformans, antigeeni",,
6465,Pt-Acoustic Rhinometry,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603896,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,Pt-Akustinen rinometria        ,,
6466,"COVID-19-coronavirus disease, nucleic acid (qual)",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,706163,SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection,Measurement,MAPS_TO,,HUS,1596153600000,,2000603897,LABfi Level 0,Measurement,2020-03-01,2030-12-31,,,"COVID-19-koronavirustauti, nukleiinihappo (kval)",ERROR OUTDATED conceptName: conceptName for conceptId 706163 is different in the target vocabularies,2025-03-27 | conceptName changed from SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with probe detection to SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
6467,P -Sterols,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603898,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,P -Sterolit,,
6468,"S -Coriongonadotropin, total",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603899,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"S -Koriongonadotropiini, totaali",,
6469,"P -Coriongonadotropin, total",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603900,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"P -Koriongonadotropiini, totaali",,
6470,"B -Drug and drug screening, comprehensive",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603901,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"B -Huume- ja lääkeainetutkimus, laaja",,
6471,Me-Drug and Drug Screening (Qualification),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603902,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"Me-Huume- ja lääkeainetutkimus, osoitus",,
6472,"U -Drug and drug screening, comprehensive, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603903,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"U -Huume- ja lääkeainetutkimus, laaja, varmistus",,
6473,"B -Blood group, rare",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603904,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"B -Veriryhmä, harvinaiset",,
6474,"B -Blood group, Rh, further examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603905,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"B -Veriryhmä, Rh, jatkotutkimus",,
6475,"B -Blood group, ABO, continued examination",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603906,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"B -Veriryhmä, ABO, jatkotutkimus",,
6476,"S -COVID-19 coronavirus disease, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,706179,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000603907,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"S -COVID-19 -koronavirustauti, vasta-aineet",,
6476,"S -COVID-19 coronavirus disease, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,706181,"SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay",Measurement,MAPS_TO,,HUS,1596153600000,,2000603907,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"S -COVID-19 -koronavirustauti, vasta-aineet",,
6476,"S -COVID-19 coronavirus disease, antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,723473,SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000603907,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"S -COVID-19 -koronavirustauti, vasta-aineet",,
6477,"S -COVID-19 coronavirus disease, IgA antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,723473,SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000603908,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"S -COVID-19 -koronavirustauti, IgA-vasta-aineet",,
6478,"S -COVID-19 coronavirus disease, IgG antibodies",-1,,0,APPROVED,UNREVIEWED,HUS,1596153600000,723474,SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay,Measurement,MAPS_TO,,HUS,1596153600000,,2000603909,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"S -COVID-19 -koronavirustauti, IgG-vasta-aineet",,
6479,"S -COVID-19 coronavirus disease, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603910,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"S -COVID-19 -koronavirustauti, IgM- vasta-aineet",,
6480,"P -COVID-19 coronavirus disease, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603911,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"P -COVID-19 -koronavirustauti, vasta-aineet",,
6481,"P -COVID-19 coronavirus disease, IgA antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603912,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"P -COVID-19 -koronavirustauti, IgA-vasta-aineet",,
6482,"P -COVID-19 coronavirus disease, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603913,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"P -COVID-19 -koronavirustauti, IgG-vasta-aineet",,
6483,"P -COVID-19 coronavirus disease, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603914,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"P -COVID-19 -koronavirustauti, IgM-vasta-aineet",,
6484,"B -COVID-19 coronavirus disease, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603915,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"B -COVID-19 -koronavirustauti, vasta-aineet",,
6485,"B -COVID-19 coronavirus disease, IgA antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603916,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"B -COVID-19 -koronavirustauti, IgA-vasta-aineet",,
6486,"B -COVID-19 coronavirus disease, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603917,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"B -COVID-19 -koronavirustauti, IgG-vasta-aineet",,
6487,"B -COVID-19 coronavirus disease, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603918,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,"B -COVID-19 -koronavirustauti, IgM-vasta-aineet",,
6488,B -Everolimus,-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3030703,Everolimus [Mass/volume] in Blood,Measurement,MAPS_TO,,tays,1630368000000,,2000603919,LABfi Level 0,Measurement,2020-04-07,2030-12-31,,,B -Everolimuusi,,
6489,"Sk-MMR, mismatch repair in DNA, special technique (Lynch syndrome)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603920,LABfi Level 0,Measurement,2020-07-01,2030-12-31,,,"Sk-MMR, DNA-virheenkorjauskyky, erikoistekniikka (Lynch syndrooma)",,
6490,"P -Phospholipid, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603921,LABfi Level 0,Measurement,2020-07-01,2030-12-31,,,"P -Fosfolipidi, vasta-aineet",,
6492,"COVID-19 coronavirus disease, antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603922,LABfi Level 0,Measurement,2020-01-09,2030-12-31,,,"COVID-19-koronavirustauti, antigeeni",,
6493,"β-Beta-2-glycoprotein, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603923,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Beeta-2-glykoproteiini, IgM-vasta-aineet",,
6494,"β-Beta-2-glycoprotein, IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603924,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Beeta-2-glykoproteiini, IgG-vasta-aineet",,
6495,"β -Cardiolipin, IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603925,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Kardiolipiini, IgG-vasta-aineet",,
6496,"β -Cardiolipin, IgM Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603926,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Kardiolipiini, IgM-vasta-aineet",,
6497,"P -Hepatitis B virus, c-antigen, IgM antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603927,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Hepatiitti B -virus, c-antigeeni, IgM-vasta-aineet",,
6498,"P -Hepatitis B virus, c-antigen, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603928,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Hepatiitti B -virus, c-antigeeni, vasta-aineet",,
6499,"P -Hepatitis C virus, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603929,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Hepatiitti C -virus, vasta-aineet",,
6500,"P -Hepatitis B virus, s-antigen",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603930,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,P -Hepatiitti B -viruksen s-antigeeni,,
6501,"P -Hepatitis C virus, nucleic acid (quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603931,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Hepatiitti C -virus, nukleiinihappo (kvant)",,
6502,"P -Hepatitis B virus, nucleic acid (quantum)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603932,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Hepatiitti B -virus, nukleiinihappo (kvant)",,
6503,"P -Hepatitis B virus, s-antigen, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603933,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Hepatiitti B -virus, s-antigeeni, vasta-aineet",,
6504,"Pt-Electroencephalography (EEG), alarm indication",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603934,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG), hälytysindikaatiot",,
6505,"Pt-Electroencephalography (EEG) outpatient long-term recording with video image, first day",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603935,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) ambulatorinen pitkäaikaisrekisteröinti videokuvalla, ensimmäinen vuorokausi",,
6506,"Pt-Electroencephalography (EEC) outpatient long-term recording with video image, additional days",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603936,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) ambulatorinen pitkäaikaisrekisteröinti videokuvalla, jatkovuorokausi",,
6507,"Pt-Electroencephalography (EEC) long-term registration with video image, first day",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603937,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) pitkäaikaisrekisteröinti videokuvalla, ensimmäinen vuorokausi",,
6508,"Pt-Electroencephalography (EEC) long-term registration with video image, additional days",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603938,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Elektroenkefalografia (EEG) pitkäaikaisrekisteröinti videokuvalla, jatkovuorokausi",,
6509,"Pt-EEG registration with subdural electrodes, first day",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603939,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-EEG-rekisteröinti subduraalielektrodein, ensimmäinen vuorokausi",,
6510,"Pt-EEG registration with subdural electrodes, additional days",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603940,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-EEG-rekisteröinti subduraalielektrodein, jatkovuorokausi",,
6511,"Pt-Stereo-EEG recording, first day",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603941,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Stereo-EEG-rekisteröinti, ensimmäinen vuorokausi",,
6512,"Pt-Stereo-EEG recording, additional days",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603942,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Stereo-EEG-rekisteröinti, jatkovuorokausi",,
6513,"Pt-Electron Neurography, Nerve or Muscle Threshold Response",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603943,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Hermo- tai lihasvasteen ärtyvyyskynnysmittaus,,
6514,"Pt-Neuromuscular examination with ultrasound, plain",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603944,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Neuromuskulaarinen ultraäänitutkimus, tavallinen",,
6515,"Pt-Neuromuscular examination with ultrasound, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603945,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Neuromuskulaarinen ultraäänitutkimus, vaativa",,
6516,Pt-Other psychophysical measurement,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603946,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Muu psykofyysinen mittaus,,
6517,Pt-Other examination of the autonomic nervous system with special technology,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603947,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Muu autonomisen hermoston tutkimus erityistekniikoilla,,
6518,Pt-Kinesiological Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603948,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Kinesiologinen tutkimus,,
6519,Pt-Examination of eye movements,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603949,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Silmänliiketutkimus,,
6520,Pt Nystagmography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603950,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Nystagmografia,,
6521,Pt-Other motion or balance survey with specialteknik,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603951,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Muu liike- tai tasapainotutkimus erityistekniikoilla,,
6522,Pt-Pattern Electroretinography (pERG),-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603952,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Elektroretinografia kuvioärsykkeelle,,
6523,Pt-Multifocal-ERG,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603953,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Multifokaalinen ERG,,
6524,Pt Electrooculography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603954,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Elektro-okulografia,,
6525,Pt-Navigated Magnetic Stimulation for Determining the Threshold of the Motor Cerebral Cortex,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603955,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Navigoitu aivokuoren motorisen kynnyksen määritys,,
6526,Pt-Navigated magnetic stimulation for determining the speech areas of the cerebral cortex,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603956,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Navigoitu magneettistimulaatio aivokuoren puhealueiden määrittämiseksi,,
6527,"Pt-Motor Transcranial Magnetic Stimulation Examination (MEP), Paired Pulse",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603957,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Motorinen herätevastetutkimus magneettistimulaatiolla, paripulssitekniikka",,
6528,Pt-Determination of short-term afferent inhibition by magnetic stimulation technique,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603958,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Lyhytkestoisen afferentin inhibition määritys magneettistimulaatiotekniikalla,,
6529,Pt-EEG Magnetic Stimulation Reaction Potentials,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603959,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-EEG-herätevaste magneettistimulaatiolle,,
6530,Pt-Other stimulation study with special technology,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603960,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Muu herätevastetutkimus erityistekniikoilla,,
6531,"Pt-Treatment with magnetic stimulation, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603961,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Magneettistimulaatiohoito, vaativa",,
6532,"Pt-Treatment with magnetic stimulation, very demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603962,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Magneettistimulaatiohoito, erittäin vaativa",,
6533,"Pt-Treatment with magnetic stimulation, without navigation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603963,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Magneettistimulaatiohoito, ilman navigointia",,
6534,Pt Magnetic Stimulation Therapy with Intermittent Theta Bursts,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603964,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Magneettistimulaatiohoito keskijaksoisella purskestimulaatiolla,,
6535,Pt-Combined pair stimulation with magnetic stimulation technique,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603965,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Yhteenliitetty paristimulaatio magneettistimulaatiotekniikoilla,,
6536,Pt-EEC Controlled Magnetic Stimulation Therapy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603966,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-EEG-ohjattu magneettistimulaatiohoito,,
6537,Pt-Thermocoagulation treatment in conjunction with stereo-EEG examination,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603967,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Termokoagulaatiohoito stereo-EEG-tutkimuksen yhteydessä,,
6538,Pt-MER-controlled placement of deep brain stimulators,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603968,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Syväaivostimulaattorien asennus MER-ohjauksessa,,
6539,Pt-Electrocorticography,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603969,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Elektrokortikografia,,
6540,Pt-Intraoperative Stereo-EEG Examination,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603970,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Intraoperatiivinen stereo-EEG-tutkimus,,
6541,"Pt-Night Polygraphy, outpatient with registration of foot movements",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603971,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Yöpolygrafia, ambulatorinen, jalkaliikerekisteröinnein",,
6542,"Pt-Night Polygraphy in Children, Outpatient",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603972,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Yöpolygrafia, ambulatorinen, lapselle",,
6543,"Pt-Night polygraphy in children, outpatient, with registration of foot movements",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603973,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Yöpolygrafia, ambulatorinen, lapselle, jalkaliikerekisteröinnein",,
6544,"Pt-Night Polygraphy, Outpatient, Special Techniques",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603974,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Yöpolygrafia, ambulatorinen, erikoistekniikka",,
6545,"Pt-Night polygraphy in children, outpatient, special technology",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603975,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Yöpolygrafia, ambulatorinen, erikoistekniikka, lapselle",,
6546,Pt-Night Polygraphy in Sleep Laboratory with Registration of Foot Movements,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603976,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Yöpolygrafia unilaboratoriossa jalkaliikerekisteröinnein,,
6547,Pt-Night Polygraphy on Children in Sleep Laboratories,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603977,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Yöpolygrafia unilaboratoriossa lapselle,,
6548,Pt-Night polygraphy of children in sleep laboratory with registration of foot movements,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603978,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Yöpolygrafia unilaboratoriossa lapselle jalkaliikerekisteröinnein,,
6549,"Pt-Night Polygraphy in Sleep Laboratory, Special Technology",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603979,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Yöpolygrafia unilaboratoriossa, erikoistekniikka",,
6550,"Pt-Night polygraphy of children in sleep laboratory, special technology",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603980,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Yöpolygrafia unilaboratoriossa lapselle, erikoistekniikka",,
6551,"Pt-Night Polygraphy, Registration",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603981,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Yöpolygrafian rekisteröinti,,
6552,Pt-Treatment intervention under night polygraphy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603982,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Hoitointerventio yöpolygrafian yhteydessä,,
6553,Pt-Treatment intervention under sleep polygraphy,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603983,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Hoitointerventio unipolygrafian yhteydessä,,
6554,"Pt-Statement on neurophysiological examination, alarm indication",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603984,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Lausunto neurofysiologisesta tutkimuksesta, hälytysindikaatiot",,
6555,"Pt-Consultation with hospital physicists in clinical neurophysiology, regular",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603985,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Kliinisen neurofysiologian sairaalafyysikon konsultaatio, tavallinen",,
6556,"Pt-Consultation with hospital physicists in clinical neurophysiology, demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603986,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Kliinisen neurofysiologian sairaalafyysikon konsultaatio, vaativa",,
6557,"Pt-Consultation with hospital physicists in clinical neurophysiology, very demanding",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603987,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Kliinisen neurofysiologian sairaalafyysikon konsultaatio, erittäin vaativa",,
6558,Pt-Initiation of treatment with noninvasive ventilator in sleep laboratory,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603988,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Noninvasiivisen hengityslaitehoidon aloitus unilaboratoriossa,,
6559,"Pt-Transcranial DC Stimulation, Prolonged Treatment",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603989,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Transkraniaalinen tasavirtastimulaatio, pitkäaikaishoito",,
6560,Pt Awareness Survey,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603990,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,Pt-Vireystutkimus,,
6561,"Pt-Registration of movement activity, actigraphy, special technology",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603991,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-Liikeaktiviteettirekisteröinti, aktigrafia, erikoistekniikka",,
6562,"β -Cardiolipin, IgA Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603992,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Kardiolipiini, IgA-vasta-aineet",,
6563,"β-Beta-2-glycoprotein, IgA antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603993,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"P -Beeta-2-glykoproteiini, IgA-vasta-aineet",,
6564,"Pt-ECG, 12 clutches, rhythm",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603994,LABfi Level 0,Measurement,2021-01-01,2030-12-31,,,"Pt-EKG, 12 kytkentää, rytmi",,
6565,"S -PML, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603995,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -PML, vasta-aineet",,
6566,"S -Sp100, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603996,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Sp100, vasta-aineet",,
6567,"S -gp210, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603997,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -gp210, vasta-aineet",,
6568,"S -Levercytosol Antigen 1, Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603998,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Maksan sytosoliantigeeni 1, vasta-aineet",,
6569,"S -Soluble supplier antigen, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000603999,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Maksan liukoinen antigeeni, vasta-aineet",,
6570,"S -Natalizumab, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604000,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Natalitsumabi, vasta-aineet",,
6571,S -Sekukinumab,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604001,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Sekukinumabi,,
6572,"S -Vedolizumab, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604002,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Vedolitsumabi, vasta-aineet",,
6573,S -Vedolizumab,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604003,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Vedolitsumabi,,
6574,"S -Ustekinumab, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604004,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Ustekinumabi, vasta-aineet",,
6575,S -Ustekinumab,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604005,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Ustekinumabi,,
6576,"S -Tocilizumab, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604006,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Tosilitsumabi, vasta-aineet",,
6577,S -Tocilizumab,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604007,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Tosilitsumabi,,
6578,"S -Certolizumabpegol, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604008,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Sertolitsumabipegoli, vasta-aineet",,
6579,S -Certolizumabpegol,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604009,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Sertolitsumabipegoli,,
6580,"S-rituximab, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604010,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Rituksimabi, vasta-aineet",,
6581,S -Rituximab,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604011,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Rituksimabi,,
6582,"S -Golimumab, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604012,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"S -Golimumabi, vasta-aineet",,
6583,S -Golimumab,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604013,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Golimumabi,,
6584,S -Etanercept,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604014,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Etanersepti,,
6585,S -Abatacept,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604015,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,S -Abatasepti,,
6586,"B -Hemoglobin S, share",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604016,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Hemoglobiini S, osuus",,
6587,"P -Hepatitis C virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604017,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"P -Hepatiitti C-virus, nukleiinihappo (kval)",,
6588,"P -Hepatitis B virus, nucleic acid (qual)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604018,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"P -Hepatiitti B-virus, nukleiinihappo (kval)",,
6589,"B -Leucocytes, patient-centered tests",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604019,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Leukosyytit, vieritutkimus",,
6590,"B -Hemoglobin, patient-centered test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604020,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Hemoglobiini, vieritutkimus",,
6591,"B -Hemoglobin-A1c, patient-centered test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604021,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Hemoglobiini-A1c, vieritutkimus",,
6592,"B-C-reactive protein, patient-centered test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604022,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -C-reaktiivinen proteiini, vieritutkimus",,
6593,"B -Troponin T, patient-centered test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604023,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Troponiini T, vieritutkimus",,
6594,"B -Troponin I, patient-centered test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604024,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Troponiini I, vieritutkimus",,
6595,"B -Natriuretic peptide, B-type N-terminal propeptide, patient-centered test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604025,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Natriureettinen peptidi, B-tyypin N-terminaalinen propeptidi, vieritutkimus",,
6596,"B -Fibrin D-dimers, patient-centered test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604026,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Fibriinin D-dimeerit, vieritutkimus",,
6597,"B-Thromboplastin time, patient-centered test",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604027,LABfi Level 0,Measurement,2021-07-01,2030-12-31,,,"B -Tromboplastiiniaika, vieritutkimus",,
6598,P -Coppers,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604028,LABfi Level 0,Measurement,2022-01-01,2030-12-31,,,P -Kupari,,
6599,"S -COVID-19-coronavirus disease, top protein, antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604029,LABfi Level 0,Measurement,2022-01-01,2030-12-31,,,"S -COVID-19-koronavirustauti, piikkiproteiini, vasta-aineet",,
6600,"B -Hemoglobin, electrophoresis from blood",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604030,LABfi Level 0,Measurement,2022-01-01,2030-12-31,,,"B -Hemoglobiini, elektroforeesi, verestä",,
6601,"U -Fentanyl, confirmation",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604031,LABfi Level 0,Measurement,2022-01-01,2030-12-31,,,"U -Fentanyyli, varmistus",,
6602,Pt-Very comprehensive histological examination or multi-tissue preparation,-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604032,LABfi Level 0,Measurement,2022-01-01,2030-12-31,,,Ts-Erittäin laaja histologinen tutkimus tai monielinkudospreparaatti,,
7000,"S -Pollen from ryegrass (g5), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604033,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Englannin raiheinän siitepöly (g5), IgE-vasta-aineet",,
7001,"S -Pollen from lint (g13), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604034,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Karvaisen mesiheinän siitepöly (g13), IgE-vasta-aineet",,
7002,"S -Pollen from oats (g14), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604035,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kauran siitepöly (g14), IgE-vasta-aineet",,
7003,"S -Pollen from dogwood (g3), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604036,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S- Koiraheinän siitepöly (g3), IgE-vasta-aineet",,
7004,"S -Pollen from meadow fescue (g8), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604037,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Niittynurmikan siitepöly (g8), IgE-vasta-aineet",,
7005,"S -Pollen from meadow fescue (g4), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009208,Meadow Fescue IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604038,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Nurminatan siitepöly (g4), IgE-vasta-aineet",,
7006,"S -Pollen from meadow fescue (g16), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604039,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Nurmipuntarpään siitepöly (g16), IgE-vasta-aineet",,
7007,"S -Pollen from barley (g201), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604040,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ohran siitepöly (g201), IgE-vasta-aineet",,
7008,"S -Pollen from rye (g12), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604041,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Rukiin siitepöly (g12), IgE-vasta-aineet",,
7009,"S -Pollen from Timothy (g6), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3003888,Timothy IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604042,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Timotein siitepöly (g6), IgE-vasta-aineet",,
7010,"S -Pollen from Timothy (g6), IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604043,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Timotein siitepöly (g6), IgG-vasta-aineet",,
7011,"S -Pollen from Spring Brood (g1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604044,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Tuoksusimakkeen siitepöly (g1), IgE-vasta-aineet",,
7012,"S -Pollen from Wheat (g15), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604045,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Vehnän siitepöly (g15), IgE-vasta-aineet",,
7013,"S -Pollen from Aspen (t14), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604046,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Haavan siitepöly (t14), IgE-vasta-aineet",,
7014,"S -Pollen from elm (t45), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604047,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Jalavan siitepöly (t45), IgE-vasta-aineet",,
7015,"S -Pollen from birch (t3), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604048,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Koivun siitepöly (t3), IgE-vasta-aineet",,
7016,"S -Pollen from birch (t3), IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604049,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Koivun siitepöly (t3), IgG-vasta-aineet",,
7017,"S -Pollen from Spruce (t201), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604050,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kuusen siitepöly (t201), IgE-vasta-aineet",,
7018,"S -Pollen from α1 (t2), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604051,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Lepän siitepöly (t2), IgE-vasta-aineet",,
7019,"S -Pollen from pine (t213), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604052,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Männyn siitepöly (t213), IgE-vasta-aineet",,
7020,"S -Pollen from willow (t12), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604053,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Pajun siitepöly (t12), IgE-vasta-aineet",,
7021,"S -Pollen from hazel (t4), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604054,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Pähkinäpensaan siitepöly (t4), IgE-vasta-aineet",,
7022,"S -Pollen from oak (t7), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604055,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Tammen siitepöly (t7), IgE-vasta-aineet",,
7023,"S -Pollen from black fighter (w9), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604056,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Heinäratamon siitepöly (w9), IgE-vasta-aineet",,
7024,"S -Pollen from greyhound (w6), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3008401,Mugwort IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604057,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Pujon siitepöly (w6), IgE-vasta-aineet",,
7025,"S -Pollen from daisy (w7), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604058,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Päivänkakkaran siitepöly (w7), IgE-vasta-aineet",,
7026,"S -Pollen from rapeseed (w203), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604059,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Rapsin siitepöly (w203), IgE-vasta-aineet",,
7027,"S -Pollen from dandelion (w8), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604060,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Voikukan siitepöly (w8), IgE-vasta-aineet",,
7028,"S -Epitel from Desert Rat (e209), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604061,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Aavikkohiiren (gerbiilin) epiteeli (e209), IgE-vasta-aineet",,
7029,"S -Feathers from Duck (e86), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604062,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ankan höyhenet (e86), IgE-vasta-aineet",,
7030,"S -Epitel from chinchilla (e208), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604063,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Chinchillan epiteeli (e208), IgE-vasta-aineet",,
7031,"S -Epitel from hamster (e84), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604064,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hamsterin epiteeli (e84), IgE-vasta-aineet",,
7032,"S -Feathers from Goose (e70), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604065,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hanhen höyhenet (e70), IgE-vasta-aineet",,
7033,"S-Dandruff from Horse (e3), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3010726,Horse dander IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604066,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hevosen hilse (e3), IgE-vasta-aineet",,
7034,"S -Epitel, serum protein, mouse urine protein (e88), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604067,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hiiren epiteeli, seerumiproteiinit, virtsaproteiinit (e88), IgE-vasta-aineet",,
7035,"S -Feathers from Turkey (e89), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604068,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kalkkunan höyhenet (e89), IgE-vasta-aineet",,
7036,"S -Feathers from Chicken (e85), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604069,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kanan höyhenet (e85), IgE-vasta-aineet",,
7037,"Rabbit S-epithelium (e82), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604070,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kanin epiteeli (e82), IgE-vasta-aineet",,
7038,"S -Feathers from Canary (e201), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604071,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kanarialinnun höyhenet (e201), IgE-vasta-aineet",,
7039,"S-Dandruff from cat (e1), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023430,Cat dander IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604072,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kissan hilse (e1), IgE-vasta-aineet",,
7040,"S- Dandruff from dogs (e5), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3014133,Dog dander IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604073,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S- Koiran hilse (e5), IgE-vasta-aineet",,
7041,"S -Epitel from sheep (e81), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604074,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Lampaan epiteeli (e81), IgE-vasta-aineet",,
7042,"S-Dandruff from cow (e4), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604075,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Lehmän hilse (e4), IgE-vasta-aineet",,
7043,"Guinea pig S-epithelium (e6), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012138,Guinea pig epithelium IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604076,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Marsun epiteeli (e6), IgE-vasta-aineet",,
7044,"S -Feathers from Parrot (e213), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604077,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Papukaijan höyhenet (e213), IgE-vasta-aineet",,
7045,"S -Feathers from Parakeet (e196), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604078,LABfi Level 0,Measurement,2014-01-01,2019-12-31,,,"S -Pienen pitkäpyrstöisen papukaijan (parakeet) höyhenet (e213), IgE-vasta-aineet",,
7046,"S -Feathers from finch (e214), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604079,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Peipon höyhenet (e214), IgE-vasta-aineet",,
7047,"S -Epitel, serum protein, rat urine protein (e87), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604080,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Rotan epiteeli, seerumiproteiinit, virtsaproteiinit (e87), IgE-vasta-aineet",,
7048,"S -Epitel from rat (e73), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604081,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Rotan epiteeli (e73), IgE-vasta-aineet",,
7049,"P-epithelium from pigs (e83), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604082,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Sian epiteeli (e83), IgE-vasta-aineet",,
7050,"S -Feathers from budgies (e78), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604083,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Undulaatin höyhenet (e78), IgE-vasta-aineet",,
7051,"S -Fecation from budgies (e77), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604084,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Undulaatin uloste (e77), IgE-vasta-aineet",,
7052,"S-Pineapple (f210), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3021661,Pineapple IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604085,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ananas (f210), IgE-vasta-aineet",,
7053,"S-Orange (f33), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3007456,Orange IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604086,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Appelsiini (f33), IgE-vasta-aineet",,
7054,"S-Avocado (f96), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604087,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Avokado (f96), IgE-vasta-aineet",,
7055,"S -Banane (f92), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604088,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Banaani (f92), IgE-vasta-aineet",,
7056,"S -Gluten (f79), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604089,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Gluteeni (f79), IgE-vasta-aineet",,
7057,"S -Guava (f292), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604090,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Guava (f292), IgE-vasta-aineet",,
7058,"S-Hazelnut (f17), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012932,Hazelnut IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604091,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hasselpähkinä (f17), IgE-vasta-aineet",,
7059,"S -Pea (f12), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604092,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Herne (f12), IgE-vasta-aineet",,
7060,"S -Hirs (f55), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3011829,Common Millet IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604093,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hirssi (f55), IgE-vasta-aineet",,
7061,"S-Cheese (Cheddar) (f81), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604094,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Juusto (Cheddar) (f81), IgE-vasta-aineet",,
7062,"S-Cheese (Mold) (f82), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604095,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Juusto (Home) (f82), IgE-vasta-aineet",,
7063,"S -Cocoa (f93), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604096,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kaakao (f93), IgE-vasta-aineet",,
7064,"S -Shrimp (f24), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604097,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Katkarapu (f24), IgE-vasta-aineet",,
7065,"S -Oatmeal (f7), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3018001,Oat IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604098,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kaurajauho (f7), IgE-vasta-aineet",,
7066,"S -Kivi (f84), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3000936,Kiwifruit IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604099,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kiivi (f84), IgE-vasta-aineet",,
7067,"S -Coconut (f36), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604100,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kookospähkinä (f36), IgE-vasta-aineet",,
7068,"S -Bakery Yeast (f45), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604101,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Leivinhiiva (f45), IgE-vasta-aineet",,
7069,"S -Lax (f41), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3036312,Salmon IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604102,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Lohi (f41), IgE-vasta-aineet",,
7070,"S -Peanut (f13), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3012494,Peanut IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604103,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Maapähkinä (f13), IgE-vasta-aineet",,
7071,"S -C Maize (f8), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604104,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Maissi (f8), IgE-vasta-aineet",,
7072,"S -Milk (f2), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020874,Milk IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604105,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Maito (f2), IgE-vasta-aineet",,
7073,"S -Mango (f91), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604106,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Mango (f91), IgE-vasta-aineet",,
7074,"S-Strawberry (f44), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3017958,Strawberry IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604107,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Mansikka (f44), IgE-vasta-aineet",,
7075,"S -Almond (f20), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3016031,Almond IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604108,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Manteli (f20), IgE-vasta-aineet",,
7076,"S -Melon (f87), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604109,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Meloni (f87), IgE-vasta-aineet",,
7077,"S -Egg Yolk (f75), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604110,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Munankeltuainen (f75), IgE-vasta-aineet",,
7078,"S -Eggwhite (f1), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3014599,Egg white IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604111,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Munanvalkuainen (f1), IgE-vasta-aineet",,
7079,"S-Beef (f27), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023006,Beef IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604112,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Naudanliha (f27), IgE-vasta-aineet",,
7080,"S -Grain Flour (f6), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3007700,Barley IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604113,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ohrajauho (f6), IgE-vasta-aineet",,
7081,"S -Apple (f49), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604114,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Omena (f49), IgE-vasta-aineet",,
7082,"S-Papaya (f293), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604115,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Papaija (f293), IgE-vasta-aineet",,
7083,"S-Pepper (f218), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3003843,Paprika IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604116,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Paprika (f218), IgE-vasta-aineet",,
7084,"S-Paranute (f18), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604117,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Parapähkinä (f18), IgE-vasta-aineet",,
7085,"S -Passion Fruit (f294), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604118,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Passionhedelmä (f294), IgE-vasta-aineet",,
7086,"P-Peach (f95), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3025966,Peach IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604119,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Persikka (f95), IgE-vasta-aineet",,
7087,"S -Potates (f35), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009883,Potato IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604120,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Peruna (f35), IgE-vasta-aineet",,
7088,"S-Carrot (f31), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3025296,Carrot IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604121,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Porkkana (f31), IgE-vasta-aineet",,
7089,"S -Ris (f9), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604122,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Riisi (f9), IgE-vasta-aineet",,
7090,"S -Rye Flour (f5), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3007542,Rye IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604123,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ruisjauho (f5), IgE-vasta-aineet",,
7091,"S -Sesame Seed (f10), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3020934,Sesame Seed IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604124,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Seesaminsiemen (f10), IgE-vasta-aineet",,
7092,"S -Celery (f85), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009754,Celery IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604125,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Selleri (f85), IgE-vasta-aineet",,
7093,"S -Pork (f26), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604126,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Sianliha (f26), IgE-vasta-aineet",,
7094,"S -Sill (f205), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604127,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Silli (f205), IgE-vasta-aineet",,
7095,"S -C mussel (f37), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604128,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Sinisimpukka (f37), IgE-vasta-aineet",,
7096,"S-Soybean (f14), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015076,Soybean IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604129,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Soijapapu (f14), IgE-vasta-aineet",,
7097,"S -Tring (f204), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604130,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Taimen (f204), IgE-vasta-aineet",,
7098,"S-Buckwheat (f11), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604131,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Tattari (f11), IgE-vasta-aineet",,
7099,"S -Tomato (f25), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604132,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Tomaatti (f25), IgE-vasta-aineet",,
7100,"S -Tuna (f40), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604133,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Tonnikala (f40), IgE-vasta-aineet",,
7101,"S -Cod (f3), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604134,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Turska (f3), IgE-vasta-aineet",,
7102,"S -Veat Flour (f4), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,40760424,Tropomyosin IgE Ab [Mass/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604135,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Vehnäjauho (f4), IgE-vasta-aineet",,
7103,"S -Dermatophagoides farinae (d2), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604136,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Dermatophagoides farinae (d2), IgE-vasta-aineet",,
7104,"S-Dermatophagoides microcereases (d3), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604137,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Dermatophagoides microcereas (d3), IgE-vasta-aineet",,
7105,"S -Dermatophagoides pteronyssinus (d1), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3023351,European house dust mite IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604138,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Dermatophagoides pteronyssinus (d1), IgE-vasta-aineet",,
7106,"S -Euroglyphus maynei (d74), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604139,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Euroglyphus maynei (d74), IgE-vasta-aineet",,
7107,"S -Acarus siro (d70), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3015665,Acarus siro IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604140,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Acarus siro (d70), IgE-vasta-aineet",,
7108,"S -Glycophagus domesticus (d73), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604141,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Glycophagus domesticus (d73), IgE-vasta-aineet",,
7109,"S -Lepidoglyphus destructor (d71), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3000510,Lepidoglyphus destructor IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604142,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Lepidoglyphus destructor (d71), IgE-vasta-aineet",,
7110,"S -Tyrophagus putrescentiae d72), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3017414,Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604143,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Tyrophagus putrescentiae d72), IgE-vasta-aineet",,
7111,"S -Acremonium kiliense (m202), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604144,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Acremonium kiliense (m202), IgE-vasta-aineet",,
7112,"S -Altarnaria alternata (m6), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3038205,Alternaria alternata IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604145,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Altarnaria alternata (m6), IgE-vasta-aineet",,
7113,"S -Aspergillus flavus (m228), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604146,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Aspergillus flavus (m228), IgE-vasta-aineet",,
7114,"S -Aspergillus fumigatus (m3), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3011951,Aspergillus fumigatus IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604147,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Aspergillus fumigatus (m3), IgE-vasta-aineet",,
7115,"S -Aspergillus niger (m207), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604148,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Aspergillus niger (m207), IgE-vasta-aineet",,
7116,"S -Aspergillus terreus (m36), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604149,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Aspergillus terreus (m36), IgE-vasta-aineet",,
7117,"S -Aspergillus versicolor (Gm25), IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604150,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Aspergillus versicolor (Gm25), IgG-vasta-aineet",,
7118,"S -Aureobasidium pullulans (m12), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604151,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Aureobasidium pullulans (m12), IgE-vasta-aineet",,
7119,"S -Candida albicans (m5), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604152,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Candida albicans (m5), IgE-vasta-aineet",,
7120,"S -Cladosporium cladosporioides (Gm26), IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604153,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Cladosporium cladosporioides (Gm26), IgG-vasta-aineet",,
7121,"S -Cladosporium herbarum (m2), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3005136,Cladosporium herbarum IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604154,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Cladosporium herbarum (m2), IgE-vasta-aineet",,
7122,"S -Fusarium moniliforme (F. proliferatum, m9), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604155,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Fusarium moniliforme (F. proliferatum, m9), IgE-vasta-aineet",,
7123,"S -Mucor racemosus (m4), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604156,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Mucor racemosus (m4), IgE-vasta-aineet",,
7124,"S-Penicillium notatum (P. chrysogenum, m1), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604157,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Penicillium notatum (P. chrysogenum, m1), IgE-vasta-aineet",,
7125,"S -Penicillium spp. (Gm27), IgG Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604158,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Penicillium spp. (Gm27), IgG-vasta-aineet",,
7126,"S -Phoma betae (m13), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604159,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Phoma betae (m13), IgE-vasta-aineet",,
7127,"S -Pityrosporum orbiculare (m70), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604160,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Pityrosporum orbiculare (m70), IgE-vasta-aineet",,
7128,"S -Stachybothrys atra (chartarum, Gm24), IgG antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604161,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Stachybothrys atra (chartarum, Gm24), IgG-vasta-aineet",,
7129,"S -Trichoderma viride (m15), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604162,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Trichoderma viride (m15), IgE-vasta-aineet",,
7130,"S -Get Poison (i3), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604163,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ampiaisen myrkky (i3), IgE-vasta-aineet",,
7131,"S-Mosquito (i71), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604164,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hyttynen (i71), IgE-vasta-aineet",,
7132,"S-Grain Beetle (i202), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604165,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Jyväkärsäkäs (i202), IgE-vasta-aineet",,
7133,"S -Bigift (i1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604166,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Mehiläisen myrkky (i1), IgE-vasta-aineet",,
7134,"S-Cockroach (i6), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604167,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Torakka (i6), IgE-vasta-aineet",,
7135,"S-Amoxicillin (c6), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604168,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Amoksisilliini (c6), IgE-vasta-aineet",,
7136,"S-Ampicillin (c5), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604169,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ampisilliini (c5), IgE-vasta-aineet",,
7137,"S -Penicillin G (c1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604170,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -G Penisilliini (c1), IgE-vasta-aineet",,
7138,"S -Cefaclor (c7), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604171,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kefaklori (c7), IgE-vasta-aineet",,
7139,"S -Penicillin V (c2), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604172,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -V Penisilliini (c2), IgE-vasta-aineet",,
7140,"S -Diphenylmethane diisocyanate (MDI, k76), IgE-",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604173,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Difenyylimetaanidi-isosyanaatti (k76), IgE-vasta-aineet",,
7141,"S -Eethylene oxide (k78), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604174,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Etyleenioksidi (k78), IgE-vasta-aineet",,
7142,"S-Formaldehyde (k80), IgE Antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3027859,Formaldehyde IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604175,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Formaldehydi (k80), IgE-vasta-aineet",,
7143,"S-Phthalic anhydride (k79), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3004768,Phthalic anhydride IgE Ab [Units/volume] in Serum,Measurement,MAPS_TO,,tays,1630368000000,,2000604176,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ftaalihappoanhydridi (k79), IgE-vasta-aineet",,
7144,"S -Hexamethylene diisocyanate (HDI, k77)), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604177,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Heksametyleenidi-isosyanaatti (HDI, k77)), IgE-vasta-aineet",,
7145,"S -Cchloramine T (k85), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604178,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kloramiini T (k85), IgE-vasta-aineet",,
7146,"S -Toluene diisocyanate (TDI, k75)), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604179,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Tolueenidi-isosyanaatti (TDI, k75)), IgE-vasta-aineet",,
7147,"S -Alpha-amylase (k87), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604180,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Alfa-amylaasi (k87), IgE-vasta-aineet",,
7148,"S -Lysozyme (k208), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604181,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Lysotsyymi (k208), IgE-vasta-aineet",,
7149,"S -Latex (natural rubber, k82), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604182,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Lateksi (luonnonkumi, k82), IgE-vasta-aineet",,
7150,"S -Benjamin Ficus (k81), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604183,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Limoviikuna (k81), IgE-vasta-aineet",,
7151,"S -Cotton (o1), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604184,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Pumpuli (o1), IgE-vasta-aineet",,
7152,"S -Sperm (o70), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604185,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Siemenneste (o70), IgE-vasta-aineet",,
7153,"S -Dust as a Group, IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604186,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S- Pölyryhmä, IgE-vasta-aineet",,
7154,"S -Dust Specification, IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604187,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S- Pölyerittely, IgE-vasta-aineet",,
7155,"S -Grass as Group (gx1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604188,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Heinäryhmä (gx1), IgE-vasta-aineet",,
7156,"S -Grass Specification (gx1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604189,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Heinäerittely (gx1), IgE-vasta-aineet",,
7157,"S -Grass as a group (gx3), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604190,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Heinäryhmä (gx3), IgE-vasta-aineet",,
7158,"S -Grass Specification (gx3), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604191,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Heinäerittely (gx3), IgE-vasta-aineet",,
7159,"S -Trees as a group (tx9), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604192,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Puuryhmä (tx9), IgE-vasta-aineet",,
7160,"S -Tree Specification (tx9), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604193,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Puuerittely (tx9), IgE-vasta-aineet",,
7161,"S -Animal as a group (ex1), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604194,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Eläinryhmä (ex1), IgE-vasta-aineet",,
7162,"S -Animal Specification (ex1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604195,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Eläinerittely (ex1), IgE-vasta-aineet",,
7163,"S -Cage feathers as a group (ex72), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604196,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Häkkilintujen höyhenet -ryhmä (ex72), IgE-vasta-aineet",,
7164,"S -Cage Feathers Specified (ex72), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604197,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Häkkilintujen höyhenet-erittely (ex72), IgE-vasta-aineet",,
7165,"S-Rodents as a group (ex70), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604198,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Jyrsijäryhmä (ex70), IgE-vasta-aineet",,
7166,"S-Rodent Specified (ex70), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604199,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Jyrsijäerittely (ex70), IgE-vasta-aineet",,
7167,"S -Fruit as a group (e.g.15), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604200,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hedelmäryhmä (fx15), IgE-vasta-aineet",,
7168,"S -Fruit Specification (fx15), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604201,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Hedelmäerittely (fx15), IgE-vasta-aineet",,
7169,"S -Fish as a group (fx2), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604202,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kalaryhmä (fx2), IgE-vasta-aineet",,
7170,"S -Fish Specification (fx2), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604203,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kalaerittely (fx2), IgE-vasta-aineet",,
7171,"S -Foods as a group (fx5), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604204,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ruoka-aineryhmä (fx5), IgE-vasta-aineet",,
7172,"S -Food specified (fx5), IgE antibodies",-1,,0,APPROVED,UNREVIEWED,tays,1630368000000,3009176,Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk,Measurement,MAPS_TO,,tays,1630368000000,,2000604205,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S- Ruoka-aine-erittely (fx5), IgE-vasta-aineet",,
7173,"S-Foods as a group (fx20), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604206,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Ruoka-aineryhmä (fx20), IgE-vasta-aineet",,
7174,"S -Food specified (fx20), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604207,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S- Ruoka-aine-erittely (fx20), IgE-vasta-aineet",,
7175,"S -Nuts as a Group (fx1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604208,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Pähkinäryhmä (fx1), IgE-vasta-aineet",,
7176,"S -Nut Specification (fx1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604209,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Pähkinäerittely (fx1), IgE-vasta-aineet",,
7177,"S-Cereals as a Group (fx3), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604210,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Viljaryhmä (fx3), IgE-vasta-aineet",,
7178,"S-Cereals Specified (fx3), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604211,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Viljaerittely (fx3), IgE-vasta-aineet",,
7179,"S-Molds as a group (mx1), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604212,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Homesieniryhmä (mx1), IgE-vasta-aineet",,
7180,"S -Fungi Specified (mx1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604213,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Homesienierittely (mx1), IgE-vasta-aineet",,
7181,"S -Fungi as a group (mx2), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604214,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Homesieniryhmä (mx2), IgE-vasta-aineet",,
7182,"S-Molds Specified (mx2), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604215,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Homesienierittely (mx2), IgE-vasta-aineet",,
7183,"S -Fungi as a group (mx4), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604216,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Homesieniryhmä (mx4), IgE-vasta-aineet",,
7184,"S-Molds Specified (mx4), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604217,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Homesienierittely (mx4), IgE-vasta-aineet",,
7185,"S -House dust as a group (hx2), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604218,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kotipölyryhmä (hx2), IgE-vasta-aineet",,
7186,"S -House dust specified (hx2), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604219,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Kotipölyerittely (hx2), IgE-vasta-aineet",,
7187,"S-Disinfectant as a Group (PAX 6), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604220,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Desinfektioaineet-ryhmä (PAX 6), IgE-vasta-aineet",,
7188,"S-Disinfectants Specified (PAX 6), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604221,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Desinfektioaineet-erittely (PAX 6), IgE-vasta-aineet",,
7189,"S - Food industry allergens as a group (PAX 4), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604222,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Elintarviketeollisuuden allergeenit -ryhmä (PAX 4), IgE-vasta-aineet",,
7190,"S -General Food Allergens Specified (PAX 4), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604223,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Elintarviketeollisuuden allergeenit -erittely (PAX 4), IgE-vasta-aineet",,
7191,"S-Dandruff and Feathers from Animals as a Group (PAX 1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604224,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Eläinten hilseet ja höyhenet -ryhmä (PAX 1), IgE-vasta-aineet",,
7192,"S-Dandruff and Feathers from Animals Specified (PAX 1), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604225,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Eläinten hilseet ja höyhenet -erittely (PAX 1), IgE-vasta-aineet",,
7193,"S -Pollen and fungi as a group (PAX 3), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604226,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Siitepölyt ja homesienet -ryhmä (PAX 3), IgE-vasta-aineet",,
7194,"S -Pollen and Molds Specified (PAX 3), IgE Antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604227,LABfi Level 0,Measurement,2014-01-01,2030-12-31,,,"S -Siitepölyt ja homesienet -erittely (PAX 3), IgE-vasta-aineet",,
7300,"S -Birch, recombinant (rBet v 1, t215), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604228,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koivu rekombinantti (rBet v 1, t215), IgE vasta-aineet",,
7301,"S -Birch, recombinant (rBet v 2, t216), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604229,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koivu, rekombinantti (rBet v 2, t216), IgE vasta-aineet",,
7302,"S -Birch, recombinant (rBet v 4, t220), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604230,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koivu, rekombinantti (rBet v 4, t220), IgE vasta-aineet",,
7303,"S -Birch, recombinant (rBet v2, rBet v 4, t221), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604231,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koivu, rekombinantti (rBet v 2, rBet v 4, t221), IgE vasta-aineet",,
7304,"S -Birch, recombinant (rBet v6, t225), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604232,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koivu, rekombinantti (rBet v 6, t225), IgE vasta-aineet",,
7305,"S -Timotej, recombinant (rPhl p 1 / rPhl p 5b, g213), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604233,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p 1/rPhl p 5b, g213), IgE vasta-aineet",,
7306,"S -Timotej, recombinant (rPhl p 1, g205), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604234,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p1, g205), IgE vasta-aineet",,
7307,"S -Timotej, recombinant (rPhl p 5b, g215), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604235,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p 5b, g215), IgE vasta-aineet",,
7308,"S -Timotej, recombinant (rPhl p 7, g210), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604236,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p 7, g210), IgE vasta-aineet",,
7309,"S -Timotej, recombinant (rPhl p 12 profilin, g212), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604237,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p 12 profilin, g212), IgE vasta-aineet",,
7310,"S -Timotej, recombinant (rPhl p 7, rPhl p 12, g214), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604238,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p 7, rPhl p 12, g214), IgE vasta-aineet",,
7311,"S -Timotej, recombinant (rPhl p 2, g206), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604239,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p 2, g206), IgE vasta-aineet",,
7312,"S -Timotej, recombinant (rPhl p 6, g209), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604240,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p 6, g209), IgE vasta-aineet",,
7313,"S -Timotej, recombinant (rPhl p 11, g211), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604241,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, rekombinantti (rPhl p 11, g211), IgE vasta-aineet",,
7314,"S-Wheat, recombinant (rTri a 19, Omega-5 Gliadin, f416), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604242,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Vehnä, rekombinantti (rTri a 19, Omega-5 Gliadin, f416), IgE vasta-aineet",,
7315,"S-Wheat, recombinant (rTri a 14, f433), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604243,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Vehnä, rekombinantti (rTri a 14, f433), IgE vasta-aineet",,
7316,"S -Peanut, recombinant (rAra h 2, f423), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604244,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Maapähkinä, rekombinantti (rAra h 2, f423), IgE vasta-aineet",,
7317,"S -Peanut, recombinant (rAra h 1, f422), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604245,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Maapähkinä, rekombinantti (rAra h 1, f422), IgE vasta-aineet",,
7318,"S -Peanut, recombinant (rAra h 3, f424), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604246,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Maapähkinä, rekombinantti (rAra h 3, f424), IgE vasta-aineet",,
7319,"S -Peanut, recombinant (rAra h 9 LTP, f427), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604247,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Maapähkinä, rekombinantti (rAra h 9 LTP, f427), IgE vasta-aineet",,
7320,"S -Peanut, recombinant (rAra h 8 PR-10, f352), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604248,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Maapähkinä, rekombinantti (rAra h 8 PR-10, f352), IgE vasta-aineet",,
7321,"S -Peanut, recombinant (rAra h 6, f447), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604249,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Maapähkinä, rekombinantti (rAra h 6, f447), IgE vasta-aineet",,
7322,"S-Hazelnut, recombinant (rCor a 1 PR-10, f428)), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604250,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Hasselpähkinä, rekombinantti (rCor a 1 PR-10, f428), IgE vasta-aineet",,
7323,"S-Hazelnut, recombinant (rCor a 8 LTP, f425), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604251,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Hasselpähkinä, rekombinantti (rCor a 8 LTP, f425), IgE vasta-aineet",,
7324,"S-Hazelnut, recombinant (rCor a 9, f440), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604252,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Hasselpähkinä, rekombinantti (rCor a 9, f440), IgE vasta-aineet",,
7325,"S-Hazelnut, recombinant (rCor a 14, f439), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604253,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Hasselpähkinä, rekombinantti (rCor a 14, f439), IgE vasta-aineet",,
7326,"S-Cashew nut, recombinant (rAna o 3, f443), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604254,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Cashewpähkinä, rekombinantti (rAna o 3, f443), IgE vasta-aineet",,
7327,"S-Walnut, recombinant (rJug r 1, f441), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604255,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Saksanpähkinä, rekombinantti (rJug r 1, f441), IgE vasta-aineet",,
7328,"S-Walnut, recombinant (rJug r 3, f442), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604256,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Saksanpähkinä, rekombinantti (rJug r 3, f442), IgE vasta-aineet",,
7329,"S -Paranate, recombinant (rBer e 1, f354), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604257,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Parapähkinä, rekombinantti (rBer e 1, f354), IgE vasta-aineet",,
7330,"S-Soybean, recombinant (rGly m 4 PR-10, f353), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604258,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Soijapapu, rekombinantti (rGly m 4 PR-10, f353), IgE vasta-aineet",,
7331,"S -Celery, recombinant (rApi g 1.01, f417), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604259,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Selleri, rekombinantti (rApi g 1.01, f417), IgE vasta-aineet",,
7332,"S -Persica, recombinant (rPru p 4 Profiliini, f421), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604260,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Persikka, rekombinantti (rPru p 4 Profiliini, f421), IgE vasta-aineet",,
7333,"S -Peach, recombinant (rPru p 3 LTP, f420), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604261,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Persikka, rekombinantti (rPru p 3 LTP, f420), IgE vasta-aineet",,
7334,"S -Persica, recombinant (rPru p 1 PR-10, f419), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604262,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Persikka, rekombinantti (rPru p 1 PR-10, f419), IgE vasta-aineet",,
7335,"S -Kiwi, recombinant (rAct d 8, f430), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604263,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Kiivi, rekombinantti (rAct d 8, f430), IgE vasta-aineet",,
7336,"S -Apple, recombinant (rMal d 1, f434), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604264,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Omena, rekombinantti (rMal d 1, f434), IgE vasta-aineet",,
7337,"S -Apple, recombinant (rMal d 3, f435), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604265,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Omena, rekombinantti (rMal d 3, f435), IgE vasta-aineet",,
7338,"S -Wall, recombinant (rPar j 2, w211), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604266,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Muuriyrtti, rekombinantti (rPar j 2, w211), IgE vasta-aineet",,
7339,"S -Shrimp, recombinant (rPen a 1, tropomyosin, f351), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604267,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Katkarapu, rekombinantti (rPen a 1,tropomyosin, f351), IgE vasta-aineet",,
7340,"S -Carp, recombinant (rCyp c 1, f355), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604268,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Karppi, rekombinantti (rCyp c 1, f355), IgE vasta-aineet",,
7341,"S -Cod, recombinant (rGad c 1, f426), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604269,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Turska, rekombinantti (rGad c 1, f426), IgE vasta-aineet",,
7342,"S -Cat, recombinant (rFel d1, e94), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604270,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Kissa, rekombinantti (rFel d1, e94), IgE vasta-aineet",,
7343,"S -Cat, recombinant (rFel d 4, e228), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604271,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Kissa, rekombinantti (rFel d 4, e228), IgE vasta-aineet",,
7344,"S -Hund, recombinant (rCan f 1, e101), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604272,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koira, rekombinantti (rCan f 1, e101), IgE vasta-aineet",,
7345,"S -Hund, recombinant (rCan f 2, e102), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604273,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koira, rekombinantti (rCan f 2, e102), IgE vasta-aineet",,
7346,"S -Hund, recombinant (rCan f 5, e226), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604274,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koira, rekombinantti (rCan f 5, e226), IgE vasta-aineet",,
7347,"S -Horse, recombinant (rEqu c 1, e227), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604275,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Hevonen, rekombinantti (rEqu c 1, e227), IgE vasta-aineet",,
7348,"S -Bi, recombinant (rApi m 1 Phospholipase A2, i208), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604276,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Mehiläinen, rekombinantti (rApi m 1 Phospholipase A2, i208), IgE vasta-aineet",,
7349,"S -Bigift, recombinant (rApi m 10, i217), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604277,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Mehiläisen myrkky, rekombinantti (rApi m 10, i217), IgE vasta-aineet",,
7350,"S -Bigift, recombinant (rApi m 2, i214), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604278,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Mehiläisen myrkky, rekombinantti (rApi m 2, i214), IgE vasta-aineet",,
7351,"S -Bigift, recombinant (rApi m 3, i215), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604279,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Mehiläisen myrkky, rekombinantti (rApi m 3, i215), IgE vasta-aineet",,
7352,"S -Bigift, recombinant (rApi m 5, i216), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604280,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Mehiläisen myrkky, rekombinantti (rApi m 5, i216), IgE vasta-aineet",,
7353,"S -Geting, recombinant (rVes v 5, i209), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604281,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Ampiainen, rekombinantti (rVes v 5, i209), IgE vasta-aineet",,
7354,"S -Get poison, recombinant (rVes v 1 Phospholipase A1, i211), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604282,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Ampiaisen myrkky, rekombinantti (rVes v 1 Phospholipase A1, i211), IgE vasta-aineet",,
7355,"S -Get poison, recombinant (rPol d 5, i210), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604283,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Ampiaisen myrkky, rekombinantti (rPol d 5, i210), IgE vasta-aineet",,
7356,"S -Alternaria alternata, recombinant (rAlt a 1, m229), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604284,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Alternaria alternata, rekombinantti (rAlt a 1, m229), IgE vasta-aineet",,
7357,"S -Aspergillus fumigatus, recombinant (rAsp f 1, m218), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604285,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Aspergillus fumigatus, rekombinantti (rAsp f 1, m218), IgE vasta-aineet",,
7358,"S -Aspergillus fumigatus, recombinant (rAsp f 2, m219), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604286,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Aspergillus fumigatus, rekombinantti (rAsp f 2, m219), IgE vasta-aineet",,
7359,"S -Aspergillus fumigatus, recombinant (rAsp f 3, m220), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604287,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Aspergillus fumigatus, rekombinantti (rAsp f 3, m220), IgE vasta-aineet",,
7360,"S -Aspergillus fumigatus, recombinant (rAsp f 4, m221), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604288,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Aspergillus fumigatus, rekombinantti (rAsp f 4, m221), IgE vasta-aineet",,
7361,"S -Aspergillus fumigatus, recombinant (rAsp f 6, m222), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604289,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Aspergillus fumigatus, rekombinantti (rAsp f 6, m222), IgE vasta-aineet",,
7362,"S -D. Pteronysis sinus, recombinant (rDer p 2, d203), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604290,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -D. Pteronyssinus, rekombinantti (rDer p 2, d203),IgE vasta-aineet",,
7363,"S -D. Pteronyssinus, recombinant (rDer p 10 Tropomyosin, d205), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604291,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -D. Pteronyssinus, rekombinantti (rDer p 10 Tropomyosin, d205), IgE vasta-aineet",,
7364,"S -D. Pteronyssinus, recombinant (rDer p 23, d209), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604292,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -D. Pteronyssinus, rekombinantti (rDer p 23, d209), IgE vasta-aineet",,
7365,"S -Latex, MBP fusion protein, recombinant (rHev b 8 Profilin, k221), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604293,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Latex, MBP-fuusioproteiini, rekombinantti (rHev b 8 Profilin, k221), IgE vasta-aineet",,
7366,"S -Latex, MBP fusion protein, recombinant (rHev b 1, k215), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604294,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Latex, MBP-fuusioproteiini, rekombinantti (rHev b 1, k215), IgE vasta-aineet",,
7367,"S -Latex, MBP fusion protein, recombinant (rHev b 3, k217), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604295,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Latex, MBP-fuusioproteiini, rekombinantti (rHev b 3, k217), IgE vasta-aineet",,
7368,"S -Latex, MBP fusion protein, recombinant (rHev b 5, k218), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604296,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Latex, MBP-fuusioproteiini, rekombinantti (rHev b 5, k218), IgE vasta-aineet",,
7369,"S -Latex, MBP fusion protein, recombinant (rHev b 6.02, k220), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604297,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Latex, MBP-fuusioproteiini, rekombinantti (rHev b 6.02, k220), IgE vasta-aineet",,
7370,"S -Latex, MBP fusion protein, recombinant (rHev b 11, k224), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604298,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Latex, MBP-fuusioproteiini, rekombinantti (rHev b 11, k224), IgE vasta-aineet",,
7400,"S -Casein, native (f78, nBos d 8), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604299,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Kaseiini, natiivi (f78, nBos d 8), IgE vasta-aineet",,
7401,"S -Ananase, native (nAna c 2 Bromelin, k202), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604300,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Ananas, natiivi (nAna c 2 Bromelin, k202), IgE vasta-aineet",,
7402,"S -Dog-tooth grass, native (nCyn d 1, g216), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604301,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Varvasheinä, natiivi (nCyn d 1, g216), IgE vasta-aineet",,
7403,"S -Timotej, native (nPhl p 4, g208), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604302,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Timotei, natiivi (nPhl p 4, g208), IgE vasta-aineet",,
7404,"S -Cypress, native (nCup a 1, t226), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604303,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Sypressi, natiivi (nCup a 1, t226), IgE vasta-aineet",,
7405,"S -Olive trees, native (nOle e 1, t224), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604304,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Öljypuu, natiivi (nOle e 1, t224), IgE vasta-aineet",,
7406,"S -Ambrosia, native (nAmb a 1, w230), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604305,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Tuoksukki, natiivi (nAmb a 1, w230), IgE vasta-aineet",,
7407,"S -Gråbo, native (nArt v 1, w231), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604306,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Pujo, natiivi (nArt v 1, w231), IgE vasta-aineet",,
7408,"S -Gråbo, native (nArt v 3, w233), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604307,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Pujo, natiivi (nArt v 3, w233), IgE vasta-aineet",,
7409,"S -Soda herb, native (nSal k 1, w232), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604308,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Otakilokki, natiivi (nSal k 1, w232), IgE vasta-aineet",,
7410,"S-Serum albumin from cattle, native (Bos d 6 BSA, e204), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604309,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Naudan seerumialbumiini, natiivi (Bos d 6 BSA, e204), IgE vasta-aineet",,
7411,"S-Serum albumin from dogs, native (nCan f 3, e221), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604310,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Koiran seerumialbumiini, natiivi (nCan f 3, e221), IgE vasta-aineet",,
7412,"S-Serum albumin from cats, native (Bos d 6 BSA, e204), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604311,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Kissan seerumialbumiini (Fel d 2, e220), IgE vasta-aineet",,
7413,"S -Pigpepsin, native (nSus s Pepsin, k213), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604312,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Sian, natiivi (nSus s Pepsin, k213), IgE vasta-aineet",,
7414,"S -D. Pteronyssinus, native (nDer p 1, d202), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604313,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -D. Pteronyssinus, natiivi (nDer p 1, d202), IgE vasta-aineet",,
7415,"S -Papain, native (nCar p 1, k201), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604314,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Papaiini, natiivi (nCar p 1, k201), IgE vasta-aineet",,
7416,"S-Soybean, native (nGly m 5, f431), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604315,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Soijapapu, natiivi (nGly m 5, f431), IgE vasta-aineet",,
7417,"S-Soybean, native (nGly m 6, f432), IgE antibodies",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604316,LABfi Level 0,Measurement,2020-01-01,2030-12-31,,,"S -Soijapapu, natiivi (nGly m 6, f432), IgE vasta-aineet",,
7900,"Panbio COVID-19 Ag Rapid Test, Abbott Rapid Diagnostics",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604317,LABfi Level 0,Measurement,2021-06-21,2022-06-30,,,"Panbio COVID-19 Ag Rapid Test, Abbott Rapid Diagnostics",,
7901,"Flowflex SARS-CoV-2 Antigen rapid test, ACON Laboratories, Inc",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604318,LABfi Level 0,Measurement,2021-06-21,2022-06-30,,,"Flowflex SARS-CoV-2 Antigen rapid test, ACON Laboratories, Inc",,
7902,"mariPOC SARS-CoV-2, ArcDia International Ltd",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604319,LABfi Level 0,Measurement,2021-06-21,2022-06-30,,,"mariPOC SARS-CoV-2, ArcDia International Ltd",,
7903,"mariPOC Quick Flu+ , ArcDia International Ltd",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604320,LABfi Level 0,Measurement,2021-07-22,2022-06-30,,,"mariPOC Quick Flu+ , ArcDia International Ltd",,
7904,"STANDARD Q COVID-19 Ag, SD BIONSENSOR Inc",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604321,LABfi Level 0,Measurement,2021-06-21,2022-06-30,,,"STANDARD Q COVID-19 Ag, SD BIONSENSOR Inc",,
7905,"SARS-CoV-2 Antigen Rapid Test, Roche (SD BIOSENSOR)",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604322,LABfi Level 0,Measurement,2021-06-21,2022-06-30,,,"SARS-CoV-2 Antigen Rapid Test, Roche (SD BIOSENSOR)",,
7906,"mariPOC Respi+ , ArcDia International Ltd",-1,,0,UNCHECKED,UNREVIEWED,,0,0,Unmapped,,MAPS_TO,,,0,,2000604323,LABfi Level 0,Measurement,2021-07-22,2022-06-30,,,"mariPOC Respi+ , ArcDia International Ltd",,
